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Background: Socioeconomic deprivation is a determinant of health care access and 
quality of life in many diseases.  The current study explored this effect in Chronic 
Obstructive Pulmonary Disease (COPD) and examined the role of psychosocial 
variables in this relationship.  
Aims: The primary aim of this thesis was to establish whether lower socio-economic 
status (SES) was associated with decreased health care access (HCA) and poorer 
quality of life (QoL) in patients with COPD. The secondary aim examined whether 
psychosocial factors mediated the relationship between socio-economic status, health 
care access and quality of life. 
Methods: Cross-sectional, interview-based survey in London involving COPD patients 
> 40 years recruited in primary care. Measures included socio-economic status, illness 
perceptions, health care access, quality of life, Medical Research Council (MRC) 
dyspnoea scale, general self-efficacy scale, social capital, Hospital Anxiety and 
Depression Scale (HADS), and spirometry.  
Results: COPD confirmed by spirometry in 176 (85%) participants. 38.6% female, 
mean age 69 years, distribution of disease severity (GOLD): Grades 1-4 (mild – very 
severe) = 15%; 51%; 30%; 5%. Lower SES was not associated with more impaired 
HCA. Lower SES in terms of income level was associated with poorer QoL. The 
relationship between SES and HCA was not mediated by any of the psychosocial 
variables but the relationship between SES in terms of income level and QoL was. 
Conclusion: More deprived COPD patients were as likely to get equal HCA as their 
more affluent counterparts. More deprived COPD patients in terms of income level 
were more likely to report poorer QoL. Illness perceptions were significantly associated 
with HCA and QoL. Findings emphasized the role of SES measures and illness 
perceptions in this patient group and the variability of their effect on different outcomes. 
Future research involving longitudinal design could increase understanding of these 
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Chapter 1  
An introduction to Chronic Obstructive Pulmonary Disease (COPD) 
 
1.1 What is COPD?  
 
“Chronic Obstructive Pulmonary Disease (COPD), a common preventable and 
treatable disease, is characterised by persistent airflow limitation that is usually 
progressive and associated with an enhanced chronic inflammatory response in the 
airways and the lungs to noxious particles or gases (GOLD, 2011). Exacerbations and 
co-morbidities contribute to the overall disease severity in individual patients.  COPD is 
an umbrella term that encompasses emphysema and chronic bronchitis. Chronic 
impairment in airflow is caused by a combination of damage to the parenchyma 
(emphysema) and small airways disease (obstructive bronchiolitis) which varies in 
different people. Emphysema and chronic bronchitis are the result of inflammatory 
processes. In emphysema, inflammation leads to the destruction of the lung 
parenchyma followed by a decrease in alveoli in the small airways and loss of 
elasticity. This prevents the airways from remaining open during expiration. During the 
inflammatory process in the lung tissues, a release of trypsin and other proteolytic 
enzymes leads to the destruction of lung tissue – mainly alveoli – with the loss of lung 
surface where gas is exchanged. As a result, there is great difficulty in getting oxygen 
in and smaller difficulty in getting CO2 out. In chronic bronchitis, small airways become 
narrower and undergo changes such as thickening in their structure due to chronic 
inflammation. The inflammation leads to excess production of mucus, an inflammatory 
infiltrate by lymphocytes, thickening of the basement membrane and ultimately 
irreversible fibrosis. The narrowing of the airways, the inflammatory infiltrate and mucus 
production becomes irreversible. In the later stages of the disease, severe irreversible 
narrowing in combination with lung destruction might occur. Overall the patient has 
difficulty moving air in and out due to airway narrowing. When the air gets in, there may 
be only a small amount of surface area available for gas exchange to take place 
(GOLD, 2011).  
The main symptoms of COPD include breathlessness, chronic cough and sputum 
production (GOLD, 2011). These can deteriorate on occasions and lead to 
exacerbations. An exacerbation is defined in GOLD (2011) as “an acute event 
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characterized by a worsening of the patient’s respiratory symptoms that is beyond 
normal day-to-day variations and leads to a change in medication” (Burge & Wedzicha, 
2003; Celli & Barnes, 2007; Rodriguez-Roisin, 2000). Exacerbations contribute to lung 
function decrease, deterioration of health status and increase in mortality risk (GOLD, 
2011). 
 
1.2 Epidemiology, causes, and risk factors for COPD 
 
COPD is a major cause of increasing morbidity and mortality worldwide (GOLD, 2011). 
It is estimated that by 2030, it will be the 3rd leading cause of death globally (Buist et 
al., 2007) and 5th in terms of disease burden (Antó, Vermeire, Vestbo, & Sunyer, 
2001). 1.4 million people over the age of 15 are estimated to have COPD in the UK 
reaching a prevalence of 3.58% (Nacul et al., 2011). The mean prevalence of patients 
diagnosed with COPD recorded through the Quality and Outcomes framework (QOF) 
was 1.37% (Nacul et al., 2011). Most of the undiagnosed patients are likely to have 
relatively mild disease. The majority of patients with respiratory disease are treated by 
primary care physicians such as GPs (Bellamy et al., 2006). Based on QOF estimates, 
the average number of patients with COPD in an average UK GP practice list is 
approximately 107. COPD is responsible for 2% of hospitalisations per year making 
COPD the second largest cause of emergency admissions in the UK (Healthcare 
Commission, 2006). COPD places considerable financial and social burden on patients 
and health care systems with COPD-related expenditure for the NHS amounting to 
£800 million annually (Department of Health, 2005; Nacul, Soljak, & Meade, 2007). 
Risk factors for COPD include age and gender. Prevalence is higher in people over 45 
years of age (5.3%) compared to younger age groups (3.1%). In adults over 45 years, 
men are more likely to suffer from COPD (6.8%) compared to women (3.9%) (Nacul et 
al., 2007). Lower socio-economic status (SES) has been associated with higher COPD 
morbidity and mortality rates (Gershon, Dolmage, Stephenson, & Jackson, 2012). More 
deprived patient groups present with greater severity of COPD, more impaired lung 
function, worse physical functioning and higher risk of exacerbations (Eisner et al., 
2009).  
COPD involves changes in pulmonary pathophysiology that affect the central and 
peripheral airways, lung parenchyma and pulmonary vasculature (Saetta, 1999;  
Rennard, 1999; Peinado et al., 1999). An inflammatory response in the lungs can be 
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triggered by tobacco smoke or other noxious particles and gases. The changes 
produced by these pathogenic mechanisms lead to a number of physiological 
abnormalities that result in chronic thickening of the airways and destruction of the lung 
parenchyma (Snider, 1989; O’Donnell, 2001).  
The main cause of COPD is smoking. According to the World Health Organization, 
73% of COPD-related mortality in high-income countries is caused by smoking. Other 
risk factors for COPD include exposure to outdoor, occupational and indoor air pollution 
such as biomass fuels, heating, asbestos, fumes and vapours (GOLD, 2011). A further 
but less common cause of COPD involves a genetic vulnerability called alpha-1 
antitrypsin deficiency. Alpha-1 antitrypsin deficiency is an inherited condition in which 
symptoms of COPD manifest earlier than the usual age of onset (i.e. < 45 years) 
(GOLD, 2011). 
 
1.3 Diagnosis and assessment of COPD 
 
According to GOLD guidelines (2011), “a diagnosis of COPD should be considered in 
any patient who has dyspnoea, chronic cough and sputum production, and/or a history 
of exposure to risk factors for the disease. In order to diagnose COPD, spirometry is 
required. COPD is confirmed with a post-bronchodilator FEV1/FVC<70%. The rate of 
misdiagnosis of COPD is high because often diagnosis is made based on symptoms 
alone and is not confirmed by spirometry (Jones et al., 2008). 
Severity of COPD is assessed taking into account patient symptoms, the degree of 
airflow limitation, risk of exacerbation and co-morbidities (GOLD, 2011). Instruments 
used for assessment of severity include questionnaires such as the COPD Assessment 
Test (CAT) or the Medical Research Council (MRC) dyspnoea scale. Four GOLD 
grades are used to characterise COPD severity (see Table 1.1). Risk of exacerbation is 
defined as the likelihood of “an acute event characterised by a worsening of the 
patient’s respiratory symptoms that is beyond normal day-to-day variations and leads 
to a change in medication” (GOLD, 2011). Previous exacerbations and increasing 
airflow limitation raise the risk of frequent future exacerbations. Co-morbidities are 
assessed because they could influence mortality and hospital admission rates. Co-
morbidities in COPD patients often include cardiovascular diseases, depression, 




Table 1.1 GOLD classification of COPD severity 
_________________________________________________________________ 
Grade 1 (mild)   FEV1 ≥ 80% predicted  
Grade 2 (moderate)  50% ≤ FEV1 < 80% predicted  
Grade 3 (severe)  30% ≤ FEV1 < 50% predicted  





1.4 Management of COPD 
 
Changes in lifestyle and workplace and pharmacologic therapy are sometimes 
imperative for patients with COPD. The most important change is to stop smoking 
because it can prevent progression of COPD. There is a range of options available for 
patients with COPD to help them cope with their condition more effectively such as 
smoking cessation, reduction of exposure to pollution, uptake of exercise and adopting 
a balanced diet.  
Pharmacologic treatment aims to reduce symptoms, exacerbation frequency and to 
improve quality of life. The main medication used for symptom management in COPD 
includes short- and long-acting inhaled bronchodilators such as beta2-agonists, 
anticholinergics, theophylline, or combination therapy depending on symptom response 
and medication tolerance (GOLD, 2011). Long-acting inhaled bronchodilators decrease 
the risk of exacerbations, hospital admissions and improve quality of life (GOLD, 2011). 
Combination therapy such as inhaled corticosteroids with a long-acting beta2-agonist 
can reduce the risk of exacerbation compared to individual inhaled medication. 
Combination therapy is recommended for severe and very severe COPD. Antibiotics 
are also prescribed for exacerbations (GOLD, 2011). 
There are other treatment approaches available to patients with COPD such as 
pulmonary rehabilitation, oxygen therapy, ventilator support and surgery. Pulmonary 
rehabilitation (PR) is a programme that involves exercise training and patient 
education. It relieves dyspnoea and fatigue, increases patients’ control over their 
COPD and improves emotional function (Lacasse, Martin, Lasserson, & Goldstein, 
2007). Oxygen therapy, ventilator support and surgery are recommended for patients 
with more severe COPD but their impact on increasing survival rates varies and effects 
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on quality of life are not significant. Oxygen therapy improves survival rates in people 
suffering from hypoxia but not in people who do not while ventilator support or surgery 




Chronic obstructive pulmonary disease is a progressive respiratory condition that 
manifests with a variety of symptoms and significantly influences patients’ quality of life. 
A variety of treatment approaches are available to patients. They aim to prevent 
disease progression, provide relief from their symptoms and improve quality of life. 
Lower socio-economic status has been associated with higher morbidity and mortality 
rates, poorer quality of life and increased risk for exacerbations in patients with COPD. 
What needs to be taken into consideration is that COPD is a progressive disease that 
is not significantly improved by drugs and other treatments. Exploration of psychosocial 
influences such as SES, illness perceptions, self-efficacy and social capital might 
enhance our understanding of the ways in which patients experience and manage 
COPD. Findings could increase the likelihood of our ability to influence this disease 














Chapter 2  
Literature review I: The role of socio-economic status in health, chronic 
illness and COPD 
 
2.1 Socio-economic status (SES) and health  
 
a. Historical origin 
 
The primary aim of this thesis was to examine whether lower SES was associated with 
more impaired HCA and poorer QoL in COPD. This chapter discusses the origins and 
evidence for this link as well as the challenges arising and the explanations proposed. 
The relationship between poverty and poor health has been debated since the 19th 
century. In the United Kingdom, it was the mid-19th century when interest in the role of 
socio-economic conditions to investigate population health emerged. Details on 
occupational status were first collected during the 1841 Census (Woollard, 1999). 
Based on the data gathered from the census, all people – except for housewives, 
children and the unemployed – were originally grouped into crude occupational 
classes. This classification was later refined by William Farr in 1851 who examined 
mortality rates between people within the same and different occupations and found 
significant differences (Annual Reports of the Registrar General in England 1875, 1885; 
cited in Farr, 2000). The classification of occupations triggered further investigation into 
sanitary conditions, mortality rates, children’s and adults’ height and weight and led to 
comparisons between people who lived below poverty boundaries and people of higher 
social classes (Rowntree, 1901; Stevenson, 1911; cited in Freeman, 2011). This set 
the ground for deeper examination of social inequalities in health and associated 
possible causes.  
 
b. Contemporary debate 
 
Associations between socio-economic factors and health behaviours, healthcare 
access and health outcomes exist and persist into very old age (Brunner, Marmot, 
Marmot, & Wilkinson, 1999; Whitehead, Townsend, & Davidsen, 1992). Health 
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determinants arise from a variety of sources and interact in several ways influencing 
people’s well-being, health and quality of life (Marmot, et al., 2010). People with lower 
socio-economic status (SES) generally display higher morbidity and mortality rates 
than people from a higher socio-economic background (Adler & Rehkopf, 2008; 
Mackenbach, et al., 1997; Mielck, et al., 2000; Saydah & Lochner, 2010; Brunner et al., 
1999). The lower the SES level the higher the prevalence of chronic diseases 
especially angina, heart disease and arthritis (Callahan, 2003; Lee & Carrington, 2007; 
Liu, Ma, Yin, Kelepouris, & Eisen, 2011).  
SES is a multi-dimensional concept commonly described by income level, educational 
level and occupational status which are associated with certain outcomes in different 
ways. For example, lower income level was linked to poorer health and well-being 
through area deprivation, smoking, psychosocial stress, unhealthy eating patterns and 
limited exercise (Winkleby, Sundquist, & Cubbin, 2007; Prescott and Vestbo, 1999; 
Winkleby et al., 2007). Further pathways included quality of healthcare provision 
(Herndon, Kornblith, Holland, & Paskett, 2011), physician performance in chronic 
illness management, preventive care, diagnosis and treatment (Bernheim, Ross, 
Krumholz, & Bradley, 2008; Clegg, et al., 2009; Ford & Jones, 1991; Franks & Fiscella, 
2002). In contrast, higher educational attainment was associated with better illness 
self-management and treatment adherence in patients with diabetes and HIV and 
higher survival rates in breast cancer (Goldman & Smith, 2002; Herndon, et al., 2011). 
There is conflicting evidence for the varying importance of the three SES measures 
commonly used – income, education and occupation. For example, an association 
between occupation – but not for income and education – and gastric cancer survival 
was reported (Kuwahara, et al., 2010). These inconsistent results were attributed to 
various factors such as stage of diagnosis, treatment access and nature and biology of 
the tumours (Woods, Rachet, & Coleman, 2006). Thomson, Hole, Twelves, Brewster, & 
Black (2001) found that differences in outcomes for women with breast cancer such as 
survival rates could not be explained solely by variation in SES since they were larger 
than expected. Differences in treatment factors were also observed between more 
affluent and less affluent women but they still could not account for the differences in 
survival. The authors suggested that other factors might have been mediating the effect 
of SES such as co-morbidities or nutritional patterns. Wrigley et al. (2003) found that 
lower SES was associated with decreased survival in colorectal cancer. This 
association was statistically significant only when death from all causes and not 
specifically from colorectal cancer was used as an outcome. However, the study was 
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conducted in an affluent area with only approximately 30% of the participants living in a 
more deprived area than the national average. This could have biased results due to 
insufficient power to detect the effect exerted by deprivation. Despite the limitations of 
the studies, these results suggested that there might be additional factors implicated in 
the relationship between lower SES and poorer health. 
The aforementioned studies supported the existence of a social gradient in health. This 
gradient refers to the relationship between population health inequalities and social 
status inequalities. Higher socio-economic position is associated with better health. 
Social inequalities in health still remain a matter of concern in contemporary societies. 
The broad and pervasive effect exerted by socio-economic status on health was 
demonstrated by the findings of the Whitehall study (Marmot et al., 1991). The 
Whitehall study examined morbidity and mortality rates in British civil servants in 
different occupation grades over a period of 10 years. There was a significant 
difference between the lowest and the highest occupation grade in coronary heart 
disease mortality in addition to income level (Marmot et al., 1991). Further evidence 
that income is not the sole factor in health disparities came from the Black Report 
which emphasised that despite free health care provision through the National Health 
Service, health disparities in mortality rates by social class continued to increase 
(Black, Morris, Smith, & Townsend, 1980). Social ranking and dominance were 
proposed to explain these relationships. The considerable impact of stress on 
physiological functioning due to social ranking and dominance was also observed in 
primates (Sapolsky, 2005). Depending on their social ranking, psychological and 
physical stress were associated with most severe stress-related medical conditions. 
However, the nature of the mechanism that underlies the relationship between socio-
economic status indicators and health still remains elusive to a significant degree and 
whether this hypothesis can be extended to humans and to what degree is not clear 
(Subramanian, Belli, & Kawachi, 2002; Adler & Ostrove, 1999). 
The hypothesis that social ranking might be implicated in the association between 
socio-economic status and health makes the assumption that absolute income is not 
sufficient to explain health inequalities more likely. Lack of financial resources alone 
cannot explain differences in population health. Further factors relating to the 
immediate and wider social environment as well as psychological functioning need to 
be considered such as relative deprivation (Wilkinson, 1997). The relative deprivation 
hypothesis, was defined as "the conscious experience of a negative discrepancy 
between legitimate expectations and present actualities” (Schaffner & Torgler, 2008). 
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An increase in relative deprivation was associated with higher likelihood of self-
reported poor health even when socio-economic and demographic variables were 
controlled for (Subramanyam, Kawachi, Berkman, & Subramanian, 2009). Lower-rank 
employees within the same reference group experienced worse health based on self-
report. The authors emphasized the difficulty in defining a reference group in the same 
way in which people try to compare themselves with individuals from higher SES levels 
(Subramanyam et al., 2009).  
Pham-Kanter (2009) found that health status was associated only with extremes of 
relative deprivation and physiological stress. Position at the lowest end of SES was 
linked to poorer self-rated health, higher burden of disease and increased incidence of 
cardiovascular disease. In contrast, individuals at the highest end of social position 
were less likely to report diabetes, ulcers or hypertension problems. The author 
emphasized that the psychosocial stress mechanism affecting health could only 
partially explain differences in health status suggesting that there may be other 
variables that could help explain health disparities. 
Health inequalities can influence health care access and survival in lower SES groups 
through financial or social pathways. For example, socio-economic factors had a 
modest effect on stage diagnosis for cancer but a significant effect on survival in 
Canada where universal health insurance provides free health care for the whole 
population (Booth, Li, Zhang‐Salomons, & Mackillop, 2010). The breast cancer survival 
gradient could be explained only partially by cancer stage when diagnosis was made. 
This inconsistency was attributed to the facilitation to health care access due to 
universal health insurance. The same could be true for the United Kingdom where 
health care provision is not determined by insurance status (Thomson et al., 2001; 




There is significant evidence for the association between lower socio-economic status 
and poorer health status as well as increased morbidity and mortality rates. However, 
lower SES cannot solely explain worse health because despite the availability of equal 
health care access, morbidity and mortality rates were not improved in lower SES 
groups. This suggested that factors other than HCA such as household income, 
personality characteristics or illness beliefs might contribute to poorer outcomes. These 
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factors could have an influence on health status by mediating the relationship between 
lower SES and poorer health. What appears to be the case is that socio-economic 
factors alone are not sufficient to explain poorer health. This suggests that identification 
of additional variables such as illness beliefs or personality characteristics could 
increase our understanding of the mechanisms underlying this relationship. 
 
2.1.1 Pathways of SES influence on Health  
 
There are different pathways through which lower SES could be linked to poorer health 
such as material resources and psychosocial factors (Lynch & Kaplan, 2000; 
Wilkinson, 1999). The distinction between material and cultural circumstances 
proposed by the Black Report was not well-defined since material resources can 
significantly influence both culture and behaviour. Sally Macintyre & Ellaway (2003) 
suggested that there are other factors beyond the individual that should be taken into 
consideration to explain disease occurrence and health status such as socio-economic 
circumstances of the population. These suggestions are not mutually exclusive but may 
interact or complement each other.  
Inequality in access to health care has been examined in an attempt to explain the 
relationship between SES and health. While lack of universal health care coverage was 
reported to increase health disparities by limiting access to health care services 
(Lasser, Himmelstein, & Woolhandler, 2006) the evidence appears to vary depending 
on the outcomes examined. For instance, although general practitioner visits and 
hospital services utilization were more frequent in lower SES groups, specialist 
referrals were more frequent in higher SES groups (Veugelers & Yip, 2003). Specialist 
services in the last three years of life were considerably higher in the more affluent 
group. These findings suggest that increased utilisation of GP and hospital services by 
lower SES groups would attenuate the effect of SES on mortality but the increase in 
specialist care provided to higher SES groups would increase the socioeconomic 
inequalities in health. Lack of power in this study prevented strong conclusions 
regarding difference in mortality based on income and its impact on health services. 
Could universal health coverage eliminate health disparities? Additional factors 
implicated in health care access complicate this issue. For example, accessing free-at-
point-of-use health care services involves additional costs relating to practical issues 
such as transportation availability and expenses. Research suggested that impaired or 
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unavailable health care access as well as poor quality of medical treatment only 
account for approximately 10% of premature mortality worldwide (McGinnis et al., 
2002).  
Differences in health status and disease rates both between and within countries have 
partly been attributed to socio-economic structures and factors such as poor health, 
living environment, work status, social exclusion, availability of social networks and 
relationships, lifestyle (Hemingway & Marmot, 1999; Marmot, 1999) in childhood and 
adulthood (Galobardes, Lynch, & Smith, 2004; Galobardes, Lynch, & Smith, 2008; 
Davey Smith & Lynch, 2004). Adult health status and physical function can be 
predicted even half a century later by adverse childhood socio-economic conditions 
such as poor nutrition, health problems and family background (Huang, Soldo, & Elo, 
2011; Guralnik, Butterworth, Wadsworth, & Kuh, 2006). 
The evidence appears to support the relationship between lower SES and poorer 
health through a number of different pathways leading to social inequalities in health: 
(a) unhealthy lifestyles which are more prevalent in lower socio-economic levels (Lantz 
et al., 2001; Lynch et al., 1997); (b) unequal provision of healthcare quality and access 
to health services (Feinstein, 1993; Mackenbach, Stronks, & Kunst, 1989); and (c) 
material deprivation and exposure to stressful psychosocial environments from as early 
as in-utero through to childhood and later adulthood life (Kuh & Ben Shlomo, 1997; 
Marmot & Wilkinson, 2001). 
 
2.1.2 “Social causation” or “social selection?” 
 
Socio-economic status can affect health, a phenomenon termed “social causation” 
(Marmot, Shipley, & Rose, 1984; Marmot et al., 1991; van Rossum, Shipley, van de 
Mheen, Grobbee, & Marmot, 2000). Health can also influence socio-economic status 
termed “social selection” (The Black Report, DHSS; Black, et al., 1980). “Social 
selection” refers to people with better health having the opportunity to ascend the 
socio-economic ladder while those with poorer health – disadvantaged in terms of 
occupation and income – are more likely to descend it (Blane, Smith, & Bartley, 1993; 
Bartley & Plewis, 1997). Different occupations and associated activities place varying 
demands on people. Poorer health could influence people’s career choices and could, 
for example, steer them to a higher academic level which would place fewer demands 
on the physical component compared to a more physically demanding job (Ostlin, 
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1988). This kind of “social selection” follows a direct pathway. Poorer health leads to 
lower socio-economic status in society. There is also an indirect pathway (Sally 
Macintyre & West, 1991; West, 1988; West, Macintyre, Annandale, & Hunt, 1990; 
Wilkinson, 1986). This involves factors other than health that can influence mobility on 
the social ladder such as education, childhood deprivation and height which are used 
to predict adult SES and health. These factors can have an effect on either health or 
SES or both. Evidence for “social causation” is stronger than for “social selection” 
based on findings showing associations between lower SES and major depression, 
substance abuse and antisocial personality (Dohrenwend, Levav, Shrout, & Schwartz, 
1992). Social factors unrelated to health such as unemployment or adverse life events 
can also lead to lower SES (Hamilton, Broman, Hoffman, & Renner, 1990; Shrout, et 
al., 1989). 
 
2.1.3 Does the SES gradient exist for all diseases?  
 
The SES gradient exists in various diseases such as arthritis, cardiovascular disease, 
tuberculosis, chronic respiratory and gastrointestinal diseases (Matthews, Kelsey, 
Meilahn, Muller, & Wing, 1989), mild cognitive impairment and dementia (Cantwell, 
McKenna, McCray, & Onorato, 1998; Cunningham & Kelsey, 1984; Goldbourt, 
Schnaider-Beeri, & Davidson, 2007; Kaplan & Keil, 1993; Marengoni, Fratiglioni, 
Bandinelli, & Ferrucci, 2011; Matthews, et al., 1989). In general, cancer incidence is 
more likely to be linked to lower SES (Dalton, et al., 2008) particularly co-morbidity in 
cancer (Louwman, et al., 2010). The effect of SES varies depending on the type of 
cancer and whether incidence or survival is examined. For instance, incidence of 
breast and prostate cancer and malignant melanoma is more common in higher SES 
groups while cervical, lung and colorectal cancer in lower SES populations (Devesa & 
Diamond, 1980; Hakama, Hakulinen, Pukkala, Saxen, & Teppo, 1982; Yin, et al., 
2010). Survival rates are also increasing with higher SES in colon and breast cancer 
(Carnon, et al., 1994; Dayal, Power, & Chiu, 1982; McBride, Lebwohl, Hershman, & 
Neugut, 2010; McBride et al., 2010). 
 
 




Most developed countries also exhibit a gradient in SES (Adler & Ostrove, 1999). This 
gradient appears to be weaker in more privileged countries such as in Scandinavia 
(Feinstein et al., 1993) but can vary according to time. An increase in mortality rates 
after a period of recession were not observed in Finland (Valkonen, et al., 2000). 
Therefore, the authors suggested that a delayed effect of the impact of the recession 
on health might only be evident in later years. 
SES is a multidimensional and complex concept which includes a wide range of 
variables relating to financial, occupational, and educational domains (Duncan, 1961; 
Green, 1970; Mueller & Parcel, 1981). Despite the interrelationship among these 
dimensions of SES, each of them reflects relatively different individual and societal 
forces associated with health and illness. Educational attainment, occupational class, 
and income level represent overlapping resources in terms of general social status to a 
degree. For instance, more educated people might acquire knowledge of health-
improving behaviour easier than less educated people. Indirect pathways between 
education and well-being have to be considered such as better jobs which can secure 
higher income (Galobardes, Shaw, Lawlor, Lynch, & Smith, 2006; Lahelma, 
Martikainen, Laaksonen, & Aittomäki, 2004; Martikainen, Blomgren, & Valkonen, 2007; 
Mirowsky, Ross, & Reynolds, 2000). Certain dimensions of SES are more predictive of 
health than others in different ways (Fuchs, 1979; Kitagawa & Hauser, 1973; Williams, 
1990). For instance, income level reflects spending power, housing conditions, dietary 
patterns, and medical care; occupational class reflects prestige, responsibility, physical 
activity, and work exposure; education indicates skills required for the acquisition of 
positive social, psychological, and economic resources (Antonovsky, 1967; Susser & 
Watson, 1962).  
Differences in the pathways of SES influence on health also exist between countries 
(Banks, Marmot, Oldfield, & Smith, 2009) involving neighbourhood SES, social 
exclusion and ethnicity (Clarke, Farmer, & Miller, 2010; Nayar, 2007; Yin et al., 2010). 
For example, the equivalent of the Whitehall study was conducted in Nigeria and 
findings were contradictory to the ones in the British study. Officials in higher grades 
had greater likelihood of cardiovascular disease based on the risk factor incidence, for 
example, obesity, high blood pressure and unhealthy diet (Bunker, Gomby, & Kehrer, 
1989). Bunker et al. (1989) concluded that higher socio-economic status rather than 
occupational factors was associated with increased prevalence of hypertension among 
the male higher ranking staff. However, job demands and stress could not be 
measured reliably and could have differed between employees and countries. Other 
45 
 
studies did not find evidence for differences in blood pressure according to occupation 
in lower to middle SES groups (Idahosa, 1987; Oviasu & Okupa, 1980; Simmons, 
Koblinsky, & Phillips, 1986). However, these studies only measured one aspect of 
health status – blood pressure – and they were all conducted in Africa. The differences 
observed could be due to the Western lifestyle and work conditions and demands 
which differ from those existing in Africa.  
Similar findings were reported for the Western world regarding lower SES and poorer 
health. When the SES gradient was compared between the USA and the UK, 
differences were found for various diseases (Banks et al., 2009). Higher incidence of 
diabetes was found in higher SES groups in the USA but the reverse was true for the 
UK. In contrast, the SES gradient was similar for stroke, heart attacks and lung disease 
with lower SES increasing the risk of their incidence. No particular SES gradient was 
detected in cancer occurrence in either country, but this was thought to be due to 
various other factors (Banks et al., 2009). 
The SES gradient can vary within the same country, for example, in terms of ethnicity 
and neighbourhood SES (Clarke et al., 2010). Life expectancy followed a gradient in 
SES among Whites and African-Americans in a study in California but not in Hispanics 
and Asians. This was partly attributed to neighbourhood SES. These variations in SES 
suggest caution when making conclusions regarding its influence on health status. The 
different SES indicators and their relationship with certain health outcomes as well as 
people’s individual and social circumstances have to be taken into consideration when 
exploring the role of SES in health. The aforementioned findings highlight the 
complexity of SES and the weaknesses and strengths of each SES dimension. Some 
SES measures reflect more individual-based aspects of deprivation while some 
measure more area-level-based elements. They can complement each other and – if 
used in combination – may contribute to a more comprehensive assessment and global 
reflection of the pathways that could be operating in the relationship between SES and 
health. In addition, particular characteristics of the country and the population in 
question need to be considered when interpreting findings. 
 




The most common SES markers in research involve income, education and 
occupation. One or two markers may be more strongly associated between them 
compared to a third one (Rosengren, et al., 2009; Marengoni et al., 2011; Banks et al., 
2009) especially when investigated at the societal level such as neighbourhood SES 
(Clarke et al., 2010). Additional markers of SES such as neighbourhood deprivation 
were associated with increased risk of premature mortality, chronic diseases and their 
risk factors irrespective of income, education and occupation (Bosma & Kunnen, 2001; 
Pickett & Pearl, 2001) although in some the associations were moderate (Major, et al., 




Lower income and educational level as well as lower occupation class appear to be 
associated with a poorer effect on health but they are not the only factors to influence 
well-being. They are not sufficient on their own to provide a satisfactory explanation of 
health inequalities. Psychosocial and environmental exposures, biological, behavioural 
and personal characteristics of the different populations have to be considered in order 
to fully understand and explain the differences in health status, some of which will be 
discussed in the following sections. 
 
2.2   Socio-economic status and COPD 
 
2.2.1 COPD prevalence and mortality 
 
Socio-economic deprivation is linked to increased COPD prevalence and mortality 
(Prescott and Vestbo, 1999; Yohannes and Connolly, 2001; Yohannes et al., 1998; 
Shohaimi et al., 2004). Higher prevalence of COPD is associated with more deprived 
backgrounds in terms of social and occupational class, higher area deprivation, relative 
poverty, lower education and income levels, social isolation and limited social support, 
sedentary lifestyle and loneliness (Prescott and Vestbo, 1999; Yohannes et al., 1998; 
Yohannes and Connolly, 2001; Shohaimi et al., 2004). Some studies have failed to find 
support for significant effects of higher deprivation in terms of social class, heating or 
crowding in the home which could influence the emergence of COPD (Farr, Bartlett, 
Wadsworth, & Miller, 2000).  
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COPD prevalence and mortality have been associated with low socio-economic status 
partly due to its relationship with smoking (Doll et al., 1994; Peto et al., 1996). Tobacco 
smoking has been reported as the main cause of the development of COPD, especially 
in high and middle-income countries. 73% of COPD deaths in high-income countries is 
attributed to smoking whereas in low- to middle-income countries death rates drop to 
40% (Mannino & Buist, 2007). This difference could be due to additional factors such 
as indoor air pollution involving biomass fuels used for heating and cooking, outdoor 
pollution and occupational exposure to fumes and vapours ((WHO, 2010; Mannino & 
Buist, 2007; Pandey, 1984; Pérez-Padilla et al., 1996; Behera & Jindal, 1991; Buist et 
al., 2007). Reasons for higher rates in COPD deaths due to smoking include longer 
history of smoking in industrialized countries, and incomplete mortality and smoking 
data for developing countries (Ezzati & Lopez, 2004).  
Poverty confers a greater risk of developing COPD and results in more complications in 
poorer people in comparison to wealthier groups (Anto et al., 2001; Shohaimi et al., 
2004). However, poverty is used as an umbrella term to include various factors that can 
increase the risk of COPD such as poor diet due to financial hardship, high smoking 
rates, poor housing standards, exposure to fumes and gases, impaired access to 
health care services and childhood respiratory infections (Anto et al., 2001; Shohaimi et 
al., 2004). A detailed discussion of some of the risk factors that contribute to the 
incidence of COPD is provided below. 
 
2.2.2   Pre-natal exposure and childhood infections 
 
Fetal intra-uterine growth retardation in childhood is linked to adult respiratory function 
and status (Barker, et al., 1991; Shaheen & Barker, 1994; Shaheen, et al., 1994; Stein, 
et al., 1997). In-utero exposure to tobacco smoke due to maternal smoking (Young et 
al., 2000; Hanrahan et al., 1992) influenced lung function to a significant degree 
causing greater long-term damage to lung development and function than tobacco 
exposure after birth (Stein, et al., 1999; Tager, et al., 1993; Young et al., 2000). Lung 
function and wheezing after birth and through childhood (Martinez, Morgan, Wright, 
Holberg, & Taussig, 1988; Murray, et al., 2002; Young et al., 2000; Tager et al., 1993) 
and adolescence were associated with wheezing and asthma occurrence in later years 
(Håland, et al., 2006; Turner, Tutt, & Ashworth, 2004) ultimately increasing the risk of 
developing COPD in adult years (Barnes & Celli, 2009).  
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Whether a direct link between tobacco exposure in childhood and COPD exists is not 
clear. A relationship between lifetime exposure to tobacco smoke – as established by 
self-report – and COPD was observed (Yin, et al., 2007). This association disappeared 
when childhood and adult exposure were examined separately in a cross-sectional 
analysis of a prospective cohort study (Yin et al., 2007). Results showed an association 
between older adults who had been exposed to passive smoking at the workplace and 
at home and higher prevalence of COPD compared to non-exposed adults. However, a 
non-representative sample, different smoking rates, self-report and the cross-sectional 
design of the study could have influenced results. Tobacco exposure during childhood 
was linked to the development of COPD in later life in a case-control study 
(Johannessen, Bakke, Hardie, & Eagan, 2012). This relationship was stronger for 
childhood tobacco exposure than exposure in adulthood. The authors’ findings differed 
from those of a study conducted in China that did not find a relationship between 
childhood passive tobacco exposure and risk of COPD. Johannessen et al. (2012) 
suggested that this could have been due to more equally distributed smoking rates 
among males and females in Norway whereas in China the majority of smokers were 
men (67%) with significantly lower percentage of women smoking (4%). This would 
mean that children would be equally exposed to tobacco smoking whether they spent 
time with their mother or their father. Possible bias in recalling past smoking exposure 
should also be taken into account when interpreting Johannessen et al.’s (2012) 
findings. 
Decreased lung function in childhood and adult life was related to more frequent early 
childhood respiratory infections (Burrows, Knudson, & Lebowitz, 1977) mainly due to 
lung damage caused by a viral agent (Samet, Tager, & Speizer, 1983). Early childhood 
respiratory infections were also associated with more impaired lung function later in life 
(Martinez et al., 1988; Young et al., 2000; Tager et al., 1993) Early childhood 
respiratory infections as well as a history of asthma in the family were significant 
determinants of COPD risk (de Marco, et al., 2011). A small sample size due to COPD 
being relatively uncommon in younger age and possible misclassification of COPD due 
to lack of post-bronchodilator measurement might have affected results. 
 




Poor housing conditions have been implicated in increasing the risk of respiratory 
symptoms and COPD through overcrowding, dampness, use of biomass fuels and 
other mediators mentioned in detail below.  
Exposure to harmful particles not only in the household but also at the workplace and 
the environment were associated with increased risk of developing COPD (Gothi, 
Shah, & Joshi, 2007; Weinmann, et al., 2008). Use of gas stove and solid fuels for 
cooking and heating (Torres-Duque, Maldonado, Pérez-Padilla, Ezzati, & Viegi, 2008; 
Viegi, Scognamiglio, Baldacci, Pistelli, & Carrozzi, 2001) and residential exposure to 
radon gas (Turner, et al., 2011) as well as air pollution and biomass fuel (Liu, et al., 
2007; Orozco-Levi, et al., 2006; Zhang & Smith, 2007) have all been linked to 
increased respiratory symptoms, impaired lung function, higher mortality and lower 
socioeconomic status and confer higher risk of developing COPD. 
Biomass smoke was an independent risk factor for COPD especially in early-life and 
long-term exposure (Chan-Yeung, Ait-Khaled, White, Ip, & Tan, 2004; Kurmi, Semple, 
Simkhada, Smith, & Ayres, 2010; Perez-Padilla, Schilmann, & Riojas-Rodriguez, 
2010). Biomass smoke has been consistently reported to confer higher risk for the 
emergence of COPD, acute respiratory infections as well as wheezing episodes (Ekici, 
et al., 2005; Po, FitzGerald, & Carlsten, 2011). In addition, wood smoke increased the 
risk of COPD especially among current smokers, non-Hispanic whites, and men in 
comparison to former smokers, Hispanics, and women in a cohort study of smokers 
conducted in the United States. Wood smoke exposure was also strongly associated 
with decreased FEV1, increased incidence of airflow obstruction as well as chronic 
bronchitis (Sood, et al., 2010). These effects remained even when controlling for age, 
smoking, and educational level. 
Household crowding has also been linked to higher rates of respiratory infections and 
disorders (Britten, Davies, & Colley, 1987; Coggon, Barker, Inskip, & Wield, 1993) 
Coggon et al., 1993) especially domestic crowding at the age of two (Britten et al., 
1987). Sub-standard housing conditions have been associated with increased COPD 
incidence for decades, as well as humidity (Brunekreef, et al., 1989; Burr, St Leger, & 
Yarnell, 1981) and dust mites (Soliman & Rosenstreich, 1986). Not all of these studies 
had adjusted for smoking in their analyses. The effect of smoking on the outcomes 
examined needs to be considered when interpreting findings. 
People who perceived their home as being cold reported increased respiratory 
symptoms but not specifically for COPD (Gemmell, 2001). Rudge & Gilchrist (2005) 
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found that areas with a high Fuel Poverty Risk (homes with low energy efficiency levels 
with more than 10% of the household income spent on maintaining ideal temperatures 
indoors) showed significantly increased emergency respiratory admissions rates in the 
winter months from 1993 to 1997. However, the study did not specifically focus on 
COPD but included all respiratory diseases and did not control for any confounding 
variables. The authors did not find associations between deprivation and increased 
winter mortality rates. This finding suggested that it was probably not general poverty 
that was related to poor health status in winter but the combination of hard-to-heat 
buildings and decreased ability to afford heating. Lack of associations between socio-
economic conditions and excess winter mortality could have been due to the use of 
measures of deprivation which do not include an indicator specifically assessing hard-
to-treat housing such as the Townsend score. 
 
2.2.4   Smoking 
 
Smoking is main cause of COPD. There has been a worldwide increase of smoking 
rates in developing countries and a decrease in developed countries such as in the 
USA (Pierce, Messer, White, Cowling, & Thomas, 2011) as well as in the United 
Kingdom (Simpson, Hippisley-Cox, & Sheikh, 2010). In the UK, Simpson et al. (2010) 
found a significant decrease in smoking rates between 2001 and 2007. This could have 
been due to enhanced provision of smoking cessation services and specialist referrals. 
However, this decrease could merely have been a continuation of the secular trend that 
had started from 1972 and reached a plateau in 1997 (Office for National Statistics, 
2000; Bridgwood Ann, 1998) The authors stressed that smoking rates remained 
increased in people from areas which displayed high socio-economic deprivation as 
well as young adults. The estimated number of smokers in the United Kingdom in 2007 
was 13.7 million (Simpson et al., 2010) highlighting the fact that more research is 
required into the reasons why these people smoke and additional or more targeted 
interventions needed to aid them in stopping smoking. 
A review by Hiscock, Bauld, Amos, Fidler, & Munafò (2012) found that prevalence of 
smoking is greater in low SES groups and these groups may be more vulnerable to the 
harmful effects of tobacco. Hiscock et al. (2012) suggested that smoking rates were 
higher in more deprived populations and the likelihood of success in quitting smoking 
was lower in these groups. Limited support and low motivation in quitting smoking, 
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stronger addictions and differences in psychological characteristics such as low self-
efficacy were considered as factors influencing smoking cessation. For example, 
Businelle, et al. (2010) found that the association between SES and smoking was 
mediated by neighbourhood deprivation, social support, low mood or stress, and self-
efficacy. These effects were true across three ethnic groups. Similarly, Pisinger et al. 
(2010) observed that the more likely reasons for low SES smokers to quit smoking 
included the cost of tobacco or health problems. Smokers from more deprived 
backgrounds were more likely to report that smoking cessation attempts had been a 
negative experience for them and that their relapse was due to nervousness, 
restlessness or depression. These findings highlight the need for smoking cessation 
programmes to be tailored to specific population needs such as lower SES groups. The 
reasons for starting, quitting and relapsing differ significantly between lower and higher 
SES groups. Therefore, different strategies need to be incorporated into interventions 
aimed at preventing initiation of smoking and aiding smokers in quitting or preventing 
relapse. 
Forey, Thornton, & Lee (2011) suggested a causal relationship between smoking and 
COPD based on the fact that estimates did not change when adjusting for confounding 
variables and followed a dose-response relationship. This relationship was reflected in 
the increasing risk of COPD with long-term and heavy smoking, early starting age of 
smoking and prolonged smoking cessation, decreasing risk of COPD with increasing 
starting age and increasing quitting duration. 
COPD affected between 25-45% of COPD patients who had never smoked depending 
on the country examined (Fukuchi, et al., 2004; Menezes, et al., 2005; Salvi & Barnes, 
2009). It was suggested that smoking could increase risk of developing COPD later in 
life but COPD could also develop and progress in people who had never smoked 
before with a prevalence rate of 5.2% (Zhou, et al., 2009). Alternative factors such as 
social ranking, manual labour, educational attainment, environmental exposure to 
tobacco and biomass smoke, genetic factors, family history, childhood infections and 
poor home ventilation have been proposed as the causes of COPD in these patients 
(Hnizdo, Sullivan, Bang, & Wagner, 2002; Trupin, et al., 2003; Zhou et al., 2009). 
Passive exposure to tobacco smoke increased the likelihood of COPD developing in 
non-smokers (Eisner, et al., 2005) possibly through the additive effects on already 
existing burden of the lungs by inhaled particles and gases (Dayal, Khuder, Sharrar, & 




2.2.5   Occupational exposure – social class (education, income, occupation) 
 
Increased risk of COPD has been associated with exposure to toxic fumes in the 
workplace (Chester, Gillespie, & Krause, 1969), grain residue in farms (Husman, 
Koskenvuo, Kaprio, Terho, & Vohlonen, 1987) and dust particles and fumes in factories 
(Becklake, 1989). Balmes (2005) found that approximately 15% of COPD cases could 
be attributed to inhaled particles at work such as production of rubber, plastics, textiles 
and leather, building and construction, armed forces, food, chemicals, petroleum, and 
coal mines. Others have reported rates between 9% and 31% (Trupin et al., 2003). 
Difficulty in clearly defining COPD and the relatively small number of studies conducted 
may have masked the accuracy of the risk of COPD attributed to occupational 
exposure.  All the above investigated industries were associated with lower SES 
possibly because they involved manual and blue-collar jobs indicating higher likelihood 
of lower income, education and occupational status. 
Farming, due to its association with pesticides, animal contact and dust and particles, 
has also been implicated in the incidence of COPD (Lamprecht, Schirnhofer, Kaiser, 
Studnicka, & Buist, 2007) with 7.7% of COPD cases attributed to it and approximately 
one third of farmers suffering from COPD. Other factors linked to COPD include 
occupational exposure as in miners (e.g. coal, hard-rock, gold) and people working in 
tunnels and with concrete. The effect of this exposure – if heavy and prolonged – may 
supersede even that of smoking (Ulvestad, Bakke, Eduard, Kongerud, & Lund, 2001). 
Prolonged inhalation of dust, diesel, beauty salon products, textiles, car fumes, food 
production, silica, iron, steel, brick dust or mineral particles was associated with 
increased COPD incidence and mortality (Hnizdo et al., 2002; Weinmann et al., 2008). 
Similarly, Blanc, et al. (2010) found associations between vapour, gas, dust or fumes 
exposure and increased risk of COPD which showed further increase if this exposure 
was combined with smoking. Bakke, Hanoa, & Gulsvik (1995) argued that occupational 
exposure alone does not provide an adequate explanation for the incidence of COPD. 
They observed a relationship between educational attainment and increased likelihood 
of experiencing respiratory symptoms even when controlling for occupational exposure 
(Bakke et al., 1995).   
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Occupation was associated with income and education although each of them reflects 
different things (Antonovsky, 1967; Susser, Watson, & Hopper, 1985). For example, 
occupation is associated with social status while income level reflects spending power 
and educational attainment can be indirectly related to both. The link between lower 
SES that includes education and income in addition to occupation and higher 
prevalence of COPD must be considered. Yin, Zhang, Li, Jiang, & Zhao (2011) found a 
relationship between educational attainment and household income and increased 
prevalence of COPD in both urban and rural areas in China when adjusting for age, 
smoking status, geographical area and passive tobacco exposure.  When classified by 
smoking status, educational attainment and COPD prevalence were still significantly 
associated both in smokers and non-smokers. This indicated that education might have 
been a risk factor for COPD independent of smoking. Household income was related to 
COPD in never smokers, but not in smokers. The authors attributed these differences 
in the findings to the fact that both education and household income were imperfect 
indicators of SES. The association between COPD prevalence and educational level 
was also supported by other studies conducted in Latin America (Menezes et al., 
2005). These studies had controlled for confounding factors such as age, sex, ethnic 
origin, education, pack-years of smoking and exposure to biomass fuels, coal, 
occupational exposure and BMI. 
Kanervisto et al., (2011) found an association between low SES and  lower educational 
level with higher COPD incidence when controlling for gender, age, smoking history, 
and BMI in a study conducted in Finland confirming previous research in Norway 
(Bakke et al., 1995). Decreased lung function in lower SES groups in comparison to 
higher SES populations and increased respiratory symptoms have consistently been 
reported even after adjustment for smoking (Bednarek, Maciejewski, Wozniak, Kuca, & 
Zielinski, 2008; Burr & Holliday, 1987; Prescott, Lange, Vestbo, & And The 
Copenhagen City Heart Study, 1999; Stebbings, 1971). This difference dependent on 
SES, particularly lower education and income, was also linked to increased risk for 
admission to hospital (Prescott et al., 1999). 
The role of SES in COPD requires increased attention because of its multifaceted 
nature which includes a variety of socio-economic factors such as financial resources, 
power or status (Macintyre, Ellaway, Der, Ford, & Hunt, 1998; Roux, 2001; Lynch et al., 
1997). SES indicators may also be operating differently in COPD patients depending 
on age. COPD affects mainly people over the age of 40 years and because its 
progression is very slow, the disease is more pronounced in later stages of life. An 
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individual’s health status could be affected by different socio-economic factors on 
various levels (e.g. individual, household or neighbourhood) and in varying ways (e.g. 
vulnerability, effects on physical status) depending on their age or stage in life (Singer 
& Ryff, 1997; Steptoe & Marmot, 2002). Educational and income level as well as 
occupational class might not be able to capture aspects of SES in the same way as in 
later age as compared to younger adulthood (Braveman et al., 2005; Kaplan, Seeman, 
Cohen, Knudsen, & Guralnik, 1987; Liberatos, Link, & Kelsey, 1988). SES 
characteristics held earlier in life such as occupation or education might not be 
reflected in measures of current SES. For example, loss of income or loss of prestige 
associated with one’s occupational class due to retirement (Kaplan et al., 1987). This 




Research findings strongly support an association between low SES and higher risk for 
the development, severity and prevalence of COPD when examining the most 
commonly used measures of SES (income, education, occupation). These three 
measures are related to other indices such as housing, smoking occupational 
exposure. Pre-natal exposure is associated with SES to a certain degree. The inclusion 
of these additional SES indicators makes the effect of SES on COPD clearer and 
uncovers its multifaceted nature and wide extent of operation. There are a number of 
risk factors that contribute to the risk of developing COPD to varying extents. A 
combination of these risk factors – with some operating as early as in-utero – may 
increase an individual’s susceptibility to COPD. The evidence so far indicates the 
existence of not only an association between low SES and increased COPD incidence 












Socio-economic status in health leads to the wider issue of health inequalities in health 
care.  The inverse care law stated that the provision of good health care tends to be 
inversely related to the need of the population in receipt of that care (Tudor Hart, 1971). 
The more deprived the population, the greater the need for more medical treatment but 
the more barriers exist for these people to acquire access to health care.  
Before focusing on health care access, reference to the distinction between health care 
access and health care utilisation needs to be made. These two terms might be distinct 
but are not mutually exclusive. Health care access refers to “the ease with which an 
individual can obtain needed medical services” (RAND Corporation, 2010). The focus 
in this definition is on the word “can”. HCA describes the degree of an individual’s 
ability to approach and receive health services. Access to health care has also been 
described as the “goodness of fit” between patients and the health care system 
(Penchansky & Thomas, 1981) referring to the suitability of available health care 
services to patients’ needs. The fact that health care services are available does not 
necessarily mean that patients will use them when and as needed. Thus, while access 
to health care denotes both the availability of services as well as people’s ability to use 
them, utilisation of these services refers to the actual use of these services also 
described as “realised access” (Andersen, 1995). Therefore, health care access is an 
essential but not sufficient antecedent to health care utilisation. It could be argued that 
access to healthcare may only be properly assessed in utilisation rates and that under-
utilisation could partly be a representation of inadequate access. However, it could also 
be that people do not utilise health care services despite their ability to do so and the 
availability of the services. The decision to utilise health care services could be 
influenced by other factors such as the way individuals perceive their health problem 
and whether it requires medical attention or not. 
Health inequalities have been associated with access to health care.  Providing equal 
access to health care entails one important facet: equity. Equity refers to providing 
equal opportunity for everybody who has the same needs to have and gain access to 
health care services. A further distinction is that between horizontal and vertical equity. 
Horizontal equity refers to fairness in providing health care to people who have the 
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same medical needs (Mooney, 1983;  Gulliford et al., 2002) – in other words, equal 
treatment for equals. For example, access to primary care services such as GPs or 
hospital services should be equal for everybody who would need treatment. Vertical 
equity, on the other hand refers to the provision of unequal health care to people who 
have different medical needs. For example, people with greater needs should receive 
higher health care provision such as specialist referrals and treatment.  
The most common method of measuring horizontal inequity is the extent of the 
relationship between health care utilisation and income after accounting for differences 
in need across the different income levels (Wagstaff, 2002). In theory, horizontal equity 
in health care access should only depend on the need of the population or the person 
in question and not on socio-economic factors that may be exerting an influence on the 
use of these services (O’Donnell, et al., 2008). Research has not found strong support 
for inequity in horizontal health care access. On the contrary, there has been evidence 
that in a number of European countries such as Belgium, the UK, the Netherlands and 
Italy, access to GPs and hospital services favour the lower SES groups  (Van der 
Heyden et al., 2003; van Doorslaer et al., 2006;  Sutton, 2002;  Masseria & Giannoni, 
2010). These countries offer a universal health care system which could account for 
differences when compared to other countries such as the USA where access depends 
on insurance status. Findings differ for vertical health care access. The evidence 
mostly suggests that there is inequity in vertical health care access. For example, for 
specialist services, the pattern appears to follow the opposite direction namely 
favouring the higher socio-economic groups (Masseria & Giannoni, 2010; Finkelstein, 
2001; Dunlop et al., 2000; Hurley & Grignon, 2006). Still, equity in specialist 
consultations has been found, for example in Spain, possibly due to different patterns 
in health care seeking (Regidor, et al., 2008). This was attributed to high expertise and 
ability of GPs to treat patients eliminating the need for further specialist treatment or 
high rates of specialist care consultations regardless of socio-economic position 
(Regidor et al., 2008).  
Social determinants of health need to be considered when attempting to explain the 
pathways underlying the relationship between SES and health care access. These 
determinants refer to the circumstances in which people are born, raised, work, live 
and grow old (Marmot, 2009). The curve of a health gradient can fluctuate depending 
on changes in the political, social, and economic circumstances. This means that the 
focus of attempts to decrease health inequalities needs to target these three 
circumstances and their sources (Marmot, 2009). Measuring equity in health care 
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access is not a straightforward issue. Dimensions such as the variety and different 
degrees of health problems, differing needs for the same health conditions as well as 
personal priorities and attitudes need to be considered (Gulliford et al., 2002). 
 
2.3.2 Socio-economic status and health care access (HCA) 
 
Socio-economic factors have been linked to access to health care. For example, low 
SES was related to delayed and lower quality of care provision (Weissman & Epstein, 
1993). Ethnic influence was associated with impaired health care access when 
controlling for SES factors (Hayward, Shapiro, Freeman, & Corey, 1988). Perneger, 
Whelton, & Klag (1995) explored the association between differences in ethnic 
background and socio-economic status in end-stage renal disease (ESRD) based on 
previous evidence that supported a partial link between them (Navarro, 1990). 
Perneger et al. (1995) reported that low SES status and lower health care access 
accounted for approximately 30% of the excess risk for ESRD Black Americans. 
Pernerger et al.’s (1995) findings showed that the mediating role of health care access 
between low SES and increased likelihood of getting ESRD in poorer groups was not 
as strong as expected while impaired access to health care services was an 
independent risk factor for ESRD. Evans et al. (2011) found differences between 
Blacks and Whites who had higher likelihood of CKD occurrence regarding availability 
and quality of health services. Influencing factors included lack of health insurance and 
variability in the ways Blacks used health services such as seeing a GP privately. 
Evans et al.’s (2011) findings indicated that lower health care access accounted for 
higher CKD incidence in Blacks in addition to socio-economic, lifestyle-related and 
clinical factors. 
The effect of ethnic origin was found to be significantly lower than socio-economic 
factors in some studies. For example, Mutchler & Burr (1991) showed that when 
controlling for SES variables and resources, the effect of ethnicity disappeared in some 
measures of health care access. Self-rated health, however, remained worse for 
Blacks as compared to Whites which suggested that the impact of SES may have been 
different in the two groups. 
Multi-morbidity can also influence access to health care. Glynn, et al. (2011) 
investigated health care utilisation in primary and secondary care settings and found a 
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significant positive and linear association with multi-morbidity when adjusting for age, 
gender and socio-economic status. Health care access measures included 
consultations with GPs, consultants on an outpatient-basis, hospitalisations and health 
care expenses. These healthcare access measures – although not comprehensive – 
reflect patients’ access to health care services in different ways. For example, 
hospitalisations might reflect poor health care access provided in primary care which 
might result in hospital admission instead of good health care access. Caution must be 
taken when attempting to interpret the direction of HCA using various measures.  
Wagner, et al. (2011) explored the relationship between household income and health 
care provision including medicines aided by health insurance and public sector 
resources. The study used the World Health Survey data collected based on reports 
from 70 countries (WHO, 2003). Access to emergency care was found for more than 
90% of households. People suffering from a chronic illness reported significantly lower 
access with less than 50% of them utilising health services when needed. Costs 
associated with health care access in low and middle income countries place a 
significant burden on family income. Wagner et al. (2011) concluded that lack of health 
insurance and lack of contribution from the public sector were related to impaired 
access and increased financial burden for households. More support for the 
association between low SES and increased likelihood of consulting a GP and 
receiving prescriptions for medication was reported by Van Der Meer, Van Den Bos, & 
Mackenbach (1996) and Bongers, Van Der Meer, Van Den Bos, & Mackenbach, 
(1997). The latter group found that higher SES was linked to increased specialist 
consultation but lower GP consultation in comparison with lower SES groups when 
controlling for health status. The authors suggested that other factors such as distance 
to health service facilities, time and cost of travelling, doctor-patient communication as 
well as people’s attitudes and values may contribute to the way people seek health 
care access. These factors are discussed in more detail in Chapter 3. 
 
2.3.3 Health care access in COPD 
 
Research examining health care access in COPD is relatively limited. The main 
dimensions in relation to health care access in COPD that were examined included 
doctor-patient communication, prescriptions for medication and hospital admissions. 
Because of the higher incidence of COPD in lower SES groups, and taking into 
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consideration the evidence for the link between lower SES and more impaired HCA, it 
would be expected that health care access would be lower in patients with COPD given 
their more deprived background. However, Goldstein, Concato, Bradley, O'Leary, & 
Fried (2005) investigated communication between physicians and patients focusing on 
discussion of prognosis. Higher likelihood of discussion regarding prognosis was 
associated with lower SES and non-white ethnic background. However, participants in 
this study were seriously ill and included patient groups with different conditions 
(congestive heart failure, cancer and COPD). These results do not support previous 
findings which reported a relationship between non-white ethnicity and lower SES with 
worse patient-physician communication specifically in regards to end-of-life care 
(Borum, Lynn, & Zhong, 2000; Collins, Clark, Petersen, & Kressin, 2002) and higher 
likelihood of discussion of prognosis in cancer patients with increased SES (Ward, 
1974). Goldstein et al. (2005) suggested that their findings could be attributed to poorer 
patients of non-white ethnicity being more “attuned” to hearing bad news and accepting 
it. A second suggestion was that physicians may have focused more on providing this 
information to specific groups especially since some of them were more likely to prefer 
life-sustaining care (McKinley, Garrett, Evans, & Danis, 1996; Krumholz, et al., 1998). 
 
a. Smoking referrals 
 
A number of strategies have been introduced in the UK since 1998 to reduce smoking 
rates and help smokers quit (Callum, 1998; Reid, Killoran, McNeill, & Chambers, 1992) 
such as a national network of smoking cessation services (National Health Service 
(NHS) Stop Smoking Services (SSS); McNeill, Amos, McEwen, Ferguson, & Croghan, 
2012). This led to a significant reduction in cigarette smoking, but not in socio-
economic inequalities in smoking (Hiscock et al., 2011; Kotz & West, 2009). While 
smoking decreased in higher SES groups in England from 22.8 to 19.4% between 
2001–03 and 2006–08, it did not decrease in the more deprived groups (42.6 versus 
42.4%) (Hiscock et al., 2012). This led to a decrease in inequalities between the two 
groups but not in a mutual trend. This means there was a decrease of smoking in 
higher and lower SES groups resulting in lower inequality. Stopping smoking services 
aimed to reach more deprived smokers and attempted to decrease health inequalities 
at the same time (Bauld, Judge, & Platt, 2007). However, fear of being judged, of failing 
and insufficient or distorted knowledge about smoking cessation services and the 
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associated medication available were perceived barriers in the uptake of services and 
success in smoking cessation (Roddy et al., 2006). Success of smoking cessation 
increases with age because of higher likelihood of adherence to a programme and 
lower risk of relapse. More deprived and minority populations are less likely to succeed 
in quitting smoking due to their more disadvantaged situation and attitudes that make 
cessation harder to undertake. Both of these are associated with poorer preventive 
health care in comparison to more affluent groups in the UK and the US (David, Esson, 
Perucic, & Fitzpatrick, 2010; Fagan, Shavers, Lawrence, Gibson, & Ponder, 2007; 
Hiscock, Judge, & Bauld, 2011). These treatment inequalities could be attributed to 
physician beliefs about minority and low SES patients (van Ryn & Burke, 2000). They 
could also be due to the nature of the healthcare system that leads to fatigue, work 
overload, and time constraints all of which raise the risk for discrimination in thinking 
and treatment patterns (Burgess, Fu, & Van Ryn, 2004). 
In the UK, the introduction of the Quality and Outcomes Framework (QOF) system in 
primary health care contributed to recording patients’ smoking status at least every 27 
months and offering cessation advice. This was not always feasible due to significant 
proportions of people, mainly from lower SES or hard-to-reach groups, not registered 
with primary healthcare teams.  
No research is available examining the association between lower SES and smoking 
cessation referral rates in COPD patients at this time. However, the existence of 
inequalities in smoking cessation services indicate that more deprived groups might be 
at a disadvantage of receiving them. This would pose a significant problem especially 
for patients with COPD since stopping smoking is the main approach to prevent further 
deterioration of the disease. 
 
b. Pulmonary Rehabilitation (PR) 
 
Pulmonary rehabilitation (PR) referral and attendance are important dimensions of 
health care access in COPD. PR is an exercise and educational programme which has 
been proven beneficial in facilitating breathing, enhancing exercise performance, 
improving health status and increasing patients’ perceptions of control over their COPD 
(Lacasse, Goldstein, Lasserson, & Martin, 2006; Nici, et al., 2006). PR has also 
contributed to reductions in exacerbation rates and hospital admissions as well as 
duration of stay (Griffiths, Phillips, Davies, Burr, & Campbell, 2001; Guell, et al., 2000). 
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However, attendance and completion rates in PR have been low with approximately 
1.5% of COPD patients accessing PR annually (Yohannes & Connolly, 2004). In a 
systematic review exploring the barriers associated with PR attendance and 
completion, Keating et al. (2011) found that lack of means of transportation as well as 
perceptions of no benefit from PR were associated with attendance rates. Current 
smoking and depression were related to lower completion rates. The authors stressed 
that they had not taken into account patients who had rejected PR at the time of 
referral and that the number of referrals offered had not been well-documented. 
According to Young, Dewse, Fergusson, & Kolbe, (1999) approximately 30% of 




Important aspects of access to health care in COPD include provision of appropriate 
medication as well as rates and accuracy of diagnosis  (Foster, et al., 2007; Snider, 
1989). The role of SES in medication use in patients with COPD is not clear. Restrepo, 
et al. (2008) did not find any significant associations between educational attainment 
and medication use which contradicted earlier findings suggesting that higher 
education was related to better adherence in nebuliser use (Turner et al., 1995).  
Decreased likelihood of adherence was associated with patients’ perceptions of no 
significant beneficial effect of inhaler use on their breathing, lower educational 
attainment as well as forgetting to take the inhalers and prescriptions charges (Dolce, 
et al., 1991; Turner, Wright, Mendella, & Anthonisen, 1995). A socio-economic gradient 
was observed regarding self-reported use of tiotropium with lower SES groups 
reporting decreased intake of tiotropium (Blanc, et al., 2008). 
 
d. Exacerbations and hospitalisation  
 
Treatment needs for COPD patients who experience exacerbations and are 
hospitalised constitutes one further aspect of health care access. However, both 
exacerbations and admissions are considered more a measure of outcome of disease 
rather than of health care access (Prescott et al., 1999). Limited access to primary care 
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services such as GP consultations and lack of prescriptions could lead to deterioration 
of the illness and thus contribute to higher likelihood of exacerbations. Therefore, 
exacerbations and hospital admissions could be the result of more limited access to 
health care. Prescott et al. (1999) found a significant association between education 
and income and hospital admissions in COPD. An association between educational 
attainment and low income and hospital admissions was also found by Miravitlles et al. 
(2006) and Agabiti et al. (2009). Miravitlles et al. (2006) suggested that impaired health 
status was a predictor of increased risk as well as a consequence of exacerbations and 
admissions. If decreased health care access was associated with impaired health 
status then this could suggest that exacerbations and admissions would be more 
frequent as a result of poor health. Begley et al. (1994) found evidence for lower SES 
and impaired access to primary care services leading to increased hospital admission 
rates. Limitations of the study included lack of adjustment for confounding variables 
such as higher occurrence of disease, quality of care by health professionals and 
patient choices. Begley et al. (1994) emphasised that additional factors apart from 
lower health care access could be associated with the increased number of 
preventable hospital admissions. Apart from COPD, asthma, urinary tract infections, 
diabetes, pneumonia and epilepsy were also included in the study. Thus, results 
cannot be generalised to COPD patients only although the effect was strongest in 
COPD as compared to the other conditions. More support for the association between 
poorer access to health services and increased rates of admissions was provided by 
Bindman, et al. (1995) for COPD, asthma, hypertension, diabetes and congestive heart 
failure. Self-reported health care access as well as incidence of illness, medical 
treatment seeking and physician care patterns were included in the analyses. Results 
showed that limited access to health care services was linked to increased hospital 
admissions for all five conditions when adjusting for SES factors, demographics, 
individual patterns of health care seeking and physician practice routines. Self-rated 




Health care access is a multi-dimensional concept that involves a variety of factors 
influencing horizontal and vertical equity in health care access. Firstly, socio-economic 
status relates to people’s ability to access health care on the basis of health insurance 
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and other barriers associated with expenses incurred in the process of access 
(McCarrier, Zimmerman, Ralston, & Martin, 2011; Quinn, et al., 2011). Secondly, 
behavioural factors which include psychological, lifestyle and cultural elements can 
influence actual utilisation of health services available such as GP visits or prescription 
uptake (Gulley, Rasch, & Chan, 2011). Third, location-related factors such as distance, 
duration of travel, means of transport available as well as the supply of health care 
services in certain areas exert a significant influence on people’s ability to access 
health care services (Comber, Brunsdon, & Radburn, 2011; Masseria & Giannoni, 
2010). 
The mechanism of influence of the factors discussed above as well as contradictory 
evidence for the relationship between SES and health care access highlight the degree 
of caution that needs to be taken when examining health care access in different 
population groups and health conditions. A combination of all these dimensions is 
required to provide detailed insight into the causes and correlates of health care 
access, which can set the ground for targeting the barriers and improving access to 
services. 
 




Quality of life data aids in monitoring population’s health status and contributes to the 
identification of health inequalities and information of public policy. In the clinical field, 
quality of life also provides evaluation of the impact of interventions on health outcomes  
(Moriarty, Zack, & Kobau, 2003). 
The definition, dimensions, measurement and external influences on QoL has been 
debated for years (Taillefer, Dupuis, Roberge, & LeMay, 2003). Quality of life 
encompasses different dimensions including physical, psychological and social 
functioning and well-being and perceptions of health (Hennessy, Moriarty, Zack, 
Scherr, & Brackbill, 1994; Siegrist & Junge, 1989).  
Quality of life may also refer to wider elements including functional ability, happiness or 
level of satisfaction, goal attainment and social network availability (Dupuis, et al., 
64 
 
2000; Ferrans, 1990; Meeberg, 1993). According to Feinstein (1987) “the idea (of QoL) 
has become a kind of umbrella under which are placed many different indices dealing 
with whatever the user wants to focus on”. Objective health status of life is different 
from subjective quality of life (Cummins, Yuan, Yuen, & Low, 1999). These two 
variables are not strongly correlated. Arguments against the use of both have been 
raised such as that subjective well being does not necessarily reflect the availability of 
material and social resources. One person may perceive himself to be well despite 
adverse conditions in his social or financial environment. Another person, despite 
having sufficient financial and social resources, may report a low level of subjective 
well being (Hagerty, et al., 2001). Cummins (2000) emphasised that quality of life 
should not be defined in subjective terms (people’s perceptions of their well-being) but 
also in objective dimensions (e.g. social network connections) and should be measured 
in both dimensions in order to reflect the global view of quality of life. 
The use of QoL measures which include a variety of domains has been supported in 
the literature (Kaplan & Ries, 2007). In the current study, quality of life was defined as 
perceived well-being in terms of physical, social and psychological status. 
 
2.4.2 Socio-economic status, health status and quality of life 
 
Quality of life refers to general well-being and health is influenced by a range of factors 
not only in people’s immediate environment but also by personal characteristics such 
as socio-economic status and life events (Brown, 1995; MacIntyre, MacIver, & 
Sooman, 1993; Mattevi, Bredemeier, Fam, & Fleck, 2012). Lower socio-economic 
status and poorer self-rated levels of well-being has been associated with worse health 
(Mackenbach & Britain, 2006). The effect of SES on health status can follow various 
pathways such as lower access to health care services including lack of preventive 
services such as screening (Blendon, Aiken, Freeman, & Corey, 1989; Hayward et al., 
1988). Lack of insurance and poverty increase the likelihood of poorer quality and 
lower provision of care (Burstin, Lipsitz, & Brennan, 1992; Weissman et al., 1991).   
Quality of life reflects a person’s subjective health status and their perception of their 
well-being on a physical, social and psychological level. Two people might have 
identical conditions or symptoms, but their experience of them may vary significantly. A 
number of factors are associated with this difference of experience such as the 
65 
 
availability of social networks, the conditions people live in and their expectations from 
life itself (Mattevi et al., 2012). The subjective nature of the experience of QoL is 
reflected in the “response shift”. Response shift has been defined as “a change in the 
meaning of one's self-evaluation of a target construct as a result of: (a) a change in the 
respondent's internal standards of measurement (scale recalibration, in psychometric 
terms); (b) a change in the respondent's values (i.e. the importance of component 
domains constituting the target construct); or (c) a redefinition of the target construct 
(i.e. reconceptualisation)” (Schwartz & Sprangers, 1999; Sprangers & Schwartz, 1999). 
Chronic illness patients may adjust their baseline for their experience of symptoms and 
well-being as long as their condition is not deteriorating any further. Despite their well-
being baseline being lower than before the emergence of their illness, patients can 
adjust to it and perceive it as “normal” after a period of time because it has become 
their new baseline. 
 
a. Educational attainment, occupational status, income level and QoL 
 
Bowling & Windsor (2001) found that expectations of QoL may vary depending on 
educational attainment. People who were more educated reported poorer quality of life. 
This was attributed to people having set a higher threshold for life expectations in this 
group and experienced greater disappointment if their goals were not achieved in their 
work or personal environment compared to groups who were less educated.  
The evidence also indicates that more deprived individuals might perceive their quality 
of life to be poor when experiencing a health problem likely to be deteriorating due to 
limited socio-economic resources. Mielck, Reitmeir, Vogelmann, & Leidl (2012) used 
the EQ-5D because it could capture health inequalities (König, et al., 2010) which 
included five dimensions relating to quality of life (degree of mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression). Results showed that all dimensions 
of quality of life that were assessed were more prevalent in the group with lower 
educational attainment when adjusting for age and sex. Further analyses conducted on 
subgroups of participants who were suffering from a chronic illness revealed a 
relationship between lower educational attainment and decreased quality of life as 
compared to the higher education group.  
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Similarly, Regidor, et al. (1999) observed a positive association between educational 
attainment and quality of life in a non-institutionalised population aged over 15 years in 
Spain. Differences in self-rated health status between educational levels were 
examined using the SF-36 Health Survey. People with higher education (university) 
rated their quality of life better than people with lower educational level (primary and 
secondary). This relationship was linear; the higher a person’s education the better the 
self-rated health. This was consistent with Ross & Mirowsky’s (2011) findings who 
observed a social gradient in quality of life based on both income and education. 
Higher educational attainment and higher income were associated with better QoL. 
Increasing age was linked to decreased QoL in women from the upper-middle and 
highest levels of the socio-economic scale in comparison to women from lower SES 
groups. Ross & Mirowsky (2011) concluded that QoL followed a gradient which was 
dependent on income and education and exerted its influence starting in the early 
years of adulthood and persisting into late adulthood. 
   
b. Neighbourhood environment and QoL 
 
The effect of the immediate neighbourhood environment was examined in relation to 
four different dimensions of QOL: physical, psychological, social, and environmental by 
Mõttus, Gale, Starr, & Deary (2012) in a population aged 68 to 71 years in Edinburgh. 
Although some aspects of quality of life such as physical functioning and environmental 
satisfaction were independently related to neighbourhood deprivation, other aspects 
such as psychological and social functioning were not. Education and occupation were 
adjusted for in the analyses. The number of a person’s co-morbidities such as stroke, 
arthritis or diabetes, was not only linked to both quality of life and neighbourhood 
deprivation but also mediated this relationship. Mõttus et al. (2012) concluded that 
neighbourhood environment exerted a significant influence on the way residents rated 
their quality of life in various aspects. 
Neighbourhood deprivation was associated with poorer physical health status in people 
of more advanced age (Mõttus et al., 2012). In their systematic review, Yen, Michael, & 
Perdue (2009) stressed that the evidence for this association was only moderate and 
did not indicate which aspects of the neighbourhood environment were linked to health 
status. However, the criteria used in the review, the cross-sectional nature of the 
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studies and the non-comprehensive inclusion of databases might have influenced 
findings.  
Associations between neighbourhood quality and perceived quality of life in older 
people were also investigated by Webb, Blane, McMunn, & Netuveli (2011) in the 
English Longitudinal Study of Ageing. In this study, quality of neighbourhood included 
elements such as vandalism, trust, support amongst others and quality of life was 
measured with the CASP-19 which assessed perceived control, independence, 
satisfaction and self-realisation (Hyde, Wiggins, Higgs, & Blane, 2003). Four years after 
baseline, findings suggested that neighbourhood quality was independently related to 
self-reported quality of life, which echoed Wiggins, Higgs, Hyde, & Blane’s (2004) and 
Yohannes & Connolly’s (2004) results.  
Previous research has provided evidence for an association between neighbourhood 
deprivation and increased incidence of depression and anxiety independent of 
individual-level socio-economic factors (Fone, et al., 2007; Galea, et al., 2007; 
Sundquist & Ahlen, 2006).  Walters, et al. (2004) found that residing in areas of high 
deprivation and specifically high population density was related to depression but this 
effect disappeared when individual-level deprivation characteristics were controlled for. 
Their findings indicated that population density rather than deprivations was related to 
anxiety. Walters et al. (2004) concluded that individual-level characteristics and health 
status mediated the effect of area deprivation on depression. The cross-sectional 
design and limitations in measuring the expected dimensions of SES, health care 
utilisation or environmental factors should be considered when attempting to draw 
conclusions. 
Studies in Sweden, the United Kingdom and The Netherlands (Lofors, Ramírez-León, 
& Sundquist, 2006; Propper, et al., 2005; Reijneveld & Schene, 1998) did not find an 
association between depression and anxiety and neighbourhood deprivation when 
adjusting for individual-level socio-economic status. Gale, Dennison, Cooper, & Sayer 
(2011) claimed that it was not neighbourhood deprivation per se that was associated 
with population mental health based on their results from in a cross-sectional study 
conducted in Hertfordshire with residents aged 69-78 years. Elements of social capital 
such as sense of cohesion in the neighbourhood were linked to better mental health. 
Characteristics such as physical limitations, for example mobility or disability or 
availability of social support were significantly related to better mental health. The 
authors attributed the lack of association between neighbourhood deprivation and 
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psychological health to increased levels of neuroticism. The importance of 
neighbourhood quality was attributed to the fact that older people, due to mobility or 
disability issues, may spend more time at home and thus are more exposed and 
dependent on the effect of their immediate environmental factors (Yen et al., 2009). 
 
c. SES and QoL in chronic illness 
 
Montazeri, Hole, Milroy, McEwen, & Gillis (2003) investigated whether quality of life 
differed in patients who had recently received a diagnosis of lung cancer depending on 
their socio-economic status. QoL was assessed with the Nottingham Health Profile 
(NHP), the European Organization for Research and Cancer Treatment Quality of Life 
Questionnaire (EORTC QLQ-C30) and its supplement for lung cancer (QLQ-LC13) at 
baseline and three months after the first treatment. Socio-economic status was 
measured using the Carstairs and Morris Deprivation Category, a composite score. 
Results showed that over half of the patients with lower SES reported increased health 
problems and symptoms as well as impaired functioning in comparison to higher SES 
individuals. Patients from both SES groups appeared to have responded similarly to 
treatment in certain aspects of quality of life such as physical mobility, energy levels, 
role functioning, physical functioning, and breathlessness between baseline and at 
follow-up. Montazeri et al. (2003) suggested that quality of life was not only associated 
with the illness and its treatment but also significantly linked to patients’ socio-
economic status. 
Lower socio-economic status was linked to poorer quality of life in prostate cancer 
patients using annual income as an index of SES (Penson, et al., 2001). When 
education was used to assess SES results did not support this link (Litwin, McGuigan, 
Shpall, & Dhanani, 1999). Early prostate cancer patients with higher education were 
slower in returning to baseline QoL 1 year after prostatectomy (Litwin et al., 1999). 
However, wealthier and more educated participants were over-represented in the 
participant sample. 
Barbareschi, Sanderman, Kempen, & Ranchor (2009) reported that increased social, 
physical and role functioning was observed in CHD patients from higher SES groups as 
compared to lower SES groups 1 year post-diagnosis. However, Barbareschi et al. 
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(2009) noted that the attrition rate in their study was high and that may have biased the 
results in the direction of less severe CHD and lower levels of depression and anxiety. 
Mental and physical quality of life in end-stage renal disease (ESRD) was poorer in 
lower SES patients in comparison to higher SES groups and had deteriorated further at 
follow-up (Sesso, Rodrigues-Neto, & Ferraz, 2003). SES did not only affect short-term 
quality of life in ESRD but also persisted in the long-term. Sesso et al. (2003) attributed 
this effect to people with higher SES being more able to cope with both stress and the 
burden of the disease physically and emotionally. In the lower SES group, limited or 
impaired availability of resources and social support may have had a negative effect on 
patients’ QoL. A small sample size and the use of the SF-36 to assess QoL – which 
was not disease-specific for ESRD – may have prevented identification of additional 
relationships. 
Harris, Luft, Rudy, & Tierney (1993) found that low SES in terms of income, 
educational level and employment was associated with increased levels of disability in 
patients with chronic kidney failure. Higher income and education were related to 
improved well-being in moderate to advanced renal failure patients (Rocco, Gassman, 
Wang, & Kaplan, 1997) and patients on dialysis (Moreno, Gomez, Sanz-Guajardo, 
Jofre, & Valderrabano, 1996). However, investigation of the relationship between SES 
and QoL was not the aim of these studies and the methods of measuring SES were not 
reported in detail. This warrants caution when interpreting findings. 
 
2.4.3 Socio-economic status and quality of life in COPD 
 
QoL is an important factor for prognosis in COPD (Balcells, et al., 2010). For example, 
impaired quality of life in COPD patients has been linked to higher risk of hospital 
admission, mortality and morbidity when disease severity was adjusted for (Domingo-
Salvany, et al., 2002; Osman, Godden, Friend, Legge, & Douglas, 1997; Sullivan, 
Ramsey, & Lee, 2000). 
The majority of research has investigated the relationship between QoL and various 
aspects of COPD such as lung function decrease, exercise performance, degree of 
dyspnoea, number of co-morbidities and treatment efficacy (Ferrer, et al., 1997; 
Ketelaars, et al., 1996; Sullivan, Buist, & Weiss, 2003; Wijnhoven, Kriegsman, 
Hesselink, De Haan, & Schellevis, 2003; Wijnhoven, Kriegsman, Hesselink, Penninx, & 
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de Haan, 2001). Sleep difficulties, physical and mental disturbances such as low 
oxygen level, depression, anxiety, and even demographic characteristics such as 
socio-economic factors, age and environmental irritants can also influence QoL in 
COPD (Eisner, et al., 2010; Engström, Persson, Larsson, & Sullivan, 2001; Jones, 
1991; McSweeny, 1982; Okubadejo, Jones, & Wedzicha, 1996; Prigatano, Wright, & 
Levin, 1984; Ternesten-Hasséus, Larsson, & Millqvist, 2011; Balcells et al., 2010). 
Quality of life is significantly impaired in patients with COPD in comparison to healthy 
populations and is poorer with increasing level of disease severity (Ketelaars et al., 
1996; Okubadejo et al., 1996; Ferrer et al., 1997). Due to the association between 
severity and QoL, the need to adjust for disease severity in analyses to eliminate 
confounding effects is highlighted.  
Ethnic differences can have an impact on QoL in COPD (Han, et al., 2011). When 
controlling for confounding variables such as FEV1 , dyspnoea, smoking history, SES 
variables, prior exacerbations, QoL was similar in Caucasians and African American 
patients with COPD without exacerbations but worse for the latter group with 
exacerbations. This was observed despite the lack of significant difference in frequency 
of exacerbations between Caucasians and African Americans (Han et al., 2011). The 
authors concluded that the impact of hospitalisation was more severe on African 
Americas than on Caucasians suggesting that this could be attributed to socio-
economic, cultural or biological factors. For example, increased admission rates to 
intensive care unit for African Americans were an indicator of their higher vulnerability 
to more severe exacerbations (Sarrazin, Cannon, Rosenthal, & Kaldjian, 2009). Ethnic 
disparities could affect provision of treatment for COPD patients such as prescriptions 
for oxygen at home, vaccinations, and smoking cessation referrals due to health 
professionals’ stereotypes or biases against certain ethnic groups. Ethnic minority 
background could be associated with lower SES reflected in lack of health insurance 
and access to primary care physicians as well decreased lung function, all of which 
could possibly increase the likelihood of exacerbations (Chandra et al., 2009; 
Dransfield & Bailey, 2006) 
Despite evidence for the association between SES and QoL the exact pathways 
through which this influence is exerted still remains elusive. A variety of mechanisms 
have been proposed such as impaired health care access and biological vulnerability 
(Chandra et al., 2009; Dransfield et al., 2006). Other explanations include decreased 
mobility which prevents patients from full-time employment and therefore inability to 
finance treatment or insurance premiums which are considerably high in COPD 
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(Sullivan, et al., 2000). Saadat et al., (2007) emphasized that low SES was a significant 
factor in impaired QoL in COPD patients and noted that this effect was more apparent 
in COPD as compared to other conditions (Prescott & Vestbo, 1999). Evidence of a 
socio-economic gradient in QoL in COPD according to income level was found  despite 
the fact that Saadat et al. (2007) had matched participants according to SES, co-




The evidence supporting the link between lower SES and poorer quality of life across a 
number of diseases is irrefutable. It also highlights the multifaceted nature of SES 
involving different elements such as educational attainment, occupational status, 
income levels and neighbourhood deprivation. Therefore, it is vital for studies that 
examine SES in relation to HCA and/or QoL to consider assessing SES in various 
ways in order to capture its full impact on these outcomes especially in diseases 
associated with low SES such as COPD. 
 
2.6 Social capital and health 
 
Socio-economic deprivation manifests itself both in the material and in the social 
domain. Lack of income and limited material resources contribute to poorer quality of 
life and well-being through deprivation of amenities, comfort and security (Geyer & 
Peter, 2000; Lynch & Kaplan, 2000). Social resources such as availability of social 
networks and social support as well as group activities and interactions are important 
for people’s well-being (Berkman & Breslow, 1984). Decreased participation of lower 
SES groups in social, recreational and cultural activities, limited and unstable social 
networks can lead to social exclusion. This exclusion can also be accompanied by a 
sense of deprivation in terms of social rewards which, in turn, contributes to 
deterioration of self-rated health and can increase symptoms of depression (Berkman, 




The availability of social networks, social cohesion, trust and activities in the community 
are embedded within a wider concept which is termed social capital. Social capital is 
defined by Lynch & Kaplan (1997) as “the stock of investments, resources and 
networks that produce social cohesion, trust and a willingness to engage in community 
activities”. Social cohesion is described by Wilkinson (2002) as “the social nature of 
public life, dominated by peoples’ involvement in the social, ethical and human life of 
the society, rather than being abandoned to market values and transactions. People 
come together to pursue and contribute to broader, shared social purposes”. Therefore, 
a social environment that includes an increased number of networks providing 
participation as well as a high degree of social trust and reciprocity can lead to better 
health. Decreased social cohesion and trust were associated with increasing inequality 
between wealthier and poorer groups in society (Kaplan, Pamuk, Lynch, Cohen, & 
Balfour, 1996; Kawachi & Kennedy, 1997; Kennedy, Kawachi, & Prothrow-Stith, 1996; 
Wilkinson, 1994). 
Kawachi, Kennedy, Lochner, & Prothrow-Stith (1997) found a strong relationship 
between social capital and income inequality and mortality. A strong but negative 
association between the magnitude of this gap and the degree of social capital 
investment between wealthy and poor groups was observed. This indicated that one 
route through which financial inequality had an impact on mortality was through limited 
investment in social capital. Kawachi et al. (1997) suggested that the sources of 
financial inequality and limited investment in social capital could be attributed to 
attitudes existing in society which had not yet been measured such as low levels of 
trust (Brehm & Rahn, 1997). Social capital mediated the relationship these two 
dimensions (Kawachi et al., 1997). However, the study was cross-sectional which 
limited identification of causal relationships and not all factors that could have been 
implicated in the relationship between income inequality and social capital were 
investigated. 
Christakis & Fowler (2007) claimed that networks are associated with biological and 
behavioural traits of obesity observing that obesity seemed to be spreading through 
people’s social interactions and relationships. Christakis & Fowler (2008) argued 
further that people’s smoking and happiness are influenced and are dependent on the 
smoking and happiness of other people with whom they maintain connections found in 
up to three degrees of separation. These studies highlighted the importance of social 
interaction and community ties between individuals and the possibly collective nature of 
health-related phenomena. These findings indicated that social capital and health may 
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be associated but the mechanism underlying this association is still unknown (Abbott & 
Freeth, 2008). 
Veenstra (2002) claimed that social capital and income inequality may be associated 
with people’s health but that their relationship was not clear. Veenstra (2002) 
suggested that the relationship between mortality and income inequality was stronger 
than that between social capital and mortality. Similarly, Drukker, Kaplan, Feron, & Van 
Os (2003) examined the relationship between socio-economic status and social capital 
on children’s health-related quality of life in the Netherlands and found associations for 
both in regards to children’s general health status and satisfaction.  
One of the difficulties in exploring the relationship between social capital and health is 
social capital itself. Social capital is a relatively wide concept (Abbott & Freeth, 2008).  
Putnam (1993) referred to social capital as ‘social trust, norms of reciprocity, networks 
of civic engagement, and successful cooperation’. Other studies focus specifically on 
social relations and support (Cooper, Arber, Fee, & Ginn, 1999; Coulthard & Britain, 
2002). These concepts are not necessarily mutually exclusive but could be 
supplementing each other (Putnam, 1993). The challenge lies in the fact that these 
elements are linked to different domains. While social relationships and collaboration 
reflect behavioural patterns, trust and reciprocity reflect people’s attitudes (Harpham, 
Grant, & Thomas, 2002; Johnston & Soroka, 2001). The difficulty in defining the 
components of social capital makes its measurement and examination more complex. 
In an attempt to investigate how these components may be linked to health, two of 
them – trust and reciprocity – are discussed in further detail below. 
 
 Trust and health 
 
Various elements of social capital including trust were examined as to their association 
with health (Hurtado, Kawachi, & Sudarsky, 2011). High level of interpersonal trust was 
related to decreased likelihood of poor self-rated health when controlling for 
demographic variables.  
Fujiwara & Kawachi (2009) conducted a twin study in the US investigating whether 
differences in physical and mental health between twins were associated with 
differences in their reports of social capital. The twin who reported receiving higher 
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levels of trust also reported better physical health. Positive associations between self-
rated health and various measures of social capital have been observed (Carlson, 
2004; Lindström, 2004; Subramanian, Kawachi, & Kennedy, 2001). Sundquist & Yang 
(2007) found that individuals living in neighbourhoods with the lowest levels of linking 
social capital had a significantly higher risk of poor self-rated health than individuals 
living in neighbourhoods with the highest levels of linking social capital. The authors 
suggested that this relationship might be due to opportunities for interaction across the 
power gradient (Szreter & Woolcock, 2004) available to individuals living in 
neighbourhoods with well-functioning social networks and high levels of horizontal and 
vertical trust. These individuals might perceive more power and greater control over 
their lives. In contrast, limited opportunities for social interaction in neighbourhoods with 
lower social functioning could lead to stress due to powerlessness or lack of control. 
This stress could be involved in the relationship between low neighbourhood linking 
social capital and poor self-rated health. 
Low levels of social trust were related to income inequality (Brehm et al., 1997). 
Increasing income inequality significantly predicted decreasing interpersonal trust.  
Decrease in interpersonal trust was associated with low civic engagement which 
suggested that people who trusted others less were more likely show lower 
participation in societal activities. 
Chappell & Funk (2010) found a direct relationship between income and general 
perceived health as well as physical functioning. No direct association was found 
between health status and educational attainment or any of the social capital elements 
(social participation and trust). Indirect effects, however, showed that trust was 
significantly associated with health through its effect on self efficacy. Chappell & Funk 
(2010) emphasised that it was not social participation but trust that was related to 
health. They suggested that the concept of social capital may have more validity on a 
collective level echoing previous research by Veenstra (2000) who did not find a 
evidence for social participation and health status. Veenstra (2000) questioned the 
benefit of social capital on the individual level but stressed that individual benefits could 
still be obtained through collective social participation and trust. 
Happiness appears to be influenced by trust (Layard, 2005). Others claimed that it is 
wealth rather than trust that promotes better health (Halpern, 2005) based on the 
assumption that richer countries also have higher levels of trust. When this association 
was adjusted for wealth, the effect weakened significantly supporting this view.  
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There are various pathways through which social trust may exert its influence on 
health. Trust may not have a direct effect on health but could be mediating the 
relationship between health and other elements of social capital. For example, social 
networks that people have developed are based on trust and associated with better 
health (Berkman, 1995; House, Landis, & Umberson, 1988). Lack of trust and 
suspicion led to social isolation which was associated with impaired health (Glass & 
Balfour, 2003) especially in older people. 
Trust has an impact on social anxiety promoting feelings of security and safety 
(Wilkinson, 2000). This could decrease the likelihood of chronic stress which was 
associated with poorer health especially with cardiovascular disease and increased 
blood pressure due to high strain, pressure and stress levels at work and at home 
(Greenwood, Muir, Packham, & Madeley, 1996). Cohen, Janicki-Deverts, & Miller, 
(2007) found that prolonged stress was linked to adverse health outcomes such as 
higher risk of depression, diabetes, autoimmune conditions and respiratory infections 
as well as impaired wound healing. Possible immunological pathways were suggested 
as explanatory mechanisms indicating that chronic stress was linked to inflammation in 
the body which contributes significantly to the onset and progression of a variety of 
diseases (Cohen, et al., 2012). 
Hibino, et al. (2012) found a negative association between social trust and safety in the 
neighborhood and self-rated health but not for social participation.  When analyses 
controlled for demographic variables and SES, social trust was still negatively related 
to poor self-rated health. This study was conducted in Japan and possible differences 
in cultural and social factors need to be taken into consideration when interpreting the 
findings. 
Neighbourhood issues could be associated with chronic stress independent of social 
capital (Steptoe & Feldman, 2001). More affluent neighbourhoods were rated as having 
higher social capital. They displayed stronger social cohesion and controls, higher 
levels of trust and mutual support. In contrast, neighbourhoods with weaker informal 
social controls were associated with problems, for instance, littering and walking after 
dark. These issues would be expected to be more critical in areas where antisocial 
behaviour is not prohibited. Relationships found between neighbourhood problems and 
social cohesion and control were moderate which – according to Steptoe and Feldman 
(2001) – indicated that there was not only an overlap in the measures but that they 
were also measuring distinct phenomena. Self-reported health, distress, decreased 
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physical functioning were linked to problems in the neighbourhood. These problems 
showed positive associations with deprivation on an individual level but negative 
correlation with social capital. Analyses had adjusted for age, sex, SES neighbourhood 
and individual deprivation level. Still, the difficulty in clearly defining and measuring 
social capital needs to be taken into consideration when interpreting these results. 
The effect of social capital in terms of trust and social support extends to health 
behaviours. Giordano & Lindström (2011) reported that smoking was significantly 
associated with marital and occupational status as well as with components of social 
capital. Income, social class and health status were not associated with smoking 
behaviour change. Giordano and Lindström (2010) concluded that psychosocial 
domains such as being married or employed and components of social capital such as 
increased trust and participation were important in aiding people to quit or not initiate 
smoking in the first place. Their findings provided support that social capital and marital 
status and employment were significant factors in quitting smoking probably not only 
for the financial security they provided but also through provision of social support. 
Considerable evidence for the association between social capital and health exists. 
However, measurement difficulties and different components of social capital were 
associated with different outcomes. But does social capital also play a role in health 
care access and quality of life in patients with COPD and in what ways? 
 
2.6.1 Social capital and COPD 
 
No published evidence has been found to the time of writing this research that has 
investigated the association between social capital and COPD. Since social capital 
includes elements such as social participation or social networks, these aspects can – 
in theory – also be used as social capital measures when examining research on social 
capital and COPD. 
Progressive decline in pulmonary function associated with physical limitations can lead 
to social isolation and negative affect in patients with COPD due to loss of 
independence and feelings of self-blame (Guthrie, Hill, & Muers, 2001; Leidy & Haase, 
1999; Nicolson & Anderson, 2003; Toms & Harrison, 2002). Integration with the social 
environment and provision of social support were significantly associated with health 
status and outcomes (Cohen, 2004). COPD patients were more likely to enjoy social 
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participation, and the giving and taking in their social environment despite their physical 
impairments (Mars, Kempen, Mesters, Proot, & van Eijk, 2008; Williams, Bruton, Ellis-
Hill, & McPherson, 2007). 
Pulmonary rehabilitation (PR) can provide access to social networks and participation 
for patients with COPD. PR is a course that targets COPD management and 
rehabilititation and also provides support with coping with the illness (GOLD, 2011; 
Lacasse et al., 2007; Lacasse et al. 2006). PR is usually conducted in groups and 
involves an exercise regime and counseling on diet and education COPD. 
PR was positively associated with peer and health professional support through 
provision of renewed hope, increase in patients’ perceptions of control and self-
confidence, renewal of their engagement in social activities and stronger participation 
in society (Arnold, et al., 2006; Chan, 2004; Monninkhof, et al., 2004; Norweg, Bose, 
Snow, & Berkowitz, 2008; Wilson, O'Neill, Reilly, MacMahon, & Bradley, 2007; Toms & 
Harrison, 2002). 
Halding, Wahl, & Heggdal (2010) observed that integration of patients in their PR 
groups as well as social support received from health professionals was very important 
for participating COPD patients. PR offered them the opportunity to engage with other 
people, exchange experiences and knowledge. It also encouraged provision and 
receipt of trust and support among patients and reinforcement of their self-confidence 
to manage their illness and extend their social participation. These elements were, in 
turn, related to improved adaptation and coping with COPD as well as improved quality 
of life. Halding et al. (2010) found that lack of trust towards the health care system due 
to past experiences was likely to prevent patients from integrating successfully into 
their PR groups. However, the authors emphasized that the findings might not be 
generalisable due to the characteristics of the geographical area in which participants 
resided. The location was relatively isolated which might have limited social networking 
among patients due to physical distance. A second reason was that 15 out of the 33 
PR participants approached did not participate in the study which could have biased 
the results because these patients could have experienced and received social support 
in a different way. 
The main message derived from Halding et al.’s (2010) study was COPD patients’ 
desire to experience a sense of belonging to a social group and to develop social 
relationships that could offer them support. This was also stated by patients with COPD 
who were socially isolated due to their disease (Guthrie et al., 2001; Leidy & Haase, 
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1999; Nicolson & Anderson, 2003; Toms & Harrison, 2002) which led to reduced ability 
to relate to other people (Gullick & Stainton, 2008; Jónsdóttir & Baldursdóttir, 1998). 
Kara & Mirici (2004) also found an association between loneliness and depression 
which was stronger for lower social support received from family and friends. 
Social support was linked to improved quality of life in COPD patients (Arne, et al., 
2011). Better health, based on self-rating and quality of life, was related to increased 
exercise performance, social support, and lack of financial worries. However, severity 
was not adjusted for in the analyses. In addition, cause and effect cannot be 




Research so far supports the importance of social capital in health status and health 
behaviours such as smoking and participation in pulmonary rehabilitation.  Specific 
elements of social capital have been associated with better health, mainly higher 
interpersonal trust, reciprocity and social participation. Some of these components 
exert their influence indirectly through psychosocial mediators for example self-efficacy. 
This increases the complexity of the pathways in which social capital and its 
components are associated with health. The relationship between social capital and 
socio-economic variables suggests that these interrelationships may be more intricate 
than previously thought. 
 
2.7 Additional factors to consider when examining health care access and quality of life 
in COPD 
 
The most common pathways through which SES can exert an impact on the availability 
and accessibility of health care services as well as on people’s well-being and quality of 
life in COPD have been discussed in previous sections. The focus of these pathways 
has been mainly on wider socio-economic variables associated with HCA and QoL in 
COPD such as deprivation in terms of income, education and occupation and 
neighbourhood SES. However, there are further factors which could more directly 
influence the way people seek health care and adjust and cope with their condition that 
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are more specific to the individuals themselves and their immediate surroundings. 
These will be described in the following sections. 
 
2.7.1 Self-management in COPD 
 
Self-management programmes aim to actively involve patients in their treatment 
process by providing them with the knowledge and skills to cope effectively with 
various aspects of their disease management such as medication adherence, 
monitoring their condition such as identifying early signs of exacerbation of COPD and 
responding accordingly to prevent deterioration and progression as well as making 
changes to health behaviours (Worth & Dhein, 2004).  
In COPD, exacerbations can be reduced by medication such as long-acting 
bronchodilators combined with anti-inflammatory drugs. Inhaled corticosteroids were 
associated with a reduction in rate of 25% compared to placebo in patients with 
moderate to severe COPD (Burge, et al., 2000). Hopes that admissions could be 
reduced by drug intervention have not been so clearly realised (Wilkinson, Donaldson, 
Hurst, Seemungal, & Wedzicha, 2004). These findings suggested that pharmacological 
treatment contributes to the reduction of exacerbations and hospital admissions in 
COPD. While medication has a significant impact on patients’ health status, there has 
not been much evidence of an effect in admission rates. Self-management plays an 
important role in COPD and can supplement and enhance the effects of 
pharmacological treatment. 
Patient education and self-management programmes have been associated with 
improvement in patients’ quality of life, lower morbidity rates and reduced health care 
costs in various chronic diseases such as asthma, diabetes and heart failure (Gibson, 
et al., 2002; Gazmararian, Williams, Peel, & Baker, 2003). In COPD, the evidence is 
not as consistent as in other chronic illnesses (Bourbeau, et al., 2003; Rice, et al., 
2010). Monninkhof, et al.’s (2003) review of eight studies comparing self-management 
education with routine care found no effect on hospitalisation rates, accident and 
emergency visits, days lost from work, and lung function. Findings regarding health-
related quality of life showed a positive trend but did not reach statistical or clinical 
significance. The authors attributed these findings to variability in the measurement and 
use of COPD-specific instruments. The review did highlight that the need for rescue 
medication was reduced in the intervention groups possibly indicating an association 
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between self-management education and improved disease control in COPD patients. 
Findings that half of the exacerbations in patients with COPD were not reported to a 
doctor led to the hypothesis that more educated patients were more likely to have 
increased oral steroid and/or antibiotic intake for their symptoms thus decreasing the 
likelihood of GP or A&E visits (Seemungal, et al., 1998). Insufficient data and 
heterogeneity in the definition and measurement of outcome measures used in the 
studies included in their review prevented Monninkof et al. (2003) from making 
recommendations for self-management programmes in COPD. In contrast, an updated 
Cochrane review by Effing, et al. (2007) showed that self-management education was 
associated with a decrease in hospital admissions justifying a generic recommendation 
of self-management education in COPD. However, results did not show positive effects 
regarding GP and nurse visits, symptoms, use of steroids and/or antibiotics and rescue 
medication, exacerbation rates, A&E visits, lung function, exercise performance, and 
days lost from work associated with self-management. Effing et al. (2009) were also 
unable to provide clear recommendations on the type and components of self-
management education programmes in COPD due to significant heterogeneity in the 
design and content of the interventions, study populations, follow-up time, and outcome 
measures of the reviewed studies. 
It appears from the evidence that self-management programmes could be 
recommended as a way to enhance the effects of medication in patients with COPD. 
Certain components and specific content of self-management education might provide 
more positive effects. Self-management education for COPD patients may require a 
more patient-tailored approach in terms of treatment, patient education and self-
management due to the characteristics of the disease and associated factors such as 
higher number of co-morbidities, patients’ age and complexity of treatment regimen. 
Additional factors should be considered such as adherence to self-management 
programmes. Studies reported adherence rates between 40-42% in self-management 
education components in COPD patients (Bischoff, et al., 2011; Bucknall, et al., 2012). 
The patients who adhered to the intervention did show improved outcomes. These 
findings suggested that targeting patient characteristics such as self-efficacy might 
contribute to increasing adherence rates to self-management programmes. Self-
efficacy refers to the patients’ belief in their ability to achieve desired goals (for a 
detailed discussion of self-efficacy see Chapter 3). Having information about the 
disease is one half of the story. The other half is patients’ perceptions of their skills and 
ability to integrate this knowledge and the demands of the disease into their daily life 
(Bourbeau, Nault, & Dang-Tan, 2004). Self-efficacy or the perception of having the 
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skills to perform a desired behaviour is associated with health-related behaviour 
changes (Bandura, 1978). Self-efficacy has been found in many COPD studies to 
influence specific health behaviours (Scherer & Schmieder, 1997; Atkins, Kaplan, 
Timms, Reinsch, & Lofback, 1984b; Gormley, Carrieri-Kohlman, Douglas, & Stulbarg, 
1993;  Kaplan, Ries, Prewitt, & Eakin, 1994). Thus, an intervention aiming to increase 
self-management in COPD should ideally include components to increase patients’ 
efficacy beliefs and confidence in outcomes in addition to patients’ knowledge about 
COPD.  
Last but not least, such as health-related education, cognitions and beliefs have to be 
considered when designing self-management interventions. According to the World 
Health Organization (1998) health education was defined as "comprising of consciously 
constructed opportunities for learning involving some form of communication designed 
to improve health literacy, including improving knowledge, and developing life skills 
which are conducive to individual and community health." (WHO, 1998). Some patients 
might naturally be better self-managers than others and this might increase their 
benefits. For example, a study by Fan, et al. (2012) suggested that patients may not 
always comprehend what they are being asked to do. Patients with COPD are called to 
identify and self-manage complicated and variable events that could also be related to 
co-morbidities and a number of different diagnoses such as pneumonia, heart failure, 
and pulmonary embolism. The ability to self-manage more effectively which includes 
self-efficacy has been linked to health literacy. Health literacy refers to having the 
knowledge and skills to understand and act upon health information, communicate 
one’s history effectively to the health care professionals and follow their 
recommendations. Health literacy also encompasses additional aspects of health care 
such as understanding how to access medical services, make appointments, complete 
and sign consent and insurance forms and being aware of medication and medical 
procedures costs as well as sources of payment (Sadeghi, Brooks, Stagg-Peterson, & 
Goldstein, 2013). Population groups that are at greater disadvantage for lower health 
literacy include immigrants, unemployed and elderly people (Wilson, Racine, Tekieli, & 
Williams, 2003) especially those who suffer from chronic illnesses such as asthma 
(Davidsona, Liub, & Sheikhc, 2010; Mancuso & Rincon, 2006), COPD (Partridge, 
Karlsson, & Small, 2009) and diabetes (Reid, et al., 1995). People with chronic 
illnesses and low health literacy have limited information and education about their 
illness, poorer health status and symptom management in comparison to people who 
have sufficient disease-related education (Gazmararian, et al., 2003). The following 
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section provides a more detailed discussion of health literacy and its importance in 
chronic illness self-management. 
 
2.7.2 Health literacy in COPD 
 
Health literacy or patient education is one of the factors that can influence the degree 
and effectiveness of self-management in COPD. Health literacy is defined by the World 
Health Organization (WHO) as ‘‘the cognitive and social skills that determine the 
motivation and ability of individuals to gain access to understand and use information in 
ways which promote and maintain good health” and “Health literacy means more than 
being able to read pamphlets and successfully make appointments. By improving 
people’s access to health information and their capacity to use it effectively, health 
literacy is critical to empowerment’’ (Nutbeam, 1998).  Thus, health literacy could be 
considered as one of the pre-requisites for successful patient education and optimal 
disease and medication management. Health literacy is not only personal but also 
social in nature. It is important for effective communication between the health care 
professional and the patient with COPD. One of the challenges specifically in COPD is 
that disease management is not straightforward due to the presence of multiple co-
morbidities and complex treatment regimens in the majority of patients (Crisafulli et al., 
2008). 
Pulmonary rehabilitation is one of the treatment options available to COPD patients. It 
involves provision of supervised exercise training, self-management education and 
psychological support (Hill et al., 2010). Effective communication between health care 
professionals (HCPs) and patients is central to all three components of pulmonary 
rehabilitation. Patients’ capacity to understand complex verbal or written information is 
related to the degree of knowledge of their underlying disease. Lower health literacy is 
associated with less effective symptom management and poorer health status in 
comparison to patients with higher health literacy levels (Berkman, Sheridan, Donahue, 
Halpern, & Crotty, 2011). Patients may not understand what is wrong and how it can be 
addressed and they may also be too embarrassed to admit this lack of understanding. 
However, health care professionals are equally unaware of the importance of health 
literacy in their communication with patients (Baker, et al., 2004). This was evident in 
Sadeghi, Brooks, & Goldstein’s (2013) study who interviewed COPD patients and 
health care professionals at a Pulmonary Rehabilitation Centre about their views on 
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health literacy in health care communication. Findings indicated that the majority of 
patients were not aware of what constituted health literacy but did acknowledge the 
importance of knowledge in relation to their quality of life which was a view also shared 
by health care professionals. Patients reported that time constraints and use of medical 
terminology were barriers to effective communication with their health care 
professional. For health care professionals, barriers included patient characteristics 
such as language, culture and awareness of the availability and purpose of health care 
services. A variety of sources such as family and peer support, informational resources 
and trust and empathy between patient and health care professional were reported as 
being beneficial in improving patient-health care professional communication (Sadeghi, 
Brooks, & Goldstein, 2013). 
Successful self-administration of medication was a further treatment component of 
COPD care that was associated with patient education as shown in a study of 191 
COPD patients across 7 outpatient clinics (Bourbeau, et al., 2003). Patients who had 
received the education self-management intervention were less likely to have been 
hospitalised, to have visited A&E and to have consulted their GPs compared to patients 
who had not received the intervention (Bourbeau, et al., 2003). Insufficient health 
literacy skills have been associated with higher hospital admission and mortality rates 
and poor disease control (DeWalt, Berkman, Sheridan, Lohr, & Pignone, 2004; Sudore, 
et al., 2006; Wolf, Gazmararian, & Baker, 2005). Health literacy in COPD refers not 
only to self-management skills but also to the ability to utilise health care services in the 
most beneficial way for one’s quality of life and prevention of exacerbations (Kiser, 
Jonas, Warner, Scanlon, Bryant Shilliday & DeWalt, 2012). Health literacy in COPD is 
especially important given the particular characteristics of the disease. For example, 
the pharmacological regimen for patient includes a number of inhalers each of which 
may require a very different inhalation technique. Inhaler technique is crucial because it 
can support or prevent the delivery of the inhaled medication to the lungs which is 
necessary for successful management of the disease. Low health literacy in patients 
with asthma has been associated with worse inhaler technique compared to patients 
with sufficient literacy (Paasche-Orlow et al., 2005; Williams, Baker, Honig, Lee, & 
Nowlan, 1998). Self-management programmes that also addressed inhaler technique 
in their education content were associated with improved health care use, quality of life 
and rescue medication use (Blackstock & Webster, 2007; Lemmens, Nieboer, & 
Huijsman, 2009; Peytremann-Bridevaux, Staeger, Bridevaux, Ghali, & Burnand, 2008). 
Similarly, Kiser et al. (2012) evaluated the effect of a self-management educational 
intervention compared to routine care in lower and higher health-literacy patients with 
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COPD. The intervention addressed inhaler technique, smoking cessation, and the use 
of a COPD action plan. Findings indicated that a self-management intervention tailored 
to patient literacy needs was associated with improvements in inhaler technique for 
both patient groups. 
In view of the evidence, it has been suggested that self-management programmes for 
COPD are beneficial but should be patient-centred and tailored to the needs of 
individual patients based on their disease and personal characteristics, taking into 
consideration the patients’ capacity of understanding their exacerbation symptoms and 
incorporate skills and self-health behaviours (Bourbeau, et al., 2004; Wedzicha & 
Vestbo, 2012). So far, the discussion of the evidence regarding factors influencing 
health care access and utilisation of services in COPD has been limited to patient- and 
health care professional-specific factors. The third variable to be discussed in order to 
acquire a better understanding of the situation in COPD refers to structural factors and 
is provided below.  
 
2.7.3 Structural factors in accessing health care services in COPD 
 
In addition to factors relating to self-management including health literacy and support 
from health care professionals, there are also structural barriers that may hinder 
patients’ access and use of health care services for their COPD. Structural factors refer 
to aspects relating to the organisation and supply of services that are essential for 
managing chronic and acute illness in primary and secondary care. 
Previous research has indicated that patients with COPD reported a number of barriers 
in accessing their GP practice such as lack of transportation to the surgery, walking the 
distance from the car park to the surgery or going up the stairs to the doctor’s office 
which placed additional demands on patients’ physical limitations such as 
breathlessness, lack of continuity of care due to seeing a different GP every time, good 
relationship with practice staff including delays in telephone requests for prescriptions 
and receiving response from a practice answerphone, provision of regular routine 
appointments and the option for home visits (Shipman, White, Gysels, & White, 2009). 
Patients’ mobility difficulties had been cited in previous studies as being an important 
barrier in COPD patients having less contact with their GPs which showed a steady 
decrease over time (Elkington, White, Addington-Hall, Higgs, & Edmonds, 2005). 
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With regard to the primary care setting, the quality of GP practice services available to 
their patients is another structural factor that needs to be taken into consideration. For 
example, McLean, Sutton, & Guthrie (2006) did not find evidence of an improvement in 
treatment quality with the provision of incentive payments to GPs in the NHS GP 
contract (Quality and Outcomes Framework - QOF). However, for 17 of the 33 QOF 
indicators – for which payments were made – that were examined, they did observe 
that poorer quality of care was associated with higher deprivation. The difference in 
delivered quality provided by GP surgeries was smaller for the majority of simpler 
process measures, such as recording of smoking status or blood pressure 
measurement while for more complex process measures such as diagnostic 
procedures, for example, glycaemic control in diabetes and influenza immunisation, 
differences in quality were significantly greater. 
Secondary and tertiary care settings contain similar barriers from an organisational and 
supply aspect for COPD services. Hospitalisation rates in COPD were associated with 
high mortality and extended lengths of stay (Roberts, et al., 2001). However, both of 
these variables varied significantly between hospitals (Roberts, et al., 2002). These 
differences were partly due to patient-related factors such as health care seeking 
patterns of effective self-management (Price, et al., 2006) and partly due to hospital-
specific factors such as availability of resources.  
Price et al. (2006) found a strong correlation between the number of of specialists per 
hospital bed and per patient outcome such as decreased mortality rates. This 
relationship followed a linear trend with increasing number of specialists associated 
with better outcomes. Both the numbers of specialists and organisational component 
such as the availability of local management guidelines, higher number of beds and a 
composite organisational score derived from good medical practice were associated 
with shorter hospital stays. The authors emphasized that this might be an issue of 
organisation relating to the whole system of health care and resource availability 
affecting quality of patient care rather than any individual component such as specialist 
numbers. Price et al. (2006) also highlighted that their findings did not show that any of 
the organisational or resource factors could account for the variation in readmission 
rates. They suggested that this variation in readmissions could be attributed to the 
degree of disease severity before admission or a lack of effective ways of coping 
employed by acutely breathless COPD patients. Price et al. emphasised the need for 
patient empowerment and their ability to effectively self-manage their exacerbation 
using rescue medication and access to health care services at home as possible 
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alternative strategies which would, however, still need validation. While Price et al.’s 
(2006) evidence is indicative of a good effect, it cannot provide information for causal 
effects without data from a trial setting.  
Considerable variation between units of organisation and resources in the quality of 
secondary care provision which could affect patient care was also reported by George, 
et al. (2011) based on data from the 2008 COPD Audit. Despite significant 
improvement in resources, organization and delivery of acute COPD care across the 
UK with greater accessibility to COPD-specific services as well as a slight decrease in 
mortality and length of hospitalisation, considerable variation between units remained. 
For instance, while utilisation and availability of pulmonary rehabilitation programmes 
was increased from 64% in 2003 to 90% in 2008, only 59% of units were able to 
provide access to all eligible patients – based on NICE guidelines – and other units 
offered limited availability of the programme.  
Hospitals with greater resources were found more likely to achieve better outcomes ( 
Roberts, Barnes, Lowe, & Pearson, 2003). Hospital size also seemed to be inversely 
related to the availability of services such as pulmonary rehabilitation programmes, 
non-invasive ventilation (NIV) and invasive ventilatory support, specialist respiratory 
wards, speciality triage or early discharge scheme (Hosker, Anstey, Lowe, Pearson, & 
Roberts, 2007). Despite great variation in all elements of acute hospital care for COPD 
patients in the UK, findings indicate that smaller hospitals offer the fewest services and 
those hospitals that can offer specialist services are more likely to have better patient 
outcomes and be offered interventions of proven effect. 
However, availability of resources must be proportionate to demand. Landry, Hamdan, 
Al Mazeedi, & Brooks (2008) stressed the fact that the demand for health care services 
is always increasing and despite allocating monetary and human resources to meet 
needs, there will rarely be sufficient resources available to allocate to all diseases and 
settings. The authors cited research findings which reported a significant increase in 
health services demand for COPD which exceeded health care supply and would in 
theory lead to a problem in accessing services for COPD (Cao, Ong, Eng, Tan, & Ng, 
2006; Crockett & Price, 2007; Han, et al., 2007; Ninot, et al., 2006; Varkey, 2004; 
Wilkinson & Wedzicha, 2006; Wilson, 2006). Landry et al. (2008) proposed that the 
availability of rehabilitation services for COPD patients could act as a mediating factor 
to balance health service demand involving more expensive and resource-intensive 
health services on a long-term basis. However, despite its benefits for COPD patients, 
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there is great difference between demand and supply of pulmonary rehabilitation 
programmes for people with COPD with only 2.8% of Canadians receiving these 
services and the average wait time for inpatient rehabilitation services reaching 6 days 
(Canadian Institute for Health Information [CIHI], 2005). Data from North America, 
Europe, and Japan provided similar results with availability of pulmonary rehabilitation 
at only 56% of hospitals (Kida, et al., 1998) supporting the finding that services for 
respiratory conditions are only available for a minority of patients (Brooks, Lacasse, & 
Goldstein, 1999; Brooks, et al., 2007). Data from the UK COPD Audit from 2008 
(National COPD Audit, 2008) on the availability of pulmonary rehabilitation 
programmes described above are in line with these findings. 
2.7.4 Conclusion 
Evidence has been discussed highlighting the complexity of the role of socio-economic 
status in the health care access and quality of life in patients with COPD. There is more 
than one pathway through which SES can influence access to health services. The first 
is the “societal” pathway. It refers to the lack of or limited availability of resources such 
as primary and secondary health care services and great variability in the quality of 
care provided within them. This pathway reflects the societal or public aspects of 
accessing services. The second is the “personal” pathway. This pathway refers to the 
availability of the patient’s own resources that can influence their access to health 
services. Health literacy and self-management skills are two of the more personalised 
factors described so far that can influence whether, how and when patients access 
services they need. Lack of education and knowledge as to the meaning and urgency 
of experienced symptoms as well as of the existence and ways of utilising available 
services can be as great a barrier as the non-existence of services. Similarly, for quality 
of life in COPD, both pathways – the “societal” and the “personal” can influence a 
patient’s well-being. Findings from the literature do consistently show that access to 
health care services and quality of life in COPD cannot be accounted for by one 
category of factors such as SES or availability of health care services. There is another 
side to the story which involves the personal attributes and cognitions of the patient. 
These involve a variety of concepts such as the ways patients think about their illness 
and attempt to make sense of it as well as their perceptions of their ability to achieve 
desired outcomes such as increasing control over their condition. Understanding how 
SES is associated with HCA and QoL in COPD and improving these outcomes would 
require addressing a combination of patient- and health care professional-related 
characteristics as well as associated structural factors. On the one hand, patients need 
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to learn skills such as knowing how to use resources and manage their relationship 
with health care professionals as well as problem solving, decision making, identifying 
early exacerbations signs and taking action and following a predefined action plan 
(Bourbeau & Van Der Palen, 2009). The availability and use of these skills will enhance 
patients’ self-efficacy which needs to be supported by regular follow-ups – provided by 
health care professionals – leading to improved disease control and patient outcomes. 
The need for health care professionals to be proactive and reactive in their relationship 
with the patient is highlighted in research findings. Health care professionals need to be 
able to identify potential barriers that may prevent patients’ access and use of health 
services to their benefit and support their patients in overcoming these obstacles. They 
must also address structural factors that may hinder effective management of their 
patients’ condition. The role of further individual-level factors such as illness 
perceptions and self-efficacy and how they may be affecting HCA and QoL in COPD 
will be described in detail in Chapter Three.  
2.8 Overall conclusion 
There is evidence for the existence of an association between low SES and low HCA 
especially in COPD. Contradictory findings have also been described emphasizing the 
variability in the operationalisation and measurement of SES and HCA. Higher 
deprivation was also consistently associated with poorer QoL particularly in COPD. 
This, however, cannot be attributed to inequality in the access to health care services. 
The fact that higher deprivation is usually associated with poorer QoL and more severe 
disease highlights the need to adjust for severity when examining the relationship 
between SES and QoL in order to eliminate confounding effects and treatment 
variables. The question emerges as to the true nature of the relationship between SES 
and HCA and QoL in COPD and additional factors that could be involved in these 
associations since SES cannot fully account for this link. Therefore, the aim of the 
current study was two-fold. First of all, it was to examine whether lower SES was 
related to more impaired HCA and poorer QoL in COPD. Secondly, it was to 
investigate whether additional psychosocial factors such as social capital, illness 
perceptions and self-efficacy mediated the relationship between lower SES and lower 
HCA and between lower SES and poorer QoL. The role of illness perceptions and self-
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3.1 Psychosocial variables associated with SES, HCA and QOL in COPD  
 
A detailed description of the role of SES in relation to health care access and quality of 
life in a range of diseases and particularly in COPD was provided in Chapter Two. 
Socio-economic deprivation cannot account fully for limited healthcare access and poor 
health outcomes despite the fact that SES can influence people’s beliefs about disease 
and disease prevention (Saint-Germain & Longman, 1993). Access to medical care on 
its own does not provide a sufficient explanation for the association between SES and 
health either (Adler, Boyce, Chesney, Folkman, & Syme, 1993). As described in 
Chapter Two, accessing health care services entails two aspects: (a) the availability 
and provision of these services and (b) utilisation of these services by patients. If it is 
hypothesized that these services are freely available to people, then factors that might 
influence health care utilisation should be considered. Socio-economic factors could 
pose a barrier in accessing free health care services due to additional costs involved 
such as transportation. However, as stated above socio-economic factors cannot fully 
account for limited access to health care services. Therefore, it is important to take into 
account people’s individual characteristics, for example, how they make sense of their 
illness and what it means to them or whether they feel sufficiently confident to seek 
medical care, communicate effectively with health care professionals and follow 
treatment (Sensky, MacLeod, & Rigby, 1996; Leslie, Urie, Hooper, & Morrison, 2000; 
Gecas & Schwalbe, 1983).  Both of these characteristics can influence the way patients 
cope with their condition and access and utilise services. Thus, psychological variables 
were included in this research study focusing specifically on illness perceptions and 
self-efficacy.  
Socio-economic status can influence self-efficacy because it affects people's 
opportunities to take effective measures, especially at their work, and also because 
self-efficacy leads to people having different beliefs which define how they may 
evaluate the way people act. It can be hypothesised that the same might be true for the 
way patients make sense of their illness. Previous studies have established that higher 
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education and occupational status are associated with stronger self-efficacy and ability 
to master life events. Losing one's job, making less money and receiving less 
education were found to decrease a person's sense of self-efficacy (Duncan & Morgan, 
1980).  
To sum up, there appears to be a link between SES and HCA and SES and QoL as 
well as evidence for the likelihood of a relationship between SES and illness 
perceptions and SES and self-efficacy. Therefore, it could be hypothesised that SES 
may influence the way patients with COPD perceive and make sense of their illness as 
well as their level of self-efficacy. Patients’ illness perceptions and self-efficacy may, in 
turn, have an impact on the way they utilise healthcare services and engage in health-
related behaviours such as medication adherence or exercising. These links led to 
including illness perceptions and self-efficacy in this research and examining their role 
as possible mediators in the relationship between SES and HCA and SES and QoL in 
COPD. Findings would contribute to increasing our understanding of possible pathways 
between these variables and the nature of their associations. Chapter Three will 
present the background to what constitutes illness perceptions and self-efficacy, 
describe their origin and the research evidence that suggest a relationship between 
SES and health care access and quality of life in chronic illness and particularly in 
COPD. 
 
3.2 Illness perceptions: origin and development 
 
Illness perceptions arose when exploring factors that could positively influence healthy 
people’s attitudes towards disease and increase the likelihood of preventing disease 
(Dabbs & Leventhal, 1966; Leventhal, Singer, & Jones, 1965). The common-sense 
model or CSM postulated that the individual is an active problem-solver who deals with 
both the perceived reality of a health danger and the emotional responses to this 
danger. This means that individuals engage in parallel processing on two levels: the 
cognitive and the emotional. The CSM model is based on three principles. First, the 
individual is actively trying to solve the health-threat problem by seeking relevant 
information and developing and testing hypotheses. These hypotheses involve 
attributions about the meaning of experienced symptoms and the person’s health 
status and how they relate to information derived from the media and interpersonal 
relationships. Second, illness perceptions are a major cognition that influences coping 
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response and appraisal of behaviour outcomes. Third, illness perceptions are not 
always in agreement with medical facts but are highly individualised. The model also 
posits that memories of previous health and illness experiences lead to the formation of 
schemas which contribute to decoding illness perceptions triggered by internal and 
external stimuli. In the case of an internal stimulus, the similarities it bears to a schema 
developed based on a previous illness experience or an imagined disease such as 
cancer will influence its subsequent interpretation. These schemas are matched with 
five dimensions of illness perceptions involving identity, timeline, cause, controllability 
and consequences, discussed in detail below. A visual representation of this process is 
provided in Figure 3.1. 
 
_____________________________________________________________________________ 
Figure 3.1 The common-sense model of illness representation (Diefenbach & Leventhal, 1996) 
 
Diefenbach & Leventhal (1996) proposed that the development of illness perceptions 
follows a chain of events and actions which can be could be thought of as follows: a 
person watching a message on television regarding melanoma or associated 
symptoms such as a mole of unusual colour or shape might start suspecting that they 
may have melanoma. Depending on the person’s emotional response to the fear of 
melanoma, the way they think about it might be influenced. The way people perceive a 
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health threat (fear) can trigger a series of actions: (a) they identify what needs to be 
done and take action to control the health threat; (b) they then appraise how effective 
these actions were in controlling the threat; and (c) they feed this appraisal back to the 
way they think about the threat and update their illness perceptions. According to 
Diefenbach & Leventhal (1996) an emotional response to a health threat could trigger a 
cognitive response which could lead to certain actions. The appraisal of the 
effectiveness of these actions in terms of controlling the threat would be fed back to the 
person’s cognitions and emotions and they would be updated accordingly. Diefenbach 
& Leventhal (1996) proposed a similar pathway for a cognitive response triggered by a 
health threat that could ultimately influence an individual’s emotional response and 
perceptions of illness. 
 
3.2.1 How are illness perceptions formed and how do they function? 
 
a. Two-level processing 
 
Leventhal (1970) proposed a framework termed “the parallel response model” in an 
attempt to explain the two-level response described above i.e. the emotional and the 
cognitive response to a health threat. A person responds on two levels to health 
messages that involve fear: (a) the cognitive level and (b) the emotional level. These 
responses are suggested as being the result of two systems which process 
information: the objective-cognitive processing system and the subjective-emotional 
processing system. These two systems are separate and partially independent but 
function in parallel.  
The theory postulates that the functions of these two systems are quite distinct. The 
objective-cognitive system can generate two actions. First, it can produce a 
representation of the disease danger. Secondly, based on that representation, it can 
produce a plan of action for a coping strategy for that danger. The representation would 
be derived from present and previous experiences. Present experiences would involve 
information received from the media, health professionals, and sensation of physical or 
emotional symptoms. According to Leventhal et al. (1983), previous experiences might 
include abstract memories about health information provided from family and friends or 
past experience of symptoms and associated treatment.  Leventhal (1970) and Nerenz 
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& Leventhal (1983) also proposed that conceptual, concrete and emotional memories 
could be integrated with the perception of sensory and perceptual stimuli and increase 
a person’s awareness of an illness threat  
Miller & Galanter (1960) suggested that an individual can consider alternative options 
when, for example the coping strategy initially adopted was not effective in dealing with 
the health threat. According to Miller & Galanter (1960), this process could be 
performed through a rehearsal of possible options which would be weighted as to their 
benefits and costs. The individual would also consider how to achieve a specific goal. 
This process of developing illness representations and coping mechanisms might also 
be influenced by a person’s cognitive skills such as perception, memory and thinking 
patterns. 
Leventhal et al. (1983) proposed that the subjective-emotional system functions 
differently. Health threat messages can trigger a variety of emotional responses in 
people such as fear, depression or feelings of disgust and anger. Zajonc (1980) 
suggested that the source of these responses is a processing system which is sensitive 
to concrete perceptions and relatively independent of cognitive functions (i.e. thoughts) 
Thus, a pictorial representation of the consequences of a health threat such as having 
lung surgery would trigger fear more readily than a verbal message about cancer being 
fatal and avoidable. Leventhal et al. (1983) suggested that this was an indication that 
emotions and thoughts are not always consistent, proposing that different actions 
would be required to handle and control emotions compared to the ones used to cope 
with disease danger. 
According to Leventhal et al. (1983) these two processing systems would be relatively 
independent but would tend to supplement, interfere with or mutually facilitate each 
other. For instance, people may feel afraid of having car accident but this does not 
mean that they will use their seatbelt or drive carefully. Chances are they will do either. 
Thus, the action would be relatively independent of the emotional sensation and would 
offer the possibility to generate two separate plans, each to control one level (i.e. the 
emotional and the cognitive). For example, when driving on a dangerous road, in order 
to control the car, caution would be needed in braking and steering. Leventhal et al. 
(1983) suggested that this could control the action or coping behaviour. Instead, to 
control the emotional response i.e. decrease the anxiety from driving on the dangerous 
road, one could think of having a cup of tea or relax when arriving at home.  
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The theory went on to state that interference between the two processing systems 
would occur when the reaction triggered by fear is not consistent with the action 
recommended by the health professional. For instance, the fear of getting a diagnosis 
of lung cancer would prevent a smoker from getting an X-ray. Instead, facilitation would 
occur if there was consistency between the reaction to fear and the action required to 
meet the objective.  
Leventhal & Niles (1965) suggested that independence and interaction between the 
cognitive and emotional processes would be reflected in their different time patterns 
after interception of a fear message (Leventhal & Niles, 1965) The likelihood of the 
interaction effect to occur is greater when the levels of fear are higher. This is more 
likely to happen immediately after the fear warning because fear dissipates quickly.  
Rogers & Mewborn (1976) proposed that the cognitive representation of health danger 
has a longer duration and may vary as time elapses  Thus, Rogers & Mewborn (1976)  
claimed that the effect of the cognitive system would be stronger in the long-term as in 
Leventhal’s fear studies (1965) where the emotional response resulting from fear 
messages began to dissipate after 24 hours. In contrast, the cognitive representation of 
the health threat would last longer and would be a pre-requisite in combination with 
action plans for long-term behaviour change. 
 
b. Parallel processing models 
 
Observation of human behaviour led to the development of a number of dual-process 
theories (Chaiken & Trope, 1999; Epstein, 1994; Kahneman, 2003; Smith & DeCoster, 
2000; Strack & Deutsch, 2004). These are called dual-processing theories because 
they classified mental processes that people employ to make social judgements and 
behaviour into two categories based on the mode of their operation: automatic or 
controlled. Smith and DeCoster (2000) emphasised that the most significant difference 
between these models was whether the process of their operation was simultaneous or 
mutually exclusive. 
Models similar to Leventhal’s CSM were proposed. Epstein (1994), for example, 
maintained that the two systems – the perceptual and the conceptual - followed a 
parallel mode of operation and could lead to different response patterns in an 
independent fashion. Conflicts might arise due to inconsistencies in the emotional and 
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the cognitive responses. However, these two systems may also engage in interaction 
so that the implicit processes on the emotional level could influence the cognitive level. 
This interaction would be asymmetric because the perceptual experience occurred 
beyond conscious awareness. Strack and Deutsch (2004) proposed the reflective-
impulsive model (RIM) of social behaviour supporting the existence of two information 
processing systems that operated in parallel fashion and guided social behaviour. The 
two systems were termed the reflective system (RS) and the impulsive system (IS). 
Despite the two systems operating simultaneously, the IS exerted greater influence 
because it operated independently of resources. The operation of the RS, however, 
depended on sufficient cognitive capacity. 
The way people perceive illness and engage in health behaviours was explored by 
Meyer, Leventhal, & Gutmann (1985) who asked hypertensive patients whether they 
could identify when their blood pressure was raised. 92% of them said they could on 
the basis of symptoms they were experiencing such as headache, tension, tachycardia 
and warm face. The same participants had been asked earlier whether they thought 
individuals could tell when they were hypertensive and 80% thought that they could 
not. This suggested that people perceived illness differently on the emotional level such 
as experiencing symptoms which influences medication uptake or on the cognitive 
level, for example, agreeing that hypertension is not associated with symptoms.  
The individual attempts to match the physical experience to the cognitive process. The 
experience of somatic symptoms, for example, encourages attributing a disease label 
to them. Having a disease label promotes the experience of physical symptoms. 
Easterling & Leventhal (1989) found that perceived susceptibility to breast cancer was 
associated with increased reporting of worry and symptoms. Symptoms were not 
always specific to cancer. These findings indicated that both perception of vulnerability 
and experience of symptoms were required in order to lead to worrying about cancer. 
For instance, a woman who discovered a lump in her breast and has a family history of 
breast cancer, which increases her perceptions of vulnerability to the disease, would be 
more likely to seek immediate professional help in comparison to a woman who did not 
have a family history. 
In addition, low mood was associated with increased reporting of symptoms (Salovey & 
Birnbaum, 1989) and symptom severity (Croyle & Sande, 1988). The symmetry 
hypothesis postulated that physical symptoms would trigger a search and attribution of 
meaning by everybody affected.  
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In conclusion, illness perceptions may function on many different levels and influence 
various aspects of the disease threat and preventative or treatment behaviour such as 
accessing health care services and engaging in healthy behaviours. The illness 
perception model suggests that affective and cognitive processes interact and can lead 
to reappraisal of the way the patients try to make sense of the illness and adjust their 
coping strategies accordingly. This reappraisal may lead to modification of the person’s 
initial beliefs, their coping strategy or both depending on a variety of individual, cultural, 
psychological or social factors. 
 
c. Illness perception dimensions 
 
Reference has been made mainly to symptoms and labels of illness perceptions so far. 
Further dimensions to illness perceptions were identified in later studies. Penrod et al. 
(1980) reported the dimensions of severity, timeline and cause (Linz, Penrod, & 
Leventhal, 1981). With the aid of qualitative research, the dimensions identified 
included: (a) identity -  referring to the label and symptoms attributed to a disease, for 
example eczema and rash or itchiness (Lau & Hartmann, 1983); (b) causes of the 
disorder, for example genetic susceptibility e.g. allergies; (c) consequences of the 
illness, for example how the illness will affect the physical, social, financial and 
psychological aspects of one’s life; (d) timeline which refers to the perceived duration of 
the illness, its progression and whether it will be ongoing, temporary or cyclical in 
nature and (e) cure or control which is the degree of control a person feels they, the 
medications or the doctor have over the disease as to its treatment or progression (Lau 
& Hartman, 1983). Further components were added with the development of the 
revised illness perceptions questionnaire which is the one of the main measurement 
instruments used for illness perceptions and which was used in the current study. 
These additional dimensions included: (a) the division of control into treatment and 
personal, referring to the perceived control that medications and the patients 
themselves have over the illness; (b) the addition of cyclical timeline to describe the 
nature of symptom frequency (i.e. relapses or remissions); (c) the addition of illness 
coherence was developed to measure the degree to which a patient had a coherent 
understanding of their illness on the basis of his perceptions. It was thought of as the 
result of a process involving meta-cognition on the part of the patient in their attempt to 
evaluate how coherent or useful their perceptions were. This would influence the 
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degree of their understanding their illness; and (d) the addition of emotional 
representation referring to the emotional response to the health condition  (Moss-
Morris, et al., 2002). 
These dimensions provided a framework which allowed researchers to better 
understand a person’s behaviour when faced with a health threat and determine how 
the self-regulatory process occurs (Linz, Penrod, & Leventhal, 1981; Penrod, 1980). A 
significant discrepancy between the degree of self-reported illness-related dysfunction 
and the severity of the underlying pathology has been found which suggests that the 
way patients perceive their illness is not always dependent on their objective disease 
severity. 
 
d. Do illness perception dimensions vary? 
 
Leventhal et al. suggested that people’s perceptions of illness may vary depending on 
the social and environmental conditions in which people live and grow as well as their 
experience of illness. Anthropologists proposed that cultural differences and beliefs 
could influence the way people perceived an illness and could lead to the identification 
of different perceptions to those already identified (Kleinman, 1980). Leventhal et al. 
maintained that different cultures would not necessarily lead to the formation of 
different illness perceptions but rather could influence the intensity of the illness 
perceptions in relation to cultural elements. The strength of these effects and the 
factors determining them were still to be explored. Leventhal et al. suggested 
categorising illness perceptions but Swartzman & Lees (1996) claimed that this 
categorization would depend on a population’s experience of the illness as well as their 
understanding of it. For example, living in an area characterized by water-borne 
infectious diseases would encourage people to attribute the cause of a disease to this 
external factor. Having a family history of cancer would increase the likelihood of 
attributing the cause of a disease to internal factors such as genetic vulnerability. The 
way people perceive the consequences of a disease could be dependent on the stage 
people find themselves in life and the responsibilities they may have. Examples include 
physical status, social and financial impact which would vary depending on a person’s 
age and personal and professional status. Age, for example, could influence people’s 
illness perceptions by reducing their willingness to tolerate risks. Older people were 
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quicker in seeking health care (Cameron, Leventhal, & Leventhal, 1993) possibly due 
to their perceived increased vulnerability to illness because of their advanced age. 
Cameron et al. (1993) emphasised that these differentiations are important and might 
influence how people choose and maintain their preventive and treatment behaviours. 
 
e. Illness perceptions: separate entities or clusters? 
 
The CSM posits that illness perception dimensions do not function independently but 
as sets. There are different types of illness perception models depending on the nature 
of the illness. Leventhal et al. described three types: (a) one for acute illnesses such as 
the common cold; (b) one for diseases characterized by cyclical flare-ups such as 
allergies and (c) one for chronic illnesses such as cancer or arthritis. All models consist 
of the same dimensions but differ in their pattern which varies depending on the illness. 
The initial illness perception model is not always maintained and people can shift from 
one model to the other. For instance, Leventhal, Easterling, Coons, Luchterhand, & 
Love (1986) found that 29% of women suffering from metastatic breast cancer 
considered their illness to be acute and curable at the beginning of their chemotherapy 
treatment. 6 months later only 11% of these women maintained the same beliefs. The 
extent of the treatment duration did not only influence the dimension of timeline but 
other dimensions as well. For example, the ineffectiveness of chemotherapy in 
achieving cancer remission was associated with ineffectiveness of the treatment as 
well as perceptions of controllability and timeline. It appeared treatment was always 
assessed in relation to a number of criteria including duration of illness, elimination of 
symptoms, illness control and elimination of discomforting consequences. One 
dimension on its own is highly unlikely to be able to exert an effect on illness 
perceptions. Instead these dimensions are interlinked. Correlations between specific 
dimensions of illness perceptions suggest that there is an underlying systematic and 
logical pattern of association. For instance, disease identity and perception of illness 
control are always related to a timeline and these three dimensions are likely to be 
associated with a causal explanation (Leventhal et al., 2003). The correlation between 
identity, perceived control and timeline indicated that patients who perceived their 
condition to be characterized by many symptoms and would be expected to have a 
strong illness identity were also more likely to perceive their illness as uncontrollable, 
chronic and having a severe impact on their everyday life (Hagger & Orbell, 2003).  
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Leventhal et al. emphasized the influence of contextual factors on the perception of 
illness. These factors include individual-level elements such as a person’s home, 
school or work setting and culture. They also include community-level components 
such as neighbourhood violence, and social elements such as social cohesion or social 
capital. These factors can be both mediators and moderators of self-regulation through 
integration with everyday behaviours and experiences (Raffaelli, Crockett, & Shen, 
2005) or interaction with wider community factors such as highly deprived 
neighbourhoods (Aber, Jones, & Cohen, 2000; Maughan & Cicchetti, 2002). Moreover, 
these contextual factors possibly contribute to the development of illness perceptions 
from childhood and into adulthood (Maniar & Zaff, 2011). The situational context 
incorporates the social determinants of health which have been associated with a 
broad range of outcomes (Graham & Kelly, 2004; Krieger, 2001; Lynch & Smith, 2005); 
Graham, 2004) and were discussed in detail in Chapter Two.  
Culture holds an important role in defining illness perceptions. Different words and 
expressions are used to differentiate between and categorise various health- and 
illness-related events. Specific illnesses will be subject to shared views of the people 
belonging to the same culture. The cultural context also provides interpersonal 
relationships which influence the development of perceptual schemas. Culture provides 
a social guide about specific behaviours and processes which contributes to illness 
management. It can influence the way illness threat is perceived as well as how people 
plan and engage in preventative and treatment behaviours.  
Leventhal et al. claimed that contextual factors might be both determinants and 
mediators of perceptions, coping and evaluation of outcome. They suggested that 
contextual factors could be mediators but also exert independent effects on outcomes. 
Coping strategies refer to the behaviours and cognitive processes people adopt. 
Coping procedures could be influenced by the cause attributed to the threat (e.g. flu) 
which would decrease its threat level to the person and thus delay action (Leventhal, 
Leventhal, & Contrada, 1998). The strategies people choose to adopt are influenced by 
the way the problem is represented which is influenced by the way coping strategies 
are performed and appraised. Coping responses are influenced by the way illness is 
perceived. For example, the experience of different symptoms triggers different 
responses. When experiencing headaches, 93% of the people would take over-the-
counter medication while only 12% would do so in the case of chest pain (Stoller & 
Forster, 1994). These differences contribute to the CSM model increasing its accuracy 
in identifying the way coping responses and illness perceptions are associated and 
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interact for specific symptoms. Other dimensions of the CSM such as timeline or 
treatment control and consequences can also affect coping responses (Horne, 1997). 
People assign a timeframe for the time of action and duration of a medication (e.g. 
aspirin takes 20 minutes to an hour to act and its effect is experienced for 6-8 hours 
after that). The selection of medications also depends on the cause of illness and the 
side effects, potency and effectiveness of the treatment. For example, chemotherapy in 
cancer treatment has a range of severe side effects which may be effective in 
controlling the progression of the cancer but may not be able to cure it. Thus, patients 
may not adhere to this treatment. Patients first try to achieve symmetry between their 
perceptions and coping responses. If there is inconsistency between them, 
considerable distress may arise. Therefore, the selection of medications can be 
influenced by a person’s perceptions guided by the social environment such as the 
media regarding their appropriateness and effectiveness for specific ailments (Horne, 
1997). 
 
f. Can illness perceptions influence coping strategies? 
 
Coping strategies used to manage a condition are described by “if-then” rules 
postulated by the CSM. The “if-then” rule entails two parts: the “if” part refers to the 
nature of the illness threat, its perceived cause, identity, consequences and timeline. 
For example, “if this headache doesn’t ease, I will take an aspirin”. All of these 
components determine the appropriateness and set the outcome expectancies for 
specific behaviours. The “then” part refers to the actual behaviour that follows as a 
result of the problem in question. For instance, “If the aspiring doesn’t ease my 
headache, I will go to my GP”. Then, the person appraises the consequences of the 
coping response which might change the way the health threat is perceived. For 
example, a wound that is not improving despite applying the prescribed ointment might 
indicate that it could be a potential cancer rather than a sore. A stomachache which is 
not improving despite anti-acid medication becomes a possible ulcer. This leads to a 
second set of “if-then” rules which refer to the coping response, its appraisal and 
transformation of the illness representation (Leventhal et al., 1998). 
Coping responses can overlap with illness perceptions (Horne, 1997). For example, 
while exercise is considered as a health enhancing behaviour, it could be perceived as 
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dangerous for patients recovering from coronary heart disease due to the strain placed 
on the patient’s cardiovascular system. This overlap may increase specificity of “if-then” 
rules depending on the domain, for example “These headaches are due to stress so 
only relaxation will help”. Health care access can be considered a form of coping 
strategy because it can follow from the “if-then” rule. For example if a person who has a 
headache, takes an aspirin but the headache does not stop, they might think that it 
could something more serious such as meningitis and would be more likely to cope 
more actively and so visit their GP. 
 
g. How might illness perceptions influence the experience of HCA? 
 
Illness perceptions can provide insight into symptom perception and help-seeking. The 
way people seek help for a health threat follows a chain of processes involving 
perception, interpretation and appraisal of symptoms. This is followed by consideration 
of ways of coping as well as perceptions of self-efficacy and motivation to put this into 
action (Scott & Walter, 2010). Experiencing symptoms alone does not mean that they 
will be interpreted in a way that would motivate people to visit their doctor (Komaroff 
2001). Even if they were interpreted as a threat, this would not necessarily mean that 
the individual would seek help. For instance, significant delay was observed between 
the first experience of acute myocardial infarction symptoms and treatment-seeking in 
older and younger people (Maynard, Every, Litwin, Martin, & Weaver, 1995; McKinley, 
Moser, & Dracup, 2000; Yarzebski, Goldberg, Gore, & Alpert, 1994). Older people took 
considerable longer to seek treatment than younger people. Four categories of factors 
were identified which were found to influence response time in older people: (a) 
attribution of symptoms to aging, (b) severity and duration of symptoms, (c) attribution 
of symptoms to co-morbid and chronic conditions, and (d) previous cardiovascular 
experience (Ryan & Zerwic, 2003). However, other studies did not find evidence for this 
delay (Conigliaro et al., 2002; Ruston, Clayton, & Calnan, 1998) possibly because older 
people were better at dealing with health threats compared to their younger 
counterparts due to their efforts to conserve energy (Cameron et al., 1993). Older 
cohorts responded quicker than younger cohorts for all degrees of perceived severity of 
disease and independent of the number of problem-related symptoms or the degree of 
pain experienced. This suggested that the response time differences between younger 
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and older people were indicative of differences in the individual procedures used to 
manage a health threat (Cameron et al., 1993). 
Delay in accessing health care has significant implications such as disease progression 
and deteriorating of quality of life (Allgar et al., 2006; Neal & Allgar, 2005). A variety of 
factors such as personal characteristics, the nature of the health care system and 
health professionals’ attitudes can predispose, encourage and motivate people to 
adopt health-related behaviours (Aday & Andersen, 1974; Dutton, 1986). Some of the 
factors relate to patients’ socio-economic status, age and sex. Health care level factors 
include access to and availability of health care services, financial factors and previous 
experience with services and health care professionals. Psychological and cognitive 
factors such as perceived vulnerability or self-efficacy as well as anxiety, beliefs and 
attitudes and expected outcomes can also influence health-seeking behaviour. Illness 
perceptions play a significant role in explaining how and when a patient would seek 
medical care. Illness perceptions address the elements of these different processes, for 
example, assessment of severity, decision regarding responses and evaluation of 
these options.  Illness perceptions were strongly associated with later use of primary 
healthcare services (Frostholm, et al., 2005). Patients who associated more symptoms 
with their illness, and had longer timeline and more severe illness consequence beliefs 
showed increased healthcare utilisation in the 3 years of the duration of the study and 
also at 2-year follow-up (Frostholm, et al., 2005). Identity, timeline and consequences 
may be critical in predicting future health care utilisation in primary care patients. 
Jackson & Kroenke (2006) investigated predictors of healthcare use in patients with 
medically unexplained symptoms attending outpatient neurology, cardiology and 
gastroenterology clinics. The number of symptoms associated with their condition or 
illness identity was a predictor of patients’ health care use in the following 6 months. 
Such findings emphasised the importance of patients’ illness perceptions and 
emotional responses to their symptoms and illness in relation to health care utilisation. 
 
h. How might illness perceptions influence the experience of QoL? 
 
Illness perceptions can provide insight into the relationship between coping and quality 
of life. Measuring quality of life is one method of assessing a patient’s personal and 
social context (Bowling, 1995). The use of quality of life measures transfers the focus 
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of assessment from the illness to the patient (Higginson & Carr, 2001). Assessment of 
quality of life relies on patients’ self-report and perceptions of their status which follow 
complex cognitive processes (McColl, Meadows, & Barofsky, 2003). Quality of life is 
dependent on individual perception and differs significantly in terms of importance and 
its definition. What is more, components of quality of life change over time depending 
on changing circumstances (Joyce, McGee, & O'Boyle, 1999). For instance, a 
phenomenon known as response shift (Sprangers & Schwartz, 1999) commonly occurs 
in patients with chronic illness (see Chapter Two). Illness perceptions emerge from the 
ways people conceptualise and think of illness. They could overlap with patients’ 
perception of their quality of life and lead to measurement errors in both. When 
measuring quality of life we are assessing patients’ perceptions of it. Illness 
perceptions, when assessed in combination with disease outcome, could provide 
insight how these two are related to each other (Fayers, 2007; Schwartz, 1999).  
However, illness severity can be objectively measured with the use of physical or 
disease markers such as lung function performance in COPD in terms of FEV1% 
predicted. There is significant difference between subjective and objective measures. 
For example, COPD patients underestimated their morbidity. The discrepancy between 
patients’ perception of disease severity and the actual grade of severity – assessed by 
an objective breathlessness scale – was significant (Rennard, et al., 2002). Another 
example of the way COPD patients perceive symptoms, regardless of disease severity, 
is reflected in the frequency and duration of exacerbations. Patients’ perceived 
frequency of exacerbation of COPD was higher (Haughney, et al., 2005) than the 
frequency found in clinical trials (Herland, Akselsen, Skjønsberg, & Bjermer, 2005). 
This could suggest either that the trial sample was not representative or that patients 
had a different understanding of what constituted an exacerbation as compared to 
doctors’ perceptions. These inconsistencies between patients’ and doctors’ perceptions 
were also observed in the duration of exacerbations. Patients perceived the 
exacerbations to last longer than recorded recovery time (Miravitlles, et al., 2003; 
Seemungal, Donaldson, Bhowmik, Jeffries, & Wedzicha, 2000; Haughney et al., 2005). 
Calverley, et al. (2005) concluded that the relationship between patient-perceived 
exacerbations as assessed by changes in individual symptoms and physician–
perceived, event-based exacerbation was weak. This suggested that the way patients 
perceive their illness is not always indicative of the severity of the illness. However, 
these perceptions are important because they influence the way patients think and act 
within the illness. This could affect their patterns in accessing health care services and 
their quality of life. For example, patients with COPD might perceive their illness to be 
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severe because they experience significant breathlessness despite having mild COPD. 
In order to cope with their dyspnoea, they might increase their visits to their GP who 
might prescribe them more medication. More prescriptions might lead the person to 
believe their COPD is deteriorating and thus their perceptions of their illness would 
become more negative. Alternatively or simultaneously, they might engage in less 
physical activity because of fear of getting breathless and collapsing. Less exercise, in 
turn, would possibly lead to higher levels of dyspnoea which would reinforce patients’ 
already negative perceptions of their dyspnoea. 
 
3.2.2 Social cognition models: can they successfully predict health behaviours? 
 
There are a number of psychosocial theories that address determinants of behaviour 
and aim to predict, explain and change health behaviours. They are embedded in 
social cognition models which are the most commonly used models in health behaviour 
research. Social cognition models provide theories that specify cognitive and affective 
elements, for example, beliefs and attitudes as determinants of behaviour. These 
models postulate that behaviour is influenced by a number of other factors such as the 
social or cultural environment or personal characteristics. They also posit that the 
effects of these factors are mediated to a great degree by elements proposed by their 
models. These elements are modifiable, for example provision of information and can 
be adopted as a framework for developing health behaviour interventions. These 
models help explain how and why people might act in a certain way within the health 
context. For example, the CSM attempts to explain health-related behaviour such as 
treatment adherence in chronic illness (Leventhal, Diefenbach, & Leventhal, 1992) 
which is considered as one of a number of procedures that patients can choose in 
order to ‘cope’ with their illness. According to the CSM, the patient is an ‘active problem 
solver’ whose coping behaviour, for example, following the doctor’s treatment 
recommendation or not, represents a ‘common sense’ response to the way they 
interpret their experience on a cognitive and emotional level, for instance their 
symptoms or diagnosis. Depending on the patients’ perceptions of the effectiveness of 
the treatment, they might choose to continue it or not. This process of evaluation and 
coping response feed backs into the way patients conceptualise their illness.  Illness 
perceptions have been used to examine quality of life, hospital admissions, and 
medication adherence in COPD patients and participation in pulmonary rehabilitation 
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(Fischer, et al., 2007; Scharloo, et al., 1998; Scharloo, Kaptein, Weinman, Willems, & 
Rooijmans, 2000; Scharloo, et al., 2007). 
Other social cognition models used in health behaviour research include: (a) the health 
belief model (HBM) (Becker, 1974); (b) the protection motivation theory (PMT) (Rogers, 
1983); (c) self-efficacy theory (Bandura, 1986; Leventhal, Brissette, & Leventhal); (d) 
the theory of reasoned action (TRA) (Ajzen & Fishbein, 1980); (e) the theory of planned 
behaviour (TPB) (Ajzen, 1991) and (f) the transtheoretical model (TTM) (Prochaska & 
DiClemente, 1992). 
Taylor et al. (2006) concluded that these models could successfully predict significant 
variance in behavioural intentions in adults. These models have been applied to 
different areas of research (Taylor et al., 2006). The HBM for example, was most 
frequently used in health service utilisation such as medication adherence or 
immunization. The TRA and TPB, on the other hand, were more commonly used in 
almost all health behaviours such as exercise promotion and dietary change and HIV 
prevention. The behaviour-intention gap is a limitation of most health theories and 
shows significant variations. For example, McEachan, Conner, Taylor, & Lawton’s 
(2011) meta-analysis suggested that the temporal distance between measuring the 
intention and observing the behaviour could be moderating this relationship. The 
occurrence of various circumstances or events could influence and possibly transform 
people’s behavioural, normative or control beliefs and also change their attitudes, 
subjective norms or their perception of control leading to modified intentions. This 
would lead to a decrease of the predictive validity of intentions measured prior to the 
occurrence of these modifications (Conner, Sheeran, Norman, & Armitage, 2000; 
Sheeran & Orbell, 1999). Nevertheless, shorter delays are also poor predictors of the 
intention-behaviour process (Kor & Mullan, 2011). This suggested that another 
component might be implicated – self-regulation – which refers to having actual control 
over actions. In comparison to the TRA and the TPB, the ability of the CSM to predict 
health-related behaviour, for example coping strategies and perceived health in breast 
cancer patients was significantly higher. Two of the illness perceptions – identity and 
consequences – explained 57% of variance in physical health, while emotional illness 
representation and treatment control explained 47% of variance in mental health when 
adjusting for confounding variables (Rozema, Völlink, & Lechner, 2008). Similarly, in 
Hagger and Orbell’s (2003) meta-analysis, a significant amount of the variance in 
coping could be explained by timeline and cure/control (27.7%) and cure/control and 
consequences (27.4%) across a number of studies.  
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Godin & Kok (1996) found strong correlations between people’s intentions to attend 
screening and their attitudes, a weaker correlation with subjective norms and PBC 
across eight studies. When reviewing six additional studies, the authors observed 
moderate correlations between intention and behaviour and between PBC and 
behaviour. These findings are consistent with other meta-analyses of the TPB involving 
a range of behaviours and a greater number of studies (Armitage & Conner, 2001). 
More studies examining the TPB found that intentions and perceived behavioural 
control (PBC) explained 27% of the variance in behaviour and that other variables such 
as attitudes, subjective norms and PBC explained 39% of the variance in intention. The 
component of perceived behavioural control (PBC) contributed significantly to 
explaining a considerable proportion of the variance between intention and behaviour 
(Armitage & Conner, 2001). Furthermore, the amount of variance explained by the TRB 
increased by 11% when objective behaviour rather than subjective behaviour was 
examined. 
When compared to other models of health-related behaviour, such as Protection 
Motivation Theory (PMT) and the Health Belief Model (HBM), intentions and behaviour 
accounted for significantly smaller proportion of the variance (Conner & Norman, 
2005). One criticism of the TPB was that the social context is not taken into account 
when examining attitudes (Eagly & Chaiken, 1993; Sutton, 1996) which could influence 
the relationship between attitudes and intentions and PBC and intention (Cooke & 
French, 2011).  
 
a. How is the Common-Sense Model (CSM) different from other health behaviour 
models? 
 
The differences between the CSM and the other health behaviour models lie in three 
areas. First, the CSM describes the content of illness perceptions such as identity, 
timeline, causes etc. The CSM also specifies a link between illness perceptions and 
coping strategies (e.g. if my cold gets worse, I will see a doctor). Illness perceptions are 
the result of an interaction between physical sensation and previous experience with an 
illness. They specify the health threat and form the targets for coping. These targets 
are used to appraise coping which is suggested to mediate the relationship between 
illness perceptions and patients’ well-being (Rutter & Rutter, 2002; Cameron & 
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Leventhal, 2003; Idler & Leventhal, 1999). No evidence for mediation of coping in this 
relationship was reported by Scharloo et al. (1998) and Moss-Morris, Petrie, & 
Weinman (1996) but illness perceptions did influence patients’ well-being directly. 
Second, it specifies that illness perceptions are processed on two levels, the emotional 
and the cognitive level. Third, the CSM attempts to explain the cognitive processes 
between the way the illness and the self are represented and provides a more 
systematic and detailed description of the self-regulation mechanism compared to 
previous literature (Hooker & Kaus, 1994). This is achieved through a description of a 
detailed mechanism of the motivational and procedural factors that guide health-related 
behaviours in a given context. The CSM takes into account people’s active involvement 
in problem-solving through their representations of their environment and themselves. 
It also includes the coping strategies people adopt in order to manage and prevent 
health threat as well as the way in which appraise their actions. Moreover, the CSM 
provides the opportunity to investigate a set of different health behaviours and not 
individual and focused ones such as smoking cessation, diet or sun protection (Trans-
Theoretical Model of Health Behavior Change; Velicer, et al., 2006) which are 
important in the context of COPD. For instance, smoking cessation is the most effective 
way to slow progression and deterioration of the illness and diet can influence quality of 
life. The CSM can also be used to assess everyday behaviours in chronic illness which 
the other health models are limited due to their insufficient predictive validity. Last but 
not least, the CSM incorporates the emotional response to illness while the other 
models do not. For all these reasons, the Common Sense Model (CSM) of self-
regulation (Leventhal et al, 1980) or illness perception model, was deemed the most 
appropriate to be used in this research. 
 
3.3 Illness perceptions in chronic illness 
 
Illness perceptions have been associated with a number of different outcomes in 
patients with a variety of physical illnesses. A meta-analytic review of the CSM by 
(Hagger & Orbell, 2003) provided support for the role of illness perceptions in a broad 
range of chronic diseases based on 45 studies. Hagger and Orbell (2003) identified 
and classified various types of coping strategies regarding illness beliefs and 
conducted a meta-analysis of the relationships between these behaviours and illness 
perceptions embedded in the CSM. Findings indicated significant and positive 
associations between the dimension of identity and coping strategies adopted by 
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patients, in particular, avoidance and expression of emotions. The latter was 
associated with the control that patients perceive they had over their illness. Perceived 
control was also related to cognitive reappraisal and coping strategies focusing on 
problem-solving. Patients who perceived their illness to be curable or controllable were 
more likely to have improved psychological, social and physical function (Hagger & 
Orbell, 2003). Cure and control were negatively associated with distress and disease 
status (Hagger & Orbell, 2003). The dimensions of consequences, timeline and identity 
were negatively correlated to psychological status, physical and social functioning and 
vitality levels. The authors concluded that examination of studies confirmed the 
expected relationships between illness perceptions, coping strategies and outcomes.  
The number of studies included in the different health conditions examined was small 
and different illnesses could have been associated in different ways with illness 
perceptions. Moreover, most of the studies were cross-sectional which prevents 
conclusions on causal relationships. Effect sizes were also small. Cross-sectional 
studies can only capture illness perceptions at one given point in time but illness 
perceptions are changeable (Bijsterbosch, et al., 2009), therefore results might differ 
later on. Meta-analysis results showed significant variability in the strength of 
correlations (Hagger & Orbell, 2003). For instance, correlations found between illness 
perceptions and coping behaviours were low-to-moderate compared to the ones 
between illness perceptions and outcomes which were strong. Outcomes included 
physical functioning, psychological distress and well-being, role and social functioning, 
vitality and disease state. Similar patterns were observed between control/cure 
dimensions and generic and specific problem-focused coping (rc=0.27, p<0.05) and 
(rc=0.20, p<0.05) respectively, as well as social support seeking (rc=0.08, p<0.05). 
Timeline also showed low correlations with cognitive reappraisal (rc=0.14, p<0.05) and 
avoidance/denial (rc=0.12, p<0.05). In contrast, correlations for outcomes were much 
stronger. For example, consequences, identity and timeline were strongly correlated to 
psychological well-being, role functioning, social functioning and vitality (range: -0.67≥ 
rc≤0.11). In addition, consequences (rc=-0.18, p<0.05) and identity (rc=-0.28, p<0.05) 
were moderately-to-strongly correlated to physical functioning. Timeline did not show 
significant associations with physical functioning. Hagger & Orbell (2003) attributed 
these weak-to-moderate effect sizes partly to the variability in the assessment of 
coping and confounding feedback effects (Hagger and Orbell, 2003). The appraisal of 
the coping responses could have altered the representations of the illness and could 
have shown a different pattern at the time of assessment. These measures were too 
generic and not able to account for person-specific characteristics relating to coping 
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strategies, coping goals and perceived probability of success contradicting previous 
studies (Coyne & Racioppo, 2000). 
A review conducted by French, Cooper, & Weinman (2006) found that illness 
perceptions in coronary artery disease patients were predictors of cardiac rehabilitation 
attendance. French et al. (2006) reported that patients’ higher attendance was 
associated with higher perceived control and symptoms, more severe consequences 
and higher understanding of their illness. 
 
3.3.1 Different illness perception clusters associated with different outcomes? 
 
a. Past research on illness perceptions and quality of life 
 
Illness perceptions are associated with different outcomes and illnesses. Timmers, et 
al. (2008) and Benyamini, Goner‐Shilo, & Lazarov (2012) found strong associations 
between identity, personal and treatment control, consequences, and emotional 
representations and quality of life on patients with end-stage renal disease (ESRD) and 
contact dermatitis. More perceived symptoms and consequences, lower perceived 
control and more serious consequences were related to poorer physical, psychological 
and social well-being for patients with ESRD. Similarly, other studies have reported 
strong associations between identity, cure/control and consequences but not emotional 
representations in Huntington’s Disease (Kaptein, et al., 2006), rheumatoid arthritis 
(Groarke, Curtis, Coughlan, & Gsel, 2005), chronic fatigue syndrome (Heijmans, 1998; 
Moss‐Morris, Petrie, & Weinman, 1996) and psoriasis (Scharloo, et al., 2002). There 
are variations in the patterns and strength of the dimensions depending on the disease 
such as Huntington’s (Helder, et al., 2002) and systemic sclerosis (Arat, et al., 2012) 
which have been attributed to variability in the measures used. 
Definition and measurement of QoL has been a frequent matter of discussion in the 
literature (Gerritsen, Steverink, Ooms, & Ribbe, 2004; Bowling 2005). The degree to 
which QoL can be measured objectively has been disputed because even when 
“objective” measures such as financial, social and health markers (UNDP, 1998) are 
employed, the scope of the measures is narrow. It does not include other domains 
which contribute to QoL such as psychological and social participation and identity 
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which are assessed through an individual’s “subjective” experience (Costanza, et al., 
2008). However, the presence of physical disability or illness does not necessarily 
translate into poorer QoL. A detailed discussion of QoL was provided in Chapter Two.  
Illness perceptions do not function as separate entities but can form clusters. For 
example, example, Le Grande, et al. (2012) found not all patients who suffered from 
the same illness to have similar illness representations and their quality of life varied 
accordingly. The authors observed different profiles of illness perceptions in different 
groups of cardiac patients within the sample studied. Le Grande et al. (2012) identified 
at least ﬁve different patterns of illness perceptions: (a) patient who focused heavily on 
consequences; (b) patients who had weak emotional representations; (c) patients who 
perceived high personal and treatment control; (d) patients who perceived low control 
and severe consequences and (e) patients who perceived even lower control and 
extremely severe consequences of their illness. The last two patterns were associated 
with poor quality of life while the first three with good quality of life. 
In a review of the dimensions that showed strong associations with quality of life and 
functional outcome in asthma, (Kaptein, Klok, Moss-Morris, & Brand, 2010) reported 
that identity, control, emotional representations and illness coherence were consistently 
related to patients’ well-being. Specifically, perceptions of stronger personal and 
treatment control as well as chronic timeline and weaker emotional representations 
were related to better quality of life and higher functioning. In contrast, patients who 
perceived their asthma to have severe consequences on their lives, and had low 
perceived personal and treatment control were more likely to experience greater 
limitations in functioning and poorer quality of life. 
A further outcome associated with illness perceptions is disability and work disability. 
More perceived consequences were consistently associated with higher disability 
levels (Boot, Heijmans, van der Gulden, & Rijken, 2008; Bijsterbosch et al., 2009; 
Moss-Morris et al., 1996). Moss-Morris et al. (1996) found a significant relationship 
between identity, control and causes and disability. Moss-Morris et al.’s (1996) 
participants, however, were had only chronic fatigue syndrome while Boot et al. (2008) 
included various diseases in their study. Furthermore, Moss-Morris et al. (1996) 
investigated disability in general while Boot et al. (2008) focused on work disability. 
Bijsterbosch et al. (2009) reported correlations between identity and consequences and 
disability in osteoarthritis patients and observed changes in illness perceptions and the 
degree of disability in time. At 6 year follow-up patients’ disability levels had increased 
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and showed associations with stronger identity and consequences. Associations were 
also found with lower personal and treatment control, timeline, causes and emotional 
representations in patients with progressing disability. Bijsterbosch et al.’s (2009) study 
was longitudinal and confirmed previous findings regarding changes in illness 
perceptions over time (Foster, et al., 2008). 
 
b. Past research on illness perceptions and psychological well-being 
 
Certain illness perceptions emerge as strong predictors of psychological status. 
Consequences was the strongest and most consistent dimension associated with 
depression and anxiety in a number of conditions such as rheumatoid arthritis (Groarke 
et al., 2005), irritable bowel syndrome (Rutter & Rutter, 2002), breast cancer (McCorry 
et al., 2012), cardiac disease (LeGrande et al., 2012) and diabetes (Skinner, et al., 
2011). LeGrande et al. (2012) did not find a relationship between consequences and 
depression possibly due to the use of different measures. Most other studies employed 
the Hospital Anxiety and Depression Scale (HADS) while LeGrande et al. (2012) used 
the Beck Depression Inventory II (BDI II). In addition to consequences, lower perceived 
personal and treatment control/cure were related to higher levels of depression and 
anxiety (Murphy et al., 1999; Groarke et al., 2005; Rutter & Rutter, 2002, McCorry et 
al., 2012; LeGrande et al., 2012). Half of the studies employed a longitudinal design, 
one was a randomized control trial (RCT) while the rest of the studies were cross-
sectional. A variety of depression and anxiety measures were used but despite these 
differences and the heterogeneity in patient populations, the correlations between 
control and psychological status remained strong. Stronger perceived causes such as 
self-blame were related to pathological worry (Fortune, Richards, Main, & Griffiths, 
2000). McCorry, et al. (2012) found that weaker beliefs about causes were associated 
with lower levels of distress in breast cancer patients. Both these studies were either 
over-represented by women or only included women due to the nature of the disease 






c. Past research on illness perceptions and coping strategies 
 
The illness perceptions strongly associated with coping involve identity and control/ 
cure found in various conditions such as Huntington’s Disease (Helder et al., 2002; 
Kaptein et al., 2006), chronic fatigue syndrome (CFS) (Heijmans, 1998) and Addison’s 
Disease (AD) (Heijmans, 1999). In patients with Huntington’s Disease stronger 
perceived identity and higher perceived levels of control or cure were associated with 
mental disengagement from the illness and positive reappraisal and growth as well as 
social support seeking. Both studies employed a cross-sectional design, were 
conducted in the Netherlands, and had identical sample sizes. Helder et al. (2002) also 
reported that beliefs about longer duration of the illness were negatively related to 
passive coping. This was also supported by Heijmans (1998; 1999) who found further 
associations between passive coping and stronger consequences in CFS and AD 
patients. Heijmans (1998; 1999) assessed coping with the Utrecht Coping 
Questionnaire while Helder et al. (2002) and Kaptein et al. (2006) employed the COPD 
Inventory which could explain the difference in findings. 
 
d. Past research on illness perceptions and HCA 
 
Illness perceptions are associated with health care access. For example, stronger 
beliefs of perceived personal and treatment control were consistently related to higher 
rates of attendance at rehabilitation programmes for cardiac patients (Cooper, Lloyd, 
Weinman, & Jackson, 1999), higher perceived receipt of information regarding illness 
for cancer patients (Husson, et al., 2012), higher treatment adherence in diabetes 
(Broadbent, Donkin, & Stroh, 2011) and increased outpatient visits in psoriasis 
(Scharloo et al., 2002). In their prospective cohort study, Cooper et al. (1999) found 
correlations between higher levels of perceived control, stronger beliefs in the cause of 
the illness (e.g. lifestyle) and increased rates of attendance at cardiac rehabilitation 
programmes. Illness coherence was related to perceptions of higher provision of 
disease-specific information (Husson et al., 2012). Scharloo et al. (2002) found 
evidence for identity linked to number of outpatient visits in patients with psoriasis. This 
could have been due to the nature of the condition which could have influenced 
patients’ perceptions of their illness. In diabetic patients, Griva, Myers, & Newman 
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(2000) found different illness perceptions associated with treatment adherence from 
Broadbent et al. (2011). The first study observed a relationship between higher 
perceived consequences and stronger identity beliefs and higher treatment adherence 
while the latter reported higher personal control and higher treatment adherence. This 
difference could be attributed to the sample sizes (64 vs 157) and the fact that 
Broadbent et al. (2011) distinguished between type 1 and type 2 diabetic patients. 
 
3.3.2 Illness perceptions in COPD 
 
Certain illness perceptions show stronger associations with certain outcomes 
depending on the disease. A review by Kaptein, et al. (2008) found that illness 
perceptions were significantly associated with a number of outcomes such as 
functional status and disability, depression, anxiety and quality of life. The authors 
reported that worse outcome defined by poorer QoL, more outpatient visits, poorer 
physical and social functioning were related to stronger illness identity (i.e. attribution of 
many symptoms to COPD), perceptions of lower control over the illness and stronger 
emotional representations such as higher anxiety, depression or catastrophizing. In 
contrast, higher perceived control and higher self-efficacy and more positive emotional 
representations were associated with better outcomes. These relationship patterns 
were in line with those found in other illnesses. It must be noted, however, that the 
number of participants in the studies varied from 10 to 266, most of the studies were 
cross-sectional, not all used the same instruments to measure illness perceptions and 
disease severity was not controlled in all. These limitations warrant caution when 
interpreting results and attempting to make causal attributions. 
It is worth providing an overview of the relationship of illness perceptions and outcomes 
such as quality of life or health care utilisation in COPD. Some of the studies that are 
going to be discussed were included in Kaptein et al.’s (2008) review while others were 
not. Overall, the evidence indicates that more negative illness perceptions such as 
associating more symptoms to the disease, perceiving it to be chronic and having less 
control over the illness as well as perceptions of more severe impact of COPD on 
patients’ everyday life is related to poorer outcomes in terms of QoL. Identity has 
consistently been reported to be related to physical and psychological outcomes in 
COPD.  Scharloo et al. (1998) found associations between strong identity beliefs and 
physical, role and social functioning. The authors also observed strong correlations 
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with timeline, consequences and control (Scharloo et al., 1998, 2002; Fischer et al., 
2007; Kaptein et al., 2008; Howard, Hallas, Wray, & Carby 2009). Patients who 
perceived their illness as chronic, with a severe impact on their life, and less 
controllable had poorer outcomes. Scharloo et al. (1998) did not focus only on COPD in 
their study but also included patients with rheumatoid arthritis and psoriasis. In a later 
longitudinal study, Scharloo et al. (2000) found only weaker identity beliefs to be 
related to better social functioning and better self-rated health. The measures used in 
the two studies were identical, therefore, the differences in illness perceptions found 
could have been due to the longitudinal design and the fact that the later study 
(Scharloo et al., 2000) included only COPD patients. On the other hand, Hoth, 
Wamboldt, Bowler, Make, & Holm (2011) found a single illness perception, instead of a 
combination of them, that was associated with quality of life and psychological status: 
causes. Patients who attributed their illness to psychological factors instead of 
smoking, a virus or genetic causes were more likely to report poorer quality of life and 
higher levels of depression and anxiety. The authors attributed this finding to the nature 
of COPD which can be due to a variety of underlying causes such as smoking, genetic 
and environmental factors. COPD patients may hold different beliefs regarding the 
causes of their condition. Patients with COPD also felt stigmatized and experienced 
self-blame and shame (Berger, Kapella, & Larson, 2011) especially since smoking is 
significantly involved in the emergence of COPD. These perceptions of causes and 
emotional impact were related to higher levels of depression and greater impact of 
COPD on health status (Laurin et al., 2012; Halding et al., 2011). Scharloo et al. (2007) 
found that patients’ attributions of their illness to psychological factors were associated 
with their psychological status while Fischer et al. (2007) observed strong associations 
between weaker perceived identity and better quality of life in their participants with 
COPD.  
Identity, timeline and consequences were strongly associated with the experience of 
panic (Howard et al., 2009). Patients who had a stronger illness identity (more 
perceived symptoms), believed that their illness would be chronic and have greater 
impact on their everyday activities were more likely to have experienced a panic attack 
within the previous 12 months. Howard et al.’s (2009) findings confirmed Scharloo et al. 
(1998) who reported the same dimensions and their relationship with poorer emotional 
adjustment. Scharloo et al. (2000) observed that lower perceived symptoms (i.e. 
weaker identity beliefs) were associated with improved social functioning and perceived 
health status. However, they did not find evidence for other illness perceptions.  This 
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could be due to the fact that their study was longitudinal in contrast to the cross-
sectional design that Scharloo et al. (1998) and Howard et al. (2009) had employed.  
Illness perceptions have been linked to health care access suggesting that more 
negative illness perceptions are related to greater access to health care services. 
Variations in the conceptualization and measurement of health care access makes 
identification of the nature of this relationship more complicated compared to quality of 
life. Scharloo et al. (2000) found that patients’ weaker belief in psychological factors as 
causes of their COPD was strongly correlated with a higher number of outpatient clinic 
visits while identity was related to prescriptions for disease-specific medications. 
Scharloo et al. (2000) reported that weaker identity beliefs were associated with 
seeking more distraction when trying to cope with the illness. Seeking more distraction 
was, in turn, associated with reduced prescription of COPD medications.  
A further measure of health care access is attendance at pulmonary rehabilitation (PR) 
programmes. Fischer et al. (2009) found that weaker beliefs regarding effectiveness of 
treatment were associated with lower participation rates in pulmonary rehabilitation 
consistent with previous studies (Arnold et al., 2006; Fischer et al., 2007). Williams, 
Bruton, Ellis-Hill, & McPherson (2010) found that after completion of PR, patients’ 
degree of breathlessness had not changed but their perception and management of 
breathlessness had. This suggested that patients’ beliefs about their ability to exercise 
could have strengthened and their belief in their ability to manage dyspnoea whilst 
exercising had increased which could have led to a reduction of anxiety and panic. 
Possible desensitisation to perceptions of breathlessness through pulmonary 
rehabilitation was suggested as an explanation. However, due to the qualitative nature 
of their research a more detailed account of the mechanism of that effect could not be 
provided. Similarly, patients’ negative perceptions of exercise consequences were 
related to their performance on the 6-minute walking test as well as to treatment 
response in mildly to moderately affected patients when controlling for physical 
confounders (Fischer et al., 2007). The aforementioned studies did not all use the 
same measures to assess illness perceptions and health care access. Therefore, 
variability in the findings could be attributed to the use of different measures. 
Other health care access outcomes investigated include medication adherence. Higher 
perceived control appeared to be the strongest dimension associated with higher 
adherence with pulmonary medication. Khdour, Hawwa, Kidney, Smyth, & McElnay 
(2012) found that patient beliefs regarding the degree of treatment effectiveness and 
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about their health status were significantly associated with medication adherence. 
Increased patient understanding of their illness and of the effectiveness of their 
treatment were related to higher rates of adherence in patients with COPD. Similarly, 
COPD patients who felt more in control over their illness and had stronger perceptions 
of medication effectiveness were more adherent (George, Kong, Thoman, & Stewart, 
2005). An overview of all the studies described above and their findings on the 






Table 3.1 Overview of the studies examining experiences/illness perceptions (IPs) and quality of life (QoL) and/or health care access (HCA) in patients with COPD 
Authors      Sample size/Age            Objective               Assessment of IPs/experience        Assessment of QoL/HCA          Outcome measure(s)                      Results 
Arnold et al.  20 / M=67yrs Reasons for participation          Qualitative approach          Semi-structured interviews      Pulmonary Rehabilitation    Positive doctor attitude to PR associated  
(2006)           & adherence in                                               participation & adherence     with higher attendance. Group support  
Pulmonary Rehabilitation                                       (PR) & higher self-confidence associated 
                                                             with better adherence. Lack of social  
                                 support & inefficient coping with COPD  
            negatively associated with adherence 
                                                                                                      .  
Berger et al.  16 / M=70yrs Experience of social changes    Qualitative approach       Descriptive in-depth interviews,           Effect of COPD on               Blame related to smoking from 
(2011)       & stigma in COPD            FEV1, Charlson Comorbidity           social relationships &                    self & health professionals. 
                                                                                                                                            Index (CCI), ATS-DLD 78-A          experiences with COPD-          Decrease in social activities 
                Breathlessness Scale, Functional       related stigma                       partly due to avoidance of  
                                                                                                                            Performance Inventory                            stigmatizing situations. 
 
Earnest          7/ M=69yrs  Examination of patterns of    Qualitative approach,         Semi-structured interviews,              Adherence to oxygen        Barriers to oxygen adherence: 
(2002)        adherence to oxygen            case-series     Brief Symptom Inventory (BSI),              therapy                        physical difficulty of use,  
in COPD                       St. George’s Respiratory             self-consciousness, social 
                Questionnaire (SGRQ), FEV1                  stigma, lack of perceived 
                         Benefit, fear of side-effects. 
Fischer et al.  12 / M=61yrs Examination of patient    Qualitative approach          Semi-structured interviews               Patient beliefs about PR,               Participation & non-completion  
(2007)   beliefs before treatment            treatment goals &                        related to patients’ perceived 
    & Pulmonary Rehabilitation         reasons for participation                disabilities, expected benefits & 
goals                                             & non-completion          concerns about PR, practical 
                                   barriers & low self-confidence 
                              in their abilities. 
 
Fischer et al.  217 / M=63.4 Examination of drop-out    Illness Perceptions     6-minute walking test, dyspnoea          PR drop-out & attendance       Reasons for non-completion: 
(2009)             yrs & attendance rates in PR, Questionnaire-Revised         & perceived exertion scale    rates & reasons, illness              medical, smoking, living 
    and the role of patients’  (IPQ-R)      (Borg CR10), Medical Research                  perceptions as             alone, lower fat free mass 
    illness perceptions in PR    Council (MRC) dyspnoea scale, FEV1      predictors of drop-out &         low treatment control. Socio- 
                             & attendance in PR                      demographic, clinical or 
                         psychological variable were not 






Authors    Sample size/Age               Objective              Assessment of IPs/experiences           Assessment of QoL/HCA            Outcome measure(s)                          Results 
Fischer et al.       87 / M=63 yrs       Examination of patients’         Illness Perceptions              FEV1, 6-minute walk test,    Changes in illness       Longer time after diagnosis             
(2010)       illness perceptions before    Questionnaire-Revised          dyspnoea & perceived exertion  perceptions in after PR         associated with longer duration 
       & after PR and after  (IPQ-R)                           scale (Borg CR10), Chronic   & diagnosis of COPD          of illness, more consequences, less 
     diagnosis             Respiratory Questionnaire (CRQ)                 control. After PR, achieving set goals 
                   was associated with less concern  
                         about negative consequences of 
                                   of COPD & stronger cyclical timeline 
                                 & personal control. 
Fischer et al.   166 / M=63 yrs  Examination of negative        Questionnaire about             6-minute walk (6-MW) test, FEV1,    6-minute walk test outcome       6-MW distance was positively  
(2012)    affect & exercise beliefs          perceived exercise necessity &         dyspnoea & perceived exertion      & improvement in walk    associated with younger age, 
    In relation to 6-minute walk                   concerns, Hospital                          scale (Borg CR10)                     distance after PR                   male gender, better lung function  
    test performance & treatment    Anxiety & Depression Scale           & fewer concerns about exercise. 
               outcomes                     (HADS)                Physiological & psychological 
                            variables were not associated with  
                                                                treatment response (increase in walk 
                                                 distance). Mildly & moderately affected 
                                                                      patients treatment response was  
                                                      negatively related to concerns about                     
                                          exercise. 
 
George et al.     276 / M=71yrs Examination of predictors of      30-item questionnaire about health        Medication Adherence Report      Medication adherence            Medication adherence positively 
(2005)   medication adherence and           beliefs & adherence behaviours                        Scale (Weatherall, et al.)                                        associated with acceptance of 
                               health beliefs & experiences                     disease course & treatment, 
       knowledge & faith in treatment, 
                         good patient-doctor communication 
                           & routinisation of treatment. 
 
Halding et al.      18 / Range:    Examination of daily life     Longitudinal and descriptive                 Thematic interview, questions          Daily experience of             Stigma of self-infliction & 
(2011)                      52-81yrs  experience of patients           qualitative approach      about everyday experience                      COPD                       moral weakness associated with  
                       with COPD                          of COPD               COPD. Guilt, self-blame & 
                                                      negative perception of identity. 
 
Hoth et al.       394 / 59% Examination of patterns of       Illness Perceptions              Smoking status questions, Physical       Health behaviours, QoL,            Main causal attributions for 
(2011)                  >65 yrs   causal attributions for COPD    Questionnaire-Revised              Activity Scale for the Elderly (PASE),     anxiety & depression,          COPD were: smoking, heredity, 
      in relation to health                 (IPQ-R)                                  Hospital Anxiety & Depression Scale     health care utilisation,           pollution & personal behaviour. 
behaviours & symptoms                 (HADS), Modified Medical Research    breathlessness, causal            Higher attribution of COPD to 
                                 Council Scale (MRC), St. George’s    attributions              psychological factors was  
                                  Respiratory Questionnaire (SGRQ),    associated with poorer  




Authors Sample size/Age  Objective                        Assessment of IPs/experiences              Assessment of QoL/HCA               Outcome measure(s)                Results 
Howard et al.     59 / M=62.4yrs Examination of the association    Illness Perceptions         Hospital Anxiety & Depression Scale         Panic, anxiety &       Panic was independent of disease 
(2009)   between illness perceptions &               Questionnaire-Revised         (HADS), the Panic Disorder Severity      depression, daily life,   severity, more perceived symptoms 
panic in patients with COPD               (IPQ-R)              Scale-Self-Report (PDSS-SR),                        QoL            stronger perceived duration, conse- 
                             St. George’s Respiratory Questionnaire                  consequences & emotional repre- 
                                          (SGRQ), FEV1               sentations were associated with 
                                     more panic attacks. Control/cure beliefs 
                                 were related to more adaptive functioning. 
                                           Control was not related to panic .                         
                                                                                                          
Khdour et al.    173 / M=67yrs             Examination of the effect           Hospital Anxiety & Depression        Self-reported adherence (Morisky         Medication adherence      Demographic variables (e.g. age, 
(2012)          of demographic & psycho-       Scale (HADS), COPD knowledge                 scale), perceived medication                gender, SES) were not related to 
        social factors on medication            questionnaire, COPD self-     effectiveness scale                 medication adherence. Perceived 
                             adherence in COPD            efficacy scale, Health Belief                   treatment ineffectiveness,comorbi- 
                                                                                                                     Model (HBM) questionnaire                                     dities, depression & perceived 
 barriers were independently 
                       related to non-adherence. 
 
Scharloo et al.  244 / M=64.3yrs          Examination of relationship          Structured interview about                Utrecht Coping List, Daily               Coping strategies &    Strong illness identity, passive coping, 
(1998)      between illness perceptions &      patient cognitions & illness                  Activities of Life (DAL),          daily functioning         long illness duration belief, strong 
           coping behaviours & daily                   perceptions & Illness  Medical Outcomes Study                 perceived consequences, and low 
                    functioning            Perception Questionnaire (IPQ)              Short Form General Survey        score on medical variables were related 
                                                                                   (MOS), FEV1                            to worse physical, role & social 
                                   functioning. Coping through social 
                             support  & control /cure beliefs were 
                                    associated with better functioning. 
 
Scharloo et al. 64 / M=63.8 yrs   Examination of association                   Illness Perceptions                  Utrecht Coping List (UCL),           Coping & outcome         Initial illness perceptions & coping 
(2000)    between illness perceptions &          Questionnaire (IPQ), short              MOS-SF20, FEV1, health care      & daily functioning     were associated with social functioning 
      coping and outcome in COPD           structured questionnaire to                        utilisation (hospital/outpatient                           mental health, health status perceptions 
                   elicit illness perceptions  visits, medication strength)                  total functioning score & visits to 
                          outpatient department & prescriptions. 
 
Williams et al. 9 / M=65.7 yrs Exploration of the impact of              Qualitative, interview-based                  Pre- and post-pulmonary     Qualitative interview    Post-PR: change in patients’ perceptions 
(2010)   Pulmonary Rehabilitation (PR)                         approach                    rehabilitation interviews         of breathlessness & lower fear of activity. 
                on patients’  activity levels &                   PR exerted an influence on physical,  
                       breathlessness               social activities, reducing isolation feelings 
_______________________________________________________________________________________________________________________________________________________________________ 
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3.3.3 Assessment and measurement of illness perceptions 
 
The IPQ was first developed by Weinman, Petrie, Moss-Morris, & Horne (1996) to 
measure the five dimensions of the Common Sense Model in a quantitative way. A 
shorter and simpler version of the IPQ was constructed by Broadbent, Petrie, Main, & 
Weinman (2006) featuring a single-item scale approach instead of the Likert scale in 
the original IPQ. The new scale provided the option of measuring illness perception on 
a continuous linear scale and showed good discriminant, predictive validity and test-
retest validity (Broadbent et al., 2006). In addition, a revised version of the IPQ was 
developed by Moss-Morris, et al. (2002) which addressed concerns regarding the IPQ’s 
psychometric abilities. A number of causal items including smoking, stress or worry, 
heredity, and chance or bad luck were added. Moss-Morris et al. (2002) concluded that 
there were four primary factors: psychological attributions, risk factors, immunity, and 
chance. It was emphasized that the subscales of the revised IPQ, depending on the 
nature of the illness, would vary in their applicability. This was due to different primary 
causal attributions made by patients who have different illnesses. The IPQ-R also 
contains questions addressing all the dimensions mentioned above including the newer 
items such as the distinction between personal and treatment control, cyclical timeline, 
illness coherence and emotional representations. Reliability and validity of the IPQ-R 
were reported to be good (Moss-Morris et al., 2002; Hagger & Orbell, 2005). 
  
3.3.4 Modification of illness perceptions 
 
Illness perceptions change and can influence various outcomes such as disability and 
pain. Changing perceptions about consequences, control and emotional response to 
pain significantly predicted the degree of disability in people who were suffering from 
low back pain (Foster et al., 2008). Bijsterbosch et al. (2009) reported similar effects for 
patients with osteoarthritis. In their study, changing perceptions about consequences 
and control but also about the chronic nature of the illness, its coherence and 
emotional response were associated with disability changes even after six years. 
Change in perceptions and physical outcomes in osteoarthritis was also reported by 
Kaptein, Bijsterbosch, et al. (2010). 
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Interventions targeting functioning and education of patients can modify illness 
perceptions. For example, in patients with COPD, Fischer et al. (2010) found that 
timeline and consequences strengthened after receiving the diagnosis and over a 
period of time after that while perceptions of control showed a gradual reduction. It 
would be expected that coping and subsequently control over the illness would improve 
with the passing of time since the patient would have more time to adjust to the illness. 
Fischer et al. (2010) showed that pulmonary rehabilitation increased patients’ 
perceptions of control. Perceived benefit gained from pulmonary rehabilitation was 
related to stronger perceptions of consequences and timeline. Fischer et al. (2010) 
attributed the increase in timeline to exacerbations and information provided during 
pulmonary rehabilitation. Pulmonary rehabilitation could have made patients more 
aware of their symptoms and could have strengthened their perceptions of timeline. 
Illness perceptions are significantly associated with various physical and mental 
outcomes. It would be helpful to develop interventions that would modify illness 
perceptions with the aim to improve patients’ functioning. Studies have explored the 
effect of interventions targeting illness perceptions and found a positive impact on 
patients’ health status. Improving patients’ perceptions of coherence, consequences, 
timeline and causes could increase the likelihood of their return to usual activities and 
work. Broadbent, Ellis, Thomas, Gamble, & Petrie (2009) and Petrie, Cameron, Ellis, 
Buick, & Weinman (2002) found that a brief illness perceptions modification programme 
had two positive outcomes on patients who had suffered myocardial infarction. First, it 
had modified patients’ perceptions about their illness and second, it had decreased 
recovery time and facilitated return to work. Beneficial effects of modification of illness 
perceptions were found for diabetes (Keogh, et al., 2011) and psoriasis (Fortune, 
Richards, Griffiths, & Main, 2004). Visual representation facilitated modification of 
illness perceptions. For instance, final stage kidney failure patients were presented with 
a container and a phosphate solution which represented the stomach and food, 
respectively, in order to demonstrate the way in which their medication exerted its 
effect (Karamanidou, Weinman, & Horne, 2008). This intervention aimed to increase 
patients’ understanding of the reasons why frequent intake of their medication was 
crucial. Findings showed that patients’ treatment beliefs and knowledge improved in 
the short-term but their perceived need for treatment medication and medication 
compliance did not increase significantly after the intervention. Modern technology in 
the form of content-specific text messages has also been used to modify negative 
illness perceptions in young people suffering from asthma and to increase their 
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medication adherence with persisting effects even at 6 months after discontinuation of 
the texts (Petrie, Perry, Broadbent, & Weinman, 2011). 
The presence of co-morbidity requires a slightly more complex approach because 
multiple conditions can influence patients’ illness perceptions differently such as 
identity, cause, illness coherence and consequences (Bower, et al., 2012; Anderson et 
al., 2001). Different illnesses could present with distinctive perceptions or interlinked 
perceptions extending through different conditions. For example, multiple medications 
influenced the way patients attempted to make sense of their illness. Illness 
perceptions relating to different diseases would compete with each other and in 
attempting to regulate one set the other may be misregulated (Detweiler-Bedell, 
Friedman, Leventhal, Miller, & Leventhal, 2008). For example, patients suffering from 
both depression and diabetes would probably respond well to interventions targeting 
depression. These, however, could increase their appetite and lead to dysregulation of 
their blood sugar (Detweiler-Bedell et al., 2008). 
Taking into consideration that negative illness perceptions are associated with a variety 
of outcomes in a range of patient groups, they should be embedded into routine care 




Illness perceptions play a very important role in adjustment, management and coping in 
various conditions as well as in COPD. More positive illness perceptions are related to 
more favourable outcomes in terms of physical, social and emotional functioning while 
more negative illness perceptions are associated with greater health care seeking. 
Previous evidence for the link between SES and the way patients make sense of their 
illness also provide indications for a possible association between lower SES and more 
negative illness perceptions. This chain of thought provided grounds for the hypotheses 
used in this research examining (a) whether the relationship between lower SES and 
more impaired health care access was mediated by more negative illness perceptions 
and (b) whether the relationship between lower SES and poorer QoL was mediated by 
more negative illness perceptions. 
The examination of illness perceptions as a mediator in the relationships between SES 
and HCA and SES and QoL could prove to be very useful in elucidating likely pathways 
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of SES on HCA and on QoL in COPD. However, the literature has also provided 
evidence for a further psychological variable showing strong associations with both 
SES and QoL and self-management in chronic illness and COPD: self-efficacy. 
Including self-efficacy in this thesis could possibly add to our understanding of the 
nature of associations between SES and HCA and SES and QoL in COPD. For 
example, if a COPD patient had a low level of confidence i.e. low self-efficacy in their 
ability to attend pulmonary rehabilitation or engage in physically activity this might be 
more or equally important as their beliefs about their condition. Knowing what would be 
required in order to improve their health status and taking action to do so are two 
different concepts which might be operating independently or supplement each other. 
Previous literature has provided evidence for associations between SES, QoL and both 
illness perceptions and self-efficacy. Thus, examination of illness perceptions and self-
efficacy as possible mediators in the relationship between SES and HCA and SES and 
QoL could contribute significantly to increasing our understanding of patient beliefs and 
experience of emotions regarding the experience, coping and management of COPD 
such as attendance at PR and adherence to treatment.  
One possible limitation of illness perceptions and self-efficacy is that both can vary in 
time, and age as well as environmental and social influences can make their 
examination more difficult. This is especially true for COPD which is a disease that 
progresses gradually and is more common in ages above 40 years. Moreover, the 
definitions and measures used to assess quality of life but also health care access 
might complicate matters slightly due to their variability. With regard to health care 
access, patients’ illness perceptions and level of self-efficacy may also play an 
important role in the nature of interaction between patients and health professionals. 
The nature of this interaction could be influenced by the perceptions and confidence of 
the patient as well as the health care provider. This is to say that although illness 
perceptions and self-efficacy could provide significant information on the patients’ side, 
further external factors that could be exerting an influence need to be considered in 
order to increase our understanding in a more reliable way. 
Illness perceptions and self-efficacy can be modified in order to change maladaptive 
cognitions and improve outcomes. Therefore, identification of the role of illness 
perceptions and self-efficacy in the relationship between SES and HCA and QoL could 
increase our knowledge and interventions incorporating both concepts could improve 
well-being for patients with COPD.  
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3.4 Self-efficacy in chronic illness and COPD 
 
3.4.1 What is self-efficacy? 
 
The concept of self-efficacy was introduced by Bandura (1977) and refers to an 
individual's perception of the degree of control they have over their actions so that they 
can achieve desired outcomes. It reflects the degree of self-confidence people have in 
their capability to adapt effectively to different demands and challenges of their 
environment, and exert their control over various activities and conditions.  
Self-efficacy is one of the elements comprising Social Cognitive Theory (SCT) 
(Bandura, 1986). SCT is based on three dimensions that interact with each other in a 
reciprocal way: (a) personal determinants, (b) behavioural determinants and (c) 
environmental determinants. The interaction between people’s individual attributes, the 
behaviour they engage in and the environmental influences they are subjected to 
determines their functioning. People exert some control over the way events are 
shaped and the direction their lives take but are also influenced by them. A visual 
representation of this interaction is presented in Figure 3.2 (Bandura, 2012). 
 
 
Figure 3.2 Visual representation of the interaction between the three determinants within the 
causal model of Social Cognitive Theory (taken from Bandura, 2012) 
 
This interaction between the three determinants and their influence on an individual’s 
perceived self-efficacy led to its inclusion in the current thesis in the attempt to examine 
whether lower socio-economic status might be associated with self-efficacy, health 
care access and quality of life COPD. Taking into account the impact of the 
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environmental and individual characteristics on behaviour and the role of self-efficacy, 
it would be plausible to assume that they might also exert an influence on whether and 
how patients seek access to health care services or pursue behaviours that would 
benefit their well-being. For example, higher deprivation might lower patients’ perceived 
self-efficacy and prevent them from accessing health care services due to their belief 
that they would be unsuccessful in doing so. This interaction between environment and 
self-efficacy is reflected in Bandura’s (2012) theory of the existence of three types of 
environments that surround people. These include the imposed environment, the 
selected environment and the constructed environment. The first is more or less 
imposed on humans regardless whether it is to their liking or not. People can exert 
some control over how this environment is construed and how they react to it. The 
selected environment refers to the fact that it has to be selected and activated by an 
individual. The activities people engage in and the choices they make can influence the 
direction their lives take. Finally, environments can also be created to enhance 
people’s control over their lives. The importance of the individual as an acting agent in 
this setting emphasizes the role of self-efficacy. Depending on how capable people 
perceive themselves to be, they can act in specific ways in order to select or control 
their environment to a certain extent. The higher they perceive their self-efficacy to be 
the more likely they are to engage in actions that will shape their environment to their 
liking. But could lower SES and self-efficacy be associated and could this relationship 
have a negative influence on health care access and quality of life? This will be 
discussed in the following sections. 
 
3.4.2 How does self-efficacy operate? 
 
People’s perceived belief in their abilities differs depending on the type of situation in 
which they find themselves or the type of activity they engage in (Bandura, 2012). Self-
efficacy is derived from four sources: (a) perceived mastery; (b) social modelling; (c) 
social persuasion; and (d) somatic and psychological status (Bandura, 2012).  
People from more deprived background could be subject to a variety of influences 
which could foster or lower their self-efficacy levels. On the one hand, due to more 
limited social and financial resources, lower SES groups would be more likely to have 
greater experience of failure in various tasks such as in academic or occupational 
settings. This could increase their perseverance and resilience to achieve the goals 
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they have set. On the other hand, more affluent individuals might be less likely to 
experience failure and thus would have lower self-efficacy levels because they did not 
need to persevere and develop resilience to situations. Alternatively, due to more 
resources available to them, they might experience a greater sense of control over their 
lives and so have higher levels of self-efficacy. Social persuasion as well as social 
modelling, due to exposure to similar experiences observed in their networks of 
acquaintances, friends and family, would probably contribute to strengthening these 
attributes. Higher levels of depression and anxiety that might affect more deprived 
populations due to inability to cater for everyday requirements could discourage further 
attempts or make these attempts less successful. For example, in patients with COPD, 
higher deprivation might encourage and strengthen their attempts to seek the health 
care services they require thus providing them with greater health care access than 
expected. Greater health care access would most likely have a beneficial effect on 
peoples’ QoL. In contrast, higher deprivation could also have a negative impact on 
peoples’ quality of life due to depression and anxiety and continuous attempt to secure 
services they need.   
Preventive self-efficacy in health behaviours significantly influenced actual health 
behaviour and well-being (Bandura 1986, 1992; Gecas, 1989; O'Leary, 1985). People 
with higher self-efficacy levels were more likely to engage in preventive actions such as 
exercise, smoking cessation and to have more positive perceptions of their health 
status in comparison to people with lower self-efficacy (Bandura 1986; Gecas 1989; 
Bandura, 1992). 
On an individual SES level, high self-efficacy was positively associated with higher 
occupational status and income (Hughes & Demo, 1989) as well as educational 
attainment (Gecas & Seff, 1989). The attempts to explain the pathways of the influence 
of SES on self-efficacy involve two aspects. First of all, the wide range of resources 
available to people of higher SES increases the opportunity for everyday activities and 
as a consequence the likelihood of mastery experiences (Hughes and Demo 1989). 
Secondly, self-efficacy is reinforced by occupational characteristics that are related to 
higher SES such as the degree of complexity and independence at work (Gecas & 
Schwalbe, 1983). Both of these proposed explanations rely on the principle that 
successful engagement determines the level of perceived self-efficacy through 
increasing the degree of perceived mastery derived from this experience. This 
perceived mastery can generalise to other domains of activity (Bandura, 1986). 
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However, Boardman & Robert (2000) claimed that neighbourhood SES was more 
influential on perceived self-efficacy than individual-level SES. People living in more 
deprived neighbourhoods were more likely to report lower self-efficacy as compared to 
people living in less deprived neighbourhoods. Two possible explanations have been 
proposed on how SES could affect self-efficacy superseding the individual-level SES: 
(a) spatial limitations on the availability of resources accessing and exiting 
neighbourhoods; in other words, institutional discrimination places a constraint on the 
flow of resources into more deprived neighbourhoods. Thus, a person with low SES 
who is residing in a high SES area is offered more opportunities in comparison to a 
person with low SES in a low SES neighbourhood. This would gradually lead to 
increased daily activities and subsequently greater likelihood of acquiring mastery 
experiences; and (b) the nature of the surrounding social context which includes people 
with high perceived self-efficacy who might increase the opportunities for a wider range 
of vicarious mastery experiences. This resembles the social modelling theory described 
above where people with low self-efficacy may be more likely to experience vicarious 
mastery through their exposure and observation of people with higher self-efficacy who 
live in the same surroundings (Bandura, 1986).  
The aforementioned speculations were based on the assumption that self-efficacy can 
not only exert a direct effect on behaviour but can also influence behaviour through 
other mediating variables such as goals, outcome expectations and social factors 
(Bandura, 1986). These variables provide a model for self-regulation and motivation for 
action. The goals that individuals set for themselves are influenced by their values and 
can function as a guide or incentive for action and depend on their beliefs in their 
abilities (Locke & Latham, 1990; Seo & Ilies, 2009). Outcome expectations pertain to 
physical or social costs and benefits. They also involve reflections regarding one’s 
response to these expectations which could be positive or negative. Social factors such 
as environmental structures can influence the way people react. If an individual 
recognises the opportunities and potential it can provide, they will act accordingly in 
order to benefit from them. Individuals with low self-efficacy would be easily intimidated 
and discouraged to act when facing institutional barriers. Instead, those with high self-
efficacy would find ways to overcome them. In the context of health, people from more 
deprived backgrounds would be more likely to be intimidated and not pursue the health 
care services they required in a persistent fashion. The direction of the influence of 
SES, self-efficacy and HCA is not clear. Therefore, this thesis explores whether lower 
SES would be associated with lower self-efficacy, which, in turn would be related to 
lower HCA.  
128 
 
Self-efficacy varies from person to person, between functioning domains and within 
elements of these domains. In order to acquire a comprehensive and valid view of an 
individual’s self-efficacy, the factors that determine performance of a specific action 
and the barriers that prevent realisation of the goals that have been set need to be 
identified Bandura (2006b). For example, patients with COPD benefit greatly from 
pulmonary rehabilitation in terms of dyspnoea, physical and psychosocial functioning. 
However, achieving this outcome would require them to regulate their efficacy in three 
different controllable activity domains. First, higher self-efficacy would be required to 
visit the GP and ask for available options to improve their health status. Secondly, once 
patients received a referral for pulmonary rehabilitation, they would need to attend and 
complete it despite perceived barriers such as fatigue or dyspnoea. Thirdly, maintaining 
their physical exercise after completion of the programme in order to sustain the 
benefits acquired from it would be essential as well. Focusing on only one of these 
aspects to improve physical and psychosocial functioning through self-efficacy would 
probably be ineffective. A combination of all three is required to increase the likelihood 
of achieving the desired result. Depending on the individual and their circumstances, 
these three aspects may vary and all would probably be affected by SES. Making an 
appointment with a GP might be harder due to patients’ limited access to health care 
due to deprivation in their area of residence and more limited availability of services; 
attending and completing PR might be more difficult because of lack of programmes in 
the area, long waiting lists or no available transportation due to patients’ financial 
restrictions; maintaining the benefits and exercise regime learned in PR might be 
harder due to inability to subscribe to a local gym because of patients’ low income. 
Self-efficacy theory has been applied in a variety of domains of human psychosocial 
functioning. It has been used to explain anxiety disorders (Mystakidou, et al., 2012; 
Bandura et al., 1980; 1982), depression and abstinence in substance use (Greenfield, 
Venner, Kelly, Slaymaker, & Bryan, 2012; Kanfer & Zeiss, 1983), weight loss (Byrne, 
Barry, & Petry, 2012), professional choices, career course and academic (Richardson, 
Abraham, & Bond, 2012) and athletic achievements (Cetinkalp, 2012; Wu, 2012). 
Despite exploring different aspects of psychosocial functioning, studies indicated that 
people’s perceived self-efficacy has a significant impact on people’s motivation, 





3.4.3 Self-efficacy and health  
 
Self-efficacy is distinguished between generalised and disease-specific self-efficacy. 
Generalised perceived self-efficacy affects people’s choices and behaviours in various 
domains such as the adoption or avoidance of health behaviours or chronic illness 
management. Depending on an individual’s level of self-efficacy, their efforts and 
persistence in reducing substance abuse such as alcohol or smoking, increasing 
physical activity, improving their diet and employing relaxation techniques will be 
affected accordingly (O’Leary, 1985). 
Self-efficacy is important in explaining and predicting complex behaviours and long-
term changes in behaviour and is helpful in patient assessment and illness 
management (Barlow, Wright, Sheasby, Turner, & Hainsworth, 2002; Holman & Lorig, 
1992; Lorig, 2001; Lorig & Holman, 2003). Identifying areas with low self-efficacy can 
contribute to the design of patient education programmes. This enables targeting and 
tailoring self-management education according to patient needs and characteristics. In 
addition, by assessing self-efficacy over time, it is possible to appraise the 
effectiveness of patient education programmes. Measurement of self-efficacy can help 
identify individual differences between patients, and can predict important health 
outcomes such as hospitalisations or quality of life (Frei, Svarin, Steurer-Stey, & 
Puhan, 2009). Illness-specific versus generalised self-efficacy measures have been 
developed in order to assess the relevant domains of functioning that are of particular 
interest. These self-efficacy scales focus on capturing patient beliefs about their ability 
to successfully perform certain activities and measure the strength of that belief 
(Bandura, 1977; Bandura, 2006a). Disease-specific instruments can assess selected 
patient-reported outcomes, for example, health-related quality of life (Kirshner & 
Guyatt, 1985). Maintaining good quality of life involves engaging in complex activities 
like self-monitoring, adaptation of medication, and long-term changes in behaviour 
where self-efficacy plays a critical role. Frei, et al. (2009) found a greater number of 
self-efficacy instruments for diabetes compared to asthma, arthritis, or COPD and none 
for cardiac failure. Frei et al.’s (2009) findings emphasized that there were significant 






a. Self-efficacy and health-related behaviours 
  
Self-efficacy can mediate and affect health behaviours or outcomes such as quality of 
life. Haas, Kimmel, Hermanns, & Deal (2012) found that self-efficacy mediated the 
relationship between cancer-related fatigue and quality of life in women with breast 
cancer. Based on their findings, the authors suggested that enhancing self-efficacy 
may reduce the impact of fatigue on physical activity and indirectly improve QOL in this 
patient population. Self-efficacy was correlated to physical activity levels in women 
receiving treatment for breast cancer which influenced their quality of life consistent 
with previous studies (Perkins, Baum, Carmack Taylor, & Basen‐Engquist, 2009; Pinto, 
Rabin, & Dunsiger, 2009; Perkins et al., 2009). Higher SES in terms of income level 
was associated with higher self-efficacy in women with breast cancer who were 
receiving chemotherapy (Haas, et al., 2012) supporting previous evidence (Bandura, 
1997). Women with fewer financial resources had lower levels of self-efficacy. Haas 
(2012) emphasized that while fatigue and self-efficacy accounted for 28% of the 
variance in physical activity levels, other variables such as socio-economic status or 
co-morbidities had to be taken into account too. Motl, McAuley, Wynn, Sandroff, & Suh 
(2013) found that physical activity and self-efficacy were associated with health-related 
quality of life (HRQOL) in patients with multiple sclerosis (MS). Self-efficacy was 
suggested to be a mediator due to stronger associations with HRQOL compared to 
physical activity. Brink, Alsén, Herlitz, Kjellgren, & Cliffordson (2012) found that higher 
general self-efficacy was not only associated with better HRQOL but that it was also 
mediated by fatigue. Higher general self-efficacy was correlated to lower fatigue which, 
in turn, was associated with better mental and physical health. Brink et al. (2012) 
suggested that severe illness consequences such as fatigue may affect patients’ 
HRQOL and their levels of self-efficacy significantly echoing previous research (Sarkar, 
Ali, & Whooley, 2009). 
Knittle, et al. (2011) found that self-efficacy influenced arthritis pain indirectly through 
attainment of physical exercise goals set by the patients. They suggested that this 
finding might be indicative of the fact that patients with higher self-efficacy were more 
likely to strive for higher goals regarding physical exercise than those with low self-
efficacy. Setting higher goals would probably involve more a demanding exercise 
regime which could be more beneficial to patients’ quality of life (QoL). Knittle et al. 
(2011) attributed this to patients’ stronger perception of control over their illness. In 
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addition, the attainment of goals could be associated with stronger feelings of control 
over their disease and improved QoL based on previous findings involving chronic 
obstructive pulmonary disease (COPD) patients (Fischer et al., 2010). 
 
b. Self-efficacy and health outcomes 
 
Perceived self-efficacy was found to be a significant predictor of therapeutic outcome in 
various domains and diseases (Bandura, 1992). For example, individuals with higher 
self-efficacy levels were more successful in controlling pain in comparison to those with 
low levels of self-efficacy (Altmaier, Russell, Kao, Lehmann, & Weinstein, 1993; Litt, 
1988). Pain could also be decreased through the implementation of behavioural 
interventions targeting the increase of self-efficacy (Buhrman, Nilsson-Ihrfelt, Jannert, 
Strom, & Andersson, 2011; Lorig, Ritter, Laurent, & Plant, 2008). A further domain that 
was positively associated with self-efficacy was the rate of recovery of cardiovascular 
function in coronary heart disease patients. Patients’ cardiovascular function was 
improved by reinforcing their beliefs in their physical ability and cardiac efficacy (Taylor, 
Bandura, Ewart, Miller, & DeBusk, 1985). An increase in self-efficacy had positive 
effects on stress management (Lazarus & Folkman, 1987). Stress management plays 
a significant role in quality of life because the way people cope with stressful situations 
has an impact on their immune system (Wiedenfeld et al., 1990). Higher levels of 
stress due to lower self-efficacy would be more likely to weaken the immune system 
and increase vulnerability to infections and other health problems.  
Self-efficacy has also a significant impact on other domains such as physical, 
psychological well being in chronic illness. For example, in coronary heart disease 
(CHD) populations, patients who had low perceived self-efficacy experienced worse 
health status. This involved greater experience of symptoms, poorer functioning and 
poorer quality of life (Sarkar, Ali, & Whooley, 2007). In addition, low levels of cardiac 
self-efficacy had an impact on disease consequences. Thus, low self-efficacy was 
linked to increased likelihood for heart failure and hospital admissions for CHD 
patients. Improved self-management and better mental status were related to higher 
self-efficacy in patients who had suffered a myocardial infarction (Joekes, Van Elderen, 




c. Self-efficacy and disease management 
 
Disease management in chronic illness includes healthy diet and exercise, medication 
adherence and health literacy all of which contribute to patients’ QoL. Medication 
adherence is part of disease management and crucial to a patient’s recovery and 
coping with an illness. Studies exploring the association between patients’ medication 
self-efficacy and disease outcome in HIV found contradictory evidence. Some found 
support for higher levels of self-efficacy and improved HIV medication adherence 
(Catz, Kelly, Bogart, Benotsch, & McAuliffe, 2000; Cha, Erlen, Kim, Sereika, & 
Caruthers, 2008). Their results triggered further search into other possible variables 
influencing self-efficacy such as health literacy which refers to a patient’s knowledge 
about their disease. In HIV patients, self-efficacy mediated the relationship between 
disease education and medication adherence (Wolf, et al., 2007). Belief in one’s ability 
to follow the treatment regime under varying circumstances was suggested to influence 
a patient’s ability to acquire, understand and follow medical recommendations. Others 
did not find support for self-efficacy mediating the relationship between health literacy 
and treatment adherence (Colbert, Sereika, & Erlen, 2012; Paasche‐Orlow et al., 2006; 
Wolf, et al., 2004). Authors attributed their results to different measures of health 
education and adherence used in the studies.  
 
d. Can self-efficacy be modified? 
 
Examination and knowledge of the various factors influencing self-efficacy and its 
impact on other variables can contribute to understanding how self-efficacy operates 
and affects patient well-being.  But, is it possible to modify self-efficacy for the benefit 
of the patient? 
Self-efficacy is derived from four sources of information for any specific behaviour: (a) 
enactive mastery experience; (b) vicarious experience; (c) verbal persuasion and (d) 
physiological or affective states (Bandura, 1977). Enactive mastery experience relates 
to the target behaviour being successfully performed. This would increase perceived 
efficacy levels whereas failing to perform the desired behaviour would reduce it. 
Vicarious experience, relates to imitating a behaviour after observing a person similar 
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to oneself successfully perform the behaviour in question and evaluating one’s own 
performance on the basis of the performance observed. Verbal persuasion refers to 
others expressing faith in one’s abilities to perform a specific behaviour. Finally, 
perceived self-efficacy can be increased through the reduction of negative emotional 
states and correction of misinterpretations of physical states. 
Manipulation of these four sources of self-efficacy could theoretically lead to an 
increase in perceived self-efficacy. The evidence for effectiveness of interventions to 
enhance self-efficacy in abstaining from substance use was found to be more 
consistent compared to adopting HIV-related prevention behaviours (Hyde, Hankins, 
Deale, & Marteau, 2008; Mize, Robinson, Bockting, & Scheltema, 2002). The authors 
emphasized that only a small number of the studies included in the reviews assessed 
self-efficacy as an independent outcome and only Mize et al. (2002) synthesized their 
findings in a quantitative way. 
Ashford, Edmunds, & French (2010) found a significant effect of physical activity 
interventions on self-efficacy. In addition, when vicarious experience and feedback on 
previous or other people’s performance were included in the interventions, physical 
activity self-efficacy was significantly increased compared to when these techniques 
had not been incorporated. In contrast, when persuasion and graded mastery 
strategies as well as techniques to identify barriers were used as components in the 
interventions, a reduction in self-efficacy as compared to interventions that had not 
used them was found. The authors emphasized that there was a significant degree of 
heterogeneity as well as multiple moderators in their meta-analysis which could have 
affected their findings 
Perceived self-efficacy is a concept that is of great interest in COPD because 
dyspnoea can lead to a reduction in patients’ confidence in their ability to avoid 
breathlessness while engaging in specific activities. This is true even when the 
associated physical demands are minor. Thus, some patients with COPD may be 
reluctant to engage in daily activities despite being physically able to do so for fear of 
getting breathless (Wigal, Creer, & Kotses, 1991). 
Scherer, Schmieder, & Shimmel (1998) found that a combination education and 
exercise training in a pulmonary rehabilitation programme administered to patients with 
COPD was more effective in improving long-term self-efficacy in patients with COPD in 
comparison to a programme that included education only. This effect was maintained 
for 6 months. Significant improvement in patients’ self-efficacy scores was also 
134 
 
observed in the programmes that contained only the education component but 
disappeared at 6-month follow-up. These results were consistent with previous findings 
by Atkins, Kaplan, Timms, Reinsch, & Lofback (1984a) who had used interventions 
targeting cognitions and behaviour to improve self-efficacy. 
In conclusion, there is evidence that self-efficacy can be modified with beneficial effects 
on patients’ health-related behaviours but they need to be tailored according to the 
behaviour of interest and the particular characteristics of the patient population in 
question.  
 
3.4.4 Self-efficacy in COPD 
 
a. Self-efficacy and health outcomes  
 
The impact of low self-efficacy is evident on physical symptoms such as increased 
dyspnoea in patients with COPD. Patients’ beliefs in their abilities to perform the 
activities they enjoy without the experience of breathlessness are weakened (Scherer 
& Schmieder, 1997). An association between self-efficacy and quality of life was found 
and persisted even when adjusting for disease severity and duration as well as socio-
economic status factors (McCathie, Spence, & Tate, 2002). This suggested that SES 
variables and severity of disease were not as important to QoL as patients’ beliefs in 
their ability to engage in desired activities without experiencing breathlessness. If 
patients’ perceived themselves unable to socialise or exercise without fear of becoming 
breathless and collapsing, they would probably not perform these actions even if they 
were perfectly capable of doing so without any negative effects. These results 
emphasized how important self-efficacy is in COPD and how it can affect patients’ 
behaviours. 
Further evidence for the lack of consistency between patients’ perceived self-efficacy 
and their objective abilities comes from studies showing varying degrees of functional 
outcomes in COPD patients with similar levels of impairment. Higher self-efficacy was 
a key factor in improving self-management and long-term behaviour change and 
mediated pulmonary function and quality of life (Arnold, et al., 2005; Wigal, et al., 
1991). Higher levels of self-efficacy were associated with a decrease in patients’ 
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psychosocial functioning, increased physical activity and poorer quality of life (Bentsen, 
Wentzel-Larsen, Henriksen, Rokne, & Wahl, 2010). In addition, quality of life was 
related to self-efficacy, perceived difficulty in breathing and satisfaction of household 
income level (Jee, 2011). Kohler, Fish, & Greene (2002) also found that perceived self-
efficacy for functional activities mediated the relationship between lung function and 
quality of life in COPD. Similar effects were reported for survival, engagement in 
physical activity (Kaplan, et al., 1994; Soicher, et al., 2012) and functional performance 
(Siela, 2012). In contrast, lower levels of self-efficacy were related to poorer self-
management of disease in COPD patients (Warwick, Gallagher, Chenoweth, & 
Stein‐Parbury, 2010). It appears, therefore, that the effect of self-efficacy is pervasive 
and can affect different domains and behaviours in patients with COPD. 
 
b. Factors influencing self-efficacy in COPD 
 
Illness-related education could influence self-efficacy in patients with COPD. An 
increase in illness-related education might lead to an increase in patients’ self-efficacy 
through increasing their knowledge of their illness, for example, what to expect and 
what to do. Blackstock & Webster (2007) conducted a systematic review on the effects 
COPD-specific education on outcomes which included quality of life changes, physical 
and psychological functioning, self-efficacy and health care utilisation. COPD-specific 
education for self-management was associated with decreased health care utilisation in 
COPD. Fewer hospitalisation rates were observed in patients who had received the 
educational programmes in comparison to those who had not. Health care costs in 
relation to GP visits were also reduced. Blackstock and Webster (2007) suggested that 
self-management education could have led to an increase in patients’ self-efficacy to 
handle exacerbations without requiring medical treatment. HRQOL was not associated 
with receiving the educational interventions. The authors attributed this to use of 
different measures and their varying sensitivity as well as insufficient sample sizes. 
Implementation of self-management programmes in COPD has increased in the past 
few years (Effing, et al., 2007). These programmes vary in their content depending on 
the severity of COPD, co-morbidities, patients’ self-efficacy levels and their access to 
health care. Their main aim involves teaching COPD patients the skills to follow 
treatment regimens which are disease-specific and aid behaviour change in order to 
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support patients in controlling their condition and improving their physical and mental 
status (Bourbeau, 2003). Adams et al. (2007) found that self-management was 
effective in reducing health care utilisation in COPD as long as it was part of a multiple-
component programme.  
Self-management can influence self-efficacy in COPD. Patients need to regulate their 
exercise and eating habits, they need to take their inhalers regularly and they need to 
quit smoking. All of these behaviours contribute to their quality of life. Stellefson, 
Tennant, & Chaney (2012) found a significant effect of self-management education on 
COPD patients’ self-efficacy levels in their review. For long-term effects of self-
management interventions, inconsistent evidence was reported attributed to differing 
methods and content used in education delivery (Carrieri‐Kohlman et al., 2010; Davis, 
Carrieri-Kohlman, Janson, Gold, & Stulbarg, 2006; Kara & Asti, 2004). Despite 
variability in the components included in the interventions, they all related to the four 
sources of self-efficacy postulated by Bandura. 
Medication adherence is important in COPD management and self-efficacy is amongst 
the factors influencing medication adherence in COPD (Bourbeau & Bartlett, 2008; 
Rand, 2005). COPD patients need to manage their disease and associated symptoms, 
for example breathing problems on their own. Cecere et al. (2012) investigated factors 
related to medication adherence (long-acting beta-agonists (LABA) and inhaled 
corticosteroids (ICS) in COPD. These factors included personal characteristics, 
confidence in medication effectiveness and self-efficacy.  The patients who had higher 
levels of self-efficacy also showed higher adherence to LABA. Authors attributed this 
finding to improved adherence to LABA being associated with enhanced control of 
respiratory symptoms leading to higher levels of self-efficacy. Higher age and 
educational attainment and successful smoking cessation were also associated with 
higher likelihood of adherence to LABA. Contrasting evidence was reported by Khdour 
et al. (2012) who found that self-efficacy could account for a very small proportion fo 
the variance in medication adherence. Patients’ beliefs regarding medication 
effectiveness and the presence of physical and mental co-morbidities were stronger 
predictors of medication adherence.  
COPD-specific self-management programmes appear to be effective in some domains 
but this does not mean that patients would attend them. In their review, Effing et al. 
(2007) reported that 86% of COPD patients who had attended a self-management 
education programme completed it successfully. Drop-out rates were reported to range 
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between 0-30%. Sohanpal, Seale, & Taylor (2012) investigated the reasons for 
attendance and possible barriers as well as options for attendance improvement. 
Eagerness to learn about self-management, socialising with others with the same 
condition and altruism were motivating factors for COPD patients to attend a self-
management programme. Barriers for attendance included poor health status or not 
sufficiently poor health status and practical, physical and psychological factors. 
Reasons for low attendance were denial of condition, fear of changing habits, lack of 
social support, feelings of guilt about smoking and the rigid nature of the programme 
such as its duration and length. Increasing patients’ perceived self-efficacy i.e. 
reinforcing their faith in their ability to participate in self-management programmes, is 
important in improving health status in COPD. 
 
c. Self-efficacy and Pulmonary Rehabilitation (PR) 
 
Patients’ perceived self-efficacy levels play a role in pulmonary rehabilitation 
attendance. Keating et al. (2011) found high rates of non-attendance which ranged 
from 8 to 50%. For PR completion, drop-out rates were between 20-40% (Fischer et 
al., 2009). Of the COPD patients who had received a referral by their GPs, 75% 
attended and completed PR (Fischer et al., 2009). Fischer et al. (2009) found that 
failure to complete not attend PR was due to medical or practical reasons such as time 
constraints and dissatisfaction of health care system. This suggested that increasing 
patients’ belief in their ability to overcome practical barriers may decrease the likelihood 
of drop-out.  
The social nature of PR programmes facilitates interpersonal interaction between 
COPD patients. Patients with a broader social network were found to have better 
functional status which was associated with improved mental status (Marino, Sirey, 
Raue, & Alexopoulos, 2008). Lower levels of self-efficacy in COPD patients regarding 
symptom management include increased depression and anxiety (McCathie et al., 
2002; Dowson, Town, Frampton, & Mulder, 2004). 
Garrod, Marshall, & Jones’ (2008) study explored (a) differences in self-efficacy levels 
between COPD patients who completed PR and those who dropped out and (b) 
associations between self-efficacy and physical and psychological variables.  No 
statistically significant difference in baseline self-efficacy scores in the two groups was 
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found. When scores were analysed after completion of PR, strong associations were 
found between self-efficacy and mastery, emotion and anxiety. 
 
d. Measurement and assessment of self-efficacy 
 
One of the most commonly used tools to measure self-efficacy is the Generalised Self-
efficacy Scale (Schwarzer & Jerusalem, 1993; Schwarzer & Jerusalem, 2010). The 
GSE originally included 20 items but was then revised to a shorter 10-item version. The 
individual items of the scale and its scoring are discussed in Chapter Six. The full 
version of the scale is included in the appendices (Appendix D7). General self-efficacy 
rather than illness-specific self-efficacy was selected for the present research for two 
reasons: (a) a proxy for illness-specific self-efficacy was included in the form of mastery 
within the Chronic Respiratory Questionnaire which assessed QoL in COPD; and (b) 
the aim of the study was to examine whether lower SES was related to more impaired 
HCA and poorer QoL and whether self-efficacy mediated these relationships. SES was 
assumed to influence an individual’s belief in their ability to cope with life demands as a 




The relationship between higher self-efficacy levels and improved physical and 
psychological quality of life as well as greater health care utilisation in chronic illness 
and COPD has been supported in a number of studies. Moreover, there is support for 
self-efficacy mediating the relationship between SES and health outcomes. Self-
efficacy can be modified resulting in beneficial effects on patient outcomes. Based on 
the evidence for the role of self-efficacy in HCA and QoL, the hypotheses employed in 
this study included this variable as a possible mediator in the relationship between SES 





3.5 Emotional well-being in chronic illness 
 
3.5.1 The impact of illness, coping and social support 
 
Physical illness can create feelings of distress, uncertainty and loss of control in an 
attempt to adjust to new circumstances, make lifestyle changes and manage 
unexpected challenges and threats such as symptoms and the course of the disease 
(Taylor & Aspinwall, 1993; Taylor, 1991). These adjustments are part of people’s 
coping mechanisms which are active processes that involve the receipt and 
assimilation of information about their illness, managing emotions and changing 
behaviours (Guthrie & Nayak, 2012). In chronic illness, this process has to be repeated 
or re-appraised frequently as complications or new symptoms may emerge which can 
put further strain on a person’s health status. A significant proportion of people with 
chronic conditions are affected by emotional and affective disorders due to the stress 
derived from their illness and their lack of success in adjusting to it. Not everybody with 
a chronic illness experiences the same amount of stress. A number of different factors 
can exert an influence on a person’s response to the stress of a chronic illness such as 
the nature of the illness itself, demographic characteristics, coping strategies or social 
support. These factors are discussed in detail below. 
The nature of the illness can include a variety of aspects ranging from the degree of 
debilitation an illness can cause, to whether its onset is gradual or sudden, whether it is 
fatal and progressive or non-life-threatening and stable (Pollin & Golant, 1994). A 
chronic illness diagnosis can create feelings of uncertainty regarding the future and 
one’s physical status, possible lifestyle changes as well as a sense of vulnerability, 
distress and helplessness due to loss of personal control over the illness and life in 
general (Taylor, Helgeson, Reed, & Skokan, 2010). The impact of demographic 
characteristics is reflected in the fact that people who suffer from the same chronic 
illness can experience different manifestations such as severity and duration of 
symptoms depending on their age, gender, marital status, physical states, ethnicity or 
education (Bracht, 1980).  
Coping strategies which are adopted by people to deal with a stressor that arises when 
facing a chronic illness can be influenced by different factors. One of them is the 
degree of controllability (Lazarus & Folkman, 1984). Controllability refers to the extent 
to which coping responses are effective at targeting the problem or ameliorating the 
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emotional impact of the problem. Coping strategies involve a cognitive and a 
behavioural component. The cognitive component aims to make sense of the illness 
and its impact on one’s life as well as cope with emotional responses to an experience 
such as denial or minimalisation. The behavioural component involves actions that can 
be employed to change the situation such as increasing one’s knowledge about the 
illness, learning to control symptoms and making short- and long-term plans (Sidell, 
1997).  
Social support offered by family and friends can also affect a patients’ reaction to 
chronic illness. Family and friends can have either a positive or negative effect on a 
coping response (Papadopoulos, 1995). A review by Kriegsman, Penninx, & van Eijk, 
(1995) found that when elderly people perceived family support in a positive way, they 
were more likely to have a more favourable course of illness. Gallant (2003) identified a 
number of negative effects from social support behaviours from friends and family. 
These included nagging, denying the severity of the person’s illness, poor dietary 
habits of the family that were not compatible with the patient’s recommended dietary 
pattern, overreaction and tendency to treat the person as an invalid. Social support can 
also include the wider social environment. For instance, societal emphasis on diets and 
fitness provided positive support to patients with diabetes (Maclean, 1991).  
 
3.5.2 Emotional well being in chronic illness 
 
Depression and anxiety are the most common mental health problems in chronic 
illness (Katon, 2003). The presence of a chronic somatic illness confers higher risk of 
depression (Wilhelm, Mitchell, Slade, Brownhill, & Andrews, 2003). A review by Clarke 
& Currie (2009) indicated increased prevalence of depression in people with heart 
disease, stroke, diabetes, cancer and rheumatoid arthritis compared to the general 
population. For example, in patients with asthma prevalence of depression was twice 
that found in healthy populations (14.4% vs. 5.7%) (Goldney, Ruffin, Fisher, & Wilson, 
2003), in cancer it was reported to be up to four times (Evans, et al., 2005; Rodin, et 
al., 2007) while post-stroke depression prevalence ranged from 5% to 44% (Turner-
Stokes & Hassan, 2002) and persisted for 6 months. The relationship between 
depression and heart disease was more complex with rates being similar for different 
aspects of heart disease such as myocardial infarction (MI), coronary artery disease 
and heart failure (Katon, Lin, & Kroenke, 2007; Lane, Chong, & Lip, 2005). Pre-existing 
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depression ranged from 33% to 50%. In rheumatoid arthritis, prevalence of depression 
ranged from 13% to 80% with younger patients being more likely to be depressed and 
socially withdrawn (Keefe, et al., 2002). There appears to be substantial variability in 
the prevalence levels of depression and anxiety depending on the illness, its nature 
and manifestation. 
Clarke and Currie (2009) found that various elements such as deterioration of disease, 
unrelieved pain, functional impairment and social isolation were linked to higher risk of 
depression. However, depression itself and especially co-morbid depression increased 
the risk for higher disease severity mainly due to non-adherence to the treatment 
regimen which was associated with longer hospital stays and higher morbidity and 
mortality. Depression was increased the risk of developing heart disease, stroke, 
diabetes or osteoporosis. Clarke and Currie’s (2009) found great variability in the 
measures and decreased power in the studies they reviewed. Therefore, depression 
could not be established as an independent risk factor for these chronic physical 
illnesses and especially heart disease.  
There is high prevalence of anxiety disorders in patients with heart disease (10%-50%) 
and cancer (up to 69% depending on disease progression) (Clarke and Currie, 2009). 
In childhood cancer survivors, a life prevalence of stress disorder ranged between 
20.5% to 35% (Bruce, 2006). Great variability in the percentages describing the 
prevalence of depression and anxiety, heterogeneity in patient groups and the nature 
of the disease affecting participants warrant caution when interpreting results and 
drawing conclusions. 
Depression and anxiety are key elements in chronic illness not only due to the 
additional burden placed on patients but also because they can impact other domains. 
For example, depression and anxiety can inhibit adjustment to symptoms such as pain 
(Katon, 2003) or lead to more intense experience of physical symptoms in patients with 
chronic illness (Ciechanowski, Sullivan, Jensen, Romano, & Summers, 2003; Ludman, 
et al., 2004) and higher mortality rates (Ciechanowski, et al., 2010). In addition 
depression and anxiety disorders in chronic physical illnesses can influence patients’ 
quality of life and increase their levels of physical disability (Kroenke, Spitzer, Williams, 
Monahan, & Löwe, 2007; Sareen, Stein, Campell, Hassard, & Menec, 2005). 
Depression and anxiety have also been linked to poorer health care access as well as 
less effective communication with health professionals (Ciechanowski, Katon, Russo, & 
Walker, 2001).  
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Major depression had a negative impact on health behaviours such as smoking, 
healthy nutrition and lifestyle, adherence to medical treatment and physiologic 
consequences (Katon, 2003). Katon (2003) suggested that this could provide an 
explanation for the relationship between depression and increased rates on morbidity 
and mortality mainly for heart disease and diabetes. The literature provides significant 
evidence for the association of major depression with unhealthy behaviours such 
sedentary lifestyle, smoking and poor diet (Glassman et al., 1990; Goodman & 
Whitaker, 2002; Rosal et al., 2001). Higher non-attendance and drop-out rates in 
exercise rehabilitation attendance and completion were associated with higher 
depression scores in stroke patients (Morris, Raphael, & Robinson, 1992). 
Self-management is important in optimising treatment outcomes and is affected 
significantly by major depression. Chronic illness management requires collaboration 
and good communication between patients and their doctors in a variety of domains 
such as dietary changes, increase of activity levels, regular intake of medications, 
monitoring physiological indices such as blood glucose levels and reducing unhealthy 
behaviours such as smoking or alcohol (Katon, 2003). Patients with COPD, for 
example, who may suffer from anxiety or depression would be less likely to 
communicate regularly with their doctor, engage in physical activity, adopt a healthy 
diet or adherence to their treatment regime compared to patients without anxiety or 
depression. 
Adherence to the treatment regime is a further component of self-management. A 
meta-analysis by DiMatteo, Lepper, & Croghan (2000) suggested that depression 
tripled the likelihood of non-adherence to medical treatment in chronic illness patients. 
The same adverse effects of depression were found for decreased adherence to diet 
and refills of medications in diabetic patients (Ciechanowski, Katon, & Russo, 2000) 
and heart disease patients (Carney, et al., 1995) as well as lower success rates in 
smoking cessation (Anda et al., 1990).  
The effect of depression on self-management of chronic illness appears to be better 
supported than that of anxiety. Lester, Stepleman, & Hughes (2007) found an 
association between depression and self-reported cognitive impairment and illness 
self-management in patients with multiple sclerosis (MS). Anxiety was related to 
severity of physical limitations and self-reported cognitive impairment but not to disease 
self-management. The authors attributed this finding to possible variations in the role of 
depression and anxiety in different processes in MS patients. Similarly, Bauer et al., 
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(2012) found that when depression improved in cardiac patients it was independently 
related to better self-reported adherence to treatment and health behaviours but there 
was no effect on these behaviours when anxiety improved. In other chronic illnesses 
such as COPD, anxiety appears to play a more significant role in self-management 
which will be discussed in the following section. 
The findings discussed above underline the extent of the influence of psychological 
well-being on QoL domains as well as its interaction with other psychosocial variables 
not only in chronic illness but also in healthy populations.  
 
3.5.3 Emotional well-being in COPD 
 
Prevalence of depression can reach 75% for anxiety and 80% for depression in COPD 
(Maurer et al., 2008; Yohannes, Willgoss, Baldwin, & Connolly, 2010). Apart from 
placing an additional burden on COPD patients’ psychological well-being, depression 
and anxiety were also associated with poorer prognosis, and quality of life, increased 
symptoms experience, decreased health care utilisation and higher mortality (de Voogd 
et al., 2009; Hill, Geist, Goldstein, & Lacasse, 2008; Ng et al., 2007). Laurin, Moullec, 
Bacon, & Lavoie (2012) reviewed the literature and concluded that there was an 
elevated risk for exacerbations in COPD patients with anxiety and/or depression. 
However, the authors emphasized that the relationship between these factors is 
complex because of the influence of a number of COPD-related factors such as clinical 
presentation, biological and physiological processes as well as and patient-related 
outcomes. 
The effects of depression and anxiety on health outcomes in COPD seem to be not of 
temporary nature but are rather pervasive and relatively persistent. For example, von 
Leupoldt, Taube, Lehmann, Fritzsche, & Magnussen (2011) found a positive effect of 
PR on patients’ physical and mental functioning and QoL including a reduction in 
depression and anxiety. However, it was also observed that depression and anxiety 
were associated with poorer outcomes such as greater dyspnoea and decreased 
physical and mental QoL pre- and post-PR, even when adjusting for confounders. The 
fact that controlling for possible confounding variables did not change the significance 
of the association between depression and anxiety on outcomes indicated that their 
influence was pervasive and persistent. However, whereas anxiety was associated with 
144 
 
greater dyspnoea at rest, depression was related to poorer physical functioning as 
assessed in the 6-minute walk test. Von Leupoldt et al. (2011) stressed the negative 
and stable influence of depression and anxiety on COPD patients’ physical and mental 
QoL even when improvements in these domains have been achieved.  These findings 
echoed previous studies which had found associations between depression and 
anxiety and poorer disease course, physical functioning, quality of life and increased 
dyspnoea (Eisner, et al., 2010; Giardino, et al., 2010; Ng et al., 2007).  
Self-management is very important in COPD. A number of factors can influence self-
management in COPD including anxiety, depression, hopelessness and optimism 
(Cicutto, Brooks, & Henderson, 2004; Simpson & Rocker, 2008) but not in a linear or 
simple fashion. Anxiety can have both a positive and negative influence on COPD self-
management. On the one hand, it can provide patients with the motivation to engage in 
behaviours that can control their symptoms and prevent deterioration of their condition. 
Anxiety can lead to decreased self-confidence to manage a chronic illness (Dowson et 
al., 2004) because of fear of breathlessness. Patients fear that if they engage in 
physical or other management activities, they might experience significant 
breathlessness which would in more anxiety (Bailey, 2004). This was not limited to self-
management and physical activity processes but also pertained to everyday activities 
such as personal care, household chores or socialising (Yohannes, 2008; Dowson et 
al., 2004; Simpson and Rocker, 2008). Avoidance of these activities may lead to social 
isolation, lack of social support and increased dependency on other people which 
would increase feelings of depression and anxiety and decrease physical and mental 
quality of life (Bailey, 2004; Cicutto et al., 2004; Simpson and Rocker, 2008). 
Therefore, identifying the fine line between beneficial and harmful levels of anxiety as 
well as maintaining them at an optimal point should be considered when exploring the 
effect of psychological variables on patients with COPD. 
Depression can reduce patients’ motivation to engage in various activities such as self-
management or socialising (Cicutto et al., 2004; Dowson et al., 2004; Simpson and 
Rocker, 2008). As a result, their physical, social and emotional status can deteriorate 
due to lack or reduction of self-management activities (Cicutto et al., 2004; Dowson et 
al., 2004; Simpson and Rocker, 2008). Adverse effects of depression have been 
reported for quality of life as well (Carrieri-Kohlman et al., 2005; Simpson and Rocker, 
2008). The significant effects of depression and anxiety on COPD patients’ quality of 
life, exacerbations and self-management behaviours, make it imperative to address 
them in order to improve patients’ well-being. Factors such as hope and optimism as 
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well as increased perceived control and self-efficacy were found to be key variables 
that could contribute in sustaining and improving patient’s psychological well-being 
despite the adverse effects caused by the illness (Alberto & Joyner, 2008; Bourbeau, et 
al., 2004; Cicutto et al., 2004). Therefore, depression and anxiety need to be included 
in interventions which aim to improve COPD patients’ QoL for two reasons: (a) 
additional benefits in patients’ QoL could be achieved and (b) benefits could be 
maintained in the long-term.  
 
a. How do depression and anxiety influence patients’ physical status? 
 
Two theories have been outlined based on a review of studies examining depression 
and anxiety in relation to disability (Lenze, et al., 2001). The first theory postulated that 
depression or anxiety themselves were disabling states. For instance, depression is 
associated with executive-type cognitive impairments such as attention, planning, 
behaviour which could explain greater disability. This would mainly affect instrumental 
activities of daily living (IADLs) such as cooking, cleaning or paying bills, i.e. basic 
tasks required for independent living. Despite appearing as “physical” tasks they 
incorporate a “mental” component as well. Alexopoulos, Vrontou, Kakuma, & Meyers 
(1996) found a relationship between initiation-perseveration impairment and higher 
global disability. Another pathway of influence can be that of poor appetite which is 
related to depression and has been associated with disability due to decreased body 
mass index (Galanos, Pieper, Cornoni-Huntley, & Bales, 1994).  
The second theory suggested that depression or anxiety could lead to a greater degree 
of disability in a person with other physical illnesses either through the increase of risk 
factors for these illnesses or through the adoption of poorer health behaviours in 
individuals who are suffering from both physical illness and depression. Physical 
disability has been associated with higher risk of depression mainly due to the fact that 
the emergence of disability leads to loss of perceived control and decreased self-
esteem (Schulz, Heckhausen, & O'Brien, 1994). This could lead to decreased social 
support and increased isolation due to the physical restrictions of engaging in desired 
social and leisure activities (Schulz, et al., 2000) which could increase the risk of 
depressive and anxiety symptoms. Brenes, et al. (2008) found a relationship between 
poorer levels of physical functioning and symptoms of depression and anxiety 
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throughout all ages. However, the cross-sectional design of the studies prevented 
conclusions about causality. The various pathways through which depression could 








A vital component of the relationship between depression and QoL is how people 
perceive their illness. This can influence how they will make sense of and respond to it. 
The following section will discuss the proposed mechanisms through which depression 





a. The relationship between depression, anxiety and symptom perception 
 
Severity of a physical illness could be associated with severity of depression and 
anxiety. However, in their review, Katon et al. (2007) found that patients with a chronic 
illness who also suffered from depression and anxiety reported more symptoms 
compared with patients who were suffering from a physical medical condition alone 
when severity of disease was controlled for. Katon et al. (2007) examined four different 
types of illnesses diabetes, pulmonary disease, heart disease and arthritis. They found 
equally strong associations between depression and anxiety and physical symptoms 
such as pain and objective physiological measures indicative of disease severity and 
depression and anxiety. The authors drew attention to bidirectional effects between 
depression and anxiety and severity of illness provided in the literature (Katon, 2003) 
described above. Symptom perception, regardless of disease severity, was examined 
in younger adults and adolescents with similar findings (Richardson, et al., 2006). 
Youth who had anxiety or depressive disorder were significantly more likely to report 
more days of experiencing asthma-related symptoms in the previous two weeks as 
compared to healthy young people. Moreover, the number of asthma-related symptoms 
was strongly related to the number of anxiety and depressive symptoms. This 
suggested that young people with more symptoms of depression and anxiety were 
more likely to report a greater symptom burden for their asthma. 
It appears that co-morbid depression and/or anxiety influences disease-related 
symptom perception more strongly than the severity of the physical illness. The nature 
of this influence can be explained by the symptom perception hypothesis (Costa & 
McCrae, 1987; Watson & Pennebaker, 1989) which posits that the general 
predisposition for frequent experience of a variety of negative emotions, for example 
neuroticism or trait negative affectivity, is associated with increased reporting of 
somatic symptoms. Depression and anxiety follow a different mode of operation in 
relation to potentially threatening stimuli as compared to neuroticism and trait negative 
affectivity. For example, in the context of illness threat, it is more likely that anxiety 
symptoms will precede symptoms of depression than the opposite, i.e. depression 
preceding anxiety symptoms (Alloy, Kelly, Mineka, & Clements, 1990; Mineka, Watson, 
& Clark, 1998; Mogg & Bradley, 1998).  
But how could depression and anxiety influence the ways people perceived their illness 
and symptoms? The main cognitive characteristic of anxiety is hypervigilance when 
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responding to potentially harmful stimuli. Mineka et al. (1998) found that people high in 
anxiety pay more attention to danger cues when tested in conditions of conscious and 
unconscious awareness as compared to people low in anxiety. Hypervigilance makes 
them react quicker to negative stimuli such as visual or verbal cues that convey threat, 
pain or danger (Bar-Haim, Lamy, Pergamin, Bakermans-Kranenburg, & van 
IJzendoorn, 2007; Mogg, Kentish, & Bradley, 1993). Furthermore, the literature 
supports a relationship between neuroticism/trait anxiety and higher propensity of 
exaggerating the frequency and physical symptoms experienced. People who exhibit 
high levels of neuroticism or trait anxiety were more likely to report more symptoms 
such as pain, gastrointestinal complaints and aches (Williams & Wiebe, 2000; Costa & 
McCrae, 1987; Watson & Pennebaker, 1989). This was also true when no objective 
physical illness was present (Costa & McCrae, 1987; Watson & Pennebaker, 1989). 
In contrast, individuals who experience severe symptoms of depression or have been 
diagnosed with depression, do not show high levels of vigilance (Yovel & Mineka, 
2005). These individuals process cognitive-affective information in a different way 
which involves self-focus and rumination (Nolen-Hoeksema, Wisco, & Lyubomirsky, 
2008; Williams & Wiebe, 2000). This evidence confirms Pennebaker’s theory (1982) 
who suggested a model to explain symptom perception based on competition of cues. 
The theory (Pennebaker, 1982) postulates that people are more attentive to physical 
changes when their environment lacks interesting stimuli which act as distractors from 
the symptoms they are experiencing. When people are feeling melancholic, they 
become completely absorbed in their internal worries. This exaggerated engagement in 
self-focus and rumination results in greater recall of discomforting experiences (Mineka 
et al., 1998). For instance, people with moderate to severe depressive symptoms or 
clinical depression were found to remember a greater amount of negative information 
relating to themselves compared to positive information (Mineka & Nugent, 1995). In 
contrast, people who experience high anxiety do not appear to exhibit this recall bias 
(Coles & Heimberg, 2002; Mineka & Nugent, 1995). 
Recently a revised symptom perception hypothesis was proposed by Howren & Suls 
(2011). This revised version assigned roles for specific emotions within the symptom 
perception process. The revised symptom perception theory suggested that anxiety 
and depressive emotions act at varying stages of the symptom perception and recall 
process. This means that depressive emotions, which involve intense self-focus and 
rumination, can lead to an exaggeration of somatic symptoms experienced in the past. 
Feelings of anxiety, on the other hand, which involve increased attentional alertness, 
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result in greater reporting of symptoms experienced at the current moment of reporting 
(Howren & Suls, 2011). 
A theoretical model that included illness perceptions and health care utilisation was 
developed by Katon (2003) (see Figure 3.4). The model includes factors associated 
with higher risk of depression and anxiety such as genetic susceptibility, adverse 




Figure 3.4 A theoretical model depicting the interactions between anxiety, depression, physical 
illness and healthcare utilisation (Guthrie & Nayak, 2012, adapted from Katon, 2003). 
 
 
The relationship and pathways of possible interaction between socio-economic status 
and poorer psychological and physical well-being was discussed in Chapter Two. In 
their systematic review, Gallo and Matthews (2003) proposed a theoretical framework 
to understand how SES, negative emotions and cognitions and health interact. The 
authors suggested that more socio-economically deprived environments lead to higher 
levels of stress and a reduction in people’s reserve capacity such as financial and 
material resources and social support to manage stressful events. This, in turn, 
increases their vulnerability to experience negative emotions and cognitions especially 






Figure 3.5 A general framework presenting the psychosocial pathways of interaction between 
SES, negative emotions and cognitions and health outcomes (Gallo & Matthews, 2003) 
 
 
Adopting a psychosocial perspective, Gallo and Matthews (2003) maintained that the 
primary step linking SES with negative emotions and attitudes is the increased 
frequency and intensity of exposure to stressful events and dangerous conditions. 
Lower SES was associated with greater exposure to more frequent stressful and 
negative situations (Dohrenwend, 1973; McLeod & Kessler, 1990; Murrell & Norris, 
1991; Stansfeld, Bosma, Hemingway, & Marmot, 1998). These stressful experiences 
are interpreted in a more negative way under the influence of low SES (Chen & 
Matthews, 2001). As a result, exposure to negative and stressful situations takes its toll 
on people’s emotional status (Ensel & Lin, 1991) and also directly affects health 
outcomes (McEwen & Stellar, 1993). In both models described above Guthrie & Nayak 
(2012) and Gallo & Matthews (2003) the mechanisms proposed include the cognitive 
and emotional interpretation and experience which can mediate and affect health 
outcomes. Illness perceptions could contribute in explaining this link between SES and 





3.5.4. The relationship between depression and anxiety and illness perceptions 
 
The Common Sense Model (CSM) (Leventhal et al., 1980) provided a framework to 
explain the relationship between illness outcomes and anxiety and depression. Disease 
activity can influence how an individual perceives their condition. These perceptions 
can have an impact on psychological status such as depression and anxiety. Feelings 
of anxiety and depression can, in turn, influence patients’ coping strategies, for 
example, lead to avoidance behaviours or encourage/discourage help-seeking from 
friends and family. These stages follow a feedback loop in which coping styles, 
behaviours, emotions and cognitions can be appraised and updated accordingly.  
Knowles, Wilson, Connell, & Kamm (2011) found that disease severity exerted a direct 
influence on illness perceptions in patients with Crohn’s Disease. Furthermore, illness 
perceptions directly influenced depression and anxiety which were linked to emotional 
coping responses used by patients. This effect remained when disease severity was 
adjusted and explained a significant proportion of the variance in depression and 
anxiety (Knowles et al., 2011). This was indicative of the strong role of illness 
perceptions in the association between depression and anxiety and quality of life. 
Knowles et al. (2011) developed their own model to describe this interaction which was 




Figure 3.6 Knowles et al.’s (2011) model to examine the interrelationship between disease 






A relationship between disease severity and depression and anxiety had previously 
been reported by Hagger & Orbell (2003) as well as between illness perceptions and 
depression and anxiety and quality of life (Kiebles, Doerfler, & Keefer, 2010; Hagger & 
Orbell, 2003; Rutter & Rutter, 2002; Scharloo et al., 1998). For instance, (Hagger & 
Orbell (2003) found a significant correlation between illness perceptions and coping 
strategies as well as psychological morbidity. This was suggested by findings which 
showed that poorer psychological functioning was associated with disease state – as 
assessed by objective measures of illness status – and negative illness perceptions.  
Murphy et al. (1999) found that illness perceptions were significantly associated with 
depression and anxiety in rheumatoid arthritis (RA) patients when controlling for 
disease severity. The strongest dimensions of illness perceptions associated with 
depression and anxiety were consequences and control/cure. The more severe the 
impact of disease and the lower the levels of control were, the higher the levels of 
depression and anxiety. These findings added to our knowledge of associations 
between the dimensions of perceived consequences and the degree of control/cure 
individuals feel they have over their illness in a variety of medical conditions (Hagger & 
Orbell, 2003; Groarke et al., 2005; Schiaffino et al., 1998; Rutter & Rutter, 2002; 
McCorry et al., 2012; LeGrande et al., 2012; Skinner et al., 2011). Evidence on how 
depression and anxiety may be associated with these factors can contribute to 
increasing our understanding of the mechanisms that may underlie these associations. 
Illness perceptions have a significant impact on self-management in patients with 
COPD (Dowson et al., 2004). Patients’ perceptions of negative consequences or low 
perceived control over their illness were associated with decreased motivation to 
engage in activities thus preventing improvement in their well-being. This, in turn, 
inhibited their perceived ability to manage their conditions effectively and experience 
positive outcomes (Dowson et al., 2004; Kaptein et al., 2008). Patients who felt they 
could achieve a positive influence on their condition experienced stronger motivation to 
manage their COPD and greater self-confidence in their ability to engage in self-
management processes (Clark et al., 2009; Dowson et al., 2004; Kaptein et al.,  2008). 
These findings emphasize not only the role of depression and anxiety in relation to 
various domains of QoL in patients with COPD but suggest the role of additional factors 
that may interacting and influence a patients’ adjustment to the illness, their coping 





The evidence provided in this section emphasises the roles of depression and anxiety 
in chronic illness and especially in COPD. Both variables are key elements in the 
relationship between quality of life and self-management processes as well as health 
care utilisation, exacerbations and medication adherence. The effects of depression 
and anxiety on quality of life, coping and self-management in COPD may have different 
pathways of influence and may be associated with different outcomes but they are 
appear to be pervasive. In the present study, depression and anxiety were examined 
as components of COPD patients’ QoL. 
 
3.6 The role and contribution of health psychology in COPD 
 
A variety of psychological factors such as illness perceptions, self-efficacy and 
emotional well-being in COPD were discussed earlier in this chapter and their 
associations with patients’ health care access as well as physical status and quality of 
life were described. The role and contribution of health psychology in identifying and 
addressing issues of patient experience of COPD and the ways of adjusting and coping 
with the illness is widespread and significant both in the field of research and also 
clinical practice. An overview of the methods applied and the types of interventions 
implemented in health psychology to assess and address various aspects of the 
psychosocial and physical impact of COPD on patients is provided in the following 
sections. 
 
3.6.1 Health psychology diagnostics in COPD 
 
A variety of diagnostic tools are employed by health psychology researchers in order to 
assess and design interventions to address issues such as identification of 
mechanisms that influence long-term health and well-being in patients with chronic 
illness including functional status, recovery and return to work, coping with their illness, 
wound healing and quality of life (Taylor, 2008). 
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In COPD, patients are faced with a variety of physical limitations due to the disease 
such as dyspnoea, decreased mobility, co-morbidities, reduced daily activities and 
quality of life (Bossenbroek, de Greef, Wempe, Krijnen, & ten Hacken, 2011; 
Decramer, et al., 2011). However, while the physical impact of COPD on patients is 
very important, the psychological influence of the disease is equally important. A 
number of psychological factors can affect quality of life, coping, self-management and 
daily activities in COPD such as illness perceptions, anxiety and depression, 
adjustment and coping with the illness (de Ridder, Geenen, Kuijer, & van Middendorp, 
2008; Disler, Gallagher, & Davidson, 2012; Hynninen, Breitve, Wiborg, Pallesen, & 
Nordhus, 2005;  McCathie, Spence, & Tate, 2002).  
In addition to assessment of patients’ psychological status, health psychology also 
focuses on elucidating the association between psychological and physical health and 
the ways they interact and affect each other. For instance, Weldam, Lammers, 
Decates, & Schuurmans (2013) found that more positive illness perceptions and 
reduced depressive symptoms were associated with better health-related quality of life. 
No associations were found between psychological factors and reduced daily activities 
and between proactive coping and reduced daily activities and HRQOL possibly due to 
a small sample size and the fact that participants had mild COPD. These finding are 
consistent with previous studies that provided evidence for the relationship between 
more positive illness perceptions and better HRQOL as well as enhanced treatment 
outcomes such as baseline six-minute walk (6-MW) test performance and response to 
treatment for patients with mild to moderate COPD (Fischer, et al., 2012; Scharloo, et 
al., 2007).  
Psychological morbidity especially anxiety and depression are common amongst 
COPD patients. A meta-analysis reported a prevalence of 36% for anxiety and 40% for 
depression in COPD (Yohannes, Baldwin, & Connolly, 2000). A recent review found 
increased levels of anxiety and depression in COPD patients which were associated 
with a significantly worse disease course (von Leupoldt & Kenn, 2013). While the exact 
causes for anxiety and depression in COPD patients are not known, they could be 
linked to the burden of the disease, functional limitations, social isolation, or the 
knowledge of having a serious and usually progressive disease (von Leupoldt & Kenn, 
2013). The findings of the review emphasised the increased frequency of lack of 
detection and inadequate treatment of anxiety and depression in COPD patients – both 
through pharmacological treatment and psychotherapeutic approaches – stressing the 
need for future quality studies (von Leupoldt & Kenn, 2013) 
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Patient experience of living with COPD contributes to increasing understanding on 
adjustment and coping with the disease. Cooney, et al. (2012) identified “co-existing 
with COPD” as a core category which consisted of three sub-categories: (a) controlled 
co-existence; (b) strained co-existence and (c) uncontrolled co-existence depending on 
the degree of control and living to the optimum that the patient perceived themselves to 
be experiencing. The degree of control over COPD is also reflected in one’s self-
efficacy. Self-efficacy is a person’s belief of his ability to achieve a set target or goal 
(Bandura, 1986). In the case of chronic illness, and in this case COPD, self-efficacy 
reflects the extent to which patients perceive themselves able to adjust and cope with 
COPD, for example, engaging in self-monitoring and self-management of their 
condition. Higher self-efficacy following pulmonary rehabilitation in COPD patients was 
a predictor of decreased psychosocial impact of disease, increased physical activity 
and health status and improved quality of life (Bentsen, et al., 2010). The role of self-
efficacy in COPD is described in detail in previous sections of Chapter Three. 
Different coping styles such as confronting or passive reaction coping styles are 
adopted by COPD patients and are associated with different outcomes. For example, 
patients with symptoms of depression reported decreased use of active confronting, 
higher use of avoidance strategies and passive reaction pattern coping styles. Patients 
with symptoms of depression reported lower levels of seeking social support coping 
compared to patients without symptoms of depression (Stoilkova, Wouters, Spruit, 
Franssen, & Janssen, 2013). Stoilkova et al. (2013) concluded that different coping 
styles were related to symptoms of anxiety, depression and exercise intolerance but 
not COPD-specific health status in patients entering pulmonary rehabilitation. 
 
3.6.2 Health psychology interventions in COPD 
 
Behavioural research within the scope of health psychology in COPD has been 
extensive in the past 50 years exploring a variety of health-related aspects such as 
psychoanalysis, psychosomatics, neuropsychology, quality of life, psycho-
maintenance, patient education, coping and illness cognitions, self-management and 
collaborative care (Kaptein, et al., 2009). A review by Kaptein et al. (2009) included 
research focused on the aforementioned areas and emphasised the importance of the 
patient being the key in managing their illness effectively which is, in turn, associated 
with beneficial outcomes including decreased rates of hospital admissions, higher 
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exercise performance and improved quality of life. The authors suggested that self-
management as well as patient perceptions of their condition should be integrated into 
the treatment regimen administered to patients in order to enhance physical and 
emotional outcomes in patients with COPD. For example, Rosser et al. (1983) showed 
that formal psychotherapy was not as effective as interpersonal support in patients with 
COPD in improving their quality of life e.g. reducing their dyspnea. Other studies 
associated personality and psychological characteristics such as anxiety, depression, 
personality disorders, panic and/or fear and self-esteem with COPD-related physical 
symptoms as reported in a review by Hynninen et al. (2005). Cognitive impairment and 
neuropsychological deficits were also linked to physical and emotional status in 
patients with COPD (Prigatano, Parsons, Levin, Wright, & Hawryluk, 1983; Zielinski, 
1999). The importance of the role of patient perception in relation to their physical well-
being is also reflected in research findings showing that quality of life – which is a 
subjective experience reported by the patient – is only weakly associated with 
pulmonary function and disease severity in COPD (Domingo-Salvany, et al., 2002). 
Differences in individual perceptions of their physical status held by COPD patients can 
also influence their coping strategies independent of objective COPD characteristics as 
well as self-management and collaborative care (Kaptein et al., 2009). These 
perceptions are based on how patients interpret and experience their symptoms and 
their impact on their daily life (Kaptein et al., 2009). A variety of factors can influence 
patients’ perceptions of their status such as previous illness experience, personality 
characteristics, illness cognitions and beliefs as well as influences derived from their 
social and cultural background. Examination of patients’ illness perceptions and 
cognitions might help elucidate the reasons behind the differences in their managing 
and coping with their COPD despite having identical objective disease severity 
(Kaptein et al., 2009). The way patients make sense of their symptoms is central in the 
process of coping and can be a better predictor of objective measures of disease 
severity, for example, when examining visits to out-patient departments (Scharloo, et 
al., 2000). Kaptein et al. outlined the way in which interventions aimed at COPD 
patients evolved through the years from psychotherapy and patient information to 
education about identification of early signs of an exacerbation and discussing the 
impact of COPD with partners. The authors drew attention to the fact that health care 
professionals should listen to their patients in order to increase their understanding of 
their illness experience which would supplement and maximise their treatment 
effectiveness. In addition, Kaptein et al. (2009) emphasized the need to focus on 
COPD patients’ partners in enhancing self-management as well as to explore reasons 
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why health care professionals have difficulty in adhering to guidelines for diagnosing 
and treating COPD patients and why COPD is viewed as less attractive compared to 
other illnesses such as cancer. 
Evidence for the effectiveness and important of health psychology interventions 
focusing on different outcomes in COPD patients was provided by a number of 
systematic reviews. For instance, Dickens et al. (2013) found that complex 
interventions especially those employing general education, exercise, and relaxation 
therapy significantly decreased the likelihood of urgent healthcare utilisation in patients 
with COPD. Similarly, Coventry, et al. (2013) reviewed 29 randomised controlled trials 
of psychological and/or lifestyle interventions for COPD patients and found 
associations with a decrease in depression and anxiety symptoms. The component 
showing the strongest effects was multi-component exercise training independent of 
the severity of depression or anxiety symptoms. Pires-Yfantouda, Absalom, & Clemens 
(2013) reviewed effectiveness of interventions aimed at smoking cessation in COPD 
patients. The review findings indicated that those interventions that included a 
combination of psychosocial elements and pharmacotherapy were effective in stopping 
smoking at 12 month follow-up. Difficulty in preventing attrition at community-based 
locations compared to acute or research settings was also highlighted by the authors. 
Cognitive-behavioural approaches that included various elements such as exercise, 
music, yoga, self-management education, breathing exercises were associated to 
improved dyspnoea and decreased COPD-related distress (Norweg & Collins, 2013). 
However, treatment effects for the different elements varied from small to large and the 
authors emphasised the fact that more research is required to increase effectiveness 
and availability of interventions for patients with COPD. 
The evidence on the methods and efficacy of assessment and interventions 
implemented for patients with COPD is suggestive of the collaborative nature of health 
care services and health care professionals that is required for these patients. 
Collaboration in medical management of COPD patients would involve four principles: 
(a) the acquisition and development of self-management skills which would be 
supported by the equivalent behaviour; (b) motivation and self-efficacy which are 
essential elements in self-management; (c) the influence of the social environment; and 
(d) adaptation to chronic illness which is facilitated and enhanced by self-monitoring 
changes in health status and symptoms and taking appropriate action (Von Korff, 






Behavioural research in COPD in the past few decades has drawn attention to the 
importance of patient empowerment, self-management and collaborative care in a 
variety of health outcomes. Assessment and identification of psychosocial issues 
deriving from COPD is important due to their interaction with patients’ physical status 
and quality of life. The need for research and interventions to address elements from 
the psychological, social and biological domains in order to increase understanding into 
the mechanism underlying these processes and to maximise effectiveness of 
interventions aiming to improve patients’ quality of life and coping with COPD is 
highlighted. 
 
3.7 Overall conclusion 
 
The evidence provided in Chapters Two and Three on the relationship between SES 
and HCA as well as SES and QoL indicated that higher level of financial and social 
deprivation was linked to both more impaired HCA and poorer QoL in a range of 
chronic illnesses. The first aim of this thesis was to explore whether this was true for 
COPD.  
The review of the literature revealed conflicting findings on the relationship between 
SES and HCA and SES and QoL in chronic illness and in COPD Taken together the 
evidence suggested that SES factors do play an important role in HCA and QoL in 
chronic illness and COPD but can only account for a proportion of the variance for 
these outcomes. This raised the question of whether additional factors might be 
implicated in the association between SES and HCA and SES and QoL such as 
psychological variables.  Illness perceptions and self-efficacy were considered due to 
the evidence for their involvement in HCA and QoL as well as their relationship with 
SES. Psychological variables might be influenced by a person’s socio-economic 
position i.e. higher deprivation – possibly due to restricted availability of essential 
resources – might increase the likelihood of patients having more negative perceptions 
of their disease and lower beliefs in their abilities to engage in certain behaviours that 
would provide them with the treatments they needed and improve their QoL. Thus, 
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lower SES might influence the way a person would perceive, experience and manage 
their disease. These processes are likely to be influential in the integration of a 
person’s experience and response to the disease in terms of lifestyle adjustments and 
adjustments to cope with the disability induced by the disease, their perception of their 
capacity to undertake activities, their perceptions of the impact of the disease on 
everyday life as well as how they seek and use treatment. This was the second aim of 
this thesis; to examine whether illness perceptions and self-efficacy mediated the 
relationship between SES and HCA and SES and QoL in COPD.  
Illness perceptions and self-efficacy can be assessed with the use of reliable and valid 
instruments and can also be modified with appropriate interventions. Therefore, the 
findings of this research study could: (a) elucidate the pathways through which SES 
might be influencing the way patients seek health care services and managing their 
condition in COPD and (b) inform the design and implementation of targeted 





Systematic review: “Socioeconomic status, quality of life and health care 





Background: Health inequalities are associated with worse access to health care 
potentially compromising quality of life. For Chronic Obstructive Pulmonary Disease 
(COPD), in particular, socio-economic status is associated with increased prevalence, 
mortality and exacerbation rates. This systematic review was conducted to assess the 
influence of socio-economic status (SES) on (a) healthcare access (HCA) and (b) 
quality of life (QoL) in patients with COPD.  
Methods: A systematic search of published scientific literature was undertaken using 
standard bibliographic databases. Inclusion criteria for the studies were: (1) participants 
with a diagnosis of COPD based on spirometry assessment; (2)  participants aged 18 
years or over; (3) quantitative research studies; (4) articles published in the English 
language; and (5) studies reporting associations between SES and HCA and/or SES 
and QoL.  
Results: 76 studies were reviewed in full. 14 were included in the analysis. The 
relationship between SES and HCA was examined in six studies and the relationship 
between SES and QoL was examined in eight studies. Lower SES in terms of income 
level and education was associated with better access to health care services which 
included greater likelihood of discussion about prognosis, higher medication uptake 
and adherence in three studies examining HCA. Higher SES in terms of income level, 
educational attainment and socio-economic indices was associated with greater HCA 
which included higher likelihood of receiving a diagnosis of airways obstruction and 
chronic bronchitis, lower risk of hospital admission and better access to primary health 
care services in the remaining three studies on HCA. 
Lower SES was associated with poorer QoL in five studies. Lower educational 
attainment was related to greater dyspnoea, more respiratory symptoms, poorer QoL, 
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mental health and physical function. Higher SES was related to better QoL. No 
evidence to support the relationship between SES and QoL was found in three studies. 
In order to examine whether disease severity was a potential confounder in the 
relationship between SES and QoL, studies that had adjusted for severity of disease 
were examined separately. In the three studies that had adjusted for disease severity 
quality of life did show significant differences compared with the studies that had not 
adjusted for it. 
Conclusion: Opposing outcomes were found in the relationship between SES and 
HCA in COPD in the literature that was reviewed.  One of the reasons could have been 
that the primary aim of these studies was not to examine the relationship between SES 
and HCA and QoL in COPD. Instead, they focused on exploring other associations e.g. 
ethnic differences in emergency care for COPD patients or the extent of inhaler 
variation in patients with COPD. Thus, not all indices of SES (income, education, 
occupation) were measured in these studies. Associations between demographic 
variables such as SES and outcome measures were conducted as part of their 
analyses and therefore conceptualisation and/or measurement of SES might not have 
been as comprehensive as in other studies which focused specifically on examining the 
relationship between SES and HCA or QoL. There was significant heterogeneity in the 
populations examined and in the conceptualisation of measures which complicated 
comparisons across groups. Different studies showed opposing findings with respect to 
the relationship between SES and HCA with half of them finding worse HCA in 
deprived people and the remaining half finding greater HCA in deprived people. This 
may have been due to the variability in SES measures which could have influenced the 
relationship with outcomes in different ways and could have varying effects depending 
on population characteristics such as age. For SES and QoL, most studies provided 
evidence for the relationship between lower SES and poorer QoL but some did not. 
These inconsistencies could be due to different measures used in the various studies. 
For example, the definition and instruments used to assess HCA and QoL varied 
significantly. Stronger conclusions cannot be drawn due to the relatively small number 
of studies, their focus and quality. Higher-quality studies that focus specifically on the 
relationship between SES and HCA and QoL in COPD are required to better 
understand the impact of socio-economic status on HRQOL and healthcare access in 
patients with COPD. The need for consistent conceptualisation and use of SES, HCA 
and QoL measures as well as their appropriateness according to specific patient 





The relationship between socio-economic deprivation and prevalence and mortality of 
COPD has been established in the literature (Prescott and Vestbo, 1999; Yohannes et 
al., 2001; Shohaimi et al., 2004). Higher risk of COPD has been associated with more 
deprived background, social class, occupation, area deprivation, relative poverty, 
education and income, social isolation and limited social support, sedentary lifestyle 
and loneliness (Prescott and Vestbo, 1999; Yohannes et al., 2001; Shohaimi et al., 
2004). Socio-economic status in terms of education, income and occupation may not 
always directly affect the risk of developing COPD but can do so indirectly, for 
example, through housing, lifestyle or nutrition. Smoking is implicated in the occurrence 
of COPD (Doll et al., 1994; Peto et al., 1996) and so are airborne pollutant and 
biomass fuels (Rees & Calverley, 2002). Poorer quality of life in COPD has also been 
associated with lower socio-economic status such as lower educational level and 
occupational class (Miravitlles et al., 2011). COPD generates considerable health care 
costs especially through accident and emergency department visits, exacerbations, 
hospital admissions and re-admissions, prescriptions for bronchodilators and palliative 
care provision (Ashutosh, Haldipur, & Boucher, 1997; Sullivan et al., 2000; Osman et 
al., 1997).  A detailed discussion between SES and COPD prevalence and mortality 
and implicated factors was presented in Chapter Two. 
 
a. Health inequalities and HCA 
 
The association between socio-economic factors and access to health care has been 
supported extensively in different health conditions. Lower SES was related to a variety 
of poorer HCA outcomes such as delayed and lower quality of care provision and 
limited availability of public health resources, lack of health insurance and impaired 
access to emergency care (Mutchler & Burr, 1991; Evans et al. 2011; Wagner et al., 
2011). However, evidence for the opposite, i.e. lower SES associated with greater HCA 
such as consulting a GP and receiving prescriptions for medication was also reported 
(van der Meer et al., 1996; Bongers et al., 1997). Both these studies were conducted in 
the Netherlands, however, where socio-economic difference in health care services 
utilization are less pronounced compared to most other countries (Wagstaff & Van 
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Doorslaer, 1992). A detailed discussion of the relationship between socio-economic 
status and HCA was provided in Chapter Two.  
With regard to COPD, the nature of the relationship between SES and HCA is not 
clear. The evidence provided in the literature has been inconsistent with some studies 
reporting that higher deprivation was associated with greater HCA such as access to 
GPs and hospital services while others reporting the opposite i.e. that higher SES was 
associated with greater HCA such as specialist referrals (van Heyden et al., 2003; van 
Doorslaer et al., 2006; Sutton et al., 2002; Masseria & Giannoni, 2010; Finkelstein, 
2001; Dunlop et al., 2000; Hurley & Grignon, 2006). 
 
b. Health inequalities and QoL 
 
Health inequalities and SES have also been linked to quality of life. Quality of life is 
significantly impaired in patients with COPD in comparison to healthy populations and 
is poorer with increasing level of disease severity (Ketelaars et al., 1996; Okubadejo et 
al., 1996; Ferrer et al., 1997). QoL is also an important factor for prognosis (Balcells et 
al., 2010). For example, impaired quality of life in COPD patients has been linked to 
higher risk of hospital admission, mortality and morbidity (Osman et al., 1997; 
Domingo-Salvany et al., 2002; Sullivan et al., 2000). The search for the sources of 
influence on quality of life in COPD has inevitably led back to socio-economic factors, 
amongst other things, such as biological vulnerability and cultural variables.  
Despite evidence for the association between QoL and SES the exact pathways 
through which this influence is exerted still remains elusive. A variety of mechanisms 
have been proposed such as health care access and biological vulnerability (Chandra 
et al., 2009; Dransfield et al., 2006). Other explanations suggested include decreased 
levels of mobility preventing patients from full-time employment and thus inability to 
finance diagnosis and treatment or insurance premiums which are considerably higher 
in COPD (Sullivan et al., 2000). This does depend on variation in the access and 
utilisation of the health care systems between countries. Saadat et al. (2007) 
emphasized that SES was a significant factor of impaired QoL in COPD patients and 
noted that this effect was more apparent in COPD as compared to other conditions 
(Prescott & Vestbo, 1999). The authors reported a socio-economic gradient in QoL in 
COPD based on the results from their study in which they matched three groups of 
patients of low-medium and high income levels and compared their QoL and physical 
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function.  However, despite the effect of SES on QoL, Saadat et al. (2007) stressed the 
fact that participants were matched on confounding variables such as SES, co-
morbidities and type of insurance i.e. health care access and their results were not 
likely to have been biased.  
Lower SES has been related to poorer QoL. One of the ways low SES may exert its 
effect is through more severe disease possibly due to increased tobacco or biomass 
fuel consumption which have been linked to higher deprivation. QoL and lung function 
test measure different aspects of disease severity and have been used in COPD 
(Ferrer et al., 1999). However, no significant association was found between FEV1 and 
QoL in COPD (Wijnhoven et al., 2001) suggesting that they measured different aspects 
of disease. Previous research reported that low SES conferred greater risk of mobility 
decline as compared to people with higher SES, higher likelihood of more severe 
chronic disease and more severe co-morbidities (Koster, et al., 2004). When these 
relationships were examined in relation to severity of disease, findings suggested that 
disease severity and comorbidity explained a very small proportion of the variance 
regarding socioeconomic differentials in mobility decline. This was true across all 
disease groups and all three socioeconomic status markers included in the study (i.e. 
income, education, occupation). However, in their review Hegewald & Crapo (2007) 
reported that lower SES was associated with poorer lung function in respiratory 
diseases which was attributed to smoking but also additional risk factors. As a result, 
the role of severity of COPD in relation to SES and QoL remains unclear. 
 
c. The aim of this systematic review 
 
COPD prevalence, mortality and morbidity are associated with higher deprivation. The 
aim of the systematic literature review was to explore whether socio-economic 
deprivation added to this burden through barriers to both health care access and 
quality of life. Existing literature on the relationship between socio-economic status and 
healthcare access and quality of life in patients with COPD was identified, synthesized 
and evaluated. The role of disease severity was also taken into consideration and 
examined due to inconsistent evidence as to its effect on QoL and possibly health care 
access. Severity of COPD could have acted as a significant confounder in the 
relationships observed between SES and health care access and quality of life. If 
poorer HCA and QoL were influenced by higher disease severity in addition to SES, it 
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could be assumed that patients who had more severe disease also had poorer health 
care access due to mobility problems, for example. Alternatively, patients could have 
greater health care access because of more severe COPD. This is why the role of 
disease severity was examined. The same could apply to quality of life. In order to 
examine the role disease severity and its role in the relationship between SES and 
health care access and quality of life, studies were divided into two categories: (a) 
studies that had adjusted for disease severity and (b) studies that had not adjusted for 






This is a systematic review of observational studies of the relationship between SES 
and HCA and SES and QoL in COPD. In this review, evidence of the role of SES on 
health care access and quality of life in patients with COPD was sought. The following 
sections include definitions of the subject of the review, an outline of the quality criteria 
for the inclusion of the studies that were set and analysis of the outcomes examined 
including consideration of a meta-analysis if data justified one.  
 
b. Search terms and search strategy 
 
This is the first systematic review on SES and HCA and SES and QoL in COPD. 
Therefore, a search was conducted from 1947 to December 2011 of the following 
electronic databases: Medline, IBSS, PsychInfo, Embase, Web of Science, Ingenta 
Connect and CINAHL. The search strategy included various combinations of keywords 
“socio-economic status”, “COPD”, “health care access”, and “quality of life” including 
their MESH and MESH exploded terms. Detailed search terms are presented in 
Supplementary Table 4.1 (Appendix A1). Reference lists and citation indexing were 
performed in order to capture any further relevant articles.  This review was conducted 
following the MOOSE protocol for reporting systematic reviews of observational studies 




c. Selection of studies 
 
Observational studies were selected that reported associations between socio-
economic status (SES) and (a) healthcare access (HCA) and (b) quality of life (QoL) in 




Studies in which COPD was defined by spirometry based on criteria in the GOLD 
guidelines (2011) were included in the review. Additional studies that did not include 
spirometry were reviewed to ascertain that patients who had inadequate care were not 
excluded.  Spirometry is the only accepted method of diagnosing and managing COPD 
by measuring the degree of airflow obstruction in an objective and standardised way 
(Barnes & Fromer, 2011; Qaseem, Humphrey, Chou, Snow, & Shekelle, 2011). 
 
e. Socio-economic Status (SES) 
 
Socioeconomic status (SES) was examined in terms of level of education, income and 
occupational class (CSDH, Measurement and Evidence Knowledge Network, 2007). 
These three characteristics assess different aspects of SES and would ideally be 
combined when trying to measure SES (Mackenbach, et al., 1999). Because this is not 
always feasible in studies and due to the multidimensional nature of SES which poses 
difficulties in its definition and measurement, composite scores such as the Index of 
Multiple Deprivation (IMD) scores were also included in the definition (IMD, 2010). The 
IMD (2010) score is an instrument used for assessment of multiple deprivation 
consisting of seven domains (i.e. income deprivation; employment deprivation; health 
deprivation and disability; education, skills and training deprivation; barriers to housing 
and services; living environment deprivation; and crime). The overall IMD score 
indicates the level of deprivation of a certain area on the basis of the aggregate scores 






f. Health Care Access (HCA) 
 
Healthcare access was defined as the availability of health care services and their 
utilisation by people to preserve or improve their health (Gulliford, et al., 2001). For the 
purposes of this review, health care access included services relevant for patients with 
COPD, such as attendance, treatment and referral for smoking cessation and 
pulmonary rehabilitation and specialist assessment and treatment as well as 
medication uptake. Health care access did not include exacerbations of COPD or visits 
to the Emergency Department because they were considered to be an outcome of 
worse health care access and not an indicator of it. However, quality of treatment 
provided during exacerbations and ED visits were included as health care access 
measures. 
 
g. Quality of Life (QoL) 
 
Quality of life was defined as physical, functional, social and emotional well-being, 
measured with standardised and validated instruments such as the SF-36 Health 
Survey (Stewart, Hays, & Ware, 1988), the St. George’s Respiratory Questionnaire 
(SGRQ) (Jones, 1991), or the Chronic Respiratory questionnaire (CRQ) (Guyatt, 
Townsend, Keller, Singer, & Nogradi, 1989).  
 
h. Inclusion criteria 
 
Relevant papers were screened for titles, duplicates were removed and abstracts were 
reviewed. Full texts of the abstracts that fulfilled initial screening conditions were 
retrieved and inclusion criteria were applied.  
The criteria applied for inclusion of relevant articles were: (1) participants with 
spirometry-confirmed diagnosis of COPD; (2) aged 18 years or over; (3) quantitative 
research studies; (3) articles published in the English language; (5) report of statistical 
results of associations between SES and (a) healthcare access or (b) quality of life. If 
studies clearly met the inclusion criteria or could not be excluded based solely on the 
title and abstract, full text articles were obtained. The literature searches, initial title and 
abstract screening were conducted by the primary author (SG). Two colleagues (HB 
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and HT) repeated the screening process and any disagreements that arose were 
settled by consensus. Full texts were examined by the primary author (SG) and the 
supervisor (PW). Consensus was reached, where there was disagreement, on the final 
articles to be included in the review by discussion.  
Data were extracted from 72 full-text articles using the aforementioned criteria. Data 
extracted included the following: measurement tools used; follow-up; definition of SES; 
relationship between SES & health care access examined; relationship between SES & 
QoL examined; statistical tests used for analyses; conclusions.  
 
i. Quality Assessment 
 
A 12-item scoring scale (see Appendix A2, Table 4.2) was developed to assess study 
quality. This scale was adapted from the one employed by Keating et al. (2011) who 
developed theirs based on findings from previous literature published identifying 
important qualitative and quantitative research aspects (Downs & Black, 1998; Eakin & 
Mykhalovskiy, 2003; Kitto, Chesters, & Grbich, 2008). The items on which quality of 
studies were evaluated included were: the quality of study design and procedure; 
quality of reporting methods and results; external validity; bias in measurement and use 
of validated instruments, definition of outcome and confounding variables. The range of 
the quality scores was 0 to 12. Studies that accumulated a score of ≥7 points – which 
had to include points for provision of clear definitions of SES, QoL and HCA as well as 
statistical analyses results for the association between SES and HCA and SES and 
QoL – were judged as being of high quality and were included in the review. 
 
j. Assessment of disease severity as a confounder 
 
As part of the systematic review, a second assessment of the literature was conducted 
in order to eliminate disease severity as a possible confounder in the relationships 
between SES and HCA and QoL. This was done to ensure that better or lower HCA 
and QoL was not an effect of severity of COPD. For example, it could be assumed that 
more severely affected patients had greater access to health care services due to their 
condition. Similarly, it could be speculated that more severe disease was associated 
with poorer QoL. Therefore, in the second part of the current review, only articles that 
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had adjusted for disease severity in their analyses were examined. With the elimination 
of a possible confounder in the statistical analyses, the independent effect of SES on 
HCA and QoL could be investigated more reliably and comparisons between the two 




To combine the results of the data gathered in the review and identify patterns across 
studies, a meta-analysis was considered. There was significant variability in various 
domains of the studies for both HCA and QoL outcomes. The definitions used for SES, 
HCA and QoL differed considerably. Heterogeneity in participant population 
characteristics such as inclusion of various conditions (CHF, cancer and COPD, 
healthy population which included patients with COPD) and targeted patients 
diagnosed with COPD. Differences in statistical methods of analyses employed by the 
studies further complicated conclusions (e.g. ORs, CI, regression, mediation analyses). 
Therefore, owing to the small number of studies identified and lack of homogeneity in 
the definitions, outcome measures and statistical methods used, it was decided not to 





The electronic search identified a total of 11,763 publications of which 14 articles were 
included in the first part of the review after application of the eligibility criteria and 


















































The review examined studies reporting associations between SES and HCA and SES 
and QoL in COPD. Findings will therefore be reported in separate sections for each of 
these two outcomes. 
11,763 references identified from 
database search and screened by 
title 
2,007 duplicates removed 
6,844 references remain for further 
screening 
4,765 studies excluded due to lack of data 
on definitions and/or associations between 
SES and health care access and/or quality of 
life 72 articles remain for full-text 
retrieval and assessment  
 
55 studies excluded after not meeting 
inclusion criteria (no spirometry results 
included and/or outcomes not relevant or 
insufficient results for SES, QoL and/or HCA. 
21 references for quality check 
7 studies excluded based on quality 
assessment (provision of effect sizes 
(ORs, CIs etc.) on the association between 
SES and quality of life and/or health care 
access and definition of QoL and HCA. 
14 papers included in review after 
quality assessment: 6 on health care 




4,919 papers removed because they were 
not related to SES and health care access 
and/or quality of life in COPD and after 
filtering for language, age etc.  
4,837 studies left for abstract review 
Reference search added 4 further 
studies  
 
76 articles remain for full-text 




a. SES and Health Care Access 
 
Among 76 studies which were assessed in full, six studies examining the relationship 
between SES and HCA were of adequate quality and were included in the review. Of 
those, three studies which examined the relationship between SES and HCA found that 
lower SES populations had better access to health care services (Goldstein, et al., 
2005; Simoni, et al., 2008; VanderSchaaf, Olson, Billups, Hartsfield, & Rice, 2010) 
while the remaining 3 provided evidence for higher SES associated with greater health 
care access (Chandra, Tsai, & Camargo, 2009; Enright, Kronmal, Higgins, Schenker, & 
Haponik, 1994; Prescott, Lange, & Vestbo, 2008). Study and participant characteristics 
are presented in Tables 4.1, 4.3, 4.5 and 4.6. Details of quality assessment scores for 
all 14 studies (both for HCA and QoL) are provided in Supplementary Table 4.3 
(Appendix A3). 
Evidence for the associations between SES and HCA was provided by the following 
studies. Enright et al. (1994) found lower income to be a predictor of undiagnosed 
airways obstruction.  Higher educational attainment was associated with greater 
likelihood of having received a diagnosis of chronic bronchitis compared to lower 
education [high school education (OR=1.4, [95%CI]=1.1-1.8; p=0.008) and college 
education (OR=1.5, [95%CI]=(1.1-1.9); p=0.003)]. Prescott et al. (2009) reported that 
lower SES in terms of education and income level was related to greater risk of hospital 
admission especially in females [medium SES (RR= 0.74, [95% CI]=(0.55-1.02) and 
high SES (RR=0.27, [95% CI]=(0.10-0.73) versus low SES]). Chandra et al.’s (2009) 
findings indicated that lower SES was associated with poorer access to health care as 
measured through hospitalisation rates (medium and low SES as compared to high 
SES: OR=0.7, [95%]= (0.3, 0.7) and OR=2.7, [95%CI]= (0.6, 12.3); chest radiography 
administered (medium and low SES as compared to high SES: OR= 1.0, [95% CI]= 
(0.4, 2.5) and OR=2.2, [95% CI]= (0.4, 11.1)); arterial blood gas administered: (medium 
and low SES as compared to high SES: OR=0.7, [95%]= (0.1, 4.3) and OR=0.2, [95% 
CI]= (0.1, 0.9)); corticosteroids received in ED: (medium and low SES as compared to 
high SES: OR=1.0, [95% CI]= (0.8, 3.4) and OR=1.4, [95% CI]= (0.2, 8.7)).              
The remaining three studies on HCA provided evidence for an inverse association 
between lower SES and greater HCA. Goldstein et al. (2005) observed greater 
likelihood of discussion regarding prognosis between physicians and patients with 
lower financial status (OR=2.26, [95%CI]=(1.03–4.96); p=0.001) compared to higher 
172 
 
financial status. VanderSchaaf et al. (2010) found that patients with higher educational 
attainment, defined as education beyond high school with or without an advanced 
degree, were more likely to report more variance in the use of inhalers than patients 
with a high school diploma or less education (OR 2.1; [95%CI]=(1.1-3.6). Simoni et al. 
(2008) provided evidence for less frequent use of any respiratory-related medication by 
less educated patients. High education was the reference value and intermediate or 
low had odds ratios compared to it [intermediate education OR=0.97, [95%CI]=(0.76–
1.24); low education OR=0.90, [95%CI]=(0.71–1.15)]. For the use of respiratory-
specific medication, such as antiallergic or broncho-pulmonary medicines, lower 
education was associated with more frequent medication use [ref high education: 
intermediate OR=0.84, [95%CI]=(0.55–1.27); low education OR=1.11, [95%CI]=(0.77–
1.61)]. 
 
b. SES and Quality of Life 
 
Among 76 studies which were reviewed in full, eight studies examining the relationship 
between SES and QoL were of adequate quality and were included in the review. 
Study and participant characteristics are presented in Tables 4.2, 4.4, 4.5, 4.6. Details 
of quality assessment scores for all fourteen studies are presented in Supplementary 
Table 4.2 (Appendix A2). 
Five studies reported that lower SES was associated with poorer QoL (Hesselink, et 
al., 2006; Hill, 2005; Saadat, 2007). Hesselink et al. (2006) found an association 
between higher education and an increase in QoL at 2-year follow-up in patients with 
COPD but this was not statistically significant [educational level: medium vs low 
(β=1.36, [95% CI]=(−0.22, 2.93); and high vs low (β=2.09, [95% CI]=(−0.08, 4.26); 
p<0.10). Saadat et al. (2007) showed that lower SES was associated with poorer QoL 
and physical function (difference between Group I (31.2 ±11.8), Group II (36.1±11.6); 
Group III (36.8 ±14.4) p< 0.05). Hill’s (2005) findings indicated that higher SES in terms 
of education was directly related to better QoL (β=0.22, R=0.49, R2=0.201, p<0.001). 
(Moy, et al., 2009) found that higher education (post secondary) compared to lower 
education (pre-secondary) was associated with better QoL in terms of mental health 
[(OR=4.6 [95%CI]=(3.3 to 5.8); p<0.001] and better QoL in terms of physical 
symptoms, disease activity, and effects on daily life [(OR=-4.7, [95%CI]=(−6.3 to −3.2); 
p<0.001]. Eisner et al. (2011) reported that lower educational attainment and lower 
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income level were both associated with poorer lung function and greater physical 
limitations. The lowest income category compared to the highest income category was 
associated with a lower distance walked, (-303 feet; 95% CI -380 to -227 feet), as well 
as higher risk of COPD exacerbations [(HR=1.5; [95%CI]=(1.01 to 2.1) and HR=2.1; 
[95%CI]=(1.4 to 3.4)]. Lower SES in terms of education and income level was also 
associated with poorer BODE scores (measure of disease severity status) [ref. college 
degree level education: some college [(OR=0.6, [95%CI]=(0.3-1.0)], less than high 
school [(OR=1.0, [95%CI]=(0.6-1.3) and [ref income level high: medium [(OR=0.7, 
[95%CI]=(0.4-1.0), low [(OR=1.7, [95%CI]=(1.2-2.2)]. 
The three remaining papers that examined the relationship between SES and QoL did 
not find any support for such an association or found inconsistent evidence 
(Kanervisto, et al., 2010; Van Manen, et al., 2002; Wijnhoven, et al., 2001). Wijnhoven 
et al. (2001) did not find a statistically significant association between educational level 
and QoL (β= 0.09, p≤0.10). Van Manen et al. (2002) found that educational attainment 
was not related to depression (OR=0.8, [95% CI]=(0.2-3.0)). While depression is not a 
usual element of QoL, it was considered a form of emotional well-being for the 
purposes of this review and was included in the analysis. Kanervisto et al. (2006) did 
not find evidence to support an association between lower SES in terms of income and 
educational level and poorer QoL. When compared to high income level QoL in terms 
of activities of daily living (ADL) was better for middle and low income levels [(middle 
OR=0.47, [95%CI]=(0.05–4.07) and low (OR=1.76, [95%CI]=(0.21–14.57)]. QoL in 
terms of instrumental activities in daily living (IADL) was poorer for middle and low 
income levels compared to high income level [(middle OR=1.18, [95%CI]=(0.04–0.86) 
and low OR=0.47, [95%CI]=(0.10–2.17).  QoL in terms of social functioning (pastime 
and hobbies) was better for lower compared to higher income levels: middle OR=1.75, 
[95CI]=(0.32–9.44) and low OR=1.88, [95%CI]=(0.34–10.54). When compared to high 
income level QoL in terms of psychological functioning was better for lower income 
levels [middle OR=0.69, [95%CI]=(0.19–2.43) and low OR=1.42, [95%CI]=(0.39–5.15). 
For education, compared to high educational attainment, lower educational levels 
reported were associated with poorer QoL in terms of ADL [ref high educational level: 
ADL: secondary OR=0.96, [95%CI]=(0.19–4.75) and basic OR=0.72, [95%CI]=(0.15–
3.33)] and IADL [secondary OR=0.86, [95%CI]=(0.23–3.24) and basic OR=0.52, 
[95%CI]=(0.14–1.93)]. QoL in terms of social functioning was better in lower 
educational levels compared to higher education [secondary OR=2.26, [95CI]=(0.52–
9.83) and basic OR=2.60, [95%CI]=(0.63–10.75)] as was QoL in terms of psychological 
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functioning  [secondary OR=0.98, [95%CI]=(0.29–3.26) and basic OR=1.93, 
[95%CI]=(0.63–5.91)].  
 
c. SES and HCA and QoL adjusting for disease severity 
 
The aforementioned findings could be a result of varying severity of COPD among 
people with different SES. Patients with more severe COPD could have had better 
access to health care services because they were experiencing poorer QoL. In order to 
examine whether disease severity might have confounded these relationships a 
second analysis was performed. Studies that had not adjusted their analyses for 
disease severity were excluded. Findings did not differ significantly compared to the 
ones described above. Three studies examining the relationship between SES and 
HCA (Goldstein et al., 2005; VanderSchaaf et al., 2010; Enright et al., 1994) and two 
studies examining the relationship between SES and QoL (Hill, 2005; Eisner et al., 
2011) were included in the analysis (see Tables 4.5 and 4.6). 
For HCA, one study found lower SES to be associated with greater health care access 
and two found support for the opposite. The first was Goldstein et al. (2005) who 
reported that lower financial status was associated with higher likelihood of a 
discussion regarding prognosis occurring between physicians and patients (OR=2.26, 
[95%CI]=(1.03–4.96); p=0.001) compared to higher financial status. 
VanderSchaaf et al. (2010) found that more educated patients (beyond high school 
with or without an advanced degree), were more likely to report variability in the 
frequency of use of inhaled medication than patients with a high school diploma or less 
education (OR 2.1; [95%CI]=(1.1-3.6). Enright et al. (1994) found that diagnosed 
airways obstruction was twice as likely in patients with higher education compared to 
patients with lower education [high school education (OR=1.4, [95%CI]=1.1-1.8; 
p=0.008) and college education (OR=1.5, [95%CI]=(1.1-1.9); p=0.003)]. 
Hill’s (2005) findings suggested that higher SES in terms of education was directly 
related to better QoL (β=0.22, R=0.49, R2=0.201, p<0.001). Eisner et al. (2011) found 
associations between lower educational attainment and lower income level and poorer 
lung function as well as greater physical limitations. The lowest income category was 
associated with a shorter walked distance (-303 feet; 95% CI -380 to -227 feet) when 
controlling for disease severity and higher risk of COPD exacerbations [(HR=1.5; 
175 
 
[95%CI]=(1.01 to 2.1) and HR=2.1; [95%CI]=(1.4 to 3.4)] compared to the highest 
income category. Lower SES in terms of education and income level was also 
associated with poorer disease severity status [ref college degree level education: 
some college [(OR=0.6, [95%CI]=(0.3-1.0)], less than high school [(OR=1.0, 






Table 4.1 Study Characteristics – Health Care Access (HCA) 
Authors                           Aim                                       Study           Country  Spiro-  Severity  Sample     Definition SES              Definition QoL           Definition HCA        Findings re SES & HCA/QoL 
               Design  Metry    Adjusted   
Enright et    To provide prevalence rates for     Cohort-prospective      USA     Yes          Yes      5,201     Education completed,    Baseline examination       Diagnosis of                  Undiagnosed airways  
al. (1994)    major respiratory symptoms and                                                         annual income             and a subset of         airways obstruction   obstruction was twice as likely in                                                            
           lung diseases from this cohort by                                                         ATS/DLD-78 respiratory                                     people of lower income.  
                   smoking status and identifying                   questionnaire.                                                       
                   correlates of respiratory conditions                
 
Goldstein    To examine the association of          Cross-sectional         USA    No          Yes         226       Financial status was         Not measured       Defined discussions of    Patients and clinicians were more                                                                                                                                                   
et al.                                                                            (2005)      patient ethnicity and financial status             survey                                                                 categorised as “money                                    prognosis as communi-     likely to agree that discussions 
                  with  patient and clinician reports                    left over”;“just enough                                        cation about whether    about prognosis had taken place
           of discussions about prognosis.                     to make ends meet”;                                    the patient could die as a         when patients had a lower  
                                                                                  and “not enough money”                     result of her/his illness                     financial status  
                                
Simoni et    To assess the habitual uptake        Cross-sectional             Italy      Yes     No       4,010    Educational attainment      Not measured          Habitual uptake of    Use of medicines was positively and 
 al. (2008)     of medicines in subjects with                    survey                (low-intermediate-high)                          medications     significantly associated with education. 
                   respiratory symptoms/diseases                     Medicines consumed more  frequently            
                     or impaired lung function in                  by less than more educated participants 
                      general population samples 
 
Prescott et  To analyse the effect of educa-      Cross-sectional      Denmark      Yes      No    14,223    Educational attainment       Not measured          Hospital admission       Education, household income and  
al. (2009)     tion on development of COPD             study                 & income (low-med-high)                         socio-economic index were all predictors 
                      assessing lung function and                      Socio-economic index             of hospital admission 
                              hospital admission                   (combination category of          
                                  education and income) 
 
Chandra et     To investigate quality of                   Prospective             USA &        Yes      No        330      Median family income        Not measured                 Provision of       African-American & Hispanic patients  
al. (2009)              emergency care                         multicenter            Canada                  (low-medium-high)               emergency care   with COPD had lower SES and poorer  
                       for patients with AECOPD               cohort study                   and insurance status                                                                          access to primary care compared with 
                     (commercial/private/none)              white patients 
 
                                                                                    Vander-         To determine the extent of          Cross-sectional             USA          Yes        Yes   265            Education level            Not measured      Patient-reported inhaler   Higher education level, home oxygen 
Schaaf      and reported reasons for patient-            survey            variance               use & prescriptions for ipratropium                 
et al.              reported variance in the use                           were  predictors for inhaler variance 





Table 4.2 Study Characteristics – Quality of Life (QoL) 
Authors                  Aim                                Study Design       Country     Spirometry     Severity       Sample         Definition SES                 Definition QoL            Main Findings re SES & HCA/QoL 
 
                                                                                                                       
Wijnhoven     To identify determinants of   Cross-sectional     Netherlands     Yes                No             1135        Educational attainment       Breathing problems;             Education was not associated   
et al. (2001)     pulmonary function and      community study          (asthma 837      (low-medium-high)           physical problems;                 associated with HRQOL 
                        health-related quality of life                              COPD 231)                                          emotions; general activities;                                          
                                       (HRQoL)                        daily/domestic/social relationships 
                                                                                                                                                                                                                                                  
Van Manen   To investigate the incidence       Case-control     Netherlands         Yes           No          162 COPD    Educational attainment     Frequency and severity         Education was not related to 
et al. (2002)    of depression in COPD &  to           study           (359 controls)    (low-high); insurance     of respiratory symptoms                      depression 
                      determine the demographic &                                       (NHS/private); living      and activities limited by                                
                     clinical variables associated with it                        conditions /alone/with   breathlessness; symptoms                           
                                others                 and physical functioning                                       
                                                                                              
Hill (2005)     To determine the extent to which       Cohort-             USA       Yes           Yes              148        Educational level and          QoL defined at the              Disease severity stage, comorbid  
                      manifest symptom distress, physical   Prospective                             income (l-m-h)               extent to which a           conditions,educational level, manifest  
                      function alterations, self-esteem,                    person’s assessed       symptom distress & spiritual well-being  
                      social functioning alterations and                      level of satisfaction         were found to be directly related to QoL  
                      spiritual well being explain QoL in                    with life and overall                          in COPD patients 
                                      COPD patients                    sense of well-being                                         
 
Hesselink    To examine predictors of decline        Cohort        Netherlands          Yes            No               500          Educational attainment       Breathing problems,            A decline in HRQoL was associated  
et al. (2006)   in pulmonary function (FEV1) or     prospective                                                                     120 (COPD)      (low-medium-high)            physical problems,             with lower education, lower body  
                      HRQoL in patients with asthma or                                                                                          380 (Asthma)                                        emotions, general activity,       weight, more dyspnoea, & more  
                                         COPD                                daily domestic/social activities      respiratory symptoms in COPD                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
Kanervisto   To investigate the negative impact     Health           Finland              Yes               No               6,354       Educational attainment            Spirometry, ADL,                    No significant association 
et al. (2006)   of illness on HRQoL in people with   Examination                                                                                     (basic-secondary-higher)     IADL, exercise, hobbies,                 between SES and QoL 
                                         COPD                               Survey                                                                                            Income (low-middle-high)    pastime and experiences 
Saadat          To investigate the association          Case-control      Iran                 Yes               No                131          Educational attainment              Overall QoL                     QoL and physical function were 
et al. (2007)     between income and QoL                   study                                                                                            Monthly income (low-med-hi)                                             significantly correlated to SES in  
                               in COPD patients                                                                                                                                                                                                                                           COPD patients                                                 
                                                                                                                                                                                           
Moy              To identify the independent               Multicentre       USA                  Yes               No               1,621        Educational attainment              Overall QoL                         Education was one of the  
et al. (2009)    determinants of HRQL in COPD          RCT                                                                                                  (low/ medium to high)                                                         determinants of MCS score 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
Eisner et     To determine the independent              Cohort-          USA                  Yes            Yes              1,202         Educational attainment            Severity status,                  Lower educational attainment &  
al. (2011)    impact of SES and ethnicity/ethnicity    Prospective                        and household income              functional                income were related to greater disease  
                    on COPD severity status, functional              (low-medium-high)                 limitations             severity, poorer lung function and greater  
                    limitations and acute exacerbations                           physical functional limitations 
                   of COPD among patients with  HCA               
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Table 4.3 Patient Characteristics – Health Care Access (HCA) 
Authors       Age (Mean)    Sex           Ethnicity    Groups   Co-morbidities Smoking   Mean FEV1  Measurement Tool     SES 1 (Income)  SES 2 (Education)SES 3 (Occupation)  Effect Size/OR        
                                                                           
Enright et    65+ (men       45% M   4% non-white       1        Not mentioned      Yes          Yes                ATS DLD-78                                                                        Higher education predicted                                                         
al. (1994)   M=73.3;women                         Respiratory Questionnaire    High – Low       37% Low/med.   Not measured   greater likelihood of airway 
                      M=72.2)                Baseline examination            (annual)            (high school)  obstruction diagnosis 
                                              - 34% High (Practitioners)            OR 0.32,95%CI,0.16-0.66,p=.001 
                       
Goldstein  72.8 (SD=7.3)  42.1% F      White/              3                   No                   No            No             Questionnaire on             7.9% (low)         68.7% (<HS)    Not measured   Lower financial status predicted                                    
et al.        >80yrs=19.6%   57.9% M    Non-white   (cancer/                                                 discussion about            45.3% (med)        31.3% (>HS)        discussion about prognosis  (OR=2.26,                                                      
(2005)           (60-93)          (CHF/COPD)                prognosis   (HCA)           43.9% (high)                                                        [95%CI]=(1.03–4.96); p=0.001) 
 
Simoni et     N. Italy          48.3% M   Not mentioned    2                   Yes                 Yes        Yes        Questionnaire for data     Not mentioned     42.9% (low)                     Habitual use of medications: Education 
al. (2008)    (M=39.5;         52.8% F                   (N. Italy vs urban                                           on habitual or occasional                        29.5% (med)                 Intermediate: OR 0.84,95% CI, 0.55-1.27 
                   SD=16.2)                                          Central/N. Italy)            use of medicines. Positive                   27.5% (high)               Education Low: OR 1.11,95% CI, 0.77-161 
                Centr/N. Italy                                                           response to “Are you habitually                                                                                             
       (M=45; SD=17.4)                                        taking medicines?”       
                                              
Prescott et  M=50.4 yrs (F) 54.2% F  Not mentioned   9 (3 groups   No                 Yes            Yes       National Hospital Discharge   16.7% (low)     24.5% (low)            Relative Risk (RR) for admission to hospital 
al. (2009)     M=52.7 yrs (M)        45.8% M           each category:                                       Register to monitor         25.1% (med)   21.3% (med)            for COPD by medium/high vs. low socio- 
         education ,household            patients’ hospital admissions     9.1% (high)     5.1% (high)       economic index: in females: RR: -0.74,95% CI, 
              income, socio-                     0.55-1.02),  and RR: 0.27, 95% CI, 0.10-0.73) 
               economic index                         respectively. For males: RR: 0.47, 95% CI, 
                                               0.36-0.63) and RR: 0.35 (0.17-0.70) respect.
                                 
Chandra et   M=68 yrs       53% F    66% white           3 (white/         No                   Yes           No    SF-CRQ; Health Care Effectiveness       Insurance Status (Private:          Quality of Care: Hospital admission 
al. (2009)                             47% M    25% Afr.-Amer.  (African-                                                            Data and Information Sets (HEDIS)    White 37%; African-American      African-American (OR 0.7, 95%, 0.3, 
                                                                                   American/                                                       composite guideline concordance score   12%; Hispanic 11%/Medicaid:   1.7); Hispanic (OR 2.7, 95%CI, 0.6, 12.3). 
                   Hispanic)                                                                        10% - 30% - 37%/Medicare or     Received chest radiography: Afr-Amer 
                                                                                                  None: 53% - 58% - 52%)            (OR 1.0, 95% CI, .4, 2.5); Hispanic 
                                                                 Minority Proportion (W: M=14;    (OR 2.2, 95% CI, 0.4, 11.1). Received
                                             AA: M=73; H: M=88)         arterial blood gas: Afr.-Amer. (OR 0.7, 
                       High Minority Proportion       95%, 0.1, 4.3) Hispanic (OR 0.2, 95% CI, 
                   (W: M=10; AA: M=50; H: 16)    0.1, 0.9). Received corticosteroids in ED: 
                                                         Afr.Americ.(OR 1.0, 95% CI, 0.8, 3.4); 
                            Hispanic (OR 1.4, 95% CI, 0.2, 8.7)
                                                                                                                                                                                                                                                                                              
Vander-   73 (SD=8)         48.7% M    White/Cauc.         1        No               Yes     8.7% (mild)  17-item survey    Not measured    11% not finish HS   Not measured   Higher educational level predicted 
Schaaf      Black/Afr. Amer.           47.2% (moder)            (HCA)         34.3% HS graduate                         greater inhaler variance 
et al.                                     Asian/Pacif Isl           35.1% (severe)           31% Diploma                                         OR=2.1, [95% CI]=(1.1-3.6) 
(2010)                                   Americ. Ind./Alask.Nat.            9.1% (very sev.)          21.5% College Grad 
        Hspnc/Latino/Other     (based on GOLD criteria) 
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Table 4.4 Patient Characteristics – Quality of Life (QoL) 
_____________________________________________________________________________________________________________________________________________________________________________________________________________________ 
Authors          Age (Mean)   Sex         Ethnicity        Groups      Co-morbidities Smoking   Mean FEV1  Measurement Tool     SES 1 (Income) SES 2 (Education)SES 3 (Occupation)    Effect Size/OR          
Wijnhoven        M=58          54% M   Not mentioned    2 (asthma         Yes             Yes   Yes        Quality of Life in Respi-   Not mentioned     53% (low           Not mentioned    Higher educational level  
et al. (2001)    (SD=14)        46%  F                and COPD)                                                           ratory Illness Questionnaire       29% (med)                                was not associated with QoL    
                             (Maille et al., 1997)                                    17% (high)                                (β= 0.09, p≤0.10) in COPD 
     
Van Manen  FEV1<50%:           M:    Not mentioned     2 (COPD and    Yes            Yes                 Yes      St George’s Respiratory    NHS Insurance   Low Education        Educational level was not associated with 
et al. (2002) M=67.8(SD=8.7)  FEV1<50%    (controls)                                                               Questionnaire (SGRQ)   FEV1<50%: 75%   FEV1<50%: 88.1%    depression in COPD (OR 0.8, 95% CI, 
                FEV1=50%-80%:      =73.3%,               and CES-D              FEV1 50-80%: 76.2% FEV1 50-80%: 85%     0.2-3.0). NHS Insurance was not 
               M=66.2(SD=10.3)    FEV1=50%                                  Controls: 68.5%      Controls: 80.1%         associated with depression in COPD  
         Contr: M=65.6;SD=12.8)   -80%=70.6%) Contr.:40.4%                                            (OR 1.3, 95% CI, 0.4-4.4) 
                                                   





                            30% M                                     33% (moderate)   Quality of Life Visual   24% (medium)       58%(med)           sign. t=.00; income corr. coeff=.331; 
                                      43% (severe)         Analogue Scale          29% (high)            38% (high)                 education corr.coeff=.375 
 
Hesselink   Asthma: 45.0    Male:      Not mentioned      2 (asthma         Yes            Yes                Yes              Quality of Life in Respi-  Not mentioned        69% (low)       Educational level was associated with QoL 
et al. (2006)   (SD=14.3);    Asthma: 34%                      and COPD)                                                               ratory Illness Questionnaire                                 21% (med)   medium/low (β= 1.51, 95% CI, (-0.23, 3.24); 
           COPD: 57.5;SD=13.4)  COPD: 58%                              (Maille et al., 1997)                                       10% (high)      High/low:  (β= 1.75, 95% CI, -0.61, 4.11)  
                                     
Kanervisto  30-50yrs= 11%  62% M   Not mentioned    4 (general          Yes            Yes                Yes       ADL and IADL questionnaires;   65% (low)         63% (low)       Secondary educ. for ADL(OR 0.96,95% CI, 
et al. (2006)  50-70yrs=44%  38% F                          population/chronic                                                         adaptation of Mini-Finland         26% (med)       26% (med)   0.19-4.75) for IADL(OR 0.86,95% CI:0.23-3.24) 
                           70+=45%                                           bronchitis/COPD                                                                    Health Survey                 9% (high)         14% (high)  Basic educ. for ADL)(OR 0.7295% CI, 0.15-3.33),                                                              
                                                          whole study population)                                                                                                                                                     for IADL(OR 0.52, 95% CI,0.4-1.93),                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                
Saadat      58.3±11.0yrs         61% M  Not mentioned    3 (Income           Yes             Yes                Yes                        MOS SF-36              40% (low)       36% (illiterate)    Total QoL was significantly associated with 
et al. (2007) (range, 45-82     39% F                           Group I (low)                                        47% (med)      30% (element.)    monthly income in COPD. Difference 
                        years)                                                  Group II (med)           13% (high)      14% (secondary)   between Group I (31.2 ±11.8), Group II 
                                                                                    Group III (high)             17% (dipl)/ 3% (univ) (36.1±11.6); Group III (36.8 ±14.4) p< 0.05                        
                         
Moy et    M=66 ±6years         60% M    94% white          1 COPD            Yes             Yes                 Yes     MOS SF-36; St. George’s    Not mentioned     80% High School   Education was associated with the MOS  
al. (2009)                                40%F                  Respiratory Questionnaire total                            or Higher                 SF-36 MCS Score (R
2
=0.35; OR 2.3 
                                                                                                                                                Score (SGRQ-TS), and Self-                               20% Lower than                95% CI, 1.2-3.3, p<0.001) 
                                                                                                                                           Administered Quality of-Well-Being                          High School                                        
                                                                                                                                                  Scale (QWB-SA) total score  
                                                                                                             
Eisner et  57.5 (6.4)     57.2% F    White/Black/     5 (ethnicity)       Yes             Yes      Not mentioned      BODE Index (QoL)       12.4% (low)       27.6% element.   Not measured  Lower education and income 
al. (2011)     (56.1-58.6)    42.8%M   Hispanic/Asian/                  55.8% (med)                          levels predicted greater 
              Other                  21.2% (high)                  physical functioning limitations 




Table 4.5 Study Characteristics - Disease Severity Adjusted Studies 
_______________________________________________________________________________________________________________________________________ 
Authors                   Aim                              Study Design       Country   Spirometry Severity adj. Sample   Definition SES             Definition QoL      Definition HA       Findings re SES & HCA/QoL 
                                                                                                                                       
 
Health Care Access (HCA) 
 
Enright et  To provide prevalence rates for   Cohort-prospective   USA           Yes        Yes         5,201   Education completed,  Baseline examination   Diagnosis of        Undiagnosed airways obstruction   
al. (1994)  major respiratory symptoms &                 annual income           and a subset of      airways obstruction     was  twice as likely in people of 
              lung diseases from this cohort by              ATS/DLD-78 respiratory                             lower income. Dyspnoea on exertion 
             smoking status and identifying                      questionnaire.                                         was positively associated with   
           correlates of respiratory conditions.                     lower education. 
 
Goldstein  To examine the association of     Cross-sectional      USA      No        Yes           226     Financial status was        Not measured    Defined discussions of  Patients and clinicians were more 
et al.     patient ethnicity and financial status         survey                                        dichotomized as “money                                prognosis as communi-     likely to agree that discussions 
(2005)    with  patient and clinician reports                           left over”;“just enough                           cation about whether    about prognosis had taken place
            of discussions about prognosis.            to make ends meet”;                          the patient could die               when patients had a lower  
                                and “not enough money”                          as a result of her/his    financial status or were non-white 
                                             illness            
Vander-  To determine the extent of             Cross-sectional       USA       Yes         Yes           265       Educational level          Not measured     Patient-reported inhaler    Higher educational level, home  
Schaaf   & reported reasons for patient-            survey                             variance  oxygen use and prescriptions 
et al. (2010)  reported variance in the use                                        for ipratropium were 
               of inhalers prescribed for COPD                                                   predictors for inhaler variance 
Quality of Life (QoL) 
 
Eisner et  To determine the independent           Cohort-               USA            Yes         Yes        1,202   Educational attainment     Severity status,       Exacerbations (E&D        Lower educational attainment 
al. (2011)  impact of SES & ethnicity/ethnicity   Prospective        and household income        functional        visits & hospitalisations)    & income were related to greater 
               on COPD severity status, functional             (low-medium-high)           limitations                                            disease severity, poorer lung 
              limitations and acute exacerbations                                 function and greater physical 
               of COPD among patients with  HCA                                                       functional limitations   
Hill (2005) To determine the extent to which       Cohort-              USA        Yes          Yes         148      Educational level and      QoL defined at the       Not measured         Disease severity stage, comorbid 
              manifest symptom distress, physical    Prospective                income (l-m-h)             extent to which a                       conditions, educational level, 
                 function alterations, self-esteem,                     person’s assessed                                             manifest symptom distress 
                social functioning alterations and                       level of satisfaction                      and spiritual well-being were  
               spiritual well being explain QoL in                     with life and overall                                             found to be directly related 
                            COPD patients                     sense of well-being                                        to QoL in COPD patients 
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Table 4.6 Patient Characteristics – Disease Severity Adjusted Studies 
_______________________________________________________________________________________________________________________________________
  
Authors         Age (Mean)      Sex     Ethnicity    Groups    Co-morbidities Smoking   Mean FEV1   Measurement Tool   SES 1 (Income)  SES 2 (Education)   SES 3 (Occupation)  Effect Size/OR          
 
Health Care Access (HCA) 
 
Enright et      65+ (men         45% M   4% non-white       1    Not mentioned        Yes           Yes                ATS DLD-78                                 Higher education predicted 
al. (1994)  M=73.3;women             Respiratory Questionnaire    High - Low      37% Low/med.     Not measured       greater likelihood of airway 
                      M=72.2)                 Baseline examination          (annual)           (high school)          obstruction diagnosis 
                    - 34% High (Practitioners)                         OR 0.32,95%CI,0.16-
0.66,p=.001 
              
Goldstein    72.8 (SD=7.3)   42.1% F      White/             3             No                   No               No           Questionnaire on            7.9% (low)         68.7% (<HS)        Not measured     Lower financial status predicted                    
et al.            >80yrs=19.6%   57.9% M  Non-white    (cancer/                                                             discussion about           45.3% (med)      31.3% (>HS)                       discussion about prognosis                      
(2005)           (60-93)                            CHF/COPD)               prognosis   (HCA)          43.9% (high)                                                      (OR=2.26,95%CI(1.03–4.96); p=0.001) 
 
Vander-      73 (SD=8)          48.7% M    White/Cauc.  1              No          Yes       8.7% (mild)        17-item survey         Not measured    11% not finish HS  Not measured    Higher educational level predicted 
Schaaf         Black/Afr. Amer.         47.2% (moder)        (HCA)             34.3% HS graduate                               greater inhaler variance 
et al.                                          Asian/Pacif Isl         35.1% (severe)                    31% Diploma                                    OR=2.1, [95% CI]=(1.1-3.6) 
(2010)                                     Americ. Ind./Alask.Nat.          9.1% (very sev.)               21.5% College Grad 
         Hspanic/Latino/Other              (based on GOLD criteria) 
 
Quality of Life (QoL) 
 
Eisner et     57.5 (6.4)      57.2% F     White/Black/     5 (ethnicity)   Yes           Yes     Not mentioned    BODE Index (QoL)     12.4% (low)       27.6% element.      Not measured       Lower education and income 
al. (2011)    (56.1-58.6)      42.8%M   Hispanic/Asian/           55.8% (med)                                         levels predicted greater 
               Other           21.2% (high)                                                  physical functioning limitations 
                8.8% (missing)                                                         -303 feet; (95%CI)-380 to -227feet 
 
Hill (2005)   67 (SD=9.4)     70% F      Not mentioned        1       Yes            No      24% (mild)               SF-36 &                  47% (low)             4% (low)             Not measured            Higher educational level     
                  (48-78)          30% M                              33% (moderate)  Quality of Life              24% (medium)      58%(med)                    predicted better QoL                    
              43% (severe)    Visual Analogue Scale  29% (high)            38% (high)                                           R=0.49 R
2
=0.201, p<0.01





The main finding of this systematic review was that low SES was not consistently 
associated with worse healthcare access, but low SES was consistently associated 
with worse QOL in COPD. Results were similar when disease severity was adjusted for 
in order to ascertain that disease severity was not a confounding variable in the 
relationship between SES and HCA and SES and QoL.  
The current review identified a small number of studies that examined the relationship 
between SES and HCA and QoL in patients with COPD. Statistical results on their 
associations were included in the analyses but were not the main aim of their research. 
Therefore, conceptualisation and assessment of SES, HCA and QoL was not the 
primary concern and their measures did not reflect different aspects of these outcomes. 
For instance, the studies used one or two SES indicators i.e. income, education, or 
occupation and categorised them using different criteria into low-medium-high or low-
high. Other studies defined income as the amount of money left over each month on 
the basis of patients’ insurance status. Similarly, different outcomes and instruments 
were used to assess HCA (e.g. likelihood of diagnosis, discussion about prognosis, 
medication uptake, provision of emergency care) and QoL (e.g. SF-36, ADL, social, 
physical and psychological functioning, overall QoL). Study quality and significant 
heterogeneity in the conceptualisation and measurement of SES, HCA and QoL 
measures complicated comparison across studies. The need for further research for 
studies that focus on associations between SES and HCA and QoL in COPD is 
highlighted. A further point was the lack of homogeneity in the design used across 
studies, as well as in population characteristics such as differences in age, gender 
proportion, COPD severity stages and inclusion of other patient groups (e.g. CHF, 
cancer). This posed further difficulties in drawing clear conclusions regarding the 
impact of SES on HCA and QoL in COPD. The main weakness highlighted is the fact 
that most of the studies examined did not set out to test the hypotheses which were the 
subject of this review. This led to inadequacies in study design particularly with respect 
to adjustment for disease severity, but also with respect to the measures chosen, their 





a. Variability in the definition and use of SES, HCA and QoL measures 
 
Two additional sources of complication in synthesizing the data and interpreting results 
were lack of common understanding of what constituted HCA and lack of uniform use 
of SES and QoL measures. HCA commonly refers to health care services and support 
available to people to preserve or improve their health (Gulliford, et al., 2001). This 
would include services such as attendance, treatment and referral i.e. prescribed 
medication received, attendance at medical care (including smoking cessation and 
pulmonary rehabilitation) and referral for smoking cessation, pulmonary rehabilitation 
and specialist assessment and treatment. Reference to these HCA outcomes was 
made due to their importance in COPD management. The complication arises in issues 
such as exacerbations of COPD which would not normally be considered health care 
access indicators but rather an outcome of poor disease control due to uncertainty 
about the ability of medical care to control exacerbations.  Studies employed different 
concepts and measures of HCA, for example medication uptake, inhaler variance, 
diagnosis of airway obstruction or successful communication between doctor and 
patient as proxies for HCA. Heterogeneity of the measures used prevented drawing 
conclusions. These HCA measures varied significantly and some could be considered 
as aspects of good clinical care. The lack of common understanding of HCA led 
extension of the definition and inclusion of studies with different indicators. In addition, 
the reason behind the variability in defining HCA could lie in the fact that most of the 
studies included in the review focused on exploring other relationships and included 
associations between demographic and socioeconomic variables and HCA as part of 
their research. Their aim was not to examine the effect of SES on HCA and therefore 
the need for more comprehensive and consistent assessment was not of primary 
concern to these studies. 
A further issue was the lack of uniform use of QoL measures. Some studies used 
standardised instruments such as the SF-36, others relied on the BODE Index and 
other used physical functional measures. This lack of homogeneity made comparisons 
across study findings more complicated  
Last but not least the variability in the definition and assessment of SES needs to be 
taken into account when interpreting and evaluating findings. Findings provided by 
studies examining the role of SES in relation to health inequalities are inconsistent 
(Shavers, 2007). The reasons suggested for this inconsistency include: (a) insufficient 
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precision and reliability of SES measures; (b) limitations in collecting individual SES 
data; (c) varying SES during life; (d) classification of SES (e.g. unemployed or retired 
people); (e) weak or non-existent correlation between individual SES measures and (f) 
lack of accuracy and reliable interpretation of results (Shavers, 2007). (Shavers, 2007) 
also emphasized the fact that the selection of SES measures should be based on the 
specific characteristics of the population investigated such age or health disparities. 
Further examples are educational level as well as occupational class which might not 
act as appropriate SES characteristics in later age as in younger adulthood (Braveman 
et al., 2005; Kaplan et al., 1987; Liberatos et al., 1988). SES characteristics derived 
earlier in life such as occupation or income may not reflect SES in late adulthood due 
to major life changes such as retirement. For example, social status held through one’s 
occupational class while in active employment might not be such a strong factor after 
retirement (Kaplan et al., 1987). Variability in the findings suggested that different SES 
measures might be more appropriate for assessing specific outcomes such as HCA 
and/or QoL. For example, IMD might be more sensitive in relation to HCA due to its 
reference to area-level characteristics which would include availability and access to 
health care services while weekly household income level might be more appropriate in 
reflecting more individual-based behaviours related to health status such as diet, 
exercise and lifestyle. 
 
b. Key findings for SES and HCA and QoL in COPD 
 
With the issues highlighted above, findings examining the impact of SES on health care 
access followed two directions. One group of studies suggested that lower SES was 
related to greater HCA in terms of respiratory-specific medication consumption, inhaler 
variance and likelihood of discussion of prognosis between physicians and patients.  
The other group of studies suggested that lower SES was associated with poorer HCA 
in terms of receiving a diagnosis of chronic bronchitis, greater risk of hospital admission 
and hospitalisation during an acute exacerbation of their COPD. 
In the second part of the review, where studies that had adjusted for disease severity 
were excluded, similar results emerged. The first group found that lower SES seemed 
to be related to better access to health care in terms of inhaler variance and likelihood 
of discussion of prognosis between physicians and patients.  The second group of 
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studies reported that lower SES was associated with poorer HCA in terms of receiving 
a diagnosis. 
For the relationship between SES and QoL, most studies found suggested that lower 
SES was related to poorer QoL. Three studies did not find any statistically significant 
associations between SES and QoL in COPD. Exclusion of the studies that had not 
adjusted for disease severity resulted in two remaining studies showing that lower SES 
was associated with poorer QoL. The studies that did not find significant associations 
between SES and QoL were cross-sectional community health surveys which could 
have limited conclusions to temporal associations and lack of causal relationships. In 
contrast, the studies that reported significant relationships between SES and QoL 
included cohort prospective studies, case-control studies and randomized controlled 
trials. Their robust design must be taken into consideration regarding the strength and 
authority of their findings.  
 
c. The possible confounding role of disease severity in the relationship between 
SES and HCA and QoL 
 
Disease severity was considered a possible confounder in the relationship between 
SES and HCA and QoL. If HCA was poorer in lower SES groups, it could have resulted 
in more severe COPD or vice versa. More severe COPD has been associated with 
lower SES due to greater exposure to biomass fuels and tobacco smoke. Therefore, it 
would not have been clear whether poorer QoL was due to low SES, poor HCA or 
more severe disease. The importance of this issue can be highlighted by making 
reference to two high quality studies which reported statistically significant results 
regarding SES and HCA and QoL, but were excluded from the review due to lack of 
disease severity adjustment in their analyses. Tsai et al. (2007) found that despite 
considerable ethnic and SES differences in stable COPD patients, quality of 
emergency care provision was of equal standard for all the groups during 
exacerbations and all presented similar outcomes in the short-term. However, the 
authors did not control for severity and thus it cannot be established whether this lack 
of difference in treatment quality is attributable to the severity of the COPD or to the 
patients’ SES. More severely affected patients would be expected to need and receive 
greater medical care regardless of their SES. Hesselink et al. (2006) examined 
predictors of change in pulmonary function and quality of life in patients with COPD. 
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Their findings showed that lower educational attainment was associated with a decline 
in QoL. But like in Chandra et al. (2009), disease severity was not controlled for in this 
study. Therefore, their findings cannot support a direct effect of SES on QoL. However, 
results did not differ significantly with the exclusion of the “non-adjusting” studies. This 
could be due to the small number of studies included in the current review. Future 
studies need to focus on examining the impact of SES on HCA and QoL. In addition, 




There are some limitations in this systematic review which pertain mainly to the 
material that was available to be examined. These limitations were: (a) there was a 
small number of studies investigating the role of SES in HCA and QoL in COPD (b) the 
main aim of the studies identified was not the examination of the relationship between 
SES and HCA and QoL in COPD (Enright et al., 1994; Simoni et al., 2008; Chandra et 
al., 2009; VanderSchaaf et al., 2010; Hill, 2005; Hesselink et al., 2006; Kanervisto et 
al., 2006; Moy et al., 2009); (c) the populations examined in the studies varied to the 
extent that it was difficult to draw clear conclusions (Goldstein et al., 2005; Chandra et 
al., 2009; Wijnhoven et al., 2001; Van Manen et al., 2002; Hesselink et al., 2006; 
Kanervisto et al., 2006). For example, patients who had not only COPD but also other 
chronic illnesses were examined within the same studies and patients with varying 
severity of COPD were examined across studies; (d) there was no common 
understanding of the definition of health care access; (e) there was no common use of 
a QoL outcome measure; and (f) there was no common use of an SES measure. 
The aforementioned limitations prevent strong conclusions based on the findings due 
to lack of homogeneity in measures and data. Studies that included patients who had 
received a diagnosis of COPD on the basis of their symptoms by their physician but in 
whom COPD was not confirmed through spirometry were not excluded from the review 
but examined in a separate group. The reason was to reduce bias in case of non-
provision of spirometry to patients due to their more deprived background. No 
significant differences were found between studies that had confirmed COPD through 





e. Implications for future research 
 
The need is highlighted for future studies to focus on examining the impact of SES on 
HCA and QoL in COPD. The use of more consistent measures of health care access 
and quality of life was emphasized as well as more comparable variables, outcomes, 
more concrete measures and definitions of SES. There is a need for the focus to shift 
onto the examination of SES and quality of life and health care access as the main aim 





This is the first systematic review of observational studies that examined the 
relationship between SES and HCA and SES and QoL in COPD. Despite the limited 
number of studies and the significant variability in design, participants and outcomes 
particularly in research examining health care access, the evidence that was found did 
not show a clear association between socio-economic deprivation and barriers to 
health care access. Although the evidence was inconclusive, it did not strongly support 
the common view that health care access is more impaired in lower socio-economic 
groups of the population in the case of COPD. The evidence from studies focusing on 
quality of life was limited due to quality issues but did provide some support for the 
association between deprivation and poorer quality of life in COPD when disease 
severity is controlled for. At present, insufficient information does not allow for more 
confident conclusions. A more significant finding emerging from this review was that 
very few studies focused solely on investigating associations between SES and HCA 
and/or QoL and thus did not employ sensitive and specific measures of these 
variables. Higher homogeneity in SES, HCA and QoL measures would contribute to 
more robust comparisons and stronger conclusions in increasing the understanding of 







Hypotheses, aims and objectives of this thesis 
 
 
5.1 Overview summary 
 
The focus of this thesis is on the relationship between socio-economic status (SES) 
and health care access (HCA) and quality of life (QoL) in patients with COPD.  
The hypotheses examined were whether lower socio-economic status was associated 
with: 
 
a. more impaired access to health care access in terms of smoking cessation 
referral and  
b. poorer quality of life in terms of perceived dyspnoea, fatigue, emotional function 
and mastery in patients with COPD.  
 
Further measures of HCA and QoL were also examined to examine the impact of low 
SES on other outcomes. It was also hypothesized that the psychosocial variables in 
question – more positive illness perceptions, higher self-efficacy and higher levels of 
social capital – would be associated with higher socio-economic status, greater 
smoking cessation referrals and improved perceived levels of dyspnoea, fatigue, 
emotional function and mastery in COPD. In addition, these psychosocial variables 
were hypothesized to mediate the relationship between SES and smoking cessation 
and perceived dyspnoea, fatigue, emotional function, mastery in COPD. The aim of this 
research is to increase our knowledge of the ways these variables are associated and 




5.2 Primary outcomes 
 
The primary outcomes of this study were: (a) smoking cessation referral rates in terms 
of HCA and (b) perceived dyspnoea, fatigue, emotional function, mastery, quality of life 
in terms of QoL. 
 
5.3 Secondary outcomes 
 
The secondary outcomes of this study included: (a) pulmonary rehabilitation 
awareness, referral, attendance and completion, consultant referral, regular spirometry, 
prescription patterns and hospital admissions in terms of HCA and (b) Hospital Anxiety 




In order to examine whether lower socio-economic status was related to more impaired 
health care access and poorer quality of life in patients with COPD and the possible 
underlying pathways of these relationships, the following objectives needed to be 
fulfilled: 
 
 To examine whether lower socio-economic status was associated with lower 
smoking cessation referral rates in terms of HCA. 
 To examine whether lower socio-economic status was associated with poorer 
perceived dyspnoea, fatigue, emotional function and mastery in terms of QoL.  
 To examine whether lower socio-economic status was associated with (a) lower 
rates of pulmonary rehabilitation awareness, referral, attendance and 
completion rates, consultant referral, regular spirometry, prescription patterns 
and hospital admissions in terms of HCA and (b) higher scores on the Hospital 
Anxiety and Depression Scale (HADS) in terms of QoL. 
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 To examine whether higher disease severity, more negative illness perceptions, 
lower self-efficacy and lower levels of social capital were associated with lower 
socio-economic status, lower smoking cessation rates and poorer perceived 
dyspnoea, fatigue, emotional function, mastery more impaired health care 
access and poorer quality of life.  
 To examine whether higher disease severity, more negative illness perceptions, 
lower self-efficacy and lower levels of social capital were associated with lower 
socio-economic status, pulmonary rehabilitation awareness, referral, 
attendance and completion rates, consultant referral, regular spirometry, 
prescription patterns, hospital admissions and Hospital Anxiety and Depression 
Scale (HADS) scores.  
 To examine whether illness perceptions, self-efficacy or social capital mediated 
the relationship between socio-economic status and smoking cessation referral 
rates and perceived dyspnoea, fatigue, emotional function and mastery. 
 To examine whether illness perceptions, self-efficacy or social capital mediated 
the relationship between socio-economic status, pulmonary rehabilitation 
awareness, referral, attendance and completion rates, consultant referral, 
regular spirometry, prescription patterns and hospital admissions in terms of 



















This chapter describes the methods used in this study. They include the design, 
setting, recruitment, overview of measures used, participants, sample size and power 




The study was a cross-sectional, observational survey. It aimed to involve participants 
across the whole spectrum of COPD severity and SES. Previous research has 
provided ample evidence for the relationships between lower SES and lower health 
care access as well as poorer quality of life in various chronic illnesses. The systematic 
review that was conducted as part of this thesis (see Chapter Four) suggested that low 
SES was not consistently associated with worse healthcare access, but low SES was 
consistently associated with worse QOL in COPD. The review identified a small 
number of studies that examined the relationship between SES and HCA and QoL in 
patients with COPD. Statistical results on their associations were included in the 
analyses but were not the main aim of their research. This prevented from drawing 
stronger conclusions regarding the relationship between SES and HCA and SES and 
QoL in COPD. Thus, the present study focuses on investigating whether lower socio-
economic status is associated with both lower HCA and poorer QoL in COPD. In 
addition, the fact that SES cannot fully account for the variation in HCA and QoL in 
COPD, suggested that other factors may be implicated and may aid in increasing our 
understanding of these relationships. The literature has provided evidence for an 
association between illness perceptions and self-efficacy and HCA and QoL in COPD 
and between SES, social capital and health. Therefore, a second level observation 
included the examination of the role of psycho-social factors i.e. illness perceptions, 
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self-efficacy, social capital as mediators in this relationship with the aim to elucidate the 
pathways underlying the relationship between SES and HCA and QoL in COPD.  
6.2.1 Setting 
 
In order to address the research question it was essential to achieve the best possible 
representation of disease severity and socio-economic status in patients with COPD. 
The most appropriate setting in which to recruit the study participants was the primary 
care setting because, in the UK, the majority of the population are registered with a GP 
practice and the majority of COPD patients are treated predominantly in general 
practice, particularly those with mild or moderate disease or those who are 
housebound. A sample in which the range of severity and SES is representative of the 
characteristics of people with SES was essential in the examination of associations 
between socio-economic status and health care access and quality of life in patients 
with COPD. A further reason for choosing GP practices was that COPD patients could 
easily be identified through the use of the practices’ disease registers and that it is the 
only setting in which it is possible to seek to recruit all patients with a COPD diagnosis. 
Ethical restrictions were addressed in the process of recruiting GP practices and COPD 
patients on their databases. Identification and recruitment of COPD patients from GP 
practices were performed by an administrator due to ethics restrictions regarding 
patient confidentiality which restricts access to third parties. Therefore, an administrator 
employed by one of the surgeries was seconded to the rest of the practices in order to 
identify and recruit COPD patients. This administrator was trained in data collection 
methods. In this way, co-operation of the GP practices was facilitated because the 
work required for this research study was conducted by the administrator and did not 
add to the workload of the practice staff. This workload included identification of COPD 
patients on practice databases and preparation of mail shots of the invitation letters for 
patient recruitment. Previously established relationships with the practices through 
research conducted in the past also contributed to increasing the likelihood of practice 
participation.  
In order to minimise the risk of bias in recruitment further points were taken into 
consideration and addressed accordingly described in detail in sections 6.4 and 6.5. 
These points were: First, according to the literature an anticipated non-response rate of 
approximately 25-30% (Smith, 1995) was expected which would mean that about a 
quarter of the potential participants would choose not to participate. This could result in 
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the exclusion of a specific group of patients who would be of higher SES level, milder 
or more severe disease stage or younger age. These patients would probably still be in 
employment and too busy to respond. Second, hospitals or residential care homes 
were not considered as recruitment settings due to higher bias but also non-
representative demographics. Hospital or care homes would include patients of 
advanced age and COPD severity and possibly patients who had already been offered 
referrals for specialists suggesting a potential bias in health care access in addition to 
disease severity, SES and advanced age. In addition, COPD patients resident in these 
facilities comprise a small proportion of the patient population. Due to them being 
resident outside of their homes it would also be difficult to apply SES criteria on them.  
 
6.2.2 Practice characteristics and recruitment  
 
GP practices in the London Boroughs of Lambeth and Southwark were stratified to 
participate in the study. A diagram detailing the stages of recruitment is presented in 
Figure 6.1. In order to ensure that a sample of GP practices representing patients from 
all the SES levels and COPD severity stages was obtained, a list of quality scores for 
each practice was developed. The quality scores were compiled based on: (a) the IMD 
score of the address of the GP practice used as a proxy for their patients’ SES, and (b) 
on the quality of COPD care provided by each practice – based on the rates and 
frequency of spirometry conducted and the rates of COPD diagnosis. This information 
was based on South East London practice’s scores on the Quality and Outcomes 
Framework (QOF).  
Practices’ IMD scores were classified into four categories ranging from 1 (low 
deprivation) to 4 (very high deprivation). Category 1 included IMD scores ≤ 30, 
category 2 scores 31-34, category 3 scores 35-39 and category 4 scores ≥ 40. Quality 
of COPD care was classified into A (excellent care) and B (lower quality care). The 
maximum number of combinations of scores between these categories was compiled 
to classify the practices into categories representing all IMD levels and quality scores 
(1A, 1B, 2A, 2B, 3A, 3B, 4A, 4B). For example, a GP practice score of 1A would denote 
that deprivation in its catchment area was low and the quality of COPD care it provided 
was excellent while a GP practice score 4B would indicate that it was located in a 
highly deprived area and its provision of COPD care was of low quality. This was done 
to ensure that a representative sample of patients would be recruited. A bias would be 
likely to occur if availability and quality of health care services provided by the surgeries 
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such as spirometry or prescriptions. The quality scores were developed to ensure 
randomisation would increase representativeness of GP practices in terms of 
deprivation and quality. 
20 GP practices were randomly selected from the stratified groups of practices so that 
all 8 types of practices were represented in the study. Practice managers from selected 
practices were phoned to invite them to take part. The study was introduced and they 
were asked if their practices would be able to contribute. Information about the study 
was provided and any questions or concerns were answered. The managers who were 
interested in participating were then sent a detailed study information sheet, a sample 
of the patient information sheet and invitation letter to ensure they were appropriate for 
their patients (see Appendices B1 and B2). A decision to participate in the study or not 
was made after discussion between practice managers and the partners of the 
particular practice. The administrator assigned to the process of identifying and 
recruiting COPD patients visited the surgeries, identified the COPD patients in the 
practice’s disease registers and checked whether they met the eligibility criteria. 
Eligible patients were sent a standardised invitation letter (see Appendix C1) on behalf 
of the practice. The invitation letter included an explanation and overview of the study 
as well as an invitation to participate with an attached reply slip, a pre-paid and pre-
addressed envelope and a contact details form (see Appendices C3 and C4). 3 weeks 
after the initial invitation, patients were sent a reminder letter (see Appendix C5).  
Reminder letters were sent to increase response rate (Wensing, Mainz, Kramme, Jung, 
& Ribacke, 1999). Patients were provided with the following options: (a) the provision of 
pre-paid and pre-addressed envelopes; (b) home visits that would solve issues like 
transportation especially for housebound patients; and (c) weekend or evening 
interview arrangements particularly for people who were still in employment. Patients 
returned their reply slips to the researcher using the pre-paid and pre-addressed 
envelope provided in the invitation pack sent by the practices. Consenting patients 
were given two options: (a) to return the completed contact details form and the reply 
slip indicating that they agree to participate in the research and have the researcher 
contact them to arrange an interview, or (b) phone the researcher themselves to 
arrange an appointment. Non-consenting patients were not contacted further.  
In order to ensure equal distribution and representativeness of the sample in terms of 
SES levels and COPD severity stages, data for the first 30 participants were analysed. 
Analyses included descriptives, frequencies and distributions. No indication of any bias 
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in SES groups and COPD severity stages was observed. Therefore, practice and 
patient recruitment proceeded as planned. 
 
6.2.3 Patient characteristics and recruitment 
 
Participants were recruited through GP practices for the reasons explained in previous 
sections. The majority of participants were interviewed in their home. A small number 
of patients preferred to be interviewed in their GP practice. Inclusion criteria for the 
study were that participants: (a) had to be aged over 40 years, (b) had to have received 
a diagnosis of COPD based on patient medical records and (b) had to be capable of 
understanding and responding to the questionnaire and interview questions in English. 
Illiterate participants were included as long as they were able to communicate in 
English. Participants were excluded if they: (a) were undergoing active treatment for 
cancer or (b) were suffering from ongoing major mental health problems such as acute 
psychosis, severe depression, alcoholism. Participants were identified through patient 
records from GP practices in the London Boroughs of Lambeth and Southwark. These 
boroughs were specifically chosen on three grounds: (a) high deprivation levels and 
thus higher likelihood of COPD incidence and the whole spectrum of SES and disease 
severity; (b) convenient geographical access due to area proximity and (c) easier 
access to GP practices and facilitated co-operation due to previous collaboration.  
A pilot study was conducted to confirm whether the instruments and time demands 
were suitable for patients of varying ages, SES levels and disease severity grades (1 
mild – 4 very severe). The pilot phase included the first 10 patients with COPD. Time 
and physical demands on participants were acceptable and results from analyses on 
frequencies and distribution of the scores on the measures used did not suggest that 
any changes were required. Patient demographics were collected and contained 
questions on age, sex, marital status, ethnicity, educational and income level and 
occupational status and was based on the one used in the Census 2001 (Census 
2001, Office for National Statistics). 
Ethical approval for this study was obtained from the Proportionate Review Sub-
Committee of the East London REC 3 Research Ethics Committee on 27th May 2010 
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6.6 Interview Plan 
 
Participants were provided with a brief introduction to the study in the beginning of the 
interview. Guidance on completion of the questionnaires was given and questions were 
answered. Each interview commenced with participants completing and signing the 
informed consent form (see Appendix D1) for participation in the study and for 
permission to the chief investigator to access their medical records if necessary.  After 
patients’ FEV₁, weight and height were assessed, the questionnaires were 
administered in the order mentioned above. In cases where patients had difficulty 
reading or completing the questionnaires, the questions were read out loud to them to 
make completion easier. A patient debrief sheet (see Appendix D9) concluded the 
interview. The debrief sheet thanked patients for participating in the study and included 
a request for written consent for participation in a follow-up study should one be 
arranged. An option to indicate whether participants would like feedback was also 
included. Patients were also informed of their right to withdraw from the study at any 
time without this affecting the care they received from their practices. 
 
6.2.4 Measures overview 
 
The measures used in this study relate to the assessment of SES, quality of life, and 












Table 6.1 Type of assessment and measures used in the study 
 
Type of Assessment Measures/Instrument 
  Demographics Age, sex, marital status, ethnicity, 
educational and income level, 
occupational status 
Disease Severity FEV1 (spirometry), MRC dyspnoea scale, 
oxygen saturation levels, height, weight 
Socio-economic Status (SES) Income, education, occupation, IMD 
score 
Social Capital Social Capital Questionnaire 
Illness Perceptions (IPs) Illness Perceptions Questionnaire-
Revised (IPQ-R) adapted to COPD 
Health Care Access (HCA) Client Service Receipt Inventory (CSRI) - 
included questions on GP attendance, 
prescriptions, consultant referrals, 
hospital admissions and exacerbations, 
detailed GP prescription data and 
information on GP referrals given for 
pulmonary rehabilitation and smoking 
cessation programmes 
Quality of Life (QoL) Chronic Respiratory Questionnaire (CRQ-
SAS) and Hospital Anxiety and 
Depression Scale (HADS) 









a. Disease Severity 
 
In order to confirm diagnosis of COPD, due to previously reported misdiagnosis rates 
ranging from 27% to 29% (Jones, Dickson-Spillmann, Mather, Marks, & Shackell, 
2008), full spirometry was conducted. Spirometry also provided the data on FEV1 upon 
which the grading of severity is based according to international guidelines (GOLD). 
FEV1 is poorly correlated with symptoms. Symptoms are an important separate 
dimension of severity since they represent patient perceived severity. Therefore, the 
Medical Research Council (MRC) Dyspnoea Scale was an additional measure to 
assess COPD severity based on patients’ perceived respiratory disability. Patients 
indicate the extent to which their breathlessness affects their mobility (see Appendix 
D5). The Medical Research Council (MRC) dyspnoea scale has been used for many 
years to assess the effect of breathlessness on daily activities and is a reliable and 
valid instrument in various respiratory diseases (Bestall, et al., 1999; Papiris, et al., 
2005).  
Physical status assessment also included oxygen saturation levels, height and weight. 
Oxygen saturation levels were used as an indicator for assessment of the role of long-
term oxygen therapy. This was done to assess the proportion of patients who might 
have a need for long term oxygen therapy and to see if there was a difference in 
access to this assessment by SES. Height and weight were collected in order to be 
able to predict % of expected spirometry as a way of determining severity. They were 
used to calculate the predicted FEV1 and FVC.  
Spirometry was conducted according to American Thoracic Society Guidelines 
(American Thoracic Society, 1995). The MicroLoop VIASYS spirometer (Micro Medical 
Limited, Rochester, Kent, UK) was used known for its accuracy, precision and user-
friendliness (Liistro, et al., 2006). All participants were assessed in identical fashion 
using standardised equipment i.e. Salter scales, pulse oximeter (Nonin Medical, Inc. 
Plymouth, USA) and stadiometer. The researcher conducting spirometry was trained in 
spirometry by attending a two-day training course held by a senior respiratory 
physiologist in King’s College Hospital (KCH) Chest Unit. The course involved 
description of the spirometry process on the first day and practice spirometry sessions 





b. Socio-economic Status (SES) 
 
SES is commonly assessed by educational level, income level and occupational status. 
A detailed description on the ways SES has been conceptualised and assessed was 
presented in Chapter Two. 
The assessment of SES in the current study was made on the basis of the three 
markers: education, income and occupational status based on evidence reported in the 
literature (see Chapter Two). The questions on education, income and occupational 
status were used because they were employed by the census but figures were adapted 
to reflect current data (Census 2001, Office for National Statistics) (see Appendices D2 
and D8). 
Education, income and occupational status are measures of different aspects of SES 
and are moderately correlated to each other as described in Chapter 2. In order to 
capture SES in all its dimensions such as at the neighbourhood level, the Index of 
Multiple Deprivation (IMD, 2010) Score was used as an additional marker. The IMD 
(2010) score consists of seven domains: (1) income deprivation; (2) employment 
deprivation; (3) health deprivation and disability; (4) education, skills and training 
deprivation; (5) barriers to housing and services; (6) living environment deprivation; and 
(7) crime. Each of the domains has a range of 0-100 (least deprived – most deprived). 
The IMD score used is an average of these scores. The underlying concept of the IMD 
(2010) is recognition and measurement of the different components of deprivation 
which are experienced by the population residing in a specific area. One or more 
domains can be assessed. The overall IMD score indicates the level of deprivation of a 
certain area on the basis of the averaged scores of all the individuals in the lower super 
output areas to which the IMD score applies. IMD (2010) scores were calculated based 
on the postcode of residence of the participants to supplement participants’ SES 
assessment. The IMD 2010 was used instead of the IMD 2004 or 2007 because the 
first includes more up-to-date information and because new measures and source of 
data were introduced which made assessment of deprivation more accurate (The 





c. Health Care Access (HCA) 
 
Health care access is a domain that has been conceptualised and assessed in many 
and different ways in research. A detailed discussion of HCA and the issues 
surrounding it was presented in Chapter Two. In the current study HCA was 
operationalised as not only the availability of health care services provided but also the 
uptake of an offered service on the patient’s side.  
Retrospective information about the utilisation of health and social care services as well 
as other domains such as accommodation, employment and living situation has 
previously been collected with the Client Service Receipt Inventory (CSRI) (Chisholm, 
et al., 2000). The CSRI was developed by member of the Centre for the Economics of 
Mental and Physical Health and has been applied in various mental and physical health 
care evaluations. It can also be used to calculate service costs and total costs of care. 
The CSRI can be adapted to fit the aims and characteristics of the study in which it is 
used. In the present study, the Client Service Receipt Inventory (CSRI) was tailored 
appropriately (see Appendix D2). The CSRI included questions on GP attendance, 
prescriptions such as number and type of medication prescribed for each patient to 
establish under- or over-treatment, consultant referrals, hospital admissions, 
exacerbations, referrals for pulmonary rehabilitation and smoking cessation 
programmes. The importance of assessing these dimensions of health care access 
relies on their role in relation COPD outlined in Chapter Two. 
Under-treatment is defined by the lack of prescription of remedies which guidelines 
indicate are indicated by symptoms or disease severity or both. For example, under-
treatment would be not prescribing LABA+ICS for Grades 3 and 4 only (GOLD, 2011). 
LABA or LAMA is not a substitute for this. The lack of LABA or LAMA cannot be used 
to describe under-treatment except when patients have ongoing symptoms. Over- 
treatment is defined by prescribing LABA+ICS or ICS alone in Grades 1 and 2 (GOLD, 







Table 6.2 Treatments considered acceptable at each GOLD grade (2011 revision) 
 
GOLD GRADE     FEV1% predicted  No treatment*    SAMA/SABA**  LAMA/LABA    ICS*** 
1 (mild)    ≥ 80%    Yes  Yes           No     No 
2 (moderate)     50% ≤FEV1 < 80%           Yes  Yes          Yes     No 
3 (severe)     30% ≤FEV1 < 50%    Yes  Yes          Yes    Yes 
4 (very severe     < 30%        Yes  Yes          Yes    Yes 
*Without access to current symptom data (eg breathlessness) absence of treatment was considered 
appropriate in patients at all severity stages provided they had no exacerbations. 
**SAMA/SABA Short-acting muscarinic or beta2-agonist; LAMA/LABALong-acting muscarinic or beta2-
agonist; ICS Inhaled cortico-steroid 
*** Treatment with LABA + ICS or ICS alone was acceptable for any patients with a diagnosis of asthma or 
history of asthma  
 
The questions included in the CSRI variant were selected because using them would 
enable the assessment of HCA outcomes which are important in the management of 
COPD. For example, smoking cessation is the main intervention in order to slow down 
disease progression while pulmonary rehabilitation is important in improving patients’ 
QoL. A detailed description of the reasons why these HCA are important in relation to 
COPD was provided in Chapter Two. 
 
d. Quality of life (QoL) 
 
In the current study QoL was assessed based on patients’ physical, mental and social 
functioning with the use of two instruments: (a) the Chronic Respiratory Questionnaire 
(CRQ-SAS) and (b) the Hospital Anxiety and Depression Scale (HADS). 
The CRQ is a valid and reliable measure of health status for patients with COPD 
(Guyatt et al., 1989; Griffiths et al., 2000). The self-administered version of the CRQ 
the CRQ-SAS was used because it is more user-friendly, easier for the patient to 
understand and to analyse. The CRQ-SAS is a reliable, stable and valid measure 
(Puhan, et al., 2007; Schünemann, Puhan, Goldstein, Jaeschke, & Guyatt, 2005). A 
further reason for using the self-administered version of the Chronic Respiratory 
Questionnaire (CRQ-SAS) was that it contained identical questions for all respondents 
and not individualised question as the original CRQ. The CRQ-SAS was standardised 
through inclusion of five identical questions regarding dyspnoea.  
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Despite the CRQ-SAS containing a section to assess emotional function, a more 
specific questionnaire was used to measure patients’ mental status, the Hospital 
Anxiety and Depression Scale (HADS) (see Appendix D4). There is evidence that 
patients who suffer from or are at risk of developing anxiety or depression may 
experience a greater degree of dyspnoea (Janssen et al., 2010), an increased 
likelihood of exacerbations (Laurin et al., 2012) and poorer pulmonary rehabilitation 
outcomes (von Leupoldt et al., 2011). The Hospital Anxiety and Depression Scale 
(Zigmond & Snaith, 1983) is an measures the risk for developing depression and 
anxiety in the medical out-patient clinic setting. It consists of two scales each of which 
contains 7 items one assessing anxiety risk and the other depression risk.  The HADS 
is a reliable and effective self-administered instrument. However, it is emphasised that 
it should be employed for screening purposes and not for classification or diagnosis of 
psychiatric conditions (Cameron, Crawford, Lawton, & Reid, 2008; Mykletun, Stordal, & 
Dahl, 2001). The HADS was deemed appropriate for inclusion in the study due to its 
ability to assess risk of anxiety and depression in chronic illness populations in primary 
care settings (Bjelland, Dahl, Haug, & Neckelmann, 2002; Snaith, 2003). 
 
e. Social capital 
 
The role of social capital in relation to health and socio-economic status was outlined in 
Chapter Two. A questionnaire on social capital (Bullen & Onyx, 1998) was included in 
the measures in order to examine the role of social capital in the relationship between 
SES and health care access and quality of life in COPD (see Appendix D8). This 
questionnaire is a 50-item instrument that contains questions relevant to aspects of 
social capital such as citizenship, 'neighbourliness', social networks, civic participation 
as well as patterns and intensity of networks among people and the shared values 
which arise from these networks.  
 
f. Illness perceptions 
 
Illness perceptions were assessed with the Illness Perceptions Questionnaire-Revised 
(IPQ-R) (Moss-Morris et al., 2002) (see Appendix D6). The IPQ-R measures the eight 
components of illness perceptions: (1) identity, (2) consequences, (3) timeline, (4) 
control/cure, (5) cause, (6) cyclical timeline perceptions (7) illness coherence beliefs 
(patients’ understanding of their condition) and (8) emotional representations (patients’ 
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emotional responses to their illness). The IPQ-R is a reliable and robust instrument 
used in a variety of medical conditions such as vitiligo (Papadopoulos, Bor, Walker, & 
Legg, 2001), coronary artery disease (CAD) (Hirani, Pugsley, & Newman, 2006), 
cervical screening (Hagger and Orbell, 2005), cancer (Giannousi, Manaras, 
Georgoulias, & Samonis, 2010). An adjusted version of the IPQ-R (Moss-Morris et al., 
2002) adapted to COPD (Scharloo et al., 2007) was used in the current study in order 
to address COPD patients’ particular illness perceptions. Psychometric instruments 
have been widely used in patients with COPD with good internal consistency, test-
retest reliability and construct validity (Moorer, Suurmeijer, Foets, & Molenaar, 2001; 
Metzemaekers, Berkhof, Uil, & van den Berg, 2012; Pokrzywinski, Meads, McKenna, 
Glendenning, & Revicki, 2009). The IPQ-R measures the cognitive and emotional 
adjustment to chronic illness. Therefore, its application to the present population was 




Previous research suggested that self-efficacy mediated the relationship between 
pulmonary function and symptoms with quality of life and that it was linked to improved 
health status and quality of life in patients with COPD (Kohler et al., 2002; Bentsen et 
al., 2010). A detailed overview of self-efficacy was provided in Chapter Three.  
The Generalised Self-Efficacy Scale (GSE) (see Appendix D7) was employed to 
measure patients’ perceived self-efficacy level. The GSE (Schwarzer and Jerusalem, 
1993) is a 10-item scale designed to assess optimistic self-beliefs used to cope with a 
variety of demands in life. The scaled score for each question ranges from 1 to 4. 
Higher scores indicate stronger self-efficacy. The GSE has high reliability, stability, and 
construct validity (Leganger, Kraft, & Ysamb, 2000). 
 
6.2.5 Sample size and power calculations 
 
A power calculation based on multiple regression analysis time aiming for 90% power 
to detect an R-squared of 0.1 was conducted. The adjusted sample size required to 
achieve this was 174 COPD patients. Given an anticipated response rate of 25-30% as 
well as a misdiagnosis rate of 27-29% (Jones et al. 2008), 1,104 patients were sent 
letters inviting them to participate. In addition, multiple regression analysis included up 
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to 10 independent variables with a significance level of 0.05. The variables tested were 
adjusted for additional 5 independent variables with the same R-squared, meaning that 
5 further variables such as more dimensions of the illness perceptions or of social 
capital could be included in the analyses in order to examine more potential 
relationships without losing reliability. 
 
6.3 Analysis plan 
 
The analysis plan consisted of two phases. The first phase involved examining (a) 
frequencies of all the variables included in this study and (b) associations between SES 
and HCA and SES and QoL. The second phase involved examination of the 
psychosocial variables – illness perceptions, self-efficacy and social capital – as 
mediators in the statistically significant relationships that would be found between SES 
and HCA and SES and QoL. These two phases and the statical tests employed will be 
discussed in more detail in the following sections. 
 
6.3.1 Frequency assessment of key variables and relationship between SES and HCA 
and SES and QoL 
 
Frequencies and make comparisons between the measures examined – socio-
economic status, illness perceptions, COPD severity, age, gender, ethnicity, health 
care access and quality of life will be assessed. To compare differences in HCA and 
QOL according to severity of COPD T-tests, Pearson’s and Spearman’s correlations, 
ANOVA and ANCOVA were conducted. Differences in HCA and QoL according to 
illness perceptions, self-efficacy and social capital were also assessed with the tets 
mentioned above. In all analyses, disease severity was adjusted for. 
The main question was to assess whether lower SES predicted lower HCA, multiple 
logistic regression was used, whereas for poorer QoL multiple linear regression was 
the statistical test of choice. Linear regression was applied where the dependent 
variable was continuous, while logistic regression was used where the dependent 
variable was dichotomous – in this case QoL and HCA respectively. Finally, to examine 
whether lower SES, lower HCA and poorer QoL were associated with more negative 
illness perceptions, lower self-efficacy and social capital in COPD regression analyses 
were conducted. The relationship between SES, HCA, QoL and illness perceptions, 
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social capital, and self-efficacy were also assessed using Pearson’s correlations and 
Spearman’s rho.  
 
6.3.2 Exploring the role of psychosocial variables as possible mediators in the 
relationships between SES and HCA and SES and QOL  
 
The subsidiary question addressed in the present study was to explore the role of 
psychosocial variables – illness perceptions, self-efficacy and social capital – as 
possible mediators in the relationship between SES and HCA and SES and QOL. 
When the aim of the research is to acquire information on possible underlying 
mechanisms between variables rather than establishing the existence of an effect, 
mediation analysis is used. Mediation refers to the process in which the extent of the 
influence of an independent variable (IV) X on a dependent variable (Oswald & Medvei) 
Y through one or more mediator variables (M) is examined. For instance, self-esteem 
(X) has an impact on academic performance (Y) through the motivation to study (M). 
This could suggest that higher self-esteem would be associated with greater motivation 
to study which in turn would be related to better academic performance or vice versa 
depending on the direction and strength of the relationships between variables. In 
mediation, the IV and the mediator are correlated and so are the IV and the DV. This 
suggests that X causes Y through influencing M which causes the latter indicating the 
existence of a causal pathway that provides a link between these three variables. If M 
is causally located between X and Y and can explain their relationship (at least 
partially), then it is said that M mediates the relationship (Rozeboom, 1956). 
Alternatively, it can also be said that X has an indirect effect on Y through M. The 
mediator M can explain the way an observed effect occurred (Hoyle & Robinson, 
2004). 
 
a. Mediation, direct, and indirect effects 
 
The most basic mediation model is the simple mediation model.  As described above, 
simple mediation reflects a causal process where X is assumed to impact Y. Path c is 
termed the total effect of X on Y and quantifies this effect (see Figure 6.2). The causal 
effect of the IV on the mediator M is represented by path a (see Figure 6.3). The causal 
effect exerted on the DV by the mediator – controlling for the IV – is represented by 
207 
 
path b. Path c’ depicts the causal effect of the IV – when controlling for the mediator M 
– on the DV. Thus, c’ represents the direct effect of X on Y (see Figure 6.3). 
 
      c 
                                                              
_____________________________________________________________________ 




                                                      a                                      b 
  
  c’  
____________________________________________________________________________ 
Figure 6.3 A simple mediation model depicting the causal and direct effect paths 
  
 
The direct effect c’ is different from the total effect c because the total effect is partialled 
out by the direct effect through removing the part of the causal effect that is shared with 
M. In other words, the direct effect c’ represents only the X part of the causal effect on 
Y. Similarly, a direct effect is also represented by path b but describes the part of the 
causal relationship between the mediator and the DV. Through these models, it can be 
shown that the total effect of X on Y equals the sum of the direct and indirect effects 
 
c=c’ + ab (1) 
 
Moreover, the difference between the total and the direct effects of X on Y equals the 
indirect effect  




 X  Y 
 M 
 X  Y 
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b. Multiple mediation 
Simple mediation models are not sufficient when examining the effect of variables 
through multiple mediators. In this case, multiple mediation analysis is employed 
(Preacher & Hayes, 2008). A single-step multiple mediator model (see Figure 6.4) is 
composed of several mediators but none of these mediators affects the other.  In order 
to get from X to Y only one step is required through only one mediator. There are three 
types of effects in a multiple mediation model: (a) direct effects, (b) specific indirect 
effects and (c) total indirect effects.  
Path c’ represents the direct effect of X on Y and path b represents the direct effects of 
M on Y. The specific indirect effect of X on Y through the mediator j is defined as the 
result of the two unstandardised paths connecting X to Y through that mediator. For 
instance, the specific indirect effect of X on Y via M is quantified as a1b1. The sum of 
the specific indirect effects, Σi(aibi), i=1 to j is called the total indirect effect where j 
represents the number of proposed mediators. The direct effect of X on Y and the j 
specific indirect effects sum up to the total effect of X on Y or c=c’ + Σi(aibi), i=1 to j 
(see Figure 6.4). 
Multiple mediation analysis enables two actions: (a) to assess the existence and 
strength of the total indirect effect via the proposed mediators and (b) to assess the 
existence and strength of the specific indirect effects via individual mediators. 
     
            a1      b1 
 
a2              b2 
                c’ 
 
aj-1          bj - 1 
 
   aj            bj    




Figure 6.4 A single-step multiple mediators model depicting the direct, indirect and total effects 
(taken from Preacher & Hayes, 2008) 
 
c. PROCESS 
Multiple mediation analysis was employed using PROCESS which can be used for 









study, QOL and HCA respectively. It can also provide direct and indirect effects and 
can control for covariates such as disease severity in a variety of mediation models 
with one or more mediators. Bias corrected and percentile based bootstrap confidence 
intervals for conditional and unconditional indirect effects in mediation models are also 
available. Bootstrapping is a method used for estimating confidence intervals while 
making only very limited assumptions about the probability distribution that provided 
the data (Kirkwood & Sterne, 2003)  The process relies on the assumption that the way 
the data were sampled from the population can be mimicked by taking repeated 
samples from the data. These samples can then be used to estimate standard errors 
and confidence intervals. The new samples are drawn with replacement from the 
original data. This involves selecting an observation at random from the original data 
and recording its value. Another observation is then selected at random from the same 
original data, regardless of which observation as selected first. This is repeated until a 
new dataset of the same size as the original is obtained. The samples are different 
from each other because some of the original observations are selected more than 
once whereas others are not selected at all. Bootstrapping involves fitting a regression 
model for the effect of a predictor variable on a predicted variable, controlling for a 
number of other variables and deriving a bootstrap confidence interval by repeating this 
regression on 1000 different bootstrap samples and recording the value of the 
regression coefficient estimated in each. The simplest way to obtain a 95% confidence 
interval for the difference between medians is the percentile method where the range 
within which 95% of these bootstrap differences lie is selected. The range extends from 
the 2.5th percentile to the 97.5th percentile of this distribution. Because the percentile 
method is not the most accurate method for estimating bootstrap confidence intervals, 
(a) bias corrected and (b) bias corrected and accelerated intervals have been 
developed of which the latter have been found to have the best properties. In the 
present analyses, bias corrected and accelerated confidence intervals were derived 
and a bootstrap sample of 5000 was set in order to increase accuracy of confidence 
intervals. One of the advantages of PROCESS compared to previous multiple 
mediation analysis models is that it provides the possibility to use multiple mediator 
variables in the model either in parallel (up to 10 mediators) or in sequence (up to 4 
mediators linked together). In addition, using PROCESS, covariates such as gender, 
age or demographics can also be adjusted for in mediation. This can provide 
information on associations between mediator(s) and the dependent variables that are 





Results I: Participant characteristics: demographics, health care access, 
quality of life, illness perceptions, social capital and self-efficacy  
 
7.1 Practices used in participant recruiting 
 
11 GP practices from the London Boroughs of Lambeth and Southwark were recruited. 
Characteristics of the practices, recruiting process and rates, and comparison of 
deprivation scores are presented in Table 7.1. The total number of participants 
decreased from 207 to 176 after spirometry assessment confirming diagnosis of COPD 
in 85% of participants indicating a misdiagnosis rate of approximately 15% (see Tables 
7.1 and 7.2). 
Table 7.1 GP practice characteristics and descriptive statistics 






 List Size 
Participants 
GP Practice 1 53.05 10,087 109 27 
GP Practice 2 16.87 6,934 50 14 
GP Practice 3 37.51 10,611 163 25 
GP Practice 4 31.92 8,645 129 28 
GP Practice 5 39.71 9,712 122 27 
GP Practice 6 38.06 10,500 130 14 
GP Practice 7 46.8 7,298 92 17 
GP Practice 8 41.87 10,079 70 8 
GP Practice 9 24.66 14,304 104 15 
GP Practice 10 22.6 6,637 43 6 
GP Practice 11 20.43 18,370 135 26 
Participation Descriptive Statistics 
Total number of invitation letters sent 1,104 
Total number of participating patients                                     286    (response rate ~26%) 
Total number of patients interviewed 207 
Total number of patients with COPD 
from the interviewed participants 176 
COPD misdiagnosis rate ~15% 
IMD Score Means and Comparisons 
Mean IMD Score Southwark 29.97 
Mean IMD Score Lambeth 31.15 
Mean IMD Score Southwark & 
Lambeth 30.56  
Mean IMD Score London  25.24 






7.2.1 Patient demographic characteristics 
Demographic details including participant income level, educational attainment, 
occupational class and IMD scores were collected and are presented in Table 7.2.  
Table 7.2 Patient Demographic Characteristics 
_____________________________________________________________________________ 
Total number of participants   N=176 
 
Gender      Males        n= 108 (61.4%) 
Females    n=68   (38.6%) 
 
Age (years)     Range   42 – 94        Mean=69 (SD: 11) 
 
Ethnicity                   White British                              78.4% 
              White Other                             11.4% 
            Black Caribbean                           6.8% 
            Black African                                1.7% 
            Other                                        1.7% 
 
Educational Level                  No formal education                               1.1% 
            Primary School                         3.4% 
            Secondary School                      71.6%    
      3
rd
 Level Certificate/Diploma        11.9%        
University Degree                          6.8% 
                            Postgraduate Qualification          5.1%                     
 
Household income level per week                          Income level 1 (£0-244pw)     44.3%                                                                                    
(based on national quintiles of      Income level 2 (£245-339pw)        29% 
household income per week)                       Income level 3 (£340-451pw)       9.1% 
              Income level 4 (£452-625pw)            6.3% 
      Income level 5 (£626+pw)                  11.4% 
 
Occupational Status     Retired                                     70.5% 
Unable to work due to illness        16.5% 
Unemployed                                   2.3% 
                      In paid work (FT/PT)                      10.8% 
 
Occupational Position (last job held)  Manager                                          10.4% 
Foreman/Supervisor                       25.4% 
Employee                                        45.1% 
Self-employed                                19.1% 
 
Living Arrangements     Living alone               39.8% 
Living with partner                   30.7%            
Living with children                             8% 
Living with partner and children      7.4%     
Extended/blended family            10.2% 
(e.g. living with children's family)  
Living with friends                   2.3% 
Other (e.g. sheltered housing)        1.7% 
 
Marital Status      Married/living with a partner               42% 
Divorced/separated                        17.6% 
Widowed                          21.6% 
Single                             18.8% 
 




In order to acquire more details on the pattern of the relationship between age and the 
distribution of participant SES characteristics, a sub-analysis was conducted. Mean 
ages of participants in each socio-economic status subcategory of education, 
occupational class, weekly household income and IMD score are presented in Table 
7.3. Due to limited numbers of participants in certain SES sub-categories, levels were 
merged into new groups with the aim to increase power in the main analyses to follow. 
For instance, income levels 2 and 3 formed income level group 2. Income levels 4 and 
5 were merged into income level group 3 representing the least deprived group of 
participants. Educational attainment was divided into two levels – pre-secondary and 
post-secondary. Occupational class was classified according to the three-class version 
described in the National Statistics Socio-economic Classification (NS-SEC rebased on 
the SOC2010) (Office for National Statistics, 2010). Ref IMD quintiles 4 and 5 had low 
number of participants and were merged into one group representing the least deprived 
participant group while participant numbers in the rest of the quintile groups were 
sufficient for the main analyses (see Table 7.3). 
 
Table 7.3   Mean ages of participants in each socio-economic status subcategory of education, 
occupational class, weekly household income and IMD score  
       Mean age (SD)        N (Total N=176) 
Income level 
Income level group 1 (level 1 - most deprived)  67.37 (11.23)    78 
Income level group 2 (levels 2 & 3)   72.43 (10.81)    67 
Income level group 3 (levels 4 & 5 - least deprived) 65.42   (8.63)    31 
------------------------------------------------------------------------------------------------------------------------------- 
Educational level 
Pre-secondary     68.95 (11.02)    103 
Post-secondary     68.96 (10.97)      73 
------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 




Class 2      69.16 (11.56)     38 
(intermediate 
occupations 





IMD quintile 1 (most deprived)   67.09 (10.96)     90 
IMD quintile 2      71.03 (10.50)     58 
IMD quintile 3     70.95 (12.01)     21 





7.2.2 Patient physical measures and disease severity characteristics 
 
Details on patient characteristics such as COPD severity grading, MRC breathlessness 
score, FEV1% predicted, oxygen saturation, body mass index, co-morbidities, use of 
COPD medications and smoking history are presented in Table 7.4. 
 
Table 7.4 Patient Physical Characteristics/Disease Severity Frequencies 
_____________________________________________________________________________ 
FEV1% thresholds    Grade 1 (mild)  FEV1 ≥ 80% predicted  
and grades (GOLD)       Grade 2 (moderate) 50% ≤ FEV1 < 80% predicted  
Grade 3 (severe) 30% ≤ FEV1 < 50% predicted  
Grade 4 (very severe) FEV1 < 30% predicted or 
FEV1 < 50% predicted plus 
chronic respiratory failure 
   
 
FEV1% predicted* in the present study   Range: 15-109   Mean=59.3 (SD: 19.7) 
 
GOLD severity grading       1 (mild)                  14.8%    
          2 (moderate)          50.6% 
  3 (severe)              29.5% 
  4 (very severe)        5.1% 
 
Medical Research Council (MRC)         1          6.8% 
Breathlessness score         2      36.9% 
  3        15.9% 
  4         19.3% 
  5                  21% 
 
 
Oxygen saturation      Range: 68-100    Mean=94.9 (SD: 3.7) 
 
Body Mass Index (BMI)    Range: 13.7-52.1   Mean=26.7 (SD: 6) 
 
Co-morbidities      Yes             71% 
                   No                          29% 
 
Use of COPD medications     Yes                96% 
 No                      4% 
Smoking history 
 
Current smokers          34.8% 
Past smokers          60.7% 
Never smokers           4.5% 
*FEV1% predicted is used to classify severity of COPD. A mean FEV1 predicted of 59.3 would be 










Inhaled medication was prescribed to the majority of patients with COPD. Combination 
inhaled long-acting beta-agonists and corticosteroids (abbrev. LABA+ICS) were 
prescribed to the majority of patients although they were only indicated in those with a 
history of asthma and those in Gold Grades 3 (30%) and 4 (5%). Prescriptions for oral 
medication were less frequently reported. Participants were categorised according to 
treatment appropriateness i.e. under-, over- or appropriately treated (White et al., 
2013). Prescription patterns and treatment appropriateness are presented in Table 7.5. 
 
Table 7.5 Prescription Medication Frequencies 
_____________________________________________________________________________ 
                     Inhaled Medication 
_____________________________________________________________________________ 
       Medication Type              Percentage of patients prescribed the drug 
_____________________________________________________________________________ 
Inhaled short-acting beta-agonists (SABA)      80.1% 
Inhaled long-acting beta-agonists (LABA)           8% 
Inhaled short-acting antimuscarinic bronchodilators       6.8% 
(anticholinergic) (SAMA) 
Inhaled long-acting antimuscarinic bronchodilators (LAMA)                  54% 
Inhaled corticosteroids (ICS) and SABA      11.4% 
Inhaled combination long-acting bronchodilators and     60.2% 




Oral corticosteroids          2.8% 
Theophyllins           1.7% 
Mucolytics           3.4% 
Oral antibiotics           4.5% 
Other medications (Montelukast, Singulair® or zafirlukast - Accolate®)    1.1% 




              Total n=176 
 
Appropriately treated      Yes n=85 (48.3%) 
No n=91 (51.7%) 
 
Over-treated        Yes n=62 (35.2%) 
        No n=114 (64.8%) 
 
Under-treated       Yes n=47 (26.7%) 




b. Spirometry assessment, monitoring, referrals, exacerbations and 
hospitalisations 
 
More than half of the participants (57.4%) reported that they had spirometry regular 
(every 3, 6 or 12 months). 15.3% attended the hospital for consultant follow-ups, over 
half of which (9.1%) were carried out bi-annually. The majority of patients were 
monitored by their GP (80.7%) or their nurse (9.7%). 85.8% reported that they had at 
least one exacerbation since being diagnosed with COPD. 28.6% had been admitted to 
hospital with a problem relating to their COPD. Frequencies are presented in Table 7.6. 
Half the participants were aware of the existence of pulmonary rehabilitation (PR) 
courses. The most common source of information about PR was their GPs (21.6%). 
Other sources of information about PR included practice nurses and friends, family, 
internet (see Table 7.6). Fewer than half (39.2%) of all patient interviewed were 
offered/given a referral for pulmonary rehabilitation and 32.4% of those referred 
















Table 7.6 Health Care Access Frequencies 
_____________________________________________________________________________ 
Smoking referral given                     Yes    47.7% 
       No    33.9% 
 
Regular spirometry      Yes    57.4% 
No                42% 
  
Frequency of spirometry     Every 6 months   26.1% 
              Once a year   31.8% 
                                   When necessary                    42% 
 
Hospital referral                   Yes    15.3% 
No                                 84.7% 
 
Frequency of hospital appointments    Every 3 months     1.1% 
Less than 3 months    1.1% 
N/A                               86.9% 
Don’t know     0.6% 
Every 6 months     9.1% 
                                                                                                     Once a year     1.1% 
 
COPD monitored by      GP                 80.7% 
Nurse       9.7% 
                                  Other (hospital,visiting specialist)           4% 
N/A         5.7% 
 
Exacerbations       Yes                    85.8% 
No                              14.2% 
 
Hospital admission in the past 3 months   Yes                  28.6% 
No                  70.3% 
 
Awareness of pulmonary rehabilitation                 Yes                     50% 
      No                          50% 
Informed by GPs            21.6% 
Informed by nurse                       14.2% 
Informed by other (e.g. friends, family, internet)                     12.5% 
Don’t remember                            1.7% 
 
Pulmonary rehabilitation referral     Yes    39.2% 
 No                  60.8% 
 
Pulmonary rehabilitation attendance    Yes                  32.4% 




7.2.4 Participants’ reported quality of life  
 
a. Physical and emotional function 
 
Quality of life was measured with the Chronic Respiratory Questionnaire 
(Standardised) (CRQ-SAS). Scores ranged from 1 (maximum impairment) to 7 (no 
impairment). The mean scores for quality of life (CRQ-SAS) were better in the present 
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sample compared to those reported in Dransfield et al. (2011). In contrast, dyspnoea 
scores were greater in this study in comparison to Dransfield et al. (2011). The means 
for dyspnoea and quality of life domain scores are shown in Table 7.7. The range of 
MRC Dyspnoea scores was 1 (no breathlessness) to 5 (severe breathlessness). For 
quality of life (CRQ-SAS) the range was 1 (more severe disease) to 7 (mild disease). 
Quality of life and MRC Dyspnoea score frequencies are also presented in Table 7.7. 
 
Table 7.7 Quality of life (QoL) descriptive statistics  
_____________________________________________________________________________ 
Chronic Respiratory Questionnaire (CRQ-SAS) 
----------------------------------------------------------------------------------------------------------------------------- ---
Quality of Life (QoL)                 Mean   (SD)              Mean (SE)*         Range 
            (Current sample) 
_____________________________________________________________________________ 
Dyspnoea   5.28    (1.3)   4.6 (0.05)           1-7 
Fatigue    4.10    (1.5)   3.9 (0.05)           1-7 
Emotional Function  4.92    (1.3)  4.5 (0.05)           1-7 
Mastery   5.58    (1.5)   4.8 (0.06)           1-7 
 
MRC Dyspnoea Score               3.11    (1.3)                   1.7 (0.04)                     1-5 
 




b. Risk of depression and anxiety  
 
Participants appeared relatively unaffected by risk of depression and anxiety. Scores 
were classified into: “normal” (0-7), mild (8-10), moderate (11-15) and severe (16-21) 
risk (Snaith & Zigmond, 1994). The few severe cases of depression and anxiety were 
most likely due to pre-existing psychological disturbances as suggested by patients’ 
medical history and report. For example, a number of patients were being treated for 
depression, schizophrenia or bipolar disorder before the emergence of COPD. Some 
patients reported a loss in their family or other personal issues that had a negative 
influence on their psychological state. Mean depression and anxiety scores were within 
the normal range in this group – anxiety M=5.66 (SD=4.4) (normal range 0-7) and 
depression M=4.25 (SD=3.9) (normal range 0-7). Anxiety and depression scores from 
the current study were compared with scores from previous studies (Withers et al., 
1999; Von Leupoldt et al., 2011). Depression and anxiety frequencies and means are 
presented in Table 7.8. 
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Table 7.8 Depression and anxiety frequencies and means 
____________________________________________________________________________ 
  Frequency (n=176)    Percentage 
----------------------------------------------------------------------------------------------------------------------------- -- 
Anxiety risk (as defined by Snaith & Zigmond, 1994) 
 
Normal                124         70.5% 
Mild      22         12.5% 
Moderate     24         13.6% 
Severe        6          3.4% 
____________________________________________________________________________ 
 
Depression risk (as defined by Snaith & Zigmond, 1994) 
 
Normal      147        83.5% 
Mild       15         8.5% 
Moderate       8         4.5% 
Severe        6         3.4% 
----------------------------------------------------------------------------------------------------------------------------- -- 
Mean   (SD)       Range 
-------------------------------------------------------------------------------------------------------------------------------  
 
Anxiety (current sample)    5.66    (4.4)        0-20 
Depression (current sample)    4.25    (3.9)          0-16 
 
Anxiety*      7.1      (4.4) 
Depression*      5.8      (3.1) 
____________________________________________________________________________ 
 
       Pre-PR       Post-PR 
____________________________________________________________________________ 
 
Anxiety**      6.9 (4.2)        6.2(4.1) 
Depression**      6.0 (3.8)       5.6(3.8)
  
*in patients with severe COPD (Withers et al., 1999) **in patients with moderate COPD (mean FEV1 
pred.=53.9%) (von Leupoldt et al., 2011) 
 
 
7.2.5 Illness perceptions 
 
Higher scores on identity, timeline, consequences, and timeline cyclical – compared to 
the remaining illness perceptions – reflected strong perceptions about the number of 
symptoms related to COPD, the chronic nature of the condition, its negative 
consequences on everyday life, and its cyclical nature (Scharloo, 2007). Higher scores 
on the dimensions of personal control, treatment control and illness coherence 
reflected positive beliefs about the degree of control over the illness and a personal 
understanding of COPD (Moss-Morris et al., 2002).  The strongest illness perceptions 
within the data collected were related to the duration of their illness (i.e. timeline) and 
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the degree of personal control they felt they had over their COPD. Details are 
presented in Table 7.9.  
Illness perceptions of the current patient group were compared with data from COPD 
patient groups from other studies. They were similar to those of Scharloo et al. (2007). 
However, participants in the present study had weaker identity, consequences, timeline 
cyclical, timeline chronic, and personal control beliefs but stronger treatment control 
and emotional representations compared to Scharloo et al.’s (2007) participants (see 
Table 7.9). 
 
Table 7.9 Illness perceptions descriptive statistics 
_____________________________________________________________________________ 
Illness Perceptions Questionnaire-Revised (IPQ-R) 
----------------------------------------------------------------------------------------------------------------------------- --- 
Illness perception dimension  Mean   (SD)*    Range  Mean   (SD)**    
     n= 176          n=171 
_____________________________________________________________________________ 
 
Identity     3.74    (2.3)         0-11    5.62  (2.9)      
Consequences   17.24   (4.2)        7-28  19.25  (6.1)      
Timeline Cyclical  11.50   (3.2)      4-20  12.13  (4.9)      
Timeline Chronic  22.99   (3.9)      8-30  26.66  (4.4)      
Personal Control  20.70   (4.3)     12-29  22.44  (5.9)   
Treatment Control  16.15   (2.4)     6-24  14.29  (3.7)      
Emotional Representations 15.40   (4.3)      6-30  14.13  (7.0)      
Illness Coherence  18.31   (3.4)     10-25  ----------- 
    
*Means and SD for illness perception in the present study; ** Means and SD for illness perception in 
Scharloo et al. (2007) 
 
Participants also reported on the factors they perceived to be responsible for their 
COPD. The majority of participants cited smoking as their main perceived cause of 
their COPD. Pollution and ageing ranked second and third respectively (see Table 
7.10) 
Table 7.10 Participants’ perceived causes of COPD 
_____________________________________________________________________________ 
Perceived Causes of COPD         Percentage of patients 
____________________________________________________________________________ 
 
Smoking           59.1% 
Pollution           10.8% 




7.2.6 Social capital 
 
Social capital scores ranged from 1 (low social capital) to 4 (high social capital) 
according to the range reported by Bullen and Onyx (2000). As a reference for 
comparison, means for social capital from (O’Brien, Burdsal, & Molgaard, 2004) who 
collected data in a metropolitan community in Midwestern United States are provided 
(see Table 7.11). 
Work connections was the dimension of social capital reported with the highest mean 
score at 3.0 out of 4. However, this dimension was non-applicable for the majority of 
participants because they were either retired or unemployed. Participation in the local 
community was the dimension of social capital reported with the lowest mean score at 
1.41 out of 4. The mean scores of all the social capital dimensions are presented in 
Table 7.11.  
 
Table 7.11 Social capital descriptive statistics 
__________________________________________________________________________ 
Social capital dimension              Present Sample           Midwestern US* 
                      Mean (SD)          Mean (SD)            
-----------------------------------------------------------------------------------------------------------------------------  
Participation in Local Community     1.41    (0.66)           2.24 (1.44) 
Social Agency/Social Proactivity      2.95    (0.61)        3.38 (0.88) 
Feelings of Trust and Safety        2.43    (0.72)        3.00 (0.94) 
Neighbourhood Connections      2.65    (0.78)            2.92 (1.02) 
Family and Friends Connections     2.66    (0.68)         3.03 (1.00) 
Tolerance of Diversity       2.91    (0.72)          3.37 (0.87) 
Value of Life        2.79    (0.88)          3.15   (0.90) 
Work Connections       3.00    (1.05)          3.63   (0.70) 






Self-efficacy was measured with the General Self-efficacy Scale. Scores range from 1 
(lowest) to 4 (highest). Patients’ means in the current results were relative high 
compared to means reported in previous studies (Schwarzer 1992; 1999). Details are 




Table 7.12 Self-efficacy descriptive statistics  
___________________________________________________________________________ 
Mean   (SD)    Range 
----------------------------------------------------------------------------------------------------------------------------- 
General Self-Efficacy (current sample)   3.29    (5.9)       1-4 
Great Britain*        2.92    (4.8)      1-4 
Self-efficacy score in 14 countries**    2.86    (6.2)      1-4 
*based on arthritis patients with mean age 60 years (Schwarzer, 1992) ** based on a study by Ralf 




COPD patients in this study were compared with other populations and patient groups 
in terms of SES, illness perceptions, self-efficacy, social capital, and quality of life. The 
participants in this study lived in more deprived areas when the IMD score of their 
locality was compared with the mean Index of Multiple Deprivation (IMD) in London and 
in England. They also held more positive illness perceptions and had stronger self-
efficacy compared to other patient groups. Social capital in the present study was lower 
compared with reported means of the general population observed in Australia in 2000 
(Bullen & Onyx, 2000).  
Quality of life was better in comparison to other COPD patient groups reported in 
earlier studies. COPD patients in the present research reported lower dyspnoea, 
fatigue, better emotional function and greater perceived mastery for a comparable level 
of FEV1. Perceived breathlessness was higher compared to previous studies.  
To sum up, although participants SES appeared to be more deprived, their physical 














8.1 Introduction and overview of the chapter 
 
The results presented in this chapter follow a sequence starting from the two 
hypotheses outlined below. Following the hypotheses, associations between the 
variables examined in this thesis – SES, HCA, QoL, disease severity and the 
psychosocial variables (illness perceptions, self-efficacy and social capital) – are 
examined and findings are highlighted. The next section focuses on examination of the 
relationship between SES and HCA and SES and QoL in COPD. The final part of the 
chapter aimed to explore whether psychosocial variables (illness perceptions, self-
efficacy and social capital) mediated the statistically significant relationships found 
between SES and HCA and SES and QoL. An overview of the results and a summary 
is provided at the end of the chapter. Diagrams are also presented as a visual 
representation of the findings due to the many associations found. 
The hypotheses were as follows: 
 Was lower socio-economic status associated with more impaired access to 
health care access in terms of smoking cessation referral? 
 Was lower socio-economic status associated with poorer quality of life in terms 
of perceived dyspnoea, fatigue, emotional function and mastery in patients with 
COPD?  
The primary outcomes of this study were: (a) smoking cessation referral rates in terms 
of HCA – referring to the first hypothesis outlined above and (b) perceived dyspnoea, 
fatigue, emotional function, mastery, quality of life in terms of QoL – referring to the 
second hypothesis outlined above. The secondary outcomes of this study included: (a) 
pulmonary rehabilitation awareness, referral, attendance and completion, consultant 
referral, regular spirometry, prescription patterns and hospital admissions in terms of 
HCA which refer to the first hypothesis stated above and (b) Hospital Anxiety and 
Depression Scale (HADS) in terms of QoL which refer to the second hypothesis stated 
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above. The role of psycho-social variables i.e. illness perceptions, self-efficacy and 
social capital as mediators in these relationships was also examined. 
 
8.2 Associations between disease severity and health care access, quality of life, 
illness perceptions, self-efficacy, social capital and SES measures 
 
The evidence outlined in Chapters Two and Three suggests that severity of COPD 
might be associated with HCA and QoL in COPD. COPD is linked to lower SES due to 
higher deprivation being associated with higher incidence, prevalence and morbidity of 
the disease. Thus, disease severity could be a confounder in the relationship between 
SES and HCA and SES and QoL in COPD. Preliminary analyses were conducted to 
examine whether disease severity was related to SES, HCA and QoL (Pearson’s and 
Spearman’s correlations and independent T-tests). In addition, all analyses were 
adjusted in order to eliminate any likelihood of residual confounding effects of disease 
severity. 
 
a. Disease severity and health care access (HCA) variables 
 
Patients’ access to healthcare was not significantly associated with disease severity as 
defined by FEV1% predicted except with respect to pulmonary rehabilitation 
awareness, pulmonary rehabilitation referral and over-treatment. Participants who had 
more severe COPD were more likely to have been aware of PR and more likely to have 
been referred for PR. Patients with less severe COPD were more likely to have been 
over-treated. No other HCA variables were significantly associated with disease 
severity (Table 8.1). 
 
b. Disease severity and quality of life 
 
Patients’ quality of life was not significantly associated with disease severity in terms of 
lung function (FEV1% predicted). Correlations between disease severity and QoL are 




c. Disease severity and illness perceptions, self-efficacy and social capital 
 
Patients’ illness perceptions, self-efficacy and social capital were not significantly 
associated with disease severity with the exception of one illness perception dimension 
– timeline cyclical (r= 0.15, p=0.04). However, this correlation was very weak. 
Participants who had more severe COPD, perceived their illness to be following a 
cyclical course alternating between times of stability of symptoms and exacerbations. 
No other illness perceptions or social capital elements were significantly associated 
with disease severity (see Table 8.3).  
 
d. Disease severity and SES measures 




Table 8.1 Differences in disease severity in terms of HCA (independent t-tests) 
Health Care Access  
No  
mean (M) FEV1% pred & (SD) 
Yes  
mean (M) FEV1% pred & (SD) t (n) and p values 
Smoking cessation referral M= 56.00  (SD= 21.57) M= 60.60  (SD= 18.53) t(140)=1.37, p=0.17 
Hospital referral M= 59.27  (SD= 19.55) M= 59.44  (SD= 20.88) t(174)=0.04, p=0.97 
Regular spirometry M= 57.87  (SD= 21.07) M= 60.36  (SD= 18.64) t(174)=0.83, p=0.41 
PR awareness M= 62.28  (SD= 18.14) M= 56.31  (SD= 20.81) t(174)=-2.03, p=0.04 
PR referral M= 62.76  (SD= 19.11) M= 53.93  (SD= 19.51) t(174)=-2.97, p=0.003 
PR attendance M= 57.31  (SD= 16.73) M= 53.42  (SD= 20.09) t(68)=-0.65, p=0.52 
PR completion M= 52.73  (SD= 10.95) M= 53.67  (SD= 22.58) t(55)=0.15, p=0.88 
Hospital admission M= 59.86  (SD= 19.45) M= 57.88  (SD= 20.43) t(174)=-0.60, p=0.55 
Under-treatment M= 59.92  (SD= 19.45) M= 57.57  (SD= 20.46) t(174)=-0.70, p=0.49 
Appropriate treatment M= 57.08  (SD= 19.68) M= 61.67  (SD= 19.55) t(174)=1.55, p=0.12 
Over-treatment M= 53.79  (SD= 20.04) M= 69.42  (SD= 14.42) t(174)=5.42, p<0.001 
 
Table 8.2 Correlations between disease severity (as defined by FEV1 pred.) and quality of life (Pearson’s correlations) 
  
Dyspnoea Fatigue Emotional Function Mastery Anxiety Depression 
 
 
FEV1 % Predicted 
 




Table 8.3 Correlations between illness perceptions, self-efficacy, social capital and disease 
severity (Pearson’s correlations) 

























r= -0.10; p=0.18 
 









r= 0.02; p=0.78 
Social Capital 
 
Participation in Local Community 
 
r= 0.03; p=0.67 
 
Social Agency/Social Proactivity r= 0.03; p=0.75 
 
Feelings of Trust & Safety r= 0.09; p=0.25 
 
Neighbourhood Connections r= 0.02; p=0.81 
 
Family & Friends Connections r= -0.04; p=0.57 
 
Tolerance of Diversity r= -0.06; p=0.41 
 




r= -0.11; p=0.66 
 
Table 8.4 Correlations between disease severity and SES measures (IMD scores and 
quintiles, income level, educational level and occupational class) – Pearson’s and Spearman’s 
correlations 
SES Measures Disease severity (FEV1% predicted) 
IMD scores r=-0.13; p=0.10 
IMD quintiles ρ=0.008; p=0.30 
Income level ρ=0.06; p=0.46 
Educational level ρ=0.06; p=0.44 
Occupational class ρ=0.003; p=0.97 
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8.3 Associations between individual SES measures 
 
Different measures of SES (income level, educational level, occupational class and 
IMD score) were used in this study in order to capture as many aspects of socio-
economic deprivation as possible. While there would be some overlap between what 
these SES measured, correlations were conducted to check for collinearity. Income 
level showed weak correlations with IMD scores and quintiles and a moderate 
correlation with educational level. Occupational class was not significantly correlated to 
any of the SES measures (see Table 8.5). Significant relationships between SES and 
HCA and QoL could be confounded by age. Therefore, differences in participant age 
were compared between levels of severity of the categories of SES measures. Mean 
age did not differ significantly according to SES except for income level where mean 






























  p=0.01 
-0.007;   
p=0.92 






































Table 8.6 Differences in age between levels of severity in each of the categories of SES 
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8.4 Associations between SES and Health Care Access  
 
Lower SES (in terms of IMD score) was significantly associated with the primary HCA 
outcome (smoking cessation referrals) when adjusting for disease severity (see Table 
8.7a). Lower SES in terms of educational attainment was significantly associated with 
one of the secondary HCA outcomes (regular spirometry) (see Table 8.7c) when 
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adjusting for disease severity. The relationship was not uniformly across all SES 
measures. SES in terms of income level and occupational class was not significantly 
associated with any primary or secondary HCA outcome. The remaining secondary 
measures were not significantly associated with any form of SES (income level, 
educational level, occupational class, IMD score) (see Tables 8.7b and 8.7d-8.7k). 









Variable     Odds Ratio Adjusted Odds Ratio   95% CI   Adjusted 95% CI            P value       Adjusted P Value 
 
 
IMD Quintile 1*    1  1       0.06  0.06 
IMD Quintile 2   0.44  0.43  0.21, 0.95      0.20, 0.93  0.04  0.03 
MD  Quintile 3   0.29  0.29  0.11, 0.85      0.01, 0.85  0.02  0.02 
IMD Quintile 4 (4+5)   0.92  0.84  0.16, 5.39      0.14, 4.98  0.92  0.85 
------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------- 
IMD scores    1.05  1.05  1.01, 1.08      1.02, 1.08  0.006  0.004 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*    1  1       0.001  0.001 
Income Level 2 (2+3)   0.23  0.21  0.10, 0.51      0.09, 0.48  0.000  0.000 
Income Level 3 (4+5)   0.33  0.32  0.13, 0.85      0.12, 0.85  0.02  0.02 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level (comp. to lowest) 0.6  0.58  0.30, 1.18      0.29, 1.15  0.14  0.12 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*   1  1       0.52  0.52 
Occupational Class 1   1.60  1.56  0.68, 3.75      0.66, 3.68  0.28  0.31 
Occupational Class 2   1.33  1.41  0.57, 3.09      0.60, 3.34  0.52  0.43 













Variable      Odds Ratio Adjusted Odds Ratio              95% CI   Adjusted 95% CI           P value  Adjusted P Value 
 
 
IMD Quintile 1*   1  1        0.54  0.54 
IMD Quintile 2   1.68  1.68   0.68, 4.19      0.68, 4.19  0.26  0.26 
IMD Quintile 3   1.20  1.20   0.30, 4.74      0.30, 4.75  0.80  0.80 
IMD Quintile 4 (4+5)   2.87  2.89   0.50, 16.65      0.50, 16.91  0.24  0.24 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores     0.98  0.98   0.94, 1.01      0.94, 1.01  0.21  0.2 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*   1  1        0.64  0.64 
Income Level 2 (2+3)   0.98  0.98   0.41, 2.37          0.41, 2.37  0.97  0.97 
Income Level 3 (4+5)   0.54  0.54   0.14, 2.03      0.14, 2.03  0.36  0.36 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level (comp. to lowest) 1.15  1.15   0.51, 2.64      0.50, 2.64  0.73  0.74 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*   1  1        0.79               0.79 
Occupational Class 1   0.82  0.82   0.28, 2.44           0.28, 2.44  0.73   0.72 








Table 8.7c Relationship between SES and HCA (Regular Spirometry) – unadjusted and adjusted for disease severity (logistic regression) 
 
 
Regular Spirometry  
  
 
Variable     Odds Ratio        Adjusted Odds Ratio          95% CI Adjusted 95% CI            P value    Adjusted P Value 
 
 
IMD Quintile 1                        1         1       0.66  0.62 
IMD Quintile 2                        1.20         1.22   0.62, 2.35      0.62, 2.39  0.59  0.56 
IMD Quintile 3                        0.72         0.73   0.26, 1.95      0.27, 1.98  0.51  0.53 
IMD Quintile 4 (4+5)               1.91         2.06   0.40, 9.04      0.43, 9.82  0.42  0.37 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores                             1         1                                         0.98, 1.03         0.98, 1.03  0.88  0.79 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*                      1         1        0.27  0.24 
Income Level 2 (2+3)              1.49         1.53   0.76, 2.91      0.78, 3.01  0.25  0.21 
Income Level 3 (4+5)              1.91         1.93   0.82, 4.42      0.83, 4.50  0.13  0.13 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level                  0.43         0.42   0.23, 0.79      0.22, 0.77  0.006  0.005 
(refer. lowest)  
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 1              1         1        0.54  0.53 
Occupational Class 2              0.74         0.76   0.35, 1.57      0.35, 1.62  0.43  0.47 







Table 8.7d Relationship between SES and HCA (Pulmonary Rehabilitation Awareness) – unadjusted and adjusted for disease severity (logistic regression) 
 
 
Pulmonary Rehabilitation Awareness 
 
 
Variable    Odds Ratio Adjusted Odds Ratio           95% CI   Adjusted 95% CI            P value  Adjusted P Value 
 
 
IMD Quintile 1*         1   1        0.46  0.41 
IMD Quintile 2         1.69   1.78   0.87, 3.30      0.91, 3.51  0.12  0.10 
IMD Quintile 3         1.09   1.12   0.42, 2.81      0.43, 2.95  0.86  0.82 
IMD Quintile 4 (4+5)         0.90   1.02   0.19, 4.24      0.21, 4.91  0.89  0.98 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores               0.99   0.99   0.96, 1.02      0.96, 1.01  0.47  0.32 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*                1   1        0.83  0.89 
Income Level 2 (2+3)                       0.83  0.87   0.43, 1.59      0.45, 1.69  0.56  0.68 
Income Level 3 (4+5)         0.85   0.86   0.37, 1.95      0.37, 1.99  0.69  0.72 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level (comp. to lowest)  0.95  0.99        0.52, 1.74      0.54, 1.82  0.88  0.97 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*                 1   1        0.77  0.63 
Occupational Class 1         0.99   1.04   0.47, 2.08      0.49, 2.22  0.98  0.91 







Table 8.7e Relationship between SES and HCA (Pulmonary Rehabilitation Referral) – unadjusted and adjusted for disease severity (logistic regression) 
 
 
Pulmonary Rehabilitation Referral 
 
 
Variable      Odds Ratio             Adjusted Odds Ratio                 95% CI   Adjusted 95% CI            P value  Adjusted P Value 
 
 
IMD Quintile 1*        1    1        0.88  0.78 
IMD Quintile 2        1.31    1.40   0.67, 2.57      0.70, 2.80  0.43  0.34 
IMD Quintile 3        1.06    1.11   0.40, 2.83      0.41, 3.06  0.90  0.84 
IMD Quintile 4 (4+5)        1.30    1.61   0.27, 6.15      0.33, 7.88  0.75  0.56 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores         0.99    0.99   0.97, 1.02      0.96, 1.02  0.61  0.36 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*        1    1        0.83  0.69  
Income Level 2 (2+3)       1.15    1.27   0.59, 2.24      0.64, 2.52  0.68  0.50 
Income Level 3 (4+5)       0.88    0.89   0.37, 2.09      0.36, 2.16  0.77  0.79 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level               0.85    0.89   0.46, 1.58      0.47, 1.67  0.61  0.7 
(refer. lowest) 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*       1    1        0.43  0.24 
Occupational Class 1       1.32    1.44   0.63, 2.79      0.67, 3.13  0.47  0.35 
Occupational Class 2       0.71    0.62   0.32, 1.57      0.27, 1.42  0.40  0.26 









Pulmonary Rehabilitation Attendance 
 
 
Variable       Odds Ratio               Adjusted Odds Ratio                 95% CI   Adjusted 95% CI            P value  Adjusted P Value 
 
 
IMD Quintile 1*       1    1        0.74  0.59 
IMD Quintile 2       1.40    1.50   0.69, 2.82      0.73, 3.09  0.35  0.27 
IMD Quintile 3       1.23    1.29   0.45, 3.40          0.45, 3.69  0.69  0.63 
IMD Quintile 4 (4+5)       1.85    2.33   0.39, 8.83      0.47, 11.57  0.44  0.30 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores         0.96    0.97   0.91, 1.02       0.92, 1.03  0.22  0.32 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*        1    1        0.74  0.58 
Income Level 2 (2+3)       1.26    1.39   0.63, 2.51      0.68, 2.84  0.52  0.36 
Income Level 3 (4+5)       0.92    0.93   0.37, 2.29      0.36, 2.36  0.86  0.87 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level        1.52    1.55   0.42, 5.54      0.42, 5.69  0.52  0.51 
(refer. lowest) 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*       1    1        0.53  0.33 
Occupational Class 1       1.31    1.42   0.61, 2.83      0.64, 3.15  0.49  0.39 











Pulmonary Rehabilitation Completion 
 
 
Variable        Odds Ratio Adjusted Odds Ratio               95% CI   Adjusted 95% CI            P value Adjusted P Value 
 
 
IMD Quintile 1*  (N=30)      1   1        0.69  0.73 
IMD Quintile 2   (N=23)       1.25   1.28   0.41, 3.86      0.41, 3.99  0.70  0.67 
IMD Quintile 3   (N=7)       4.00   3.61   0.43, 37.55      0.38, 34.45  0.23  0.27 
IMD Quintile 4 (4+5) (N=3)       ------   ------   ---------------      ---------------  ------  ------ 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores           0.97   0.97   0.92, 1.03      0.92, 1.03  0.32  0.33 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*          1   1        0.43  0.46 
Income Level 2 (2+3)          0.55  0.57   0.18, 1.69      0.18, 1.79  0.29  0.34 
Income Level 3 (4+5)         1.40   1.45   0.24, 8.24      0.24, 8.64  0.71  0.68 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level          3.64   3.63   0.89, 4.79      0.89, 14.83  0.07  0.07 
(refer. lowest) 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*         1   1        0.37  0.26 
Occupational Class 1         2.76   3.47   0.67, 11.44      0.77, 15.64  0.16  0.11 


















Variable                 Odds Ratio Adjusted Odds Ratio                 95% CI   Adjusted 95% CI            P value     Adjusted P Value 
 
 
IMD Quintile 1* (N=57)       1   1        0.05  0.05 
IMD Quintile 2 (N=7)           0.37   0.37   0.16, 0.85      0.16, 0.86  0.02  0.02 
IMD Quintile 3 (N=89)       1.61   1.63   0.60, 4.31         0.61, 4.38  0.34  0.33 
IMD Quintile 4 (4+5) (N=20)       0.79   0.82   0.14, 4.30      0.15, 4.49  0.78  0.82 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores         1.01   1   0.98, 1.04      0.97, 1.04  0.75  0.8 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*        1   1        0.07  0.06 
Income Level 2 (2+3)        1.78   1.81   0.87, 3.64      0.89, 3.71  0.11  0.10 
Income Level 3 (4+5)        0.55   0.55   0.19, 1.62      0.19, 1.63  0.28  0.28 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level         0.71   0.72   0.23, 2.18      0.23, 2.23  0.55  0.57 
(refer. lowest) 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*        1   1        0.87  0.88 
Occupational Class 1        0.80   0.81   0.34, 1.85      0.35, 1.88  0.60  0.62 











Variable                Odds Ratio Adjusted Odds Ratio                 95% CI   Adjusted 95% CI            P value  Adjusted P Value 
 
 
IMD Quintile 1*        1   1        0.43  0.47 
IMD Quintile 2        1.37   1.37   0.68, 2.75      0.64, 2.93  0.38  0.42 
IMD Quintile 3        2.18   2.09   0.81, 5.83         0.71, 6.18  0.12  0.18 
IMD Quintile 4 (4+5)        0.87   0.62   0.16, 4.77      0.10, 3.72  0.87  0.60 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores         1.01   1   0.98, 1.04      0.97, 1.04  0.75  0.8 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*        1   1        0.36  0.52 
Income Level 2 (2+3)        1.61   1.49   0.81, 3.22      0.71, 3.13  0.17  0.29 
Income Level 3 (4+5)        1.51   1.50   0.63, 3.61      0.58, 3.91  0.35  0.40 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level         0.71   0.72   0.23, 2.18      0.23, 2.23  0.55  0.57 
(refer. lowest) 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*        1   1        0.42  0.55 
Occupational Class 1        0.90   0.75   0.42, 1.94      0.32, 1.75  0.90  0.51 














Variable                 Odds Ratio Adjusted Odds Ratio                 95% CI   Adjusted 95% CI            P value  Adjusted P Value 
 
 
IMD Quintile 1*        1   1        0.96  0.97 
IMD Quintile 2        1.03   1.02   0.53, 2.01      0.52, 1.98  0.92  0.97 
IMD Quintile 3        0.88   0.85   0.33, 2.32         0.32, 2.26  0.79  0.74 
IMD Quintile 4 (4+5)        1.43   1.31   0.30, 6.75      0.28, 6.27  0.65  0.73 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores         1.01   1   0.98, 1.04      0.97, 1.04  0.75  0.8 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*        1   1        0.34  0.40 
Income Level 2 (2+3)        1.52   1.46   0.79, 2.92      0.75, 2.83  0.22  0.26 
Income Level 3 (4+5)        0.89   0.88   0.38, 2.06      0.38, 2.04  0.78  0.76 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level         0.71   0.72   0.23, 2.18      0.23, 2.23  0.55  0.57 
(refer. lowest) 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*        1   1        0.33  0.33 
Occupational Class 1        1.69   1.64   0.80, 3.56      0.77, 3.47  0.17  0.20 



















Variable                 Odds Ratio Adjusted Odds Ratio                 95% CI   Adjusted 95% CI            P value  Adjusted P Value 
 
 
IMD Quintile 1*        1   1        0.99  0.99 
IMD Quintile 2        1.03   1.03   0.48, 2.18      0.48, 2.21  0.95  0.93 
IMD Quintile 3        0.96   0.97   0.31, 2.93         0.32, 2.97  0.94  0.96 
IMD Quintile 4 (4+5)        1.15   1.20   0.21, 6.33      0.22, 6.64  0.87  0.84 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
IMD scores         1.01   1   0.98, 1.04      0.97, 1.04  0.75  0.8 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Income Level 1*         1   1        0.39  0.42 
Income Level 2 (2+3)         0.59   0.61   0.28, 1.27      0.28, 1.30  0.18  0.20 
Income Level 3 (4+5)         0.92   0.92   0.37, 2.29      0.37, 2.30  0.86  0.87 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Educational Level          0.71   0.72   0.23, 2.18      0.23, 2.23  0.55  0.57 
(refer. lowest) 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Occupational Class 3*         1   1        0.37  0.35 
Occupational Class 1         0.79   0.81   0.34, 1.83      0.35, 1.88  0.59  0.62 



























No=27.3% / Yes= 59.1%  
 
No=93.3% / Yes=6.7%  
 
No=40.0% / Yes=60.0%  
 




No=36.2% / Yes=43.8% 
 
No=81.7% / Yes=18.3% 
 
No=43.5% / Yes=56.5% 
 


































No=62.2% / Yes=37.8%  
 
No=66.7% / Yes=33.3%  
 
No=51.1% / Yes=48.9%  
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No=67.9% / Yes=32.1% 
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No=66.7% / Yes=33.3%  
 
No=44.4% / Yes=55.6%  
 




No=64.1% / Yes=35.9% 
 
No=54.2% / Yes=45.8% 
 



















8.3 Associations between SES and QoL  
 
Higher SES (in terms of income level) was significantly associated with better QoL 
(dyspnoea, fatigue, mastery, emotional functioning, anxiety and depression). Less 
deprived participants in terms of weekly household income level were more likely to 
report better QoL. Secondary outcome measures (anxiety and depression) were also 
related to SES in the same direction. Correlations were modest between 0.22-0.25 
(see Tables 8.9a-8.9e). These relationships were unaffected when adjusting for 
disease severity (see Appendix F1).  
Co-morbidities were not predictors of all quality of life dimensions – except for fatigue – 
either on their own or when controlling for SES. Patients without any co-existing 
illnesses were more like to report lower levels of fatigue (Table 8.10). Unadjusted 




















Mastery Anxiety Depression 
IMD scores  
r= 0.003; p=0.97 r= -0.04; p=0.64 r= -0.11; p=0.16 r= -0.02; p=0.76 r= 0.08; p=0.27 r= 0.10; p=0.20 
 



































































































F(3, 171)=1.32;  
p=0.27 
 





































































































































































F and p values 
F(1, 173)= 0.39; p= 
0.53 
F(1, 173)= 0.11; 
p= 0.75 
F(1, 173)= 0.32;  
p= 0.57 
F(1, 173)= 0.03;  
p= 0.87 
F(1, 173)= 0.08; p= 
0.78 
















































































































































































































8.4 Associations between SES and the psychosocial variables  
 
8.4.1 SES and illness perceptions 
 
Illness perceptions were significantly correlated with SES in terms of weekly household 
income level and educational attainment but not in terms of IMD quintiles, IMD scores, 
and occupational class.  
Both weekly household income level and educational level were significantly 
associated with illness perceptions. Participants with higher weekly household income 
were more likely to report weaker identity, weaker perceived consequences, higher 
personal control, greater treatment control, weaker timeline cyclical and weaker 
emotional representations (Tables 8.11c). Participants with higher education (post-
secondary) were more likely to report higher personal and treatment control regarding 
their COPD (see Table 8.11d). No other measure of SES (e.g. occupational level) was 
significantly associated with illness perceptions (see Tables 8.11a, 8.11b and 8.11e). 
These associations were not affected when adjusting for disease severity (see 


















































r= -0.06;  
p=0.46 

























































































































































































































































































































































3.59  (0.23) 
 
3.85  (0.07) 
 
2.87  (0.07) 
 
3.35  (0.07) 
 
3.13  (0.05) 
 
3.62  (0.07) 
 
2.89  (0.08) 
 





3.97  (0.27) 
 
3.80  (0.08) 
 
2.88  ( 0.08) 
 
3.59  (0.08) 
 
3.37  (0.06) 
 
3.73  (0.08) 
 








1.14; p= 0.29 
 
F(1, 174)= 
0.24; p= 0.62 
 
F(1, 174)= 0.001;  
p= 0.98 
 
F(1, 174)= 4.56; 
p= 0.03 
 
F(1, 174)= 11.45; 
p= 0.001 
 




0.14; p= 0.71 
 






















































































































































8.4.2 SES and self-efficacy 
 
Self-efficacy was not significantly correlated with SES regardless of disease severity 
(see Tables 8.12a, b, c, d and e). Unadjusted analyses are presented in Appendix F4. 
 
Table 8.12a Correlations between SES (IMD score) and general self-efficacy (GSE) – 
adjusted for disease severity (Pearson’s partial correlations) 
SES measures  Self-efficacy (GSE) 
 
IMD Score (Pearson’s r) r= 0.03; p=0.67  
 
 
Table 8.12b Differences in general self-efficacy (GSE) according to SES (IMD quintiles) – 


























F and p values 
 
F(3, 171)=1.30; p=0.28 
 
 
Table 8.12c Differences in general self-efficacy (GSE) according to SES (income level) – 






















F and p values 
 




Table 8.12d Differences in general self-efficacy (GSE) according to SES (educational level) – 
















3.38  (0.07) 
 
F and p values 
 
F(1, 174)= 2.75; p= 0.10 
 
 
Table 8.12e Differences in general self-efficacy (GSE) according to SES (occupational class) 






















F and p values 
 
F(2, 172)=3.74; p=0.06 
 
 
8.4.3 SES and social capital 
 
Social capital was significantly associated with SES (as defined by IMD scores, IMD 
quintiles weekly household income, educational level and occupational class) (Tables 
8.13a-e).  
Participants with higher weekly household income were more likely to report higher 
social agency/social proactivity, stronger feelings of trust and safety, more family and 
friends connections and stronger value of life beliefs (Table 8.13c).   
More educated participants (post-secondary) were more likely to report higher 
participation in local community activities and events and higher social 
agency/proactivity (Table 8.13d).  
More deprived participants in terms of IMD score were more likely to report lower 
agency/social proactivity, weaker feelings of trust and safety, fewer neighbourhood 
connections and fewer family and friends connections (Table 8.13a).  
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Less deprived participants in terms of IMD quintiles were more likely to report higher 
social agency/social proactivity, stronger feelings of trust and safety, more family and 
friend connections and higher tolerance of diversity (Table 8.13b).   
Occupational class was not significantly associated with most elements social capital 
except for social agency and family and friend connections (Table 8.13e). Participants 
belonging to the medium occupational class were more likely to be more socially 
proactive and have more family and friend connections compared to their counterparts 
in the low and high occupational classes. Results were similar when not adjusting for 
disease severity (see Appendix F5). 
Multiple measures of SES (IMD score, income level, educational level and occupational 
class) were used in order to examine associations with HCA and QoL in COPD. Not all 
measures were found to be significantly associated with the outcome and psychosocial 
variables (HCA, QOL, illness perceptions, self-efficacy and social capital). However, 
the effects of the SES measures that reached statistical significance were supported by 
fairly consistent effects of other forms of SES in terms of direction of effect. An 
overview of the direction of the SES measures in relation to the outcome and 




Table 8.13a Correlations between SES (IMD scores) and social capital – adjusted for disease severity (Pearson’s partial correlations) 






































































































































































































































































































































































































1.56  (0.08) 3.07  (0.07) 2.43  (0.09) 2.72  (0.09) 2.66  (0.08) 3.02  (0.08) 2.86  (0.10) 3.24  ( 0.36) 
 
F and p 
values 
F(1, 174)= 6.39; 
p= 0.01 
F(1, 174)= 5.18; 
p= 0.02 
F(1, 174)= 0.003; 
p= 0.96 
F(1, 174)= 1.04; 
p= 0.31 
F(1, 174)= 0.002; 
p= 0.97 
F(1, 174)= 
2.72; p= 0.10 
F(1, 174)= 
0.58; p= 0.45 



















































































































































Table 8.13f Direction of effects of the multiple measures of SES (IMD scores, income level, 


















** **   
 
Hospital/consultant referral 
    
 
Regular Spirometry = 
 **  
 
PR awareness 
    
 
PR referral 
    
 
PR attendance 
    
 
PR completion 
    
 
Hospital admission 
    
 
Over-treatment 
    
 
Appropriate treatment 
    
 
Under-treatment 
    
     




 **   
 
Fatigue 
 **   
Emotional function 










 **   





Table 8.13g Direction of effects of the multiple measures of SES (IMD scores, income level, 
educational level, occupational class) with psychosocial variables (illness perceptions, self-


















 *   
 
Timeline chronic 
    
 
Consequences 
 **   
 
Personal control 
  *  
 
Treatment control 
 ** **  
 
Illness coherence 
 *   
 
Timeline cyclical 
 *   
 
Emotional representations 
    
     
 
General Self-Efficacy (GSE) 
    
     
Social capital  
Participation in the community 
 ** **  
 
Social agency/proactivity 
** ** * * 
 
Feelings of trust & safety 
** *   
 
Neighbourhood connections 
*    
Family & friend connections ** ** 
        = 
* 
Tolerance of diversity 
    
 
Value of life 
 *   
 
Work connections 
    




8.4.4 Overall summary 
 
COPD patients’ illness perceptions were not significantly associated with some 
measures of SES (IMD quintiles, IMD scores, occupational level) but they were with 
weekly household income level and educational level. More deprived participants (in 
terms of income level and educational attainment) differed in the way they thought and 
made sense of their COPD. 
COPD patients did not differ significantly in their self-efficacy in terms of SES. More 
deprived participants were as likely as less deprived participants to have strong belief 
in their capabilities. 
COPD patients were found to have significant differences with respect to social capital 
depending on their SES (in terms of IMD quintiles, IMD scores, income level and 
educational level) with the exception of occupational class. Less deprived participants 
were more likely to report higher social involvement, trust and safety as well as 
stronger social networks in comparison to more deprived participants. All analyses 
were adjusted for disease severity. 
In general, stronger support was found for the relationship between social capital and 
SES than for self-efficacy and illness perceptions. The direction of effect of the SES 
measures was fairly consistent between the measures that reached statistical 
significant and the ones that did not in relation to the predictive variables examined. 
The following section will examine associations between illness perceptions, self-
efficacy, social capital and HCA. 
 
8.5 Associations between the psychosocial variables - illness perceptions, self-efficacy, 
social capital – and Health Care Access  
 
8.5.1 HCA and illness perceptions  
 
HCA was often significantly associated with illness perceptions regardless of disease 
severity (see Tables 8.14a and 8.14d). Participants who were offered smoking 
cessation referrals were more likely to report stronger emotional representations. 
Higher rates of specialist referral were associated with stronger illness identity and 
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stronger consequences beliefs.  Higher awareness of PR programmes was associated 
with stronger identity beliefs, timeline, consequences, and emotional representations 
but weaker treatment control beliefs. Patients who received a referral for PR were more 
likely to report stronger identity, timeline and consequences and weaker treatment 
control beliefs. 
Participants who had completed PR were more likely to report weaker consequences 
beliefs and stronger illness coherence.  People with higher rates of hospital admission 
were more likely to report stronger timeline cyclical beliefs. Over-treated patients were 
more likely to report stronger emotional representations. Appropriately treated patients 
were more likely to report stronger perceived consequences of their COPD. Under-
treated patients were marginally more likely to report weaker identity beliefs. Regular 
spirometry and PR attendance were not significantly associated with illness 
perceptions. Unadjusted analyses are presented in Appendix F6. 
 
8.5.2 HCA and self-efficacy 
 
HCA was not significantly associated with self-efficacy regardless of disease severity 
(see Tables 8.14b and 8.14e). Unadjusted analyses are presented in Appendix F7. 
 
8.5.3 HCA and social capital 
 
HCA was not significantly associated with social capital with the exception of smoking 
cessation referrals and over-treatment regardless of disease severity (see Tables 8.14c 
and 8.14e). Participants who were offered smoking cessation referrals were more likely 
to report weaker value of life views. Over-treated patients were more likely to report 
more family and friend connections. No other measure of HCA was significantly 




Illness perceptions in patients with COPD differed significantly according to their HCA. 
Participants with more negative cognitions and affect regarding their COPD (e.g. 
attributing more symptoms to COPD, perceiving it to have greater impact on their 
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everyday life) were more likely to have greater access to health care (e.g. more 
specialist/smoking cessation referrals) regardless of disease severity. 
Patients with COPD did not differ significantly in terms of self-efficacy according to their 
HCA. Participants with higher belief in their capabilities had equal access to health care 
as participants with weaker beliefs in their capabilities regardless of disease severity. 
HCA in COPD patients with respect to social capital did not show statistically significant 
differences, with the exception of smoking cessation and over-treatment. Patients with 
lower social capital were more likely to have been offered smoking cessation referral 
while patients with higher social capital were more likely to have been over-treated 
regardless of disease severity. 
Stronger support was found for the role of illness perceptions compared to social 
capital with regard to HCA. No evidence was found for self-efficacy and HCA. 
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(adjusted means and SD) 
 
Consultant Referrals 
(adjusted means and SD) 
 
Regular Spirometry 
(adjusted means and SD) 
 
PR awareness 
(adjusted means and SD) 
Identity  No: 3.69 (0.31)/Yes: 3.90 (0.26) No: 3.54 (0.19)/Yes: 4.85 (0.44) No: 3.81 (0.27)/Yes: 3.70 (0.23) No: 3.28 (0.24)/Yes: 4.21 (0.24) 
  F(1,139)= 0.27; p=0.60 F(1,173)= 7.57; p=0.007 F(1,173)= 0.09; p=0.77 F(1,173)= 7.32; p=0.008 
Timeline Chronic No: 3.94 (0.09)/Yes: 3.77 (0.07) No: 3.83 (0.05)/Yes: 3.86 (0.13) No: 3.77 (0.08)/Yes: 3.88 (0.07) No: 3.63 (0.07)/Yes: 4.03 (0.07) 
  F(1,139)= 2.13; p=0.15 F(1,173)= 0.05; p=0.83 F(1,173)= 1.30; p=0.26 F(1,173)= 17.72; p<0.001 
Consequences  No: 2.86 (0.09)/Yes: 2.91 (0.08) No: 2.78 (0.06)/Yes: 3.38 (0.13) No: 2.83 (0.08)/Yes: 2.91 (0.07) No: 2.64 (0.07)/Yes: 3.10 (0.07) 
  F(1,139)= 0.22; p=0.64 F(1,173)= 18.17; p<0.001 F(1,173)= 0.59; p=0.44 F(1,173)= 20.55; p<0.001 
Personal Control  No: 3.54 (0.09)/Yes: 3.49 (0.08) No: 3.43 (0.06)/Yes: 3.55 (0.14) No: 3.54 (0.08)/Yes: 3.39 (0.07) No: 3.43 (0.08)/Yes: 3.47 (0.08) 
  F(1,139)= 0.17; p=0.68 F(1,173)= 0.59; p=0.44 F(1,173)= 1.78; p=0.18 F(1,173)= 0.10; p=0.76 
Treatment Control  No: 3.25 (0.07)/Yes: 3.26 (0.05) No: 3.21 (0.04)/Yes: 3.34 (0.09) No: 3.20 (0.06)/Yes: 3.25 (0.05) No: 3.32 (0.05)/Yes: 3.15 (0.05) 
  F(1,139)= 0.000; p=0.99 F(1,173)= 1.63; p=0.20 F(1,173)= 0.50; p=0.48 F(1,173)= 5.47; p=0.02 
Illness Coherence No: 3.66 (0.09)/Yes: 3.73 (0.07) No: 3.65 (0.06)/Yes: 3.74 (0.13) No: 3.65 (0.08)/Yes: 3.67 (0.07) No: 3.60 (0.07)/Yes: 3.72 (0.07) 
 
F(1,139)= 0.40; p=0.53 F(1,173)= 0.44; p=0.51 F(1,173)= 0.04; p=0.85 F(1,173)= 1.38; p=0.24 
Timeline Cyclical No: 2.75 (0.10)/Yes: 2.93 (0.09) No: 2.85 (0.06)/Yes: 2.99 (0.15) No: 2.89 (0.09)/Yes: 2.86 (0.08) No: 2.80 (0.08)/Yes: 2.95 (0.08) 
  F(1,139)= 1.92; p=0.17 F(1,173)= 0.68; p=0.41 F(1,173)= 0.06; p=0.80 F(1,173)= 1.54; p=0.22 
Emotional 
Representations No: 2.41 (0.09)/Yes: 2.68 (0.08) No: 2.53 (0.06)/Yes: 2.80 (0.14) No: 2.47 (0.08)/Yes: 2.64 (0.07) No: 2.46 (0.08)/Yes: 2.68 (0.08) 












(adjusted means and SD) 
PR attendance 
(adjusted means and SD) 
PR completion 
(adjusted means and SD) 
Hospital Admission 
(adjusted means and SD) 
Identity  No: 3.41 (0.22)/Yes: 4.26 (0.28) No: 3.57 (0.63)/Yes: 4.29 (0.30) No: 4.61 (0.57)/Yes: 4.16 (0.34) No: 3.73 (0.21)/Yes: 3.79 (0.33) 
  F(1,173)= 5.48; p=0.02 F(1,67)= 1.07; p=0.31 F(1,54)= 0.46; p=0.50 F(1,173)= 0.02; p=0.89 
Timeline Chronic No: 3.70 (0.06)/Yes: 4.04 (0.08) No: 3.91 (0.14)/Yes: 4.07 (0.07) No: 4.02 (0.15)/Yes: 4.09 (0.09) No: 3.87 (0.06)/Yes: 3.75 (0.09) 
  F(1,173)= 11.46; p=0.001 F(1,67)= 0.96; p=0.33 F(1,54)= 0.17; p=0.68 F(1,173)= 1.15; p=0.29 
Consequences  No: 2.69 (0.07)/Yes: 3.16 (0.08) No: 3.05 (0.17)/Yes: 3.18 (0.08) No: 3.45 (0.15)/Yes: 3.08 (0.09) No: 2.82 (0.06)/Yes: 3.00 (0.10) 
  F(1,173)= 20.34; p<0.001 F(1,67)= 0.42; p=0.52 F(1,54)= 4.68; p=0.04 F(1,173)= 2.25; p=0.14 
Personal Control  No: 3.45 (0.07)/Yes: 3.45 (0.09) No: 3.41 (0.20)/Yes: 3.44 (0.10) No: 3.31 (0.18)/Yes: 3.48 (0.11) No: 3.44 (0.06)/Yes: 3.47 (0.10) 
  F(1,173)= 0.001; p=0.98 F(1,67)= 0.02; p=0.90 F(1,54)= 0.65; p=0.43 F(1,173)= 0.03; p=0.85 
Treatment Control  No: 3.31 (0.05)/Yes: 3.11 (0.06) No: 3.07 (0.13)/Yes: 3.11 (0.06) No: 3.04 (0.12)/Yes: 3.13 (0.07) No: 3.23 (0.04)/Yes: 3.24 (0.07) 
  F(1,173)= 6.88; p=0.01 F(1,67)= 0.08; p=0.79 F(1,54)= 0.41; p=0.53 F(1,173)= 0.01; p=0.92 
Illness Coherence No: 3.61 (0.07)/Yes: 3.75 (0.08) No: 3.69 (0.18)/Yes: 3.78 (0.08) No: 3.42 (0.16)/Yes: 3.92 (0.10) No: 3.67 (0.06)/Yes: 3.65 (0.10) 
  F(1,173)= 1.74; p=0.19 F(1,67)= 0.24; p=0.63 F(1,54)= 7.14; p=0.01 F(1,173)= 0.04; p=0.85 
 
Timeline Cyclical No: 2.85 (0.08)/Yes: 2.92 (0.10 No: 2.70 (0.21)/Yes: 2.91 (0.10) No: 2.82 (0.20)/Yes: 2.93 (0.12) No: 2.74 (0.07)/Yes: 3.21 (0.11) 
  F(1,173)= 0.29; p=0.59 F(1,67)= 0.78; p=0.38 F(1,54)= 0.19; p=0.66 F(1,173)= 14.00; p<0.001 
Emotional 
Representations No: 2.50 (0.07)/Yes: 2.68 (0.09) No: 2.51 (0.19)/Yes: 2.69 (0.09) No: 2.89 (0.17)/Yes: 2.62 (0.11) No: 2.51 (0.06)/Yes: 2.72 (0.10) 













(adjusted means and SD) 
 
Consultant Referrals 
(adjusted means and SD) 
 
Regular Spirometry 
(adjusted means and SD) 
 
PR awareness 
(adjusted means and SD) 
 























 F and p values 
 
 
F(1,173)= 0.02; p=0.89 
 
 
F(1,67)= 0.15; p=0.70 
 
 





















(adjusted means and SD) 
 
Consultant Referrals 
(adjusted means and SD) 
 
Regular Spirometry 
(adjusted means and SD) 
 
PR awareness 
(adjusted means and SD) 
 
Participation in Local 
Community No: 1.43 (0.09)/Yes: 1.37 (0.07) No: 1.43 (0.05)/Yes: 1.32 (0.13) No: 1.47 (0.08)/Yes: 1.36 (0.07) 
No: 1.40 (0.07)/Yes: 1.43 
(0.07) 
  F(1,139)= 0.27; p=0.60 F(1,173)= 0.63; p=0.43 F(1,173)= 1.19; p=0.28 F(1,173)= 0.09; p=0.77 
Social Agency/Social 
Proactivity No: 3.04 (0.08)/Yes: 2.93 (0.07) No: 2.94 (0.05)/Yes: 2.99 (0.12) No: 2.97 (0.07)/Yes: 2.93 (0.06) 
No: 2.89 (0.07)/Yes: 3.00 
(0.07) 
  F(1,139)= 1.16; p=0.28 F(1,173)= 0.15; p=0.70 F(1,173)= 0.23; p=0.64 F(1,173)= 1.53; p=0.22 
Feelings of Trust & 
Safety No: 2.47 (0.09)/Yes: 2.37 (0.08) No: 2.44 (0.06)/Yes: 2.42 (0.14) No: 2.45 (0.08)/Yes: 2.42 (0.07) 
No: 2.48 (0.08)/Yes: 2.39 
(0.08) 
  F(1,139)= 0.64; p=0.42 F(1,173)= 0.009; p=0.92 F(1,173)= 0.06; p=0.80 F(1,173)= 0.58; p=0.45 
Neighbourhood 
Connections No: 2.74 (0.10)/Yes: 2.61 (0.09) No: 2.65 (0.06)/Yes: 2.63 (0.15) No: 2.64 (0.09)/Yes: 2.66 (0.08) 
No: 2.68 (0.08)/Yes: 2.62 
(0.08) 
  F(1,139)= 0.84; p=0.36 F(1,173)= 0.02; p=0.88 F(1,173)= 0.02; p=0.90 F(1,173)= 0.30; p=0.59 
Friends & Family 
Connections No: 2.66 (0.09)/Yes: 2.66 (0.08) No: 2.66 (0.06)/Yes: 2.64 (0.13) No: 2.70 (0.08)/Yes: 2.64 (0.07) 
No: 2.63 (0.07)/Yes: 2.70 
(0.07) 
  
 F(1,139)= 0.000; p=0.98 F(1,173)= 0.02; p=0.88 F(1,173)= 0.34; p=0.56 F(1,173)= 0.48; p=0.49 
Tolerance of 
Diversity  No: 2.91 (0.10)/Yes: 2.99 (0.08) No: 2.91 (0.06)/Yes: 2.95 (0.14) No: 2.94 (0.08)/Yes: 2.90 (0.07) 
No: 2.86 (0.08)/Yes: 2.96 
(0.08) 
  F(1,139)= 0.40; p=0.53 F(1,173)= 0.09; p=0.77 F(1,173)= 0.12; p=0.73 F(1,173)= 0.86; p=0.36 
Value of Life  No: 2.98 (0.12)/Yes: 2.59 (0.10) No: 2.82 (0.07)/Yes: 2.67 (0.17) No: 2.85 (0.10)/Yes: 2.75 (0.09) 
No: 2.88 (0.09)/Yes: 2.70 
(0.09) 
  F(1,139)= 6.75; p=0.01 F(1,173)= 0.65; p=0.42 F(1,173)= 0.59; p=0.45 F(1,173)= 1.76; p=0.19 
Work Connections  No: 3.27 (0.46)/Yes: 2.91 (0.34) No: 2.94 (0.26)/Yes: 3.94 (1.11) No: 3.35 (0.39)/Yes: 2.72 (0.34) 
No: 3.04 (0.32)/Yes: 2.92 
(0.46) 
  F(1,14)= 0.40; p=0.54 F(1,15)= 0.76; p=0.40 F(1,15)= 1.47; p=0.24 F(1,15)= 0.04; p=0.84 
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(adjusted means and SD) 
PR attendance 
(adjusted means and SD) 
PR completion 
(adjusted means and SD) 
 
Hospital Admission 
(adjusted means and SD) 
Participation in Local 
Community No: 1.43 (0.07)/Yes: 1.38 (0.08 
No: 1.17 (0.17)/Yes: 1.42 
(0.08) 
No: 1.20 (0.16)/Yes: 1.49 
(0.10) 
No: 1.45 (0.06)/Yes: 1.31 
(0.09) 
  F(1,173)= 0.21; p=0.65 F(1,67)= 1.61; p=0.21 F(1,54)= 2.23; p=0.14 F(1,173)= 1.71; p=0.19 
Social Agency/Social 
Proactivity No: 2.93 (0.06)/Yes: 2.98 (0.07) 
No: 2.91 (0.17)/Yes: 2.97 
(0.08) 
No: 2.85 (0.15)/Yes: 3.01 
(0.09) 
No: 2.97 (0.05)/Yes: 2.89 
(0.09) 
  F(1,173)= 0.35; p=0.56 F(1,67)= 0.10; p=0.75 F(1,54)= 0.95; p=0.33 F(1,173)= 0.52; p=0.47 
Feelings of Trust & Safety  No: 2.45 (0.07)/Yes: 2.41 (0.09) 
No: 2.20 (0.18)/Yes: 2.41 
(0.08) 
No: 2.37 (0.17)/Yes: 2.42 
(0.10) 
No: 2.47 (0.06)/Yes: 2.34 
(0.10) 
  F(1,173)= 0.12; p=0.73 F(1,67)= 1.18; p=0.28 F(1,54)= 0.08; p=0.78 F(1,173)= 1.30; p=0.26 
Neighbourhood 
Connections No: 2.64 (0.08)/Yes: 2.67 (0.10) 
No: 2.35 (0.20)/Yes: 2.72 
(0.10) 
No: 2.45 (0.19)/Yes: 2.82 
(0.12) 
No: 2.59 (0.07)/Yes: 2.81 
(0.11) 
  F(1,173)= 0.06; p=0.81 F(1,67)= 2.80; p=0.10 F(1,54)= 2.69; p=0.11 F(1,173)= 2.77; p=0.10 
Friends & Family 
Connections No: 2.62 (0.07)/Yes: 2.72 (0.08) 
No: 2.66 (0.19)/Yes: 2.72 
(0.09) 
No: 2.69 (0.17)/Yes: 2.73 
(0.10) 
No: 2.63 (0.06)/Yes: 2.75 
(0.10) 
  F(1,173)= 0.79; p=0.38 F(1,67)= 0.08; p=0.79 F(1,54)= 0.03; p=0.86 F(1,173)= 1.23; p=0.27 
Tolerance of Diversity  No: 2.87 (0.07)/Yes: 2.98 (0.09) 
No: 2.84 (0.19)/Yes: 3.01 
(0.09) 
No: 2.96 (0.17)/Yes: 3.02 
(0.10) 
No: 2.92 (0.07)/Yes: 2.90 
(0.10) 
  F(1,173)= 0.83; p=0.36 F(1,67)= 0.65; p=0.42 F(1,54)= 0.11; p=0.74 F(1,173)= 0.01; p=0.91 
Value of Life  No: 2.83 (0.09)/Yes: 2.73 (0.11) 
No: 2.92 (0.25)/Yes: 2.68 
(0.12) 
No: 2.64 (0.23)/Yes: 2.69 
(0.14) 
No: 2.74 (0.08)/Yes: 2.92 
(0.12) 
  F(1,173)= 0.58; p=0.45 F(1,67)= 0.77; p=0.38 F(1,54)= 0.04; p=0.85 F(1,173)= 1.43; p=0.23 
Work Connections  No: 3.00 (0.30)/Yes: 3.00 (0.60) 
No: 3.05 (0.72)/Yes: 3.19 
(1.26) No: 3.33 (---)/Yes: --- (---) 
No: 2.72 (0.29)/Yes: 3.73 
(0.50) 










(adjusted means and SD) 
 
Appropriately Treated 
(adjusted means and SD) 
 
Under-treated 
(adjusted means and SD) 
 
Identity  No: 3.49 (0.22)/Yes: 4.21 (0.31) No: 3.60 (0.24)/Yes: 3.90 (0.25) No: 3.94 (0.20)/Yes: 3.20 (0.34) 
 F(1,173)= 3.40; p=0.07 F(1,173)= 0.74; p=0.39 F(1,173)= 3.65; p=0.06 
Timeline Chronic No: 3.76 (0.06)/Yes: 3.96 (0.09) No: 3.76 (0.71)/Yes: 3.91 (0.60) No: 3.88 (0.06)/Yes: 3.70 (0.10) 
 F(1,173)= 3.16; p=0.08 F(1,173)= 2.42; p=0.12 F(1,173)= 2.50; p=0.12 
Consequences  No: 2.80 (0.07)/Yes: 3.00 (0.09) No: 2.75 (0.70)/Yes: 3.00 (0.68) No: 2.94 (0.06)/Yes: 2.70 (0.10) 
 F(1,173)= 2.91; p=0.09 F(1,173)= 6.63; p=0.01 F(1,173)= 3.86; p=0.05 
Personal Control  No: 3.41 (0.07)/Yes: 3.53 (0.10) No: 3.48 (0.08)/Yes: 3.42 (0.08) No: 3.47 (0.06)/Yes: 3.39 (0.11) 
 F(1,173)= 1.08; p=0.30 F(1,173)= 0.27; p=0.61 F(1,173)= 3.40; p=0.07 
Treatment Control  No: 3.20 (0.05)/Yes: 3.29 (0.07) No: 3.23 (0.05)/Yes: 3.23 (0.05) No: 3.27 (0.04)/Yes: 3.12 (0.07) 
 F(1,173)= 1.26; p=0.26 F(1,173)= 0.001; p=0.97 F(1,173)= 3.64; p=0.06 
Illness Coherence No: 3.64 (0.07)/Yes: 3.70 (0.09) No: 3.61 (0.07)/Yes: 3.72 (0.07) No: 3.71 (0.06)/Yes: 3.53 (0.10) 
 F(1,173)= 0.23; p=0.63 F(1,173)= 1.27; p=0.26 F(1,173)= 2.50; p=0.12 
Timeline Cyclical No: 2.84 (0.08)/Yes: 2.94 (0.11) No: 2.88 (0.08)/Yes: 2.87 (0.09) No: 2.91 (0.07)/Yes: 2.77 (0.12) 
 F(1,173)= 0.62; p=0.43 F(1,173)= 0.005; p=0.94 F(1,173)= 1.12; p=0.29 
Emotional Representations  No: 2.49 (0.07)/Yes: 2.72 (0.10) No: 2.54 (0.08)/Yes: 2.59 (0.08) No: 2.62 (0.06)/Yes: 2.42 (0.11) 







Table 8.14e Differences in treatment appropriateness according to self-efficacy and social capital – adjusted for disease severity (analyses of 





(adjusted means and SD) 
 
Appropriately Treated 
(adjusted means and SD) 
 
Under-treated 
(adjusted means and SD) 
 
Self-efficacy 
No: 3.30 (0.06)/Yes: 3.26 (0.08) No: 3.26 (0.06)/Yes: 3.32 (0.07) No: 3.31 (0.05)/Yes: 3.23 (0.09) 
 F(1,173)= 0.16; p=0.69 F(1,173)= 0.51; p=0.48 F(1,173)= 0.53; p=0.47 
Social Capital 
    
Participation in Local Community No: 1.38 (0.06)/Yes: 1.47 (0.09) No: 1.47 (0.07)/Yes: 1.34 (0.07) No: 1.41 (0.06)/Yes: 1.42 (0.10) 
 F(1,173)= 0.54; p=0.46 F(1,173)= 1.71; p=0.20 F(1,173)= 0.03; p=0.87 
Social Agency/Social Proactivity  No: 2.94 (0.06)/Yes: 2.97 (0.08) No: 2.92 (0.06)/Yes: 2.98 (0.07) No: 2.98 (0.05)/Yes: 2.87 (0.09) 
 F(1,173)= 0.07; p=0.79 F(1,173)= 0.44; p=0.51 F(1,173)= 1.06; p=0.31 
Feelings of Trust & Safety  No: 2.40 (0.07)/Yes: 2.50 (0.10) No: 2.49 (0.08)/Yes: 2.38 (0.08) No: 2.44 (0.06)/Yes: 2.43 (0.11) 
 F(1,173)= 0.78; p=0.38 F(1,173)= 0.92; p=0.34 F(1,173)= 0.007; p=0.93 
Neighbourhood Connections No: 2.63 (0.08)/Yes: 2.69 (0.11) No: 2.65 (0.08)/Yes: 2.65 (0.09) No: 2.69 (0.07)/Yes: 2.54 (0.11) 
 F(1,173)= 0.24; p=0.63 F(1,173)= 0.001; p=0.96 F(1,173)= 1.33; p=0.25 
Friends & Family Connections No: 2.55 (0.07)/Yes: 2.86 (0.10) No: 2.62 (0.07)/Yes: 2.71 (0.07) No: 2.72 (0.06)/Yes: 2.50 (0.10) 
 F(1,173)= 7.31; p=0.008 F(1,173)= 0.71; p=0.40 F(1,173)= 3.59; p=0.06 
Tolerance of Diversity  No: 2.83 (0.07)/Yes: 3.06 (0.10) No: 2.92 (0.08)/Yes: 2.91 (0.08) No: 2.95 (0.06)/Yes: 2.80 (0.11) 
 F(1,173)= 3.48; p=0.06 F(1,173)= 0.009; p=0.92 F(1,173)= 1.45; p=0.23 
Value of Life  No: 2.73 (0.09)/Yes: 2.90 (0.12) No: 2.84 (0.09)/Yes: 2.74 (0.10) No: 2.84 (0.08)/Yes: 2.66 (0.13) 
 F(1,173)= 1.25; p=0.27 F(1,173)= 0.63; p=0.43 F(1,173)= 1.54; p=0.22 
Work Connections No: 2.85 (0.36)/Yes: 3.24 (0.46) No: 2.99 (0.32)/Yes: 3.03 (0.46) No: 3.22 (0.25)/Yes: 1.87 (0.58) 
 F(1,15)= 0.38; p=0.55 F(1,15)= 0.006; p=0.94 F(1,15)= 4.55; p=0.05 
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8.6 Associations between the psychosocial variables and quality of life  
 
8.6.1 Illness perceptions and QoL 
 
QoL was significantly associated with illness perceptions regardless of disease severity 
(see Table 8.15).  
Worse dyspnoea was significantly correlated to stronger identity, timeline, 
consequences, timeline cyclical, emotional representations and weaker personal 
control and treatment control.  
Greater fatigue showed significant correlations with stronger identity, consequences, 
timeline cyclical, emotional representations, weaker personal control and illness 
coherence.  
Poorer emotional function was significantly correlated to stronger identity, 
consequences, timeline cyclical, emotional representations and weaker treatment 
control and illness coherence.  
Greater mastery showed significant correlations with weaker identity, consequences, 
timeline cyclical, emotional representations, stronger personal control, treatment 
control and illness coherence.  
Higher risk of anxiety was significantly correlated to stronger identity, consequences, 
timeline cyclical, emotional representations and weaker illness coherence.  
Higher risk of depression was associated with stronger identity, consequences, 
emotional representations, timeline cyclical and weaker personal and treatment control 
as well as weaker illness coherence.  
The remaining dimensions of illness perceptions were not significantly associated with 





Table 8.15 Correlations between illness perceptions and QoL adjusted for disease severity (Pearson’s Correlations - partial) 
 
Dyspnoea Fatigue Emotional Function Mastery Anxiety Depression 
Identity  
r= -0.57 
 (p< 0.001) 
r= -0.36 
 (p< 0.001) 
r= -0.38 
 (p< 0.001) 
r= -0.47 




 (p< 0.001) 
Timeline Chronic 
r= -0.20  
(p= 0.007) 
r= -0.04  
(p= 0.62) 
r= -0.02  
(p= 0.79) 
r= -0.05 
 (p= 0.54) 
r= 0.02  
(p= 0.76) 




 (p< 0.001) 
r= -0.50  
(p< 0.001) 
r= -0.42  
(p< 0.001) 
r= -0.49  
(p< 0.001) 
r= 0.36  
(p< 0.001) 
r= 0.40 
 (p< 0.001) 
Personal Control  
r= 0.17 
 (p= 0.02) 
r= 0.23 
 (p= 0.003) 
r= 0.13 
 (p= 0.09) 
r= 0.26  
(p= 0.006) 
r= -0.11 
 (p= 0.17) 
r= -0.25 
 (p= 0.001) 
Treatment Control  
r= 0.20  
(p= 0.01) 
r= 0.14 
 (p= 0.07) 
r= 0.15 
 (p= 0.05) 
r= 0.16 
 (p= 0.04) 
r= -0.06 
 (p= 0.47) 
r= -0.32 
 (p< 0.001) 
Illness Coherence 
r= 0.12 
 (p= 0.12) 
r= 0.18  
(p= 0.02) 
r= 0.18  
(p= 0.02) 
r= 0.22  
(p= 0.003) 
r= -0.26 
 (p= 0.001) 
r= -0.16 
 (p= 0.03) 
Timeline Cyclical 
r= -0.24 
 (p= 0.001) 
r= -0.31 
 (p< 0.001) 
r= -0.22 
 (p= 0.003) 
r= -0.26  
(p= 0.001) 
r= 0.25 
 (p= 0.001) 
r= 0.14 




 (p< 0.001) 
r= -0.38 
 (p< 0.001) 
r= -0.49 
 (p< 0.001) 
r= -0.54 
 (p< 0.001)  
r= 0.52 
 (p< 0.001) 








8.6.2 Self-efficacy and QoL  
 
QoL was significantly associated with self-efficacy (see Table 8.16 for adjusted 
analyses). Correlations were unaffected when adjusting for disease severity (see 
Appendix F10). Better QoL was correlated to higher self-efficacy. Lower fatigue, better 
emotional function, perceptions of higher mastery and lower risk of depression and 
anxiety were significantly correlated to stronger self-efficacy. 
 
Table 8.16 Correlations between self-efficacy and QoL - adjusted for disease severity 
(Pearson’s Correlations - partial) 
 
QoL Dyspnoea Fatigue 
Emotional 
Function Mastery Anxiety Depression 




r= 0.11  
(p= 0.13) 
r= 0.24  
(p= 0.001) 
r= 0.33 





 (p< 0.001) 




8.6.3 Social capital and QoL 
 
QoL was significantly associated with certain elements of social capital (see Table 
8.17). Within these, poorer QoL was significantly correlated to lower social capital.   
Greater participation in local community was significantly correlated to greater 
dyspnoea and greater fatigue, worse emotional function and higher risk of anxiety and 
depression. 
Greater social proactivity, more family and friend connections, stronger value of life 
beliefs and more work connections were significantly associated with lower risk of 
depression.  
The correlations involving work connections must be treated with caution due to the 
small number of participants still in employment (10.8%). The remaining measures of 
social capital were not significantly correlated to QoL. Unadjusted analyses differed 








Function Mastery Anxiety Depression 
Participation Local 
Community r= -0.55 (p= 0.02) r= -0.62 (p= 0.009) r= -0.59 (p= 0.01) r= -0.04 (p= 0.89) r= 0.65 (p= 0.005) r= 0.54 (p= 0.03) 
Social 
Agency/Proactivity r= -0.04 (p= 0.90) r= -0.03 (p= 0.92) r= -0.14 (p= 0.60) r= -0.07 (p= 0.80) r= 0.21 (p= 0.42) r= -0.23  (p= 0.38) 
 
Trust and Safety r= -0.20 (p= 0.43) r= 0.02 (p= 0.94) r= 0.18 (p= 0.49) r= 0.15 (p= 0.56) r= -0.17 (p= 0.51) r= 0.13 (p= 0.62) 
Neighbourhood 
Connections r= -0.21 (p= 0.43) r= -0.22 (p= 0.39) r= -0.10 (p= 0.70) r= -0.14 (p= 0.59) r= 0.04 (p= 0.88) r= -0.15 (p= 0.57) 
Family & Friends 
Connections r= 0.22 (p= 0.39) r= 0.28 (p= 0.28) r= 0.27 (p= 0.29) r= 0.10 (p= 0.69) r= -0.12 (p= 0.65) r= -0.57 (p= 0.02) 
Tolerance of  
Diversity  r= -0.20 (p= 0.45) r= -0.04 (p= 0.88) r= 0.04 (p= 0.89) r= -0.11 (p= 0.69) r= 0.10 (p= 0.69) r= -0.19 (p= 0.47) 
 
Value of Life  r= -0.16 (p= 0.54) r= 0.06 (p= 0.81) r= 0.18 (p= 0.49) r= -0.17 (p= 0.57) r= -0.06 (p= 0.82) r= -0.49 (p= 0.05) 
 








Lower SES was associated with better HCA in patients with COPD. This finding refuted 
the hypothesis with respect to this element of the research. Higher SES was 
associated with better QoL.  The hypothesis was supported with respect to this element 
of the research. 
 
Other variables influencing these relationships were as follows: 
 
 Illness perceptions were significantly associated with QoL. Participants who had 
more negative thoughts and beliefs about their COPD (e.g. attributing more 
symptoms to their COPD, perceiving greater impact of their COPD on their 
everyday life and less control over the illness) were more likely to report poorer 
QoL (e.g. worse dyspnoea, greater fatigue) regardless of disease severity. 
 COPD patients’ self-efficacy was found to be significantly correlated to quality of 
life. Participants who had more positive beliefs about their capabilities were 
more likely to report better QoL (e.g. lower fatigue, lower risk of anxiety) 
regardless of disease severity. 
 Certain elements of social capital were significantly correlated to QoL 
Participants with greater participation in local community, greater social 
proactivity more networks and stronger feelings of value of life were more likely 
to report better quality of life. More active participation in the local community 
was associated with worse QoL in terms of anxiety and depression.  
 All three proposed psychosocial variables (illness perceptions, self-efficacy and 
social capital) were found to be significantly related to QoL in patients with 
COPD. The following section introduced multiple mediation analysis which was 
conducted in order to explore the role of these variables as mediators in the 




8.7 The role of psychosocial variables as proposed mediators in the relationship 




The aim of the final section of the analyses aimed to determine whether illness 
perceptions, self-efficacy and social capital mediated the relationship between SES 
and HCA or QoL in patients with COPD. For calculation of direct and indirect effects 
with the use of multiple mediators, Preacher and Hayes’ (2012) Process bootstrapping 
method was used. Analyses and bootstrap estimates conducted used bootstrap 
samples of 5,000. The size of indirect effect estimates is completely dependent on the 
scales used for each variable in the analysis and should not be mistaken for effect size. 
Mediation analyses were conducted only where univariate and multivariate statistical 
analyses had previously indicated the existence of statistically significant relationships 
between SES and HCA and QoL. All analyses were adjusted for disease severity and 
are presented in Tables 8.18-8.51 and Figures 8.1-8.34. Unadjusted analyses are 
presented in Appendix F10-F12. 
 
8.7.2 Was the relationship between SES and HCA mediated by psychosocial 
variables? 
 
The significant relationships between SES (in terms of income level and educational 
attainment) and HCA (smoking cessation referrals and regular spirometry) found in 
previous analyses (see Section 8.4) were mediated by social capital and illness 
perceptions respectively but not by self-efficacy. The relationship between income level 
and smoking cessation referral was mediated by value of life (social capital dimension) 
while the relationship between educational level and regular spirometry was mediated 
by treatment control (illness perception dimension). No other relationships were 
mediated by any of the dimensions of illness perceptions and social capital or by self-
efficacy. Analyses were adjusted for disease severity and are presented in Tables 





a. Was the relationship between SES and HCA mediated by illness perceptions? 
 
Illness perceptions mediated one of the significant relationships between SES and 
HCA when adjusting for disease severity. The relationship between educational level 
and regular spirometry was mediated by treatment control. The remaining statistically 
significant relationships between SES and HCA were not mediated by any of the 
dimensions of illness perceptions and social capital or by self-efficacy (see Tables 




















Table 8.18 Direct, total and specific indirect effects of IMD scores and illness perceptions on 
HCA (smoking cessation referral) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
            accelerated CI 
             _______________________ 
 
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
 
  0.06     3.06     0.002       0.0203                  0.0929 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.0008       -0.0183          0.0184 
Specific indirect effects 
Identity        0.0002       -0.0052          0.0074 
Timeline Chronic      0.0017       -0.0108                  0.0144 
Consequences      -0.0013       -0.0115                  0.0059 
Personal Control      0.0003       -0.0047                  0.0060 
Treatment Control      0.0006       -0.0071                  0.0063 
Illness Coherence      0.0000       -0.0063                  0.0072 
Timeline Cyclical      0.0004       -0.0046                  0.0063 
Emotional Representations    -0.0027       -0.0194                  0.0116 
 
 
Figure 8.1 Multiple mediation analysis examining the relationship between IMD score and HCA 
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                                                 -0.003                                                           -0.68 
                                           0.003  -0.42 
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                                             0.0000                                                   0.56 
                                       0.004                                                  0.09 
                           -0.003                                                                     1.04* 
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Table 8.19 Direct, total and specific indirect effects of IMD quintiles and illness perceptions on 
HCA (smoking cessation referral) in COPD adjusted for disease severity 
 
                          95% bias-corrected and 
                                      accelerated CI 
                  ___________________ 
        
Direct effect   Point estimate         z      p      Lower          Upper 
____________________________________________________________________________ 
 
  -0.55    -2.41       0.02      -0.9935                -0.1029 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.07        -0.1810         0.3525 
Specific indirect effects 
Identity       -0.004       -0.1146          0.0590 
Timeline Chronic      0.03        -0.0766                  0.2596 
Consequences       0.02        -0.0362                  0.1876 
Personal Control     -0.004       -0.1108                  0.0862 
Treatment Control     -0.02        -0.1955                  0.0319 
Illness Coherence      0.01        -0.0721                  0.1091 
Timeline Cyclical     -0.001       -0.0847                  0.0474 
Emotional Representations     0.04        -0.1048                  0.2838 
 
 
Figure 8.2 Multiple mediation analysis examining the relationship between IMD quintiles and 
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                                                 -0.04                                                              -0.73* 
                                          -0.04  -0.38 
   0.12    -0.03 
                                             0.06     -0.31 
                                              0.02                                                       0.57 
                                       -0.007                                                0.15 
                              0.04                                                                         0.99* 
                                                     
           -0.53* 

















Table 8.20 Direct, total and indirect effects of income level and illness perceptions on HCA 
(smoking cessation referral) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
    -0.77     -2.90   0.004      -0.5107                 -0.0395 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.007       -0.3076          0.3322 
Specific indirect effects 
Identity       -0.01        -0.1968          0.1387 
Timeline Chronic      0.008       -0.1118                  0.1877 
Consequences       0.11        -0.1146                  0.3896 
Personal Control     -0.004       -0.1807                  0.1442 
Treatment Control     -0.02        -0.2359                  0.1360 
Illness Coherence      0.08        -0.0021                  0.2262 
Timeline Cyclical     -0.02        -0.1845                  0.0764 
Emotional Representations    -0.15        -0.4974                  0.0062 
 
 
Figure 8.3 Multiple mediation analysis examining the relationship between income and HCA 
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Table 8.21 Direct, total and specific indirect effects of educational level and illness perceptions 
on HCA (regular spirometry) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
     0.26     3.33      0.001      0.1062                  0.4164 
_____________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.03        -0.0909          0.0430 
Specific indirect effects 
Identity        0.01        -0.0107          0.0544 
Timeline Chronic      0.003       -0.0216                  0.0294 
Consequences      -0.0011       -0.0256                  0.0208 
Personal Control      0.03        -0.0036                  0.0714 
Treatment Control     -0.0730        -0.1418                 -0.0229 
Illness Coherence      0.0000       -0.0196                  0.0230 
Timeline Cyclical     -0.0041       -0.0266                  0.0124 
Emotional Representations     0.0104       -0.0100                  0.0474 
 
 
Figure 8.4 Multiple mediation analysis examining the relationship between educational level 
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a. Was the relationship between SES and HCA mediated by self-efficacy? 
 
Self-efficacy did not mediate any of the significant relationships between SES and HCA 
when adjusting for disease severity (see Tables 8.22-8.25 and Figures 8.5-8.8). 
Unadjusted analyses are presented in Appendix F10. 
 
 
Table 8.22 Direct, total and specific indirect effects of IMD scores and self-efficacy on HCA 
(smoking cessation referrals) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
       0.05                 2.91     0.004       0.0159                 0.0816 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 




Figure 8.5 Multiple mediation analysis examining the relationship between IMD scores and 
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Table 8.23 Direct, total and specific indirect effects of IMD quintiles and self-efficacy on HCA 
(smoking cessation referrals) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
     -0.42                -2.04      0.04      -0.8245                  -0.0156 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 




Figure 8.6 Multiple mediation analysis examining the relationship between IMD quintiles and 
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Table 8.24 Total and specific indirect effects of income level and self-efficacy on HCA (smoking 
cessation referrals) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
          accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
   -0.69                 -2.87    0.004      -1.1641                 -0.2195 
______________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 




Figure 8.7 Multiple mediation analysis examining the relationship between income level and 
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Table 8.25 Direct, total and specific indirect effects of educational level and self-efficacy on 
HCA (regular spirometry) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
                      accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
                                                         0.23     3.03   0.003       0.0807                  0.3812 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 




Figure 8.8 Multiple mediation analysis examining the relationship between educational level 
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c. Was the relationship between SES and HCA mediated by social capital? 
 
 
Results indicated that social capital mediated: 
 
 The relationship between income level and smoking cessation referrals. 
Participants who had higher income were more likely to have stronger 
perceptions of value of life which were associated with higher likelihood of 
smoking cessation referrals.  No other social capital dimension mediated this 
relationship. Details on the coefficients between income level, social capital and 
smoking cessation referrals are presented in Table 8.28 and Figure 8.11.  
 
Social capital did not mediate any of the other significant relationships between SES 
and HCA when adjusting for disease severity (see Tables 8.26-8.27 and 8.29 8.26-8.29 















Table 8.26 Direct, total and specific indirect effects of IMD scores and social capital on HCA 
(smoking cessation referral) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate          z       p       Lower           Upper 
_____________________________________________________________________________ 
                   0.06                  3.22    0.001       0.0246                  0.1009 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.009       -0.0292          0.0103 
Specific indirect effects 
Participation in local community     0.0002       -0.0019          0.0069 
Social Agency/Proactivity     0.002       -0.0088                  0.0145 
Feelings of trust & safety    -0.003       -0.0062                  0.0091 
Neighbourhood connections    -0.007       -0.0253                  0.0037 
Family & friends connections    -0.005       -0.0218                  0.0047 
Tolerance of diversity     -0.003       -0.0143                  0.0016 
Value of life       0.002       -0.0086                  0.0144 
 
 
Figure 8.9 Multiple mediation analysis examining the relationship between IMD score and HCA 
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* significant at p< 0.05;  **significant at p< 0.001; ^ significant at p< 0.1 
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Table 8.27 Direct, total and specific indirect effects of IMD quintiles and social capital on HCA 
(smoking cessation referral) in COPD when adjusting for disease severity 
 
                 95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
 
    -0.54                 -2.32     0.02       -0.9890                -0.0837 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.09        -0.1484          0.3429 
Specific indirect effects 
Participation in local community     0.0002       -0.0617         0.0557 
Social Agency/Proactivity    -0.03        -0.2159                  0.0914 
Feelings of trust & safety    -0.003       -0.1490                  0.1472 
Neighbourhood connections    -0.004       -0.1128                  0.0410 
Family & friends connections     0.08         -0.0632                  0.3175 
Tolerance of diversity      0.07        -0.0171                  0.2513 
Value of life      -0.03          -0.1926                  0.0639 
 
 
Figure 8.10 Multiple mediation analysis examining the relationship between IMD quintiles and 
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Table 8.28 Direct, total and specific indirect effects of income level and social capital on HCA 
(smoking cessation referral) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
            accelerated CI 
          
Direct effect   Point estimate         z       p      Lower          Upper 
_____________________________________________________________________________ 
 
                     -0.69                 -2.62     0.009    -1.2011                  -0.1735 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.06        -0.3525          0.2651 
Specific indirect effects 
Participation in local community    -0.002       -0.1171          0.0836 
Social Agency/Proactivity    -0.03        -0.2657                  0.1504 
Feelings of trust & safety    -0.02        -0.1864                  0.0903 
Neighbourhood connections    -0.01        -0.1713                  0.0368 
Family & friends connections    -0.10         -0.0700                  0.3506 
Tolerance of diversity     -0.05        -0.0169                  0.2092 
Value of life      -0.14          -0.3997                 -0.0119 
 
 
Figure 8.11 Multiple mediation analysis examining the relationship between income level and 
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Table 8.29 Direct, total and specific indirect effects of educational level and social capital on 
HCA (regular spirometry) in COPD when adjusting for disease severity 
 
               95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
 
    -0.89       -2.68    0.007     -1.5376                 -0.2393 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.0009       -0.2497          0.2933 
Specific indirect effects 
Participation in local community    -0.05         -0.2797          0.0690 
Social Agency/Proactivity     0.03        -0.1089                  0.2651 
Feelings of trust & safety     0.001       -0.0574                  0.0835 
Neighbourhood connections     0.03        -0.0302                  0.2158 
Family & friends connections    -0.003        -0.1225                   0.0624 
Tolerance of diversity      0.01        -0.0838                  0.1586 




Figure 8.12 Multiple mediation analysis examining the relationship between educational level 
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8.7.3 Was the relationship between SES and QoL mediated by psychosocial variables? 
 
The significant relationships between SES (in terms of income level) and QoL 
(dyspnoea, fatigue, emotional functioning, mastery, anxiety and depression) found in 
previous analyses (see Section 8.4) were mediated by certain dimension of the 
psychosocial variables examined as mediators. Results provided support for these 
variables mediating these associations relationships when adjusting for disease 
severity (see Tables 8.30-8.47 and Figures 8.13-8.30). Unadjusted analyses are 
presented in Appendix F11. Findings are discussed below. 
 
a. Was the relationship between SES and QoL mediated by illness perceptions? 
 
Results indicated that illness perceptions mediated: 
 the relationship between income level and dyspnoea through identity and 
consequences. Patients who had higher weekly household income were more 
likely to report weaker identity perceptions and weaker consequence beliefs 
which were associated with lower levels of perceived dyspnoea. Income level 
and the mediators accounted for 6% of the variance in dyspnoea (R2=0.06, 
F(2,173)=5.80; p=0.004). No other illness perception mediated this relationship. 
Details on the coefficients between income level, illness perceptions and 
dyspnoea are presented in Table 8.30 and Figure 8.13; 
 the relationship between income level and fatigue through consequences and 
personal control. Patients who had higher weekly household income were more 
likely to report weaker consequence beliefs and stronger perceptions of 
personal control which were associated with lower levels of perceived fatigue. 
Income level and the mediators accounted for 6% of the variance in fatigue 
(R2=0.06, F(2,173)=5.40; p=0.005). No other illness perception mediated this 
relationship. Details on the coefficients between income level, illness 
perceptions and fatigue are presented in Table 8.31 and Figure 8.14; 
 the relationship between income level and emotional function through identity 
and emotional representations. Patients who had higher weekly household 
income were more likely to report weaker identity beliefs and weaker emotional 
representations which were associated with better emotional function. Income 
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level and the mediators accounted for 6% of the variance in emotional function 
(R2=0.06, F(2,173)=5.37; p=0.006). No other illness perception mediated this 
relationship. Details on the coefficients between income level, illness 
perceptions and emotional function are presented in Table 8.32 and Figure 
8.15; 
 the relationship between income level and mastery through identity, personal 
control and emotional representations. Patients who had higher weekly 
household income were more likely to report weaker identity perceptions, 
stronger perceptions of personal control and weaker emotional representations 
all of which were associated with stronger perceived mastery. Income level and 
the mediators accounted for 9% of the variance in mastery (R2=0.09, 
F(2,173)=8.93; p=0.0002). No other illness perception mediated this 
relationship. Details on the coefficients between income level, illness 
perceptions and mastery are presented in Table 8.33 and Figure 8.16;  
 the relationship between income level and anxiety through emotional 
representations. Patients who had higher weekly household income were more 
likely to report weaker emotional representations which were associated with 
lower risk of anxiety. Income level and the mediators accounted for 8% of the 
variance in anxiety (R2=0.08, F(2,173)=7.04; p=0.002). No other illness 
perception mediated this relationship. Details on the coefficients between 
income level, illness perceptions and anxiety are presented in Table 8.34 and 
Figure 8.17; 
 the relationship between income level and depression through consequences 
and treatment control. Participants who had higher income were more likely to 
have stronger perceived consequences and treatment control beliefs which 
were associated with lower risk of depression.  Income level and the mediators 
accounted for 8% of the variance in depression (R2=0.08, F(2,173)=7.07; 
p=0.001). No other illness perception mediated this relationship. Details on the 
coefficients between income level, illness perceptions and depression are 





Table 8.30 Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (dyspnoea) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
                  0.09      0.83     0.41      -0.1216                   0.2962 
____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.32         0.1444          0.4993 
Specific indirect effects 
Identity        0.10         0.0271          0.2292 
Timeline Chronic      0.001       -0.0146                  0.0396 
Consequences       0.21         0.0807                  0.3852 
Personal Control      0.009       -0.0480                  0.0714 
Treatment Control      0.02        -0.0309                  0.0861 
Illness Coherence      0.01        -0.0063                  0.0722 
Timeline Cyclical     -0.02        -0.0757                  0.0142 
Emotional Representations    -0.01        -0.0784                  0.0331 
 
 
Figure 8.13 Multiple mediation analysis examining the relationship between income level and 
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Table 8.31 Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (fatigue) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p        Lower            Upper 
_____________________________________________________________________________ 
                   0.16                  1.22     0.22       -0.1016                   0.4314 
______________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.31         0.1620          0.4885 
Specific indirect effects 
Identity        0.02        -0.0360          0.1049 
Timeline Chronic      0.004       -0.0203                  0.0640 
Consequences       0.18         0.0681                  0.3690 
Personal Control      0.06         0.0093                  0.1614 
Treatment Control     -0.02        -0.1140                  0.0297 
Illness Coherence      0.02        -0.0042                  0.0804 
Timeline Cyclical      0.03        -0.0079                  0.1244 
Emotional Representations     0.02        -0.0246                  0.0968 
 
 
Figure 8.14 Multiple mediation analysis examining the relationship between income level and 
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Table 8.32 Direct, total and indirect effects of income level and illness perceptions on QoL 
(emotional function) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                         accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    0.19                   1.63      0.11     -0.0413                  0.4292 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.23         0.0860          0.3800 
Specific indirect effects 
Identity        0.06         0.0027          0.1513 
Timeline Chronic      0.006       -0.0306                  0.0704 
Consequences       0.06        -0.0112                  0.1741 
Personal Control     -0.009       -0.0726                  0.0436 
Treatment Control      0.03        -0.0202                  0.1116 
Illness Coherence      0.01        -0.0087                  0.0625 
Timeline Cyclical     -0.02        -0.0843                  0.0221 
Emotional Representations     0.09             0.0155                  0.2103 
 
 
Figure 8.15 Multiple mediation analysis examining the relationship between income level and 
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Table 8.33 Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (mastery) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
                                                        0.23                  1.91     0.06       -0.0079                 0.4766 
______________________________________________________________________ 
 
Indirect effects    Point estimate                   Lower          
Upper 
 
Total        0.32         0.1429          0.5052 
Specific indirect effects 
Identity        0.09         0.0164          0.2067 
Timeline Chronic      0.005       -0.0212                  0.0769 
Consequences       0.07        -0.0007                  0.2047 
Personal Control      0.06         0.0057                  0.1558 
Treatment Control     -0.009       -0.0796                  0.0484 
Illness Coherence      0.02        -0.0029                  0.0874 
Timeline Cyclical     -0.02        -0.0882                  0.0231 
Emotional Representations     0.10             0.0155                  0.2452 
 
 
Figure 8.16 Multiple mediation analysis examining the relationship between income level and 
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Table 8.34 Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (anxiety) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
    -0.34     -0.83     0.41      -1.1582                   0.4709 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.62        -1.1749        -0.0862 
Specific indirect effects 
Identity       -0.03        -0.2468         0.1773 
Timeline Chronic     -0.006       -0.1821                  0.0686 
Consequences      -0.16        -0.5145                  0.0661 
Personal Control     -0.04         -0.2960                  0.1466 
Treatment Control      0.10        -0.0612                  0.3689 
Illness Coherence     -0.11        -0.3668                  0.0025 
Timeline Cyclical      0.004       -0.1742                  0.1824 
Emotional Representations    -0.39        -0.8922                 -0.0593 
 
 
Figure 8.17 Multiple mediation analysis examining the relationship between income level and 
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Table 8.35 Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (depression) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
                                                         
   -0.66                -1.76      0.08      -1.3959                  0.0810 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.74        -1.2593         -0.3161 
Specific indirect effects 
Identity       -0.17        -0.5277          0.0092 
Timeline Chronic     -0.007       -0.1576                  0.0454 
Consequences      -0.21        -0.5878         -0.0004 
Personal Control     -0.04        -0.2705                  0.1343 
Treatment Control     -0.22        -0.6279                 -0.0123 
Illness Coherence     -0.03        -0.2224                  0.0513 
Timeline Cyclical      0.06        -0.0683                  0.3032 




Figure 8.18 Multiple mediation analysis examining the relationship between income level and 
QoL (depression) mediated by illness perceptions in COPD adjusted for disease severity 
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b. Was the relationship between SES and QoL mediated by self-efficacy? 
 
Results suggested self-efficacy mediated the relationship between SES (in terms of 
income level) and all QoL domains except for dyspnoea - when adjusting for disease 
severity (see Tables 8.36-8.41 and Figures 8.19-8.24). Unadjusted analyses are 
presented in Appendix F11. 
 
Results indicated that self-efficacy mediated: 
 
 the relationship between income level and fatigue. Patients who had higher 
weekly household income had stronger self-efficacy which was associated with 
lower perceived fatigue. Income level and the mediator accounted for 6% of the 
variance in fatigue (R2=0.06, F(2,173)=5.40; p=0.005). Details on the 
coefficients between income level, self-efficacy and fatigue are presented in 
Table 8.36 and Figure 8.19; 
 the relationship between income level and emotional function. Patients who had 
higher weekly household income had stronger self-efficacy which was 
associated with better emotional function. Income level and the mediator 
accounted for 6% of the variance in emotional function (R2=0.06, 
F(2,173)=5.37; p=0.006). Details on the coefficients between income level, self-
efficacy and emotional function are presented in Table 8.37 and Figure 8.20; 
 the relationship between income level and mastery. Patients who had higher 
weekly household income had stronger self-efficacy which was associated with 
stronger perceived mastery.  Income level and the mediator accounted for 9% 
of the variance in mastery (R2=0.09, F(2,173)=8.93; p=0.0002). Details on the 
coefficients between income level, self-efficacy and mastery are presented in  
Table 8.38 and Figure 8.21; 
 the relationship between income level and anxiety. Patients who had higher 
weekly household income had stronger self-efficacy which was associated with 
lower risk of anxiety. Income level and the mediator accounted for 8% of the 
variance in anxiety (R2=0.08, F(2,173)=7.03; p=0.002). Details on the 
coefficients between income level, self-efficacy and depression are presented in 
Table 8.39 and Figure 8.22; 
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 the relationship between income level and depression. Patients who had higher 
weekly household income had stronger self-efficacy which was associated with 
lower risk of depression. Income level and the mediator accounted for 8% of the 
variance in depression (R2=0.08, F(2,173)=7.07; p=0.001). Details on the 
coefficients between income level, self-efficacy and depression are presented in 
Table 8.40 and Figure 8.23. 
 
 
Table 8.36 Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(dyspnoea) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
  
   0.39      2.89     0.004      0.1222                  0.6487 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 




Figure 8.19 Multiple mediation analysis examining the relationship between income level and 
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Income Level Dyspnoea 
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Table 8.37 Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(fatigue) in COPD when adjusting for disease severity 
 
               95% bias-corrected and 
           accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
         
        0.41                  2.86     0.005      0.1273                  0.6975 
_____________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 




Figure 8.20 Multiple mediation analysis examining the relationship between income level and 




  0.13* 0.52* 
   
 0.41* 
 











Income Level Fatigue 
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Table 8.38 Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(emotional function) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
 
    0.34                  2.72     0.007       0.0931                  0.5834 
____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 
Self-efficacy       0.08         0.0080          0.2063 
 
 
Figure 8.21 Multiple mediation analysis examining the relationship between income level and 





  0.13* 0.64** 
   
 0.34* 
 















Table 8.39 Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(mastery) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
 
     0.43                  3.24     0.001      0.1694                  0.6960 
____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 





Figure 8.22 Multiple mediation analysis examining the relationship between income level and 





  0.13* 0.93** 













Income Level Mastery 
304 
 
Table 8.40 Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(anxiety) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    -0.72                 -1.59     0.11       -1.6111                   0.1757 
_____________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 





Figure 8.23 Multiple mediation analysis examining the relationship between income level and 





  0.13* -1.98* 
   
 -0.72 
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Table 8.41 Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(depression) in COPD when adjusting for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
     -1.09                 -2.99    0.003      -1.8037                 -0.3705 
______________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 




Figure 8.24 Multiple mediation analysis examining the relationship between income level and 





  0.13* -2.48** 
   
  
   -1.09* 
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b. Was the relationship between SES and QoL mediated by social capital? 
 
Findings indicated that social capital partially mediated the relationship between SES 
and all certain QoL domains. Results are presented in Tables 8.42-8.47 and in Figures 
8.25-8.30. Unadjusted analyses are presented in Appendix F11. 
Social capital did not mediate the relationship between income level and dyspnoea. 
Details on the coefficients between income level, social capital and fatigue are 
presented in Table 8.42 and Figure 8.25. 
 
Results indicated that social capital partially mediated: 
 
 the relationship between income level and fatigue through feelings of trust and 
safety and value of life. Patients who had higher weekly household income 
were more likely to have had stronger feelings of trust and safety as well as 
higher value of life both of which were associated with lower levels of fatigue. 
Income level and the mediators accounted for 6% of the variance in fatigue 
(R2=0.06, F(2,173)=5.40; p=0.005). No other social capital dimension mediated 
this relationship. Details on the coefficients between income level, social capital 
and fatigue are presented in Table 8.43 and Figure 8.26; 
 the relationship between income level and emotional functioning through 
feelings of trust and safety and value of life. Patients who had higher weekly 
household income were more likely to have had stronger feelings of trust and 
safety as well as higher value of life both of which were associated with better 
emotional functioning. Income level and the mediators accounted for 6% of the 
variance in depression (R2=0.06, F(2,173)=5.40; p=0.005). No other social 
capital dimension mediated this relationship. Details on the coefficients between 
income level, social capital and emotional functioning are presented in Table 
8.44 and Figure 8.27; 
 the relationship between income level and mastery through feelings of trust and 
safety. Patients who had higher weekly household income were more likely to 
have had stronger feelings of trust and safety which were associated with 
greater mastery. Income level and the mediator accounted for 9% of the 
variance in mastery (R2=0.09, F(2,173)=8.93; p=0.0002). No other social capital 
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dimension mediated this relationship. Details on the coefficients between 
income level, social capital and mastery are presented in Table 8.45 and figure 
8.28; 
 the relationship between income level and anxiety through feelings of trust and 
safety and value of life. Patients who had higher weekly household income 
were more likely to have had stronger feelings of trust and safety as well as 
higher value of life both of which were associated with lower risk of anxiety. 
Income level and the mediators accounted for 6% of the variance in anxiety 
(R2=0.06, F(2,173)=5.40; p=0.005). No other social capital dimension mediated 
this relationship. Details on the coefficients between income level, social capital 
and depression are presented in Table 8.46 and figure 8.29; 
 the relationship between income level and depression through social 
agency/social proactivity and feelings of trust and safety. Patients who had 
higher weekly household income were more likely to have been social proactive 
and have had stronger feelings of trust and safety both of which were 
associated with lower risk of depression. Income level and the mediators 
accounted for 8% of the variance in depression (R2=0.08, F(2,173)=7.07; 
p=0.001). No other social capital dimension mediated this relationship. Details 
on the coefficients between income level, social capital and depression are 












Table 8.42 Direct, total and specific indirect effects of income level and social capital on QoL 
(dyspnoea) in COPD adjusted for disease severity 
____________________________________________________________________________ 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
 
     0.43                3.07      0.003      0.1529                  0.7058 
____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.02        -0.1500          0.1075 
Specific indirect effects 
Participation in local community     0.03         -0.0057          0.1139 
Social Agency/Proactivity    -0.02        -0.1198                  0.0574 
Feelings of trust & safety     0.04        -0.0035                  0.1380 
Neighbourhood connections    -0.01        -0.0841                  0.0109 
Family & friends connections    -0.04         -0.1462                  0.0208 
Tolerance of diversity     -0.03        -0.1018                  0.0034 




Figure 8.25 Multiple mediation analysis examining the relationship between income level and 
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                                                 0.19*                                                          -0.09 
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                                              0.08   -0.15 
                                              0.22**                                                   -0.18 
                                      0.13     -0.23 
                           0.23*           0.04 
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* significant at p< 0.05;  **significant at p< 0.001; ^ significant at p< 0.1 
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Table 8.43 Direct, total and specific indirect effects of income level and social capital on QoL 
(fatigue) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
   
    0.30                 2.01      0.05       0.0054                   0.6005 
______________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.18         0.0363          0.3567 
Specific indirect effects 
Participation in local community    -0.005        -0.0862         0.0472 
Social Agency/Proactivity     0.06        -0.0189                  0.1760 
Feelings of trust & safety     0.06         0.0046                  0.1732 
Neighbourhood connections    -0.02        -0.0989                  0.0101 
Family & friends connections     0.02         -0.0625                  0.1170 
Tolerance of diversity     -0.02        -0.0888                  0.0110 
Value of life       0.07           0.0090                  0.2081 
 
 
Figure 8.26 Multiple mediation analysis examining the relationship between income level and 




               0.14*  -0.03 
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Table 8.44 Direct, total and specific indirect effects of income level and social capital on QoL 
(emotional function) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    0.30      2.33     0.02        0.0452                  0.5509 
_____________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.12        -0.0271          0.2825 
Specific indirect effects 
Participation in local community    -0.03         -0.1343          0.0045 
Social Agency/Proactivity     0.03        -0.0288                  0.1221 
Feelings of trust & safety     0.08         0.0159                  0.1897 
Neighbourhood connections     0.008       -0.0119                  0.0754 
Family & friends connections    -0.03         -0.1295                  0.0341 
Tolerance of diversity     -0.004       -0.0501                  0.0303 




Figure 8.27 Multiple mediation analysis examining the relationship between income level and 
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                                                   0.19*                                                        0.17 
                                              0.18*   0.44* 
       
                                             0.08  0.10 
                                              0.22**                                                   -0.13 
                                      0.13     -0.03 
                             0.23*           0.31* 
                                                     
            0.30* 
* significant at p< 0.05;  **significant at p< 0.001; ^ significant at p< 0.1 
Income 
Level 
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Table 8.45 Direct, total and specific indirect effects of income level and social capital on QoL 
(mastery) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    0.42     2.85   0.005       0.1285                  0.7101 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.13        -0.0091          0.3000 
Specific indirect effects 
Participation in local community    -0.02         -0.0902          0.0166 
Social Agency/Proactivity     0.03        -0.0310                  0.1471 
Feelings of trust & safety     0.08         0.0137                  0.1950 
Neighbourhood connections     0.005       -0.0181                  0.0645 
Family & friends connections    -0.007        -0.1051                  0.0669 
Tolerance of diversity     -0.02        -0.0860                  0.0158 
Value of life       0.05          -0.0049                  0.1515 
 
 
Figure 8.28 Multiple mediation analysis examining the relationship between income level and 
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            0.42* 
* significant at p< 0.05;  **significant at p< 0.001; ^ significant at p< 0.1 
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Table 8.46 Direct, total and specific indirect effects of income level and social capital on QoL 
(anxiety) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect    Point estimate   t           p      Lower          Upper 
_____________________________________________________________________________ 
 
                                                  -0.74                 -1.66     0.10           -1.6207                  0.1421 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.23        -0.7882         0.2598 
Specific indirect effects 
Participation in local community     0.19         -0.0004         0.5801 
Social Agency/Proactivity    -0.03        -0.3120                  0.2024 
Feelings of trust & safety    -0.28        -0.6619                 -0.0584 
Neighbourhood connections    -0.02        -0.2158                  0.0640 
Family & friends connections     0.09         -0.1439                  0.4117 
Tolerance of diversity     -0.004       -0.1721                  0.1117 




Figure 8.29 Multiple mediation analysis examining the relationship between income level and 
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                                             0.18*                                                       -1.57** 
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* significant at p< 0.05;  **significant at p< 0.001; ^ significant at p< 0.1 
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Table 8.47 Direct, total and specific indirect effects of income level and social capital on QoL 
(depression) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
                                                         -0.83               -2.20     0.03       -1.5785                 -0.0854 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.57        -1.0954         -0.1338 
Specific indirect effects 
Participation in local community     0.06         -0.0182          0.3050 
Social Agency/Proactivity    -0.23        -0.5381                 -0.0551 
Feelings of trust & safety    -0.16        -0.4553                 -0.0201 
Neighbourhood connections    -0.05        -0.2740                  0.0243 
Family & friends connections    -0.05         -0.2901                  0.1951 
Tolerance of diversity      0.04        -0.0444                  0.2058 




Figure 8.30 Multiple mediation analysis examining the relationship between income level and 
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* significant at p< 0.05;  **significant at p< 0.001; ^ significant at p< 0.1 
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i. The relationship between SES and HCA was mediated by illness perceptions and 
social capital but not by self-efficacy when adjusting for disease severity: 
 
 Illness perceptions:  
Treatment control mediated the relationship between educational level and regular 
spirometry. Participants who had higher education were more likely to have had 
stronger perceptions of treatment control which were associated with lower likelihood of 
having regular spirometry.  No other illness perception mediated this relationship.  
 
 Self-efficacy:  
The relationship between SES and HCA was not mediated by self-efficacy. 
 
 Social capital:  
Value of life mediated the relationship between income level and smoking cessation 
referrals. Participants who had higher income were more likely to have stronger 
perceptions of value of life which were associated with higher likelihood of smoking 
cessation referrals.  No other social capital dimension mediated this relationship.  
 
ii. The relationship between SES and QoL was mediated by illness perceptions, self-
efficacy and social capital when adjusting for disease severity: 
 
 Illness perceptions: 
Identity and consequences mediated the relationship between income level and 
dyspnoea. Patients who had higher weekly household income were more likely to 
report weaker identity perceptions and weaker consequence beliefs which were 
associated with lower levels of perceived dyspnoea.  
Consequences and personal control mediated the relationship between income level 
and fatigue. Patients who had higher weekly household income were more likely to 
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report weaker consequence beliefs and stronger perceptions of personal control which 
were associated with lower levels of perceived fatigue. 
Identity, personal control and emotional representations mediated the relationship 
between income level and mastery. Patients who had higher weekly household income 
were more likely to report weaker identity perceptions, stronger perceptions of personal 
control and weaker emotional representations all of which were associated with 
stronger perceived mastery.  
Identity and emotional representations mediated the relationship between income level 
and emotional functioning. Patients who had higher weekly household income were 
more likely to report weaker identity beliefs and weaker emotional representations 
which were associated with better emotional function.  
Emotional representations mediated the relationship between income level and anxiety. 
Patients who had higher weekly household income were more likely to report weaker 
emotional representations which were associated with lower risk of anxiety.  
Consequences and treatment control mediated the relationship between income level 
and depression. Participants who had higher income were more likely to have stronger 
perceived consequences and treatment control beliefs which were associated with 
lower risk of depression.   
 
 Self-efficacy: 
Self-efficacy mediated the relationship between income level and fatigue. Patients who 
had higher weekly household income had stronger self-efficacy which was associated 
with lower perceived fatigue.  
Self-efficacy mediated the relationship between income level and mastery. Patients 
who had higher weekly household income had stronger self-efficacy which was 
associated with stronger perceived mastery.   
Self-efficacy mediated the relationship between income level and emotional 
functioning. Patients who had higher weekly household income had stronger self-
efficacy which was associated with better emotional function.  
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Self-efficacy mediated the relationship between income level and anxiety. Patients who 
had higher weekly household income had stronger self-efficacy which was associated 
with lower risk of anxiety.  
Self-efficacy mediated the relationship between income level and depression. Patients 
who had higher weekly household income had stronger self-efficacy which was 
associated with lower risk of depression.  
 
 Social capital: 
Feelings of trust and safety and value of life partially mediated the relationship between 
income level and fatigue. Patients who had higher weekly household income were 
more likely to have had stronger feelings of trust and safety as well as higher value of 
life both of which were associated with lower levels of fatigue.  
Feelings of trust and safety partially mediated the relationship between income level 
and mastery. Patients who had higher weekly household income were more likely to 
have had stronger feelings of trust and safety which were associated with greater 
mastery.  
Feelings of trust and safety and value of life partially mediated the relationship between 
income level and emotional functioning. Patients who had higher weekly household 
income were more likely to have had stronger feelings of trust and safety as well as 
higher value of life both of which were associated with better emotional functioning.  
Feelings of trust and safety and value of life partially mediated the relationship between 
income level and anxiety. Patients who had higher weekly household income were 
more likely to have had stronger feelings of trust and safety as well as higher value of 
life both of which were associated with lower risk of anxiety.  
Social agency/social proactivity and feelings of trust and safety partially mediated the 
relationship between income level and depression. Patients who had higher weekly 
household income were more likely to have been social proactive and have had 






8.7.5 Was the relationship between SES and QoL mediated by a combination of 
psychosocial variables? 
 
Additional mediation analyses were conducted to examine whether a combination of 
the psychosocial variables (illness perceptions, self-efficacy and/or social capital) that 
(partially) mediated the relationship between SES and HCA and SES (Tables 8.48-8.51 
and Figures 8.31-8.34) would do so when examined together. This was done in order 
to examine whether a combination of the psychosocial variables would be able to 
explain a greater amount of the variance in HCA and QoL.  
- SES and HCA 
Illness perceptions (treatment control) and social capital (value of life) mediated the 
relationship between SES (in terms of income level and educational attainment) and 
HCA (smoking cessation referrals and regular spirometry) individually in previous 
analyses (see Section 8.4). When treatment control and value of life were examined in 
combination as suggested mediators in the relationship between SES (in terms of 
income level and educational attainment) and HCA (smoking cessation referrals and 
regular spirometry), they did not mediate this relationship. 
- SES and QoL 
The significant relationships between SES (in terms of income level) and QoL (fatigue, 
emotional function, mastery, depression) found in previous analyses were mediated by 
a combination of psychosocial variables (illness perceptions, self-efficacy and/or social 
capital).  
 
When examined in combination, results indicated that: 
a. The suggested variables examined as mediators in the relationship between SES 
(income level) and QoL (fatigue) were illness perceptions (consequences, personal 
control), self-efficacy and social capital (feelings of trust and safety, value of life). 
Results showed that income level and fatigue were mediated by: 
 consequences. Patients who had higher weekly household income were more 
likely to report weaker consequence perceptions which were associated with 
lower levels of perceived fatigue. Income level and the mediator accounted for 
6% of the variance in fatigue (R2=0.06, F(2,173)=5.40; p=0.005). Remaining 
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illness perceptions (personal control), self-efficacy and social capital (feelings of 
trust and safety, value of life) did not mediate this relationship. Details on the 
coefficients between income level, illness perceptions, self-efficacy, social 
capital and fatigue are presented in Table 8.48 and Figure 8.31. 
b. The suggested variables examined as mediators in the relationship between SES 
(income level) and QoL (emotional functioning) were illness perceptions (identity, 
emotional representations), self-efficacy and social capital (feelings of trust and 
safety, value of life). Results showed that income level and emotional functioning 
were mediated by: 
 identity, emotional representations and self-efficacy. Patients who had higher 
weekly household income were more likely to report weaker identity perceptions 
and emotional representations but stronger self-efficacy all of which were 
associated with better emotional function. Income level and the mediators 
accounted for 6% of the variance in emotional functioning (R2=0.06, 
F(2,173)=5.37; p=0.006). Social capital (feelings of trust and safety, value of 
life) did not mediate this relationship. Details on the coefficients between 
income level, illness perceptions, self-efficacy, social capital and emotional 
functioning are presented in Table 8.49 and Figure 8.32. 
c. The suggested variables examined as mediators in the relationship between SES 
(income level) and QoL (mastery) were illness perceptions (identity, personal 
control, emotional representations), self-efficacy and social capital (feelings of trust 
and safety, value of life). Results showed that income level and mastery were 
mediated by: 
 identity, personal control, emotional representations and self-efficacy. Patients 
who had higher weekly household income were more likely to report weaker 
identity perceptions, weaker emotional representations but stronger personal 
control and self-efficacy all of which were associated with higher perceived 
mastery irrespectively of severity of COPD. Income level and the mediators 
accounted for 9% of the variance in mastery (R2=0.09, F(2,173)=8.93; 
p=0.0002). Social capital (feelings of trust and safety, value of life) did not 
mediate this relationship. Details on the coefficients between income level, 
illness perceptions, self-efficacy, social capital and mastery are presented in 
Table 8.50 and Figure 8.33.  
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d. The suggested variables examined as mediators in the relationship between SES 
(income level) and QoL (depression) were illness perceptions (consequences, 
treatment control), self-efficacy and social capital (social agency/proactivity, 
feelings of trust and safety). Results showed that income level and depression 
were mediated by: 
 consequences, self-efficacy and social agency/social proactivity. Patients who 
had higher weekly household income were more likely to have stronger 
perceived self-efficacy and higher levels of social agency/proactivity but weaker 
perceived consequences all of which were associated with lower risk of 
depression unaffected by severity of COPD. Income level and the mediators 
accounted for 8% of the variance in depression (R2=0.08, F(2,173)=7.07; 
p=0.001). Remaining dimensions of illness perceptions (treatment control) 
social capital (feelings of trust and safety) did not mediate this relationship. 
Details on the coefficients between income level, illness perceptions, self-

















Table 8.48 Direct, total and specific indirect effects of income level and illness perceptions, self-
efficacy and social capital on QoL (fatigue) in COPD adjusted for disease severity 
 
               95% bias-corrected and 
                accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
     0.14      1.06      0.29      -0.1228                  0.4064 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.34         0.1715          0.5205 
Specific indirect effects 
Consequences       0.19         0.0742                  0.3467 
Personal Control      0.04        -0.0017                  0.1224 
Self-efficacy       0.03        -0.0033                  0.1137 
Feelings of trust and safety     0.03        -0.0152         0.1171 






Figure 8.31 Multiple mediation analysis examining the relationship between income level and 
QoL (fatigue) mediated by illness perceptions, self-efficacy and social capital in COPD adjusted 
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Table 8.49 Direct, total and specific indirect effects of income level, illness perceptions and self-
efficacy on QoL (emotional function) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
      0.21                 1.86      0.06      -0.0127                  0.4305 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.21         0.0774          0.3595 
Specific indirect effects 
Identity        0.06         0.0123                  0.1420 
Emotional representations     0.09         0.0177                  0.2054 







Figure 8.32 Multiple mediation analysis examining the relationship between income level and 
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Table 8.50 Direct, total and specific indirect effects of income level, illness perceptions and self-
efficacy on QoL (mastery) in COPD adjusted for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    0.22      1.93   0.0055    -0.0048                  0.4469 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.33         0.1501          0.5333 
Specific indirect effects 
Identity        0.10         0.0325          0.2160 
Personal Control      0.05         0.0040                  0.1237 
Emotional representations     0.10         0.0111                  0.2273 






Figure 8.33 Multiple mediation analysis examining the relationship between income level and 
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Table 8.51 Direct, total and specific indirect effects of income level, illness perceptions, self-
efficacy and social capital on QoL (depression) in COPD adjusting for disease severity 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
   -0.35     -1.02     0.31       -1.0338                 0.3295 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -1.05        -1.6587         -0.5229 
Specific indirect effects 
Consequences      -0.37        -0.7072                 -0.1400 
Treatment Control     -0.10         -0.3059          0.0155 
Self-efficacy      -0.17        -0.4686                 -0.0177 
Social Agency/social proactivity    -0.19        -0.4590                 -0.0383 
Feelings of trust and safety    -0.09        -0.3253                  0.0103 





Figure 8.34 Multiple mediation analysis examining the relationship between income level and 
QoL (depression) mediated by illness perceptions, self-efficacy and social capital in COPD 
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Results indicated that the effect of SES on QoL was indeed mediated by a combination 
of different dimensions of illness perceptions and social capital as well as self-efficacy.  
 
8.8 Overall summary of findings 
 
The main points which emerged after all the statistical analyses were completed were: 
 
a. More deprived COPD patients in terms of IMD score were found to have greater 
access to health care in terms of smoking cessation referrals as compared to 
less deprived COPD patients. More deprived COPD patients in terms of 
educational level were also found more likely to have had regular spirometry 
compared to participants who were less deprived (post-secondary education) 
who did not have regular spirometry. Neither of these relationships was 
significantly associated with disease severity. 
b. Higher SES was associated with better QoL. More deprived participants (in 
terms of Income level) were more likely to report poorer QoL (dyspnoea, 
fatigue, mastery, emotional functioning, anxiety and depression risk). 
c. The overall influence of SES over HCA and QoL in COPD seemed to be minor. 
The relationship between SES and HCA and QoL in COPD were not as strong 
as expected. Thus, mediation analyses provided fairly limited information in 
explaining these relationships. A larger sample size would probably not have 
increased the likelihood of stronger findings due to the limited strength of these 
relationships. 
d. Illness perceptions were found to have a stronger relationship with QoL and a 
more consistent relationship with HCA but that was independent of SES.  
e. Self-efficacy did not mediate the relationship between SES and HCA. Illness 
perceptions (treatment control) mediated the relationship between SES (in 
terms of educational level) and HCA (regular spirometry). Social capital (value 
of life) mediated the relationship between SES (In terms of IMD score) and HCA 
(smoking cessation referral.  
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f. Illness perceptions mediated the relationship between SES (in terms of income 
level) and all QoL domains (dyspnoea, fatigue, mastery, emotional functioning, 
anxiety and depression). Self-efficacy and social capital mediated the 
relationship between SES (in terms of income level) and all QoL except for 
dyspnoea. 
g. When the proposed mediators (illness perceptions, self-efficacy and social 
capital) were examined as mediators in the relationship between SES and QoL 
in combination, mediation patterns changed. This suggested that there might 
have been substantial collinearity between some of the mediators. 
h. There exists an increased possibility that one or more statistically significant 
findings could be false positives (Type 1 errors) due to the large number of 
statistical tests of association and mediation that were conducted in this thesis. 
This is discussed in more detail in the discussion chapter (Chapter 9). 
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9.1 Overview and key findings 
 
This research is the first to examine whether lower SES was associated with lower 
HCA and poorer QoL in patients with COPD. This was done in a rigorous and robust 
way through examination of patients recruited in a population sample and adjusting for 
disease severity in the analyses. Additional objectives included examining whether (a) 
psychosocial variables – illness perceptions, self-efficacy and social capital – and SES 
were associated with HCA and QoL and (b) the role of these psychosocial variables as 
possible mediators in the relationships between SES and HCA and QoL. Lack of 
associations is as important as positive associations. For example, the finding that low 
SES was significantly associated with greater HCA in patients with COPD contributes 
to increasing our understanding of the role of SES within HCA. If HCA is not affected 
by the degree of deprivation, then this leads to the development of new assumptions 
regarding health inequalities and health care access in the context of COPD. The main 
study findings and the questions that arise are presented below. Proposed 
explanations, arguments and critical appraisal as well as comparison to existing 
literature are discussed later in this chapter. 
It was explored whether low SES was significantly associated with lower HCA in 
patients with COPD. Findings indicated that more deprived patients with COPD had 
greater HCA compared to more affluent patients regarding access to health care. 
Additional significant relationships between SES and HCA included lower SES in terms 
of educational level and more regular spirometry. Was this lack of association due to a 
flaw in the present research e.g. SES or HCA measures, or did it indeed reflect the real 
situation? The widespread assumption was the existence of socio-economic 
inequalities in HCA in patients with COPD; more deprived people were believed to be 
at greater disadvantage in accessing the health care services they required. Findings 
suggested that higher deprivation was not a barrier to greater HCA.  
It was also explored whether SES was significantly associated with QoL in patients with 
COPD. Patients who were more deprived in terms of income level did report 
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significantly worse QoL compared to their more affluent counterparts, unaffected by 
disease severity. Lower SES in terms of remaining measures i.e. IMD, educational 
level and occupational class was not found to be significantly associated with worse 
QoL compared to higher SES. The fact that income level and not the other SES 
measures was found to be significantly associated with QoL in COPD suggested that 
income level could be a more sensitive and appropriate SES measure in this patient 
population. 
It was examined whether disease severity was associated with HCA and QoL in 
COPD. Additionally, it was investigated whether disease severity was patterned 
according to SES. Disease severity was not significantly related to any of the SES 
measures suggesting that more deprived patients were not more likely to report greater 
disease severity compared to their more affluent counterparts. All analyses were 
adjusted for disease severity in case of any residual confounding. This would ensure 
that differences in HCA and/or QoL in people with lower vs higher SES were not due to 
SES or severity of COPD. More severely affected COPD patients did not differ 
significantly in terms of HCA and QoL and on most psychosocial measures compared 
to their less severely affected counterparts. The lack of an association between 
disease severity and QoL was consistent with previous research in neuromuscular 
disease (Graham, Rose, Grunfeld, Kyle, & Weinman, 2011) highlighting the complexity 
of emotional and psychological functioning. The relationships that were influenced by 
disease severity showed that more severely affected COPD patients were more likely 
(1) to have been aware of pulmonary rehabilitation programmes and (2) to have been 
referred for pulmonary rehabilitation and (3) less severely affected COPD patients were 
more likely to have been over-treated. Disease severity (in terms of lung function) was 
also significantly associated with timeline cyclical. Participants who had more severe 
COPD perceived that their illness was following a cyclical course alternating between 
times of stability of symptoms and exacerbations. More severely affected patients did 
not differ significantly in terms of the remaining illness perceptions dimensions or self-
efficacy and social capital in comparison to less severely affected patients.  
It was explored whether SES was associated with illness perceptions, self-efficacy and 
social capital. No significant association was found between SES and self-efficacy. 
More deprived COPD patients in terms of IMD, income and educational level and 
occupational class did not differ significantly in self-efficacy compared to less deprived 
patients. More deprived patients in terms of educational and income level, but not IMD 
and occupational class, differed significantly in illness perceptions (identity, 
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consequences, personal and treatment control, timeline cyclical and emotional 
representations) compared to their more affluent counterparts. Less deprived patients 
in terms of IMD, educational and income level and occupational status differed 
significantly in terms of certain social capital elements in comparison to more deprived 
patients. Less deprived participants were more likely to report higher social 
involvement, trust and safety as well as stronger social networks in comparison to more 
deprived participants. All associations were unaffected by disease severity. In general, 
patients differed significantly in their social capital levels and less in their illness 
perceptions on the basis of their SES.  
It was further explored whether HCA was related to illness perceptions, self-efficacy 
and social capital in patients with COPD. Significant differences were found in patients’ 
illness perceptions between groups that differed in terms of HCA (except for regular 
spirometry). Differences varied depending on HCA outcomes. Overall, participants with 
more negative cognitions and affect regarding their COPD (e.g. attributing more 
symptoms to COPD, perceiving a greater impact of COPD on their everyday life) were 
more likely to have had greater access to health care regardless of disease severity. 
Patients did not differ significantly in self-efficacy and most elements of social capital 
according to HCA. Exceptions included smoking cessation and over-treatment. 
Patients with lower social capital were more likely to have been offered smoking 
cessation referrals while patients with higher social capital were more likely to have 
been over-treated irrespective of disease severity.  
Was there something special about the way patients viewed their illness that evoked a 
more proactive response on behalf of physicians, thus securing greater access to 
health care services? This could possibly be true for some of the HCA outcomes that 
were physician-centred such as PR or smoking referral. Instead, for HCA outcomes 
that were patient-centred such as PR completion, more positive illness perceptions 
were associated with higher completion rates. These findings suggested that illness 
perceptions played an important role in relation to SES and HCA in COPD. The fact 
that more deprived patients were not at a disadvantage when accessing health care 
services suggested that other factors such as patients’ illness perceptions might have 
contributed to this relationship. 
It was also explored whether QoL was related to illness perceptions, self-efficacy and 
social capital in patients with COPD. More negative illness perceptions (e.g. attributing 
more symptoms to COPD, perceiving COPD to have a greater impact on their 
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everyday life and feeling less in control over the illness), weaker self-efficacy and lower 
levels of social capital were associated with poorer QoL (e.g. worse dyspnoea, greater 
fatigue, higher risk of depression) irrespective of disease severity. Different 
combinations of all three types of psychosocial variables were associated to some 
extent with QoL in COPD. The strongest associations were found for QoL and illness 
perceptions especially identity, consequences and emotional representations. HCA 
was significantly related to illness perceptions, self-efficacy and some elements of 
social capital.  
Finally, it was explored whether psychosocial variables i.e. illness perceptions, self-
efficacy and social capital mediated the relationship between SES and HCA and QoL in 
patients with COPD. No psychosocial variable mediated the relationship between SES 
and HCA but a combination of them – illness perceptions, self-efficacy and social 
capital – significantly mediated the association between SES and QoL. These findings 
suggested that SES (in terms of income level) exerted its influence on QoL through 
certain illness perceptions, i.e. identity, consequences, emotional representations and 
personal control, as well as self-efficacy and less through social capital depending on 
the outcome examined. 
Could these psychosocial variables possibly explain the finding that suggested that 
more deprived patients with COPD had poorer QoL despite their equal or - in some 
cases - better access to health care services?  This question will be addressed in the 
following section. 
 
9.2 Discussion of key findings 
 
9.2.1 Was SES associated with HCA? 
 
Lower SES was associated with greater HCA. Additional relationships found support 
for more deprived COPD patients not having less HCA in comparison to their more 
affluent counterparts which is consistent with existing literature (see Chapter Four). 
This was supported by the lack of associations between SES and HCA but also the fact 
that more deprived patients in terms of educational level were more likely to have been 
offered more regular spirometry. These relationships indicated that, lower SES was not 
associated with lower HCA but that, in certain cases, higher deprivation was related to 
greater health care access.  
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The aforementioned results are consistent with existing literature. The systematic 
review conducted as part of this thesis (see Chapter Four) found a small number of 
quality studies investigating the relationship between SES and HCA. Some of these 
studies found no evidence of higher deprivation being linked to poorer HCA. Others 
reported that lower SES was associated with greater HCA. However, there was 
considerable variability in the conceptualisation and definition of HCA (e.g. discussion 
about prognosis, quality of emergency care or inhaler variance).  
 
a. What do the associations between SES and HCA suggest and how could the 
findings be explained? 
 
The question arises whether the lack of associations between low SES and HCA was 
due to the nature of HCA or SES measures or due to other factors such as doctor or 
patient characteristics. For example, for certain HCA measures, patients could be 
considered passive recipients of health care services because these services were 
physician-initiated, for example PR or smoking referrals. For other HCA measures, 
patients may have maintained an active and assertive role because they were patient-
initiated or patient-dependent such as PR completion. A number of possible 
explanations are proposed and are presented below. 
 
 Doctor and patient attitudes and their interaction 
 
One possible explanation for the lack of association between SES and HCA is the 
nature of doctor-patient interaction. Access to health care is not only influenced by 
patient characteristics but also by clinician characteristics. The quality of 
communication between these two determines the direction of the outcome of the 
consultation. Good communication is essential for the quality of health care offered to 
patients by their providers (Bensing, Verheul, Jansen, & Langewitz, 2010). It increases 
patients’ confidence in their capability to manage their illness and leads to better health 
status and outcomes such as blood pressure reduction and better glucose control 
(DeVoe, Wallace, & Fryer, 2009; Stewart, 1995). Within this medical interaction 
context, the “explanatory model of sickness” holds an important role (Kleinman, 1978). 
According to this model, both the doctor and the patient have a conceptual construction 
that explains physical phenomena. This construction consists of the same domains for 
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both sides (e.g. cause, control, onset of symptoms, prognosis and cure, treatment) but 
their content varies significantly depending on the agent’s perspective of the illness. 
The doctor’s model is based on their clinical behaviour while the patient’s model is 
based on their illness behaviour. These models are influenced by a variety of factors 
such as socio-economic status, culture, religion or ethnicity (Kleinman, 1978). The 
higher the congruence between these two models the better the outcome for the 
patient. However, sometimes congruence is low and this may result in poor doctor-
patient communication especially with patients from a low SES background (Schouten, 
Meeuwesen, & Harmsen, 2009) who had lower satisfaction with the consultation and 
poorer access to health care (DeVoe, Krois, & Stenger, 2008; 2009). This could be due 
to doctor or patient characteristics. For example, health care access might be 
influenced due to doctor bias towards the patient influenced by their perceptions of 
patients’ ethnicity, social class or educational level (Van Ryn, 2002). Doctors perceived 
lower SES patients more negatively with regard to health and lifestyle behaviours or 
adherence to their recommendations which influenced their treatment decisions and 
clinical management (van Ryn & Burke, 2000). Variation in physician perceptions of 
patients according to ethnic background and socio-economic status was observed 
even when disease severity was controlled (Hannan, Kilburn, O'Donnell, Lukacik, & 
Shields, 1991). This suggested that a proportion of the variance in doctor behaviour 
regarding patient treatment could be explained by differences in their perceptions of 
their patients (van Ryn & Burke, 2000). In the case of the present study, however, 
congruence between doctors and their patients might have been higher and not 
influenced by patients’ SES. This could have led to better communication and greater 
rapport between them and could have secured equal HCA for more deprived and less 
deprived COPD patients. 
Good doctor-patient communication and high congruence of their perceptions could 
explain the lack of a relationship between lower SES and poorer HCA. Alternatively, 
more deprived patients might be experiencing more expressive physician attitudes. 
Because of patients’ particular situation i.e. greater need due to financial or educational 
disadvantage, doctors might be more sympathetic and show greater empathy towards 
them, thus evoking different responses. For instance, patients’ perceptions of their 
doctors’ attitude towards them (e.g. if they are caring and interested) can encourage 
them to volunteer more information and be more active in the medical interaction as 
well as become more adherent to medical recommendations (Ben-Sira, 1976, 1988; 
DiMatteo, Taranta, Friedman, & Prince, 1980; Hall & Dornan, 1988). This could well 
have been the case here. The significant associations between IMD and educational 
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level with smoking cessation referrals and regular spirometry, respectively, could have 
been the result of doctors’ attitudes and behaviour influenced by patients’ SES. Doctors 
might have perceived more deprived patients to be more likely to follow their 
recommendations and/or have greater need for smoking cessation referrals. As a 
result, more quality health care might have been provided to lower SES patients. 
The association between regular spirometry and lower SES in terms of educational 
attainment could also be a result of patients’ choice. Regular spirometry assessment 
might have been offered to more educated patients but they might not have attended it, 
possibly because they perceived themselves as being in control over their illness. This 
perception could have eliminated the perceived need to have their COPD monitored 
frequently. This was also suggested by the fact that illness perceptions, such as 
greater personal and treatment control, showed significant associations with higher 
education. Previous literature suggested that COPD patients with higher educational 
attainment, as compared to people with fewer years of education, were less likely to 
follow the treatment regime prescribed by their doctors because they felt the 
medication was not helping them breathe better (VanderSchaaf et al., 2010). This 
study focused on medication adherence which is different from spirometry though. 
However, adherence could be considered as following physician recommendations, i.e. 
taking the medications as prescribed or attending spirometry. In the present study, 
patients were asked whether they have regular spirometry. This meant that patients 
could have been invited for spirometry but chose not to attend which would be 
compatible with not having regular spirometry. This made it difficult to distinguish 
whether patients who did not have regular spirometry did so because they had not 
been invited or because they chose not to. 
Lower SES was associated with greater HCA which is consistent with VanderSchaaf’s 
findings (2010). However, the authors emphasized that the results could have been 
due to more educated patients being more willing to disclose lower adherence to 
medical recommendations. Methodological differences such as conceptualisation and 
measurement of HCA could have affected results. For example, VanderSchaaf et al. 
(2010) assessed medication adherence as number of times of inhaler use in a day. 
Other studies that defined medication adherence as minutes of use of nebuliser per 
day found that more educated patients were more likely to follow doctor’s 




 Age-related factors 
 
Current findings need to be considered within the context of particular characteristics of 
the participant sample. For instance, better access to health care in more deprived 
groups could be due to patients’ age. Studies found that elderly patients were more 
likely to interact with their doctors in a patient-centred style compared to younger 
patients (Peck, 2011) and preferred a physician-directed style of decision-making 
(Levinson, Kao, Kuby, & Thisted, 2005). Perhaps participants’ age – associated with 
greater vulnerability - might have influenced doctors’ clinical management such as 
smoking cessation referrals or regular spirometry. However, present results indicated 
that mean age did not differ significantly in the individual SES measures except for 
income level (see Chapter Eight). Mean age for medium income level was significantly 
higher than mean age for low and high income levels. This suggested that age was not 
likely to have played a role in the relationship between SES and health care access. 
 
 SES measure appropriateness 
 
Occupational status showed no significant associations with health care access in 
COPD. Participants’ age could possibly explain why occupational status might not have 
been a reliable measure of current SES due to retirement status (Braveman, et al., 
2005; Shavers, 2007). More deprived patients in terms of income level were not at a 
disadvantage for accessing health care services. A possible explanation could be that 
the health care system in the UK is free of charge at entry point making access 
independent of an individual’s financial status. In addition, integrated and further free 
health care services are available for people over the age of 60 in the UK such as free 
prescriptions, and free immunisations,  free access to dental services and sight tests 
and free transportation as part of the National Service Framework (NSF) for older 
people launched in 2001 (National Service Framework, 2001). Therefore, it would be 
plausible to assume that the more individual and financial-related SES proxies such as 
occupational status and income and level might not be linked to HCA in healthcare 







Could higher health care access in COPD patients in this study possibly be associated 
with co-morbidity? According to Simon-Tuval et al. (2011), COPD patients reported 3.4 
times higher health services utilisation compared to controls. Both the number and the 
nature of co-morbidities were predictors of increased health care utilisation in COPD 
but disease severity was not. For example, the presence of specific co-morbidities such 
as heart disease (myocardial infarct, congestive heart failure), mild liver disease and 
diabetes mellitus were significantly associated with COPD patients’ increased health 
care use. In the present study 71% of participants reported additional health conditions 
such as diabetes or cardiovascular disease. Increased health care utilization was not 
associated with severity of airflow obstruction in the current study consistent with 
Simon-Tuval et al.’s (2011) findings. Similarly, Shaya, El Khoury, Samant, & Scharf 
(2006) and Lin, Shaya, & Scharf (2010) reported 1.33 times greater healthcare 
resources use and 1.8 times greater adjusted average number of inpatient claims in 
COPD patients compared to non-COPD controls. In addition, Mapel et al. (2000) found 
that healthcare utilization among COPD patients in New Mexico was almost double of 
age and gender matched controls. However, analyses in the present research did not 
indicate that there was a significant difference in HCA between COPD patients with 
and without co-morbidity. The lack of association between co-morbidity and HCA 
suggested that greater HCA in patients with COPD in the present study was not due to 
co-existing disease. While the questionnaire on HCA administered to patients was 
COPD-specific, co-morbidities could still have contributed to exacerbations or 
complications with their COPD in an indirect way. For example, cardiac disease could 
have increased the likelihood of dyspnoea or musculoskeletal conditions through 
restricting exercise or participation in PR due to limited mobility. However, analyses did 
not show any significant associations between co-morbidities and HCA. 
 
 The Quality and Outcomes Framework (QOF) 
 
The lack of a relationship between higher deprivation and poorer HCA could be due to 
the Quality and Outcomes Framework (QOF), which is a voluntary pay-for-performance 
scheme introduced in 2004 in the UK (National Institute for Health and Clinical 
Excellence, 2012). The QOF provides incentives for GP practices through rewarding 
339 
 
them for quality patient care. Practices score points according to their level of 
achievement in a number of groups of indicators depending on the disease, such as 
coronary heart disease or COPD, following NICE guidelines. In the case of COPD, GP 
practices receive points for performing regular spirometry on their patients. This could 
partly have contributed to increased rates of regular spirometry in lower SES groups. It 
would also be consistent with Gillam, Siriwardena, & Steel’s (2012) review who found 
that differences in QoF performance between deprived areas and more affluent areas 
were decreasing. However, the QOF would not be able to explain why more deprived 
participants were more likely to receive more frequent spirometry compared to higher 
SES patients. This suggested that other factors might have contributed to this 
relationship such as patients’ or doctors’ perceptions, attitudes and cognitions. 
The lack of an association between higher deprivation and poorer HCA could be an 
indication of a possible link between the QOF and a possible decrease in inequalities in 
processes of care between highly deprived and more affluent areas (Doran, 2008). 
Doran’s findings (2008) indicated that the gap in median achievement between GP 
practices located in the most deprived and the least deprived quintiles decreased from 
4% to 0.8% between 2004 and 2007. In addition, although there was significant 
improvement (up to 38%) in quality of care for all indicators in the timeframe between 
2001 and 2007, quality reached a plateau after the first 3 years (Doran, et al., 2011). 
Higher rates of regular spirometry in lower SES could be a reflection of this 
improvement since more deprived patients were more likely to have received better 
health care services. However, there might not have been a difference in this 
relationship to begin with. The systematic review (see Chapter Four) which included 
studies from the last two decades, showed that there was no quality evidence to 
support the link between poor HCA and lower SES in COPD patients. The increased 
spirometry rate might not have been an improvement but could have been the baseline 
from the start.  
Evidence from the National COPD Audit showed that 74% of admitted patients 
contacted their general practice in the month before hospitalisation and 31% contacted 
their GP three or more times in that month (National COPD Audit, 2008) indicating that 
access to GPs was not significantly impaired. Facilitated access to GP consultation 
through rapid access to primary care during a COPD exacerbation could explain the 
association between good access to GP consultations and reduced risk of 
hospitalisation (Calderón-Larrañaga, et al., 2011). Associations between the COPD-
related quality indicators examined and reduced admission rates were found only for 
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influenza immunisation. This facilitated access might have increased the likelihood of 
offering referrals and other needed health care services to deprived COPD patients. 
The QOF could have contributed to this through promoting health care access for all 
COPD patients. Access to GPs could have been facilitated through implementation of 
certain QOF indicators such as assessment of breathlessness (MRC dyspnoea scale), 
lung function (spirometry), inhaler technique and influenza immunisations (Indicators 
for Quality Improvement, 2010). However, the systematic review (see Chapter Four) 
showed that more deprived patients had better access to health care services for 
certain outcomes. This would weaken the argument for the QOF because some of 
these studies were conducted before its introduction or in countries where the QOF 
does not exist. The small number of studies included in the review was not sufficient to 
draw stronger conclusions and thus caution is required when attempting to interpret 
findings. 
The QOF “hypothesis” could also associated with higher smoking cessation referrals. 
Smoking cessation referrals was one of the five indicators that showed the highest 
increase (Doran et al., 2011). Smoking status recording had a low baseline which was 
attributed to two possible reasons. First, practices might not have asked most of their 
patients whether they smoked or not before the incentives were introduced. Second, 
had they asked, they might not have kept records of smoking status. GPs might have 
been aware of patients’ smoking status but since this was not being recorded, they 
might not have offered them smoking cessation referrals. The QOF could have 
increased the likelihood that doctors would act on their patients’ smoking status, thus 




The evidence does not appear to support a relationship between low SES and lower 
HCA in patients with COPD. Higher deprivation was associated with better access to 
health care services in some cases, consistent with existing literature. This, combined 
with the robustness of the design (method of recruitment, comprehensive assessment 
of SES and HCA measures, sufficient sample size, representation of SES levels and 
disease severity stages) strengthen the assumption that more deprived COPD patients 
were as likely to get equal or, in certain cases, greater HCA compared to more affluent 
COPD patients. This could be attributed to a number of additional factors such as the 
341 
 
nature of health care systems, the presence of co-morbidities and other elements 
discussed above. 
 
b. Present findings on SES and HCA and comparison to existing literature  
 
A widespread assumption was that higher deprivation was related to poorer HCA (Ben-
Shlomo & Chaturvedi, 1995; Watts, 1993; Tudor Hart, 1971). This assumption did not 
appear to apply for COPD patients. A limited number of studies investigated the 
relationship between SES and HCA in COPD, as observed in the systematic review 
(see Chapter Four). Where evidence for the association between SES and HCA exists, 
it does not show a clear direction. Despite the fact that this evidence was weak and not 
as rigorously conducted as the present study, it also showed that higher deprivation 
was related to greater health care access. For example, access to GPs and hospital 
services favoured lower SES groups (Van Doorslaer, Masseria, & Koolman, 2006; van 
der Heyden et al., 2003; Sutton et al., 2002; Masseria & Giannoni, 2010). In contrast, 
access to specialist services favoured higher SES groups (Masseria & Giannoni, 2010; 
Finkelstein, 2001; Dunlop et al., 2000; Hurley & Grignon, 2006). No evidence was 
found for the HCA outcomes measured in the current study. This could be due to 
COPD being mainly treated by GPs in the UK. Specialist referrals are not routinely 
offered and, when they are, patients are usually discharged back to their GPs after 
specialist assessment. This could be indicative of high levels of expertise and ability of 
GPs in treating these patients and therefore decrease the need for specialist treatment, 
irrespective of SES (Regidor et al., 2008). Finally, lack of support for the HCA 
measures in this study could also be attributed to the more robust design employed. 
The variety of HCA and SES measures, the large sample size and the method of 
participant recruitment which ensured high representativeness could have resulted in 
stronger evidence contradicting earlier research.  
Present findings contradicted past research on hospital admissions. Admissions were 
with low SES in terms of educational attainment and income level (Agabiti, et al., 2009; 
Miravitlles et al., 2006; Prescott et al., 1999). These studies did not adjust for severity 
of disease in their analyses. More severe disease related to lower SES could have 
influenced findings. In addition, educational level was defined as low, medium and high 
based on completion or not of primary education or more than primary education. This 
could have resulted in significant differences due to the vague classification. For 
342 
 
example, more than primary education could mean either secondary education 
completed or not or higher education which does not reflect accurate levels.  
Similar evidence linking lower SES to impaired access to primary care services was 
provided by Begley et al. (1994). However, Begley, et al. (1994) used avoidable 
hospital admission rates as an indicator of impaired primary care access and included 
a variety of different health conditions such as diabetes, urinary tract infections, 
asthma, epilepsy and hypertension. In addition, Begley et al. (1994) did not adjust for 
disease severity. Moreover, the study was conducted in the USA where lack of health 
insurance might have contributed to poorer primary care access and higher rates of 
hospital admissions.  
Current findings did not indicate lower health care access in lower SES groups when 
controlling for severity. Health care access measures referred to both primary care 
services received at the GP practice and hospital admissions. There was no difference 
between low and high SES and HCA and where a relationship was found, access was 
greater for the more deprived groups. Hospital admission was not associated with 
lower SES. Based on the lack of a relationship between SES and HCA but considering 
the vast literature on health inequalities, it is tempting to speculate that health 
inequalities might be greater before the emergence of an illness but significantly 
reduced thereafter possibly due to the nature of the NHS or the availability of other 
services to patients. 
 
9.2.2 Were illness perceptions associated with SES and HCA? 
 
Income and educational level showed a number of significant associations with certain 
illness perceptions. Higher educational and income level were both associated with 
stronger perceptions of personal and treatment control. In addition, higher income level 
was related to weaker perceptions of identity, consequences, timeline cyclical and 
emotional representations. These associations suggested that people who were 
financially better off and more educated attributed fewer symptoms to their COPD, 
viewed its impact on their daily lives as less severe and considered it more stable. 
They also felt they had greater control over the illness and that their treatment was 
effective in managing their COPD successfully. It is not possible to claim that people 
had more positive perceptions of their illness because they were more affluent or more 
educated. People could have attained higher income level because they perceived 
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their illness to be less severe and under control. Thus, they might have continued 
working and engaging in a variety of activities that could have promoted their social 
and financial status. Whereas, educational attainment would probably have been 
completed by the age (i.e. over the age of 40 usually) when COPD is usually 
diagnosed or when symptoms deteriorate. The remaining aspects of SES measures 
(IMD scores and quintiles and occupational class) were not significantly associated 
with illness perceptions. 
Previous research investigated predictors of illness perceptions in coronary heart 
disease (CHD) patients and found a significant relationship between illness perceptions 
and personal and social resources (Aalto et al., 2006). People who perceived 
themselves to be more competent were less likely to attribute symptoms to their CHD, 
felt more in control of the illness, perceived less severe impact of the disease and 
attributed fewer symptoms to CHD. Aalto et al. (2006) used a stress-appraisal 
framework which postulated that people with stronger beliefs in their ability to deal with 
life events were more likely to adopt effective ways of coping with their illness and its 
challenges. This resulted in evaluating the consequences of CHD as less severe and 
threatening and reinforced their perceptions of control over the illness.  
In the present study, COPD patients who had higher weekly income and  higher 
educational attainment were more likely to report higher perceived levels of personal 
and treatment control, weaker identity beliefs and perceived consequences as well as 
weaker perceptions of timeline cyclical and more stable emotional representations. The 
stress-appraisal framework could be used to explain these findings. More affluent and 
educated patients may have had stronger belief in their abilities to cope with life due to 
more available resources. This belief might have been associated with higher likelihood 
of these patients adopting effective ways of coping with their illness and its challenges. 
All HCA measures (smoking cessation and specialist referrals, pulmonary rehabilitation 
awareness, referrals, attendance and completion, regular spirometry, treatment 
appropriateness and hospital admission) were significantly associated with illness 
perceptions except for regular spirometry. Participants who had stronger identity beliefs 
(i.e. more symptoms attributed to COPD), stronger perceptions of consequences (i.e. 
the magnitude of the impact of COPD on their daily life) and stronger perceptions of 
timeline (i.e. COPD being chronic) were more likely to have been offered referrals to 
specialists, PR programmes and given appropriate treatment for their condition. PR 
awareness and referral were also more likely in more severely affected COPD patients 
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(in terms of FEV1% predicted). In addition, higher hospitalization rates were related to 
stronger timeline cyclical beliefs. This relationship could be due to the very nature of 
COPD which is characterized by periods of symptom stability and exacerbations 
possibly leading to more frequent hospitalizations. On the other hand, frequently 
admitted patients might be more likely to have stronger timeline cyclical perceptions 
due to alternation between remissions and exacerbations of their COPD. These 
associations were unaffected by disease severity suggesting that hospital admission 
was not related to severity of patients’ COPD.  
 
a. Possible explanations for the relationship between illness perceptions and HCA 
  
The significant relationship between illness perceptions and HCA in COPD could be 
explained in different ways. These will be discussed in the following sections. 
 
 Illness perceptions and health care services providers 
 
COPD patients’ more negative illness perceptions could have influenced doctors’ 
clinical management. These patients could have provided their physician with more 
information about their history and symptoms due to higher worry or preoccupation with 
their illness. This could have increased physicians’ openness for the delivery of quality 
care (Farr, 2000) as long as the doctor allowed the patient to be expressive about 
symptoms, expectations and feelings and patients’ and doctors’ perceptions being 
congruent (Kleinman, 1978).  
Alternatively, providing patients with the responsibility to manage their COPD through 
available options could increase perceptions of the illness placing more demands on 
everyday life. This could then lead to more negative illness perceptions because of 
illness uncontrollability beliefs. PR completion was associated with weaker perceptions 
of consequences and stronger illness coherence which could be indicative of the 
positive effects of PR not only on patients’ physical and mental status but also on 
patients’ illness perceptions (Fischer et al., 2010). The opposite could also be true. 
Patients who perceived the impact of COPD on their everyday life to be less significant 
and who had a good understanding of their illness were more likely to successfully 
345 
 
complete the PR course in Fischer et al.’s (2010) study. Again causal relationships 
cannot be inferred due to the nature of the study design.  
 
 Illness perceptions, behaviour and health care seeking 
 
The role of illness perceptions could influence HCA through risk perception which can 
affect behaviour such as seeking health care (Baumann, Cameron, Zimmerman, & 
Leventhal, 1989; Cameron et al., 1993). Patients’ experience and the intensity of new, 
worrisome symptoms and their interpretation were more likely to have increased the 
likelihood of health care-seeking. Identification of symptoms or sensations that are not 
consistent with usual physical sensations set the ground for health care-seeking 
(Cameron, et al., 1993). The interpretation of these “inconsistent” symptoms depends 
on their match with an underlying abstraction of symptoms associated with a particular 
illness. For example, the controls in Cameron et al.’s (1993) study who did not seek 
medical care were less likely to have viewed their symptoms as disruptive, less likely to 
have evaluated them as “inconsistent”, and less likely to have attributed their 
symptoms to a specific illness (i.e., the “inconsistent” symptoms had not exceeded the 
threshold in order to be associated with illness-specific concepts). Although these 
examples referred to hypertension, other conditions such as asthma follow a similar 
pattern. The majority of patients considered asthma to be a chronic condition, however, 
over half of them believed they had asthma only when they experienced symptoms 
(Halm, Mora, & Leventhal, 2006). The episodic nature of asthma characterised by 
attacks and remission reinforced cyclical representation which was associated with less 
frequent use of preventer medication and routine GP visits as well as use of peak flow 
meters to evaluate lung function (Halm et al., 2006). In contrast, COPD is a slowly 
progressing disease. The chronic nature of COPD and its gradually deteriorating 
associated symptoms such as cough and breathlessness might have lead to the 
development of stronger illness perceptions.  
But would the way patients perceived their illness guide them to also act in a certain 
way? While the Common Sense Model (CSM), in which illness perceptions are the key 
construct (Leventhal et al., 2003; Leventhal, Safer, & Panagis, 1983), provides the 
framework to combine elements involved in connecting physical experiences to 
underlying constructs to create and activate illness perceptions, it cannot be used on its 
own to predict how an individual will behave. People vary in how they perceive their 
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illness due to the influence of external variables that may affect behaviour such as 
socio-economic factors which could be linked to different beliefs and perceptions even 
within an illness-specific patient population.  
Illness perceptions are associated with specific procedures following the “if-then” rules 
but not coping strategies because coping strategies may moderate specific action 
(Leventhal, Leventhal, & Breland, 2011). For instance, patients with colon or breast 
cancer may choose to select surgery over radiation therapy because they may 
consider surgery a way of removing the tumour. However, whether these patients 
make that therapy choice or how fast they make it can be influenced by coping 
strategies such as avoidance versus problem-focused coping. Strategies for self-
regulation incorporate and influence both illness and treatment representations. Based 
on the symptoms people experience and the way they interpret them, they might 
choose a procedure from a set of potential treatment or lifestyle behaviours to remove 
the inconsistent symptoms within a given time frame. However, in order for an 
individual to enact the intended behaviour, the behaviour needs to be placed in the 
appropriate context that would encourage it to occur. This framework could explain the 
associations between illness perceptions and health care access and highlight the 
possible influence of doctor-patient interaction. COPD patients may have had stronger 
illness perceptions which made them more likely to be aware of and eager to attend PR 
courses but these were dependent on cues provided by the physician as well. These 
cues would facilitate the conversion of their intentions into actions such as being 
offered referrals for smoking cessation or PR which would suit their needs and 
circumstances. Therefore, the influence of the health professional would need to be 
taken into consideration when attempting to draw conclusions or make speculations 
regarding underlying pathways.  
 
 Illness perceptions, PR and smoking cessation 
 
Pulmonary rehabilitation was not associated with socio-economic factors. Attendance 
and completion rates at PR were previously reported to be low with approximately 
1.5% of COPD patients accessing PR annually (Yohannes & Connolly, 2004). A more 
recent study by Hogg et al. (2012) reported that 73% of the COPD patients who were 
referred for pulmonary rehabilitation attended assessment, 59% started the programme 
and only 40% completed it. Low completion rates were significantly associated with 
347 
 
depression as well as deprivation and greater disease severity. However, the authors 
noted that these variables could only account for 10% of the variance in completion 
rates and suggested that further factors might be implicated. 
Keating, Lee, & Holland (2011) and Whitehead et al. (1992) found that reasons for non-
attendance included lack of means of transportation and no perceived benefit 
associated with attending. Non-completion was related to depression, smoking and 
lower physical strength. Disease markers such as lung function or dyspnoea were not 
significantly associated with attendance or completion of PR. Keating et al. (2011) drew 
attention to the fact that the factors mentioned above accounted for less than 50% of 
the variance and suggested that further factors such as personal experiences might be 
associated with PR completion.  Similarly, Fischer et al. (2009) found that failure to 
complete or not attend PR was due to medical or practical reasons such as time 
constraints and dissatisfaction with the health care system. Current smoking and 
depression were also related to lower completion rates in Fischer et al. (2009).  
What was the role of illness perceptions in PR completion in the present study? COPD 
patients who completed PR had stronger illness coherence and weaker consequences. 
These patients might have completed their programme successfully because they had 
a better understanding of their COPD and felt that the impact of their illness on their life 
was not very severe. On the other hand, as a result of completing PR, they might have 
acquired a better understanding of the illness and have realized that the consequences 
of their illness were not significant. But, causal relationships cannot be inferred due to 
the cross-sectional design of the study. In addition, patients who were aware of PR 
tended to have stronger identity, timeline, consequence perceptions as well as stronger 
emotional representations but weaker treatment control beliefs. This suggested that 
these patients felt their treatment was not sufficient in controlling their illness but they 
also felt their COPD was chronic, associated with more symptoms, and had more 
severe impact on their daily lives and emotional functioning. These perceptions could 
have made these patients more proactive in seeking information on further services 
available to improve their health status.  
 
9.2.3 Were self-efficacy and social capital associated with HCA? 
 
Self-efficacy was not associated with HCA possibly because general instead of COPD-
specific self-efficacy was examined. General self-efficacy might not be as relevant as 
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the latter in the health care context because it refers to an individual’s belief in their 
ability to cope with any demand and event that may arise in their lives. 
Overall, social capital was not significantly associated with HCA. Two significant 
relationships between HCA and SC were found: smoking cessation referral and over-
treatment. People who felt less appreciated by society were more likely to have been 
given smoking cessation referrals. On the other hand, people with more family and 
friend connections were more likely to have been over-treated (i.e. prescribed 
respiratory drugs appropriate for more severe disease). It would be tempting to 
interpret over-treatment as a sign of doctors’ eagerness to relieve the patient from their 
symptoms and improve their QoL - possibly indicating greater HCA. However, Lucas, 
Smeenk, Smeele, & van Schayck (2008) found that GPs’ lack of sufficient awareness 
of the need for proper diagnostic testing and diagnostic short-comings was associated 
with increased unnecessary  prescribing of inhaled corticosteroids (ICS) in patients with 
asthma and COPD. Overprescribing was related to higher costs and possible side 
effects. From this perspective, over-treatment could be considered as evidence of 
worse health care. Brunner et al. (1999) reported over-prescription of medication in 
54.9% of COPD patients. Over-prescription is important to consider due to not only 
unnecessary expense but also because due to increasing the risk for adverse drug 
effects and poor adherence (Franssen, Spruit, & Wouters, 2011; Mackenbach, et al., 
1997). 
Over-treatment was associated with both stronger emotional representations and more 
family and friend connections. Patients could have been prescribed unnecessary 
respiratory medication because of their preference for prescriptions or because of 
particular expectations (Virji & Britten, 1991). These could have been influenced by 
stronger emotional perceptions of their COPD reinforced by their family and friends’ 
encouragement (Virji & Britten, 1991).  
 
9.2.4 Was SES associated with QoL? 
 
Higher weekly household income level was significantly related to better QoL but the 
remaining SES measures i.e. IMD, educational level and occupational class were not. 
Less deprived people in terms of income level were more likely to report lower levels of 
dyspnoea, fatigue and lower risk of depression, better emotional function and greater 
mastery unaffected by disease severity. However, the strength of these associations 
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was moderate ranging from 0.22 – 0.25. The fact that only income level was associated 
with QoL might be an indication that it could be reflecting current SES more effectively 
compared to educational attainment and occupational status in this particular 
participant sample where the mean age was 69 years (Braveman et al., 2005). Present 
findings differ from those of Miravitlles, Naberan, Cantoni, & Azpeitia (2011) who found 
that lower educational and occupational level were significantly associated with poorer 
HRQoL in COPD patients. However, the QoL measure used by Miravitlles et al. (2011) 
was the EuroQoL-5 (Brooks, 2003) which is not COPD-specific and therefore might not 
have been able to capture the particulars of this condition. Moreover, educational level 
was classified into “low” (referring to uneducated/unfinished primary school), “medium” 
(finished primary school) and “high” (finished secondary school and university degree) 
which could have affected their results. The present study categorised educational 
level as low (secondary or less) and high (post secondary). Moreover, Miravitlles et al. 
(2011) controlled for disease severity by using the COPD severity score (COPDSS) 
which is a valid survey-based measure of disease-specific severity (Eisner et al., 2005; 
2010) but does not require lung function assessment which is the main measure of 
severity of COPD (GOLD, 2011). Last but not least, Miravitlles et al. (2011) did find an 
association between lower educational attainment and poorer QoL in COPD patients 
but effect sizes were very small and their sample size was very large. Thus, these 
results may not have been of clinical significance. 
Analyses in the present study regarding QoL showed that COPD patients’ physical and 
mental status was slightly better compared to previous findings (Saydah & Lochner, 
2010; Dransfield et al., 2011; Withers et al., 1999; von Leupoldt et al., 2011). This was 
not surprising since greater use of health care services was observed. However, it is 
not known whether this difference in QoL between the participant samples is 
statistically significant because further analyses of all the data would be required to 
establish that. If the difference was not statistically significant, it would be less likely 
that greater health care access was associated with improved QoL in COPD patients. 
In addition, it raises the question whether further factors linked to illness perceptions 
might have confounded the beneficial effect of improved HCA such as advanced age or 
existing co-morbidities. It could be possible that despite better access to health care 





a. How could findings regarding SES and QoL in COPD be explained? 
 
As discussed above, income level was significantly related to QoL in COPD. However, 
the remaining SES measures (IMD, educational levels and occupational class) were 
not. Proposed reasons for this inconsistency are discussed below. 
The QoL measures used in the present study which assessed domains such as 
mastery, fatigue or breathlessness might not have been related to IMD but to more 
specific SES indicators, for example income level. Secondly, IMD is an area-based 
rather than an individual-based indicator for SES and may not reflect the extent of 
deprivation of the participant sample. The IMD includes seven dimensions to measure 
deprivation at an area level (deprivation in income, employment, health and disability, 
education, crime, barriers to housing and services and in the living environment). 
These dimensions carry varying weights depending on the perception of their 
importance. For example in the IMD 2010, the highest weights are carried by income, 
employment, health and disability and education deprivation. Furthermore, because of 
this weighted cumulative model employed for the different domains of deprivation, lack 
of deprivation in one domain could cancel out deprivation in another domain. For 
example, low levels of income deprivation could cancel out high levels of health and 
disability deprivation. Patients of higher income would have the financial resources to 
visit a doctor privately compensating for the limited health care services in their area. 
Thus, income level appears to be the measure that would probably more accurately 
reflect patients’ financial circumstances and potential ability to counterbalance area-
level deprivation. This could be true especially when considering the diversity of South-
East London. The fact that the other measures examined this thesis such as self-
efficacy, illness perceptions and social capital did not show any significant associations 
with IMD, suggested that a true relationship between SES in terms of IMD and QoL 
was not being concealed.  
In addition, income level would reflect current SES on an individual level such as the 
receipt of a private pension and might therefore be more likely to show associations 
with QoL. Higher income could provide an individual with higher buying power in order 
to secure certain lifestyle patterns such as better nutrition, better housing, and higher 
exercise uptake. Poorer lifestyle conditions were associated with worse QoL in COPD 
(Franks & Fiscella, 2002; Winkleby et al., 2007; Di Pede et al., 1991; Arne et al., 2009). 
However, behaviour is not the only predictor of QoL. Other predictors of QoL in COPD 
patients that have been reported include the extent of perceived tension-anxiety, 
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exercise performance, FEV1, and neuropsychological status (Prigatano, 1984). In 
addition, the lack of significant associations between occupational class and QoL 
indicated that it was probably not social status derived from occupational class that was 
associated with people’s well-being. It is less likely that higher income level would be 
associated with QoL through providing higher prestige particularly when the vast 
majority of the sample was retired.  
Higher educational could exert an influence over QoL. However, even if a more 
educated person knows that exercise and good diet is essential for them to be 
healthier, this does not mean they would adopt this lifestyle for a variety of reasons. 
These reasons include factors that might interfere between the intention to engage in a 
certain behaviour and acting on it, such as planning, maintenance self-efficacy, and 
action control (Clegg, et al., 2009; Sniehotta et al., 2005) or lacking monetary 
resources. This could potentially explain why income level was associated with QoL 
and educational attainment was not. For example, more educated COPD patients who 
were aware of the value and necessity of consuming fresh fruit and vegetables or 
joining an exercise programme, would be less likely to do so if they would not be able 
to afford it. In addition, educational attainment could influence an individual’s QoL 
through other ways such as greater knowledge and awareness of their condition and 
ways of managing it successfully. Higher education could be associated with increased 
awareness of availability of health care services and ways of accessing them more 
effectively. This could be achieved perhaps through influencing doctor-patient 
interaction in a beneficial way, for instance, through showing awareness and 
understanding of the treatment options or lifestyle changes that need to be adopted. 
 
9.2.5 Were illness perceptions associated with QoL? 
 
Most illness perceptions showed significant associations with QoL in patients with 
COPD. Stronger perceptions of identity, consequences, timeline cyclical, illness 
coherence and emotional representations as well as weaker perceptions of personal 
and treatment control were associated with poorer QoL. These relationships were 
unaffected by disease severity suggesting that poorer QoL was not an effect of more 
severe COPD. Findings are consistent with previous research. Identity has consistently 
been reported to be related to physical and psychological outcomes in COPD. For 
example, Scharloo et al. (1998) found associations between strong identity beliefs and 
physical, role and social functioning. In other words, patients who attributed more of 
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their symptoms to COPD were more likely to experience poorer physical and mental 
status compared to patients who did not attribute so many symptoms to their illness. 
The authors also observed associations with further dimensions namely timeline, 
consequences and control (Scharloo et al., 1998, 2000, 2007; Kaptein et al., 2008; 
Howard et al., 2009). Patients who believed that their illness was chronic, perceived 
their illness to have a serious impact on their lives and felt they had less control over 
managing their COPD had poorer QoL outcomes. In the present study, findings were 
identical with the exception of chronic timeline. Timeline cyclical was associated with 
poorer QoL. This difference could be attributed to the specific characteristics of the 
population examined. For example, they might have had more frequent exacerbations 
compared to the other patients groups. This might have been linked to perceptions of a 
more cyclical nature of their COPD while remissions of the disease might have been 
linked to perceptions of non-chronicity. Negative consequences are related to higher 
levels of depression and anxiety in a number of conditions such as rheumatoid arthritis 
(Groarke et al., 2005; Murphy, Dickens, Creed, & Bernstein, 1999; Schiaffino, 
Shawaryn, & Blum, 1998), irritable bowel syndrome (Rutter & Rutter, 2002),  breast 
cancer (McCorry, et al., 2012), cardiac patients (Le Grande et al., 2012) and diabetes 
(Skinner et al., 2010). The strength of the correlations with depression and anxiety was 
weak for most illness perceptions in the aforementioned studies but strong for identity, 
consequences and emotional representations. It cannot be established whether poorer 
QoL influenced patients’ illness perceptions or whether their illness perceptions led to 
poorer QoL. It could be that the experience of more symptoms and a more severe 
impact of COPD on daily life led to more negative illness perceptions about their 
illness. Alternatively, poorer QoL could have resulted from maladaptive illness 
perceptions such as perceptions of lack of control or symptoms associated with COPD 
preventing patients from engaging in various positive health behaviours such as 
exercise, diet, medication adherence or stopping smoking, which would, in turn, have 
an effect on their QoL (Chen, Clark, & Talcott, 2009; Harvey & Lawson, 2009).  
 
a. Present findings on SES, illness perceptions and QoL in COPD and comparison 
to past research 
 
Present findings are consistent with previous studies that reported a link between 
illness perceptions and QoL in chronic illness (Covic, Seica, Gusbeth-Tatomir, 
Gavrilovici, & Goldsmith, 2004; Kaptein et al., 2011; Hagger and Orbell, 2003). Kaptein 
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et al. (2008) reviewed the evidence for illness perceptions in patients with COPD which 
demonstrated similar patterns to other diseases. The results of the review indicated 
that a variety of outcomes are related to illness perceptions in COPD such as physical 
and emotional functioning, for example depression, anxiety, the degree of disability and 
quality of life.  Poorer outcomes were associated with stronger perceptions of identity, 
lower perceived personal control, and stronger emotional representations while better 
outcomes were associated with a higher sense of control and self-efﬁcacy and more 
stable emotional representations. 
Quality of life was significantly impaired in patients with COPD in comparison to 
populations without health problems echoing previous literature (Ketelaars et al., 1996; 
Okubadejo et al., 1996; Ferrer et al., 1997). Similar findings were observed in Canada 
(Ross et al., 2011) where a social gradient in quality of life according to both income 
and education was observed. The higher people’s educational attainment was the 
higher their income and the better their QoL. Gómez-Olivé, Thorogood, Clark, Kahn, & 
Tollman (2010) found similar results in rural South Africa. Low education, household 
income and unemployment were associated with poorer QoL. This would suggest that 
the reasons for poorer QoL in COPD might be found in factors other than HCA such as 




There appears to be substantial support for the association between illness perceptions 
and QoL and health outcome. Although a large number of these studies were cross-
sectional, some employed a longitudinal design. Kohlmann, Rimington, & Weinman 
(2012), for example, found that the majority of patients in their study retained similar 
patterns of illness perceptions before their valve replacement one year post-surgery. 
These patterns significantly predicted patients’ health status. Still, a smaller group of 
patients showed changes in their illness perceptions in the absence of any 
interventions. Kohlmann et al. (2012) suggested that these changes were due to 
patients’ personal experiences that occurred during this time and not to changes in 
their medical status (Weinman & Petrie, 1997). Another longitudinal study showed that 
illness perceptions such as higher perceived treatment control predicted survival in 
haemodialysis patients independent of depression, comorbidity and age (Chilcot, 
Wellsted, & Farrington, 2011). Treatment control perceptions were not related to the 
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adequacy of dialysis suggesting that these perceptions were probably mediated by 
health care behaviours that were not following the treatment regimen (Chilcot et al., 
2011). More longitudinal studies are needed to increase our understanding of how 
illness perceptions develop or change over time and how they could affect health 
outcomes. 
 
9.2.6 Were self-efficacy and social capital associated with QoL? 
 
Higher self-efficacy was associated with better QoL consistent with previous literature 
(Knittle et al., 2011; Mystakidou et al., 2012). Causal relationships cannot be inferred 
and therefore the direction of the association is not clear. Patients who believed they 
could achieve their goals such as physical activity targets (Woodgate & Brawley, 2008; 
Ashford et al., 2010), smoking cessation (Schnoll, et al., 2011) or dietary change 
(Pinto, Clark, Cruess, Szymanski, & Pera, 2012) were more likely to experience better 
QoL. If their QoL was better, they would feel more confident in their abilities to achieve 
desired outcomes and their self-efficacy could be higher (Pinto et al., 2012). In his 
study, general self-efficacy was examined rather than disease- or behaviour-specific 
self-efficacy. General self-efficacy describes a person’s overall belief in their ability to 
deal with life events not restricted to their illness or specific behaviours. Therefore, all 
aspects of patients’ daily life would be affected. The relationship between specific 
(COPD) self-efficacy and quality of life in COPD has previously been supported 
(McCathie, Spence, & Tate, 2002). This association persisted even when adjusting for 
disease severity and duration as well as socio-economic status. Higher levels of self-
efficacy were related to decreased impact of COPD on patients’ psychosocial 
functioning, increased physical activity and quality of life (Bentsen et al, 2010). Lower 
levels of self-efficacy were related to poorer self-management of disease in COPD 
patients (Warwick et al., 2010) as well as perceived difficulty in breathing (Jee, 2011). 
Similar associations were reported in terms of survival, engagement in physical activity 
(Kaplan et al., 1994; Soicher et al., 2012) and functional performance (Siela, 2003). 
Current analyses supported the relationship between self-efficacy and QoL in patients 
with COPD. The higher patients’ belief in their abilities to achieve their goals and 
objectives, the more likely they were to experience better QoL. Self-efficacy was 
significantly associated with all domains of QoL i.e. perceived fatigue, better emotional 
function, greater mastery and lower risk of depression and anxiety. These results 
confirm previous reports that highlighted the importance of self-efficacy in relation to 
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QoL. However, self-efficacy and QoL could have been affected by a third factor such 
as depression. Patients with higher levels of depression could have lower levels of self-
efficacy and poorer QoL. The interrelationship between depression and self-efficacy 
and QoL could influence coping strategies or disease management negatively 
(Cleland, Lee, & Hall, 2007; McCathie, Spence, & Tate, 2002). 
Higher levels of social capital were related to poorer QoL in all domains except for 
mastery when adjusting for disease severity. For example, higher participation in local 
community events was associated with greater fatigue and dyspnoea, poorer emotional 
function and higher risk of depression and anxiety. This could have been due to the 
strain of active social involvement on patients with COPD which manifesting as 
increased fatigue and dyspnoea and poorer emotional functioning. In contrast, higher 
levels of social proactivity, more family and friend as well as work connections and 
greater value of life were associated with lower risk of depression. Findings indicate 
that different elements of social capital might be associated in different ways with QoL 
in patients with COPD. 
  
a. Present findings on self-efficacy and social capital and QoL in COPD and 
comparison to past research 
 
Present findings on self-efficacy and social capital in relation to QoL are consistent with 
previous research. Grodner et al. (1996) found that social support and self-efficacy as 
well as dyspnoea and exercise performance were positively associated in patients with 
COPD after completing pulmonary rehabilitation. However, social support was only 
measured at baseline and therefore the direction of the relationships could not be 
established. When disease severity was adjusted for, the relationships became 
marginally significant. Lower levels of social capital have previously been shown to be 
associated with poorer quality of life (Kawachi & Berkman, 2001) through a number of 
pathways such as diffusion of knowledge about health-related actions (e.g. smoking 
cessation), social control over health behaviours through facilitating access to local 
services and facilities promoting healthy living (e.g. parks and gyms) (Rogers, 2003) 
and health care services (Kawachi and Kennedy, 1999), or through psychosocial 
processes such as provision of social support and respect (Kawachi and Berkman, 
2002; Wilkinson, 2002). Participants who were still in employment and had more 
connections at their workplace experienced lower risk of depression possibly through 
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greater availability of social support through colleagues. Interpretation of results 
warrants caution because the number of participants who were still working was very 
small. The only social capital dimension that was not associated with quality of life was 
tolerance of diversity. The impact of multiculturalism of the area of residence and living 
among people of different lifestyles did not appear to have any effect on patients’ QoL. 
This could be due to patients’ limited mobility restricting their social activities and 
engagement. Alternatively, diversity might not affect QoL in patients with COPD. 
 
9.2.7 Psychosocial variables as mediators in the relationship between SES and HCA 
and QoL 
 
SES in terms of IMD scores and quintiles was significantly associated with HCA with 
respect to smoking cessation referral. SES in terms of educational level was 
significantly associated with HCA with respect to regular spirometry. However, these 
associations were weak and were not significantly mediated by illness perceptions, 
self-efficacy or social capital. This suggested that other factors could be mediating the 
effect of IMD variables on smoking cessation referral and regular spirometry. HCA data 
were based on patient self-report and thus recall of referrals and use of other health 
care services might not have been accurate. 
 
a. Did psychosocial variables (IPs, GSE, SC) mediate the relationship between 
SES and QoL? 
 
A number of illness perceptions significantly mediated the relationship between income 
and all domains of QoL (dyspnoea, fatigue, mastery, emotional function, and 
depression). For instance, patients with lower income were more likely to associate 
more symptoms with their COPD, perceive a more severe impact of COPD on their 
lives and perceive poorer emotional representations. These illness perceptions were 
associated with higher levels of dyspnoea, fatigue and higher risk of depression. Self-
efficacy mediated the impact of income in most domains (mastery, emotional function 
and depression). For example, patients who had lower income were more likely to 
perceive greater self-efficacy which was associated with greater levels of mastery, 
better emotional function and lower risk of depression. Social capital elements (feelings 
of trust and safety and value of life) only mediated the effects of income on depression 
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and the relationship between income and dyspnoea. Patients who had lower income 
were more likely to have lower feelings of trust and safety as well as weaker value of 
life beliefs. These were associated with higher levels of dyspnoea and higher risk of 
depression.  Findings suggested that the relationships between income level and QoL 
in COPD were mediated by illness perceptions to a statistically significant extent and 
less by self-efficacy and social capital elements. However, the amount of variance 
explained by these mediators was small ranging between 4 and 9%. The size of the 
observed R-squared values was smaller than expected for these relationships. While a 
bigger sample size would have increased power to show the mediating effect of illness 
perceptions, this would not have altered the present conclusions because the effect 
sizes were very small. A larger sample size would have reduced the confidence 
intervals of the effect sizes and may have made some of the p values significant but it 
would be unlikely to increase the effect sizes. Further factors not examined in this 
research could be considered as possible mediators in the relationship between 
income level and QoL in COPD patients. Factors affecting QoL in COPD reported in 
previous studies include pessimism, hopelessness, hostility or anger.  
 
b.  The possible role of negative emotions and affect in the relationship between 
SES and QoL  
 
The relationship between SES and QOL could be understood in the context of low-SES 
environments. Low SES could contribute to exacerbation of emotions and attitudes, 
and these may have deleterious effects on health. It was suggested that more deprived 
people are more reactive to stress compared to their more affluent counterparts due to 
limited availability of personal and interpersonal resources to cope with stressful events 
in life and which, in turn, would be linked to increased stress levels (Gallo and 
Matthews, 2003). Negative emotions and cognitions can have an impact on health 
through behavioural (e.g. medication adherence, lifestyle, smoking) (Smith, 1992; 
Williams, O’Connor, Grubb, & O’Carroll, 2011) and physiological pathways (e.g. 
dysregulation of the hypothalamic-pituitary-adrenocortical (HPA) axis, increased blood 
pressure and inflammatory processes) (Kiecolt-Glaser, McGuire, Robles, & Glaser, 
2002). In addition, more deprived people were more pessimistic in comparison to more 
affluent people and were more likely to anticipate bad future events. In contrast, being 
optimistic and anticipating good events in the future was not linked to SES  (Robb, 
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Simon, & Wardle, 2009). Further variables that might be considered as possible 
mediators in the relationship between SES and QoL in COPD are discussed below. 
Negative cognitions and affective states could be inversely associated with SES (Gallo 
& Matthews, 2003). Gallo and Matthews (2003) proposed a model of psychosocial 
pathways in the relationship between SES, cognitive-emotional variables and health 
status. According to this model, lower SES is associated with negative emotions and 
attitudes through the experience of frequent and intense harmful situations and chronic 
stress (McLeod & Kessler, 1990; Murrell & Norris, 1991; Stansfeld et al., 1998). Lower 
SES groups are more likely to interpret ambiguous social events in a more negative 
way due to cognitive bias, i.e. the tendency to appraise various ambiguous situations 
consistently in a negative way (Chen & Matthews, 2001). The more significant impact 
of stress on low-SES people could be explained by fewer resources available in terms 
of tangible, interpersonal, and intrapersonal support to help them deal with stressful 
events in comparison to higher SES individuals. Responses to stressful stimuli at the 
psychological, behavioural, and biological levels have harmful effect on health in the 
long-term (Adler & Snibbe, 2003). For instance, a threatening situation might increase 
feelings of distrust which could lead to heightened physiological arousal and undermine 
social trust (Chen & Matthews, 2001). Biological factors should therefore be considered 
as possible mediators in the relationship between SES and QoL in addition to the 
psychosocial variables mentioned above. Increased physical risk and decreased well-
being might not only be influenced by greater environmental exposure to stressors, but 
also by the way people psychologically react to such stimuli.  
Hopelessness is defined as “negative expectations about the occurrence of highly 
valued outcomes and feelings of helplessness about changing the likelihood of 
occurrence of these outcomes” (Alloy, Abramson, Metalsky, & Hartlage, 2011). 
Hopelessness has been associated with a number of health outcomes such as heart 
attacks and cardiac death, and has been implicated in the relationship between SES 
and health (Fiscella & Franks, 1997). However, hopelessness is associated with 
increased proneness to disease. This does not equate to hopelessness necessarily 
influencing health status after the emergence of an illness in the same way. Hostility 
and anger predicted mortality and morbidity, and in some patient populations they 
mediated the relationship between SES and cardiovascular functioning (Gump, 
Matthews, & Räikkönen, 1999). Optimism and pessimism were predictors of recovery 
from coronary bypass surgery and onset of AIDS in individuals who had tested HIV-
positive. In COPD, patients who experienced negative emotions such as anger, 
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hopelessness or helplessness were more likely to rate their breathing as more intense 
in a word association task compared to patients who did not experience these 
emotions (Michaels, Meek, & Dedkhard, 2008). Both hopelessness and helplessness 
could be associated with lower SES, poorer QoL and illness perceptions possibly 
through lower levels of personal and treatment control as well as perceptions of more 
severe consequences. These findings provided some clues for a possible association 
between negative affect and health status in patients with COPD. 
 
c. Interpretation of findings 
 
The statistically significant relationships that were found between the predictor variable 
(SES) and the predicted outcomes (QoL/HCA) and for mediation by the proposed 
mediators (illness perceptions, self-efficacy and social capital) could have increased 
the likelihood of Type 1 error. The large number of statistical tests that were conducted 
to examine the relationships between the variables could have led to false positive 
findings except where the p value was lower than 0.01. The likelihood that one of the 
variables will reach the conventional level of significance of <0.05 is increased at the 
p<0.05 level. Reducing this threshold to p<0.01 (a conventional alteration in the 
Bonferroni correction) decreases the likelihood of such an error considerably. 
Several forms of a broad predictor (income level, educational level, occupational status 
and IMD scores) were used to examine SES in this thesis. Not all of these four 
indicators reached statistical significance in their associations with the predicted 
outcomes (QoL/HCA). For example, income level appeared to be the indicator which 
showed more consistent relationships with QoL while IMD scores or educational level 
did not. This could reflect the appropriateness of the specific indicator for the particular 
participants who were recruited in this study the majority of whom are retired and/or for 
the particular outcome examined i.e. QoL. However, it is also likely that the statistical 
significance of income level in relation to QoL could also have been due to Type 1 
error. 
Although significant associations were found between predictor (SES) and predictive 
variables (HCA/QoL) as well as for mediation of these relationships by the proposed 
mediators (illness perceptions, self-efficacy and social capital), it has to be emphasised 
that the effect sizes were very small. This suggests that the focus should not be on 
whether one variable is a stronger predictor of another variable but rather on the fact 
360 
 
that these statistically significant relationships were too small to be able to account for 
a substantial proportion of the variance. Thus, the predictors identified would not be as 
strong as originally hypothesised. 
 
9.3 Strengths of the research 
 
The present study had a number of strengths. A variety of measures were used to 
assess SES, QoL and HCA in a robust manner to capture a breadth of different 
aspects of SES, QoL and HCA. Four measures of SES were employed in the current 
study: weekly household income level, educational attainment, occupational class and 
IMD which is a continuous measure of deprivation. In this study IMD was used in the 
form of both scores and quintiles. Quintiles were computed to group participants by 
deprivation level and capture potential differences in HCA and QoL. This might not 
have been identified with the scores if the relationship between IMD and HCA or QoL 
had not been linear. There were a number of reasons why five indicators of SES were 
used. First of all, SES is viewed as a multidimensional construct that consists of a 
variety of socio-economic factors such as financial resources, power or status (Lynch 
et al., 1997; Macintyre et al., 1998; Diez Roux et al., 2001). Secondly, a person’s health 
could be affected by different socio-economic factors on various levels (e.g. individual, 
household or neighbourhood) and in varying ways (e.g. vulnerability, effects on 
physical status) depending on their age or stage in life (Singer and Ryff, 1997; Steptoe 
and Marmot, 2002). Third, previous studies suggested that additional factors such as 
socio-economic characteristics of the neighbourhood where a person resides could 
influence their health status beyond their individual-level SES (Robert, 1999; Pickett 
and Pearl, 2001). This could be operating through the physical, social or service 
environments in a variety of ways such as dietary patterns, exercise levels or 
neighbourhood violence (Macintyre & Ellaway, 2000; Morland, Wing, Diez Roux, & 
Poole, 2002; Sampson, Raudenbush, & Earls, 1997). Finally, due to COPD affecting 
people mainly in their 60s, participants’ age was considered in the selection of SES 
measures. Previous research suggested that educational and income level as well as 
occupational class might not be as appropriate indicators of SES in later age compared 
to younger adulthood (Braveman et al., 2005; Kaplan et al., 1987; Liberatos et al., 
1988). SES characteristics held earlier in life such as occupation or education would 
not necessarily be reflected in current SES, for example due to loss of income or loss 
of prestige due to retirement (Kaplan et al., 1987). Prestige associated with 
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occupational class could influence HCA in a beneficial way perhaps through patients’ 
higher levels of assertiveness to secure health care services they felt they needed. 
However, in the present study, income level was the SES measure significantly 
associated with HCA and QoL in COPD while the educational level, occupational class 
and IMD score were not. This suggested that income might be able to reflect people’s 
circumstances in later adulthood more appropriately possibly due to its relevance to 
individual-level SES providing people with higher buying power and enabling them to 
secure a more comfortable lifestyle. 
Additional SES indicators that might have provided more information in the assessment 
of its effect on HCA and QoL in the present sample are liquid assets and material 
circumstances such as car and home ownership (Robert & House, 1996). Previous 
research found that liquid assets and home ownership were not better predictors of 
self-rated health but they were better predictors of functional health in comparison to 
income and education for people aged 65 to 84 (Robert and House, 1996). Liquid 
assets are essentially financial assets because they can be converted into cash 
quickly. Liquid assets include stocks or government bonds and can be considered as a 
form of investment. They are slightly different to income which is available as a ready 
sum of money to be consumed at any time (Robert and House, 1996). Childhood SES 
could have been used as a further indicator of SES due to its association with 
adulthood SES (Duncan, Yeung, Brooks-Gunn, & Smith, 1998; Rogers, Nam, & 
Hummer, 1995) and its influence on health in later life irrespectively of adulthood SES 
(Smith, Hart, Blane, & Hole, 1998; Dennehy, Smith, Harker, Smith, & Ben-Shlomo, 
1997; Lynch et al., 1997).  
The variability and the strengths and weaknesses of the different SES measures used 
in the present study are reflected in the associations between these measures. 
Educational attainment and income level were weakly correlated (r=0.29) which 
mirrored previous studies that reported correlations lower than 0.50 (Gazmararian, 
Adams, & Pamuk, 1996; Braveman et al., 2001; Winkleby et al., 1992). This suggested 
that higher education was not strongly associated with higher income level. Income can 
show variations at similar educational levels across different as well as within social 
groups (e.g. age, sex). One possible explanation is that other variables such as social 
capital might be involved in the relationship between education and income. Social 
capital i.e. the availability of social networks and relationships might contribute to the 
accumulation of resources by individual members of groups through their membership 
of those groups (Pope, 2003). IMD similarly showed weak correlations with education 
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(r=-0.16) and income (r=-0.20). This finding was not surprising due to the fact that IMD 
is a composite area-level score of deprivation whereas educational and income level 
are individual-based measures. Occupational status was the only SES measure which 
was not significantly correlated to any of the other SES measures possibly because of 
participant characteristics. Due to retirement status, occupational class held previously 
may not have been a reliable indicator of patients’ current SES (Robert and House, 
1996).  
Based on the aforementioned findings, it can be hypothesized that each measure 
assesses different aspects of SES. In the particular participant sample, findings 
indicated that weekly household income level was the SES measure that most reliably 
captured associations primarily with QoL. This was possibly due to the characteristics 
of the participant sample such as more advanced age and individual needs. Perhaps 
income could have provided people with services or goods that could improve their 
quality of life such as healthier food or exercise options. For HCA, the role of income 
was less pronounced. Some evidence for income level as well as IMD was found 
indicating that HCA outcomes might require different measures of SES to capture 
differences. 
A further strength of the present study was the number and nature of the participant 
sample. The number of participants recruited and the range of practices from which 
they were recruited was large enough to include patients across the range of SES, 
disease severity, and include a wide range of QoL, HCA and psychosocial 
characteristics. The sample size was also sufficient to allow a series of statistical 
analyses with respectable power. Participants were representative in a number of 
domains when compared with other COPD populations such as (a) SES, (b) disease 
severity, (c) quality of life, (d) illness perceptions, (e) self-efficacy and (f) social capital. 
These will be described below. 
This study included 176 patients with COPD representing the whole spectrum of socio-
economic classes as well as disease stages. Mean IMD score was 33.5 (SD=10.9) 
which indicated a relatively high level of socio-economic deprivation in comparison to 
the rest of the population in the UK, but characteristic of the specific London Boroughs 
selected for this research (IMD 2010; Office of National Statistics, 2011). For example, 
the mean IMD score for London is 25.2 and for the whole of England 21.8 (Office of 
National Statistics, 2011; IMD 2010) in contrast to Lambeth and Southwark where the 
mean IMD score is 30.6. The higher prevalence of COPD in the more deprived section 
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of the population is consistent with previous findings (Soriano, et al., 2000; Simpson et 
al., 2010) and is reflected in the participant sample characteristics. Irrespective of the 
local prevalence of COPD, as expected, the majority of COPD patients in the present 
sample were in the most socio-economically deprived groups. For instance, weekly 
household income level 1 (most deprived) included 44.3% of the sample compared to 
weekly household income level 5 (least deprived) which included 11.4%. Previous 
research reported three times higher COPD prevalence in the most socioeconomically 
deprived classes in comparison to the most affluent patients (Simpson et al., 2010; 
Soriano et al., 2000). 
With regard to disease severity, the majority of patients had moderate COPD (Grade 2: 
50.6%), a third had severe COPD (Grade 3: 29.5%) and fewer had mild and very 
severe disease (Grade 1: 14.8% and Grade 4: 5.1%, respectively) with a mean FEV1 
% predicted of 59.3%. All 176 patients had their diagnosis of COPD confirmed by 
spirometry as part of their interview. The distribution of COPD severity stages showed 
that the majority of patients had Grade 2 disease followed by Grade 3, Grade 1 and 
finally Grade 4. This pattern mirrors the severity distribution reported by previous 
studies conducted in Europe (GOLD Grade 1: 12.3%, GOLD Grade 2: 47.8%, GOLD 
Grade 3: 30.3% and GOLD Grade 4: 8% in Belgium, France, Germany, Italy, the 
Netherlands, Spain and the UK) (Jones, et al., 2011) as well as in the United States 
(GOLD Grade 1: 19%, GOLD Grade 2: 50%, GOLD Grade 3: 26% and GOLD Grade 4: 
5%) (Mapel, Dutro, Marton, Woodruff, & Make, 2011). 
Quality of life, illness perceptions and self efficacy scores were more positive compared 
to participants’ scores reported in the literature. For example, overall participants’ 
quality of life was better and their illness perceptions were more positive (except for 
personal control and emotional representations) compared to the participant samples 
with COPD in Dransfield et al.’s (2011), Wither et al.'s (1999), Vogel, Godefroy, van der 
Mey, le Cessie, & Kaptein’s (2008), Scharloo et al.’s (2007) and Geijer et al.’s (2007) 
studies. Differences in QoL between these patient groups could be due to a variety of 
factors. For example, Dransfield et al. (2011) found that 36% of their participants did 
not have airflow limitation which meant they did not meet the criteria for COPD. 
However, these patients reported burden of poor QoL and respiratory complaints 
comparable to participants with confirmed COPD. The authors attributed participants’ 
poorer QoL not to COPD but to depression or cardiovascular disease which frequently 
co-exist with respiratory problems. Withers et al.’s (1999) participant sample included 
severe COPD patients which could explain why participants in the present sample 
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reported better QoL in terms of anxiety and depression and more positive illness 
perceptions. More severely affected COPD patients might suffer more severe 
symptoms of dyspnoea and fatigue which could intensify feelings of anxiety, 
depression and negative perceptions of their illness. Differences in illness perceptions 
could be explained in the same way. Scharloo et al.’s (2007) participant sample 
included Grade II (moderate) and III (severe) COPD patients. This could be the reason 
why patients in the present study reported better QoL in terms of anxiety and 
depression and more positive illness perceptions. In addition, participants’ mean FEV1 
% predicted in Scharloo et al.’s (2007) study was 49% while in the current study it was 
59%.  
Participants’ level of self-efficacy was greater than that of arthritis patients (Schwarzer 
et al., 1992). In contrast, patients’ level of perceived breathlessness was higher 
compared to participants in other studies (Dransfield, et al., 2011). The reasons for the 
difference in dyspnoea levels between the present sample and Dransfield et al. (2011) 
were probably identical to the ones provided for QoL. 
Social capital was lower on average than that reported by Onyx and Bullen (2000) in 
Australia (mean of 2.6 vs. 3.0). Social capital reflects mainly area characteristics such 
as neighbourhood connections and feelings of trust and safety. Lambeth and 
Southwark were more deprived in comparison to New South Wales which was 
reflected in lower social capital scores, for example lower feelings of trust and safety 
and fewer neighbourhood connections. Moreover, Australian study focused on 
measuring social capital in a population without any health problems. COPD could 
have posed restrictions on the use of networks and friend and family connections - 
irrespective of deprivation - if symptoms made it difficult for patients to socialise. 
Increased limitation in engaging in social activities might be due to the very nature of 
COPD. Progressive deterioration of the disease and increased symptoms can have an 
impact on patients’ mobility. This limitation might also be intensified by higher 
deprivation and further decrease social functioning. 
Another strong point of this research was that the interviews were held at patients’ 
homes. This increased the likelihood of more severely affected individuals who might 
have been less mobile to participate in the study. The option of weekend or evening 
interviews was also provided in order to increase participation from younger patients 
who were still employed. A further strength was the fact that there were no missing 
data in the administered instruments because the researcher made sure all questions 
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had been answered. If any questions had remained unanswered by omission, the 
participant was asked to complete them before the researcher left. In addition, 
diagnosis of COPD was confirmed by spirometry in all participants. Confirmation of 
diagnosis was necessary given that the rate of diagnostic inaccuracy in COPD has 
been reported to be approximately 40% (Miravitlles et al., 2012). 
The choice of instruments added to the strengths of the study. The QoL instruments 
assessed various aspects of patients’ physical and mental status. This ensured that 
participants were offered a number of different ways to indicate the impact of COPD on 
their well-being. Assessment of HCA also included questions covering a range of 
health care access dimensions such as smoking cessation referrals, PR awareness, 
referrals, attendance and completion, pharmacological treatment approriateness. 
These data were based on patient self-report which could involve inaccuracies in 
information about referrals and services provided. This information could have been 
confirmed through GP practice patient databases. However, it was beyond the capacity 
of this research to assess HCA through individual GP records. Previous research 
provided evidence for good overall agreement between self-report and record-based 
HCA measures with variations in certain domains. For example, concordance was high 
for medication use but low for counselling and referrals in patients with a variety of 
conditions including COPD (Tisnado, et al., 2006). Counselling and referrals were 
under-reported in the medical records which could have been due to recall bias by the 
patients. However, it could also be due to under-report by physicians who might not 
have kept accurate records of these interventions (Rohrbaugh & Rogers, 1994; Stange, 
et al., 1998). Under-reporting of ambulatory physician visits extending over a year 
compared to patient-records was also observed (Roberts, Bergstralh, Schmidt, & 
Jacobsen, 1996). However, Roberts et al.’s (1996) participants included a random 
sample of healthy community dwelling. In the present study, the wide range of 
dimensions assessed and the high level of detail in relation to these dimensions such 
as duration of participation in PR, exacerbations, reasons for non-completion added to 
the robustness of the findings. 
A variety of statistical tests were used to examine multiple relationships between the 
variables such as multiple mediation analysis using bootstrapping techniques (Hayes, 
2012). This type of statistical analysis provides information on underlying pathways of 
influence within one significant relationship. For instance, the relationships between 
SES and QoL might have been due to SES affecting personal and treatment control. 
Incorporating these variables in future interventions could increase their effectiveness 
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in improving patients’ QoL. While illness perceptions, self-efficacy and social capital 
mediated the relationship between income level and QoL, they could account only for a 
small amount of the variance. The associations found between SES in terms of income 
level and QoL were partly due to these variables (i.e. illness perceptions, self-efficacy 




There were some limitations in the current study. The low response rate (26%) 
decreased the likelihood of representativeness of the population. Although self-
selected, the sample does contain patients from the full range of disease severity, a 
broad range of SES and GP practices. Thus, it is unlikely that HCA outcomes would be 
biased by a uniform style of clinical management. By implication health care access 
such as varying levels of health care services available in different GP practices e.g. 
smoking cessation referral, drug prescriptions or secondary care referral would be 
representative as well. However, it could be possible that the sample was biased in 
terms of illness perceptions and self-efficacy. For example, patients who participated in 
the study might have had more negative illness perceptions and lower self-efficacy 
compared to those who did not participate. This could have motivated them to consent 
to the research perhaps in the hope of receiving more information about illness 
management, medications or additional assessment. If demographic characteristics 
between responders and non-responders could be compared, stronger conclusions 
could be made. However, lack of data on non-responders prevents further analyse. 
A further limitation was that data was based on self-report and the likelihood of 
measurement overlap cannot be excluded. Due to the similarity between certain 
questions across the questionnaires that were used, identical concepts might have 
been measured. This could have resulted in strong correlations between the assessed 
items. For example, a number of questions of the Chronic Respiratory Questionnaire 
(CRQ-SAS) showed significant overlap with certain questions of the Illness Perceptions 
Questionnaire - Revised (IPQ-R) such as: (a): “How often during the last 2 weeks did 
you have a feeling of fear or panic when you had difficulty getting your breath?” (Q7; 
CRQ-SAS) with “My airways disease makes me feel afraid” (Q38; IPQ-R); (b) “How 
often during the last 2 weeks have you felt embarrassed by your coughing or heavy 
breathing?” (Q9; CRQ-SAS) with “My airways disease strongly affects the way others 
see me” (Q9; IPQ-R); (c) “In the last 2 weeks, how much of the time did you feel very 
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confident and sure that you could deal with your illness?” (Q 10; CRQ-SAS) with “I 
have the power to influence my airways disease” (Q16; IPQ-R) and with “There is a lot 
which I can do to control my symptoms” (Q12; IPQ-R); and (d) “In general, how much 
of the time did you feel upset, worried, or depressed during the last 2 weeks?” (Q12; 
CRQ-SAS) with “I get depressed when I think about my airways disease” (Q33; IPQ-R) 
and with “When I think about my airways disease I get upset” (Q34; IPQ-R) and with 
“My airways disease does not worry me” (Q36; IPQ-R).  
QoL is subjective and thus cannot be assessed in a way other than self-report. Disease 
status is assessed by objective measures such as FEV1 predicted and does not 
correlate strongly with QoL. A patient might have mild COPD (assessed on the basis of 
FEV1% predicted), but might perceive his or her breathlessness to be intense and 
detrimental to their everyday life. This discrepancy is supported by the fact that 
subjective measures of disease experience and subjective measures of health status 
differ significantly. For example, subjective measures such as patients’ perceptions of 
dyspnoea were strongly associated with quality of life, functional status and depression 
whereas objective measures such as disease severity based on spirometry and 
exacerbations risk were not (Adams et al., 2012). This difference could be due to the 
fact that both patients’ perceptions of dyspnoea and QoL were based on self-report 
while objective disease measures were not. Moreover, differences in biological and 
functional characteristics or co-existing conditions such as depression or 
cardiovascular disease could have contributed to the lack of concordance between 
QoL and objective measures of COPD (Dransfield et al., 2011). 
The cross-sectional nature of the study provided insight into measures at a specific 
point in time. Longitudinal studies need to be conducted in the future in order to 
examine whether these relationships change over time and in what way. In addition, 
while mediation analysis can elucidate the pathways of the relationship among 
variables, it cannot provide causal associations. The design of the present study may 
limit conclusions but it cannot be considered weak. It could be argued that change in 
health might result in a change in income. The likelihood of this change decreases in 
later life - one of the main characteristics of the participants in this study. Health can 
influence income through loss of paid employment due to health problems. The main 
source of income among the elderly is their pension, which is unaffected by 
contemporaneous health problems (Benzeval & Judge, 2001). Because SES in earlier 
life can affect health in later life irrespective of adulthood SES, direction of causality 
cannot be inferred (Lynch et al., 1997; Smith and Ben-Shlomo, 1997; Smith et al., 
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1998). Similary, causality cannot be established for the relationship between illness 
perceptions, self-efficacy, HCA and QoL. Interpretation could follow two directions. 
Poorer QoL might have led to more negative illness perceptions and lower self-efficacy 
due to the burden of the disease. Alternatively, more negative perceptions of their 
illness and lower self-efficacy could have contributed to poorer QoL through lower 
physical activity levels or poorer disease management or medication adherence. 
While patients’ illness perceptions were examined in the present study, physician 
attitudes and perceptions were not explored. The medical interaction relies on two-way 
communication and the consistency of explanatory models of illness held by health 
care professionals and patients can vary. Therefore, it is important to investigate the 
role of health care provider characteristics in the relationship between SES and HCA 
and QoL in COPD patients. 
The present study was quantitative. A qualitative section could have provided more 
detailed information and better understanding as to the nature of the associations 
investigated. Additional findings that emerged from the study such as the relationship 
between the psychosocial variables and HCA and QoL could not be pursued further 
because they were beyond the scope of the current research. However, it can provide 
the starting point for further research to explore these relationships in more detail.  
Regarding the analysis of the data, statistically significant relationships were found 
between the predictor variable (SES) and the predicted variable (QoL/HCA). However, 
the size of these relationships was smaller than expected. Therefore, the size of the 
relationship that was mediated by the proposed mediators (illness perceptions, self-
efficacy and social capital) would also be smaller than expected. This would have 
required a larger sample size than the one available in this study in order to detect 
these very small effects of mediation. It is arguable whether it would be justified to have 
a larger sample size to detect mediation of such small effects since it is unlikely that 
such mediation would have any practical value in a clinical setting.  
 
9.5 Key points and conclusions  
 
This was the first study to explore associations between SES and HCA and QoL in 
patients with COPD and to examine the role of illness perceptions, self-efficacy and 
social capital as mediators in these relationships. The significant relationships between 
SES and HCA and QoL suggested that more deprived COPD patients were not at a 
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disadvantage regarding HCA. In contrast, for certain HCA measures lower SES 
individuals in terms of IMD and educational attainment had greater access to health 
care compared to their higher SES counterparts. The remaining aspects of SES such 
as occupational status and income level were not significantly associated with HCA.  
QoL in COPD appeared to be negatively associated with SES in terms of income level. 
Other SES measures (IMD, educational level and occupational class) were not 
significantly associated with QoL. Present findings are consistent with the systematic 
review on the relationship between SES and QoL in patients with COPD (see Chapter 
Four). The review indicated that there was limited quality literature on SES and QoL in 
COPD to draw strong conclusions about these associations. Most studies found that 
lower SES was associated with poorer quality of life in patients with COPD consistent 
with present findings. 
The lack of associations between most aspects of SES and HCA and QoL could be 
attributed to the nature of COPD, increased awareness on behalf of health 
professionals which could have facilitated access for more deprived patients, or 
individual factors such as patients’ illness perceptions. Furthermore, the lack of health 
inequalities may be associated with the more advanced age of the participant sample 
according to the age-as-leveler hypothesis. This theory posits that universal biological 
frailty in old age and government support to the elderly, such as free prescriptions, or 
the National Service Framework decrease the gap in health care usage by SES 
(Beckett, 2000; House, Lantz, & Herd, 2005; House et al., 1994). According to the age-
as-leveler hypothesis, socioeconomic deprivation in risk factors such as health 
behaviours, stress, perceptions of control, and availability of social support 
accumulates throughout most of adulthood but is ameliorated in later life through 
retirement and provision of government support. This does not mean that income 
becomes less powerful because these government provisions refer mostly to the wider 
societal-level domains such as availability of free health care services while income 
would be more relevant to individual-level domains such as QoL. It must also be noted 
that, there was increased likelihood of Type 1 error depending on the size of the p 
values. The inconsistent associations found in terms of SES indicators such as income 
level, educational level, occupational class and IMD score could have been false 
positive findings because of the large number of statistical tests conducted. However, 
due to the significance level used in this research i.e. p<0.01, this would probably be 
unlikely. Still, the results possibly need to be interpreted as exploratory and as a guide 




9.6 Implications for future research 
 
The current study highlighted that most aspects of SES did not have a significant 
impact on HCA and QoL in patients with COPD living in South East London. The 
sporadic relationships and the nature of the associations that were found between 
these variables provide ground for further research into the role of psychosocial factors 
in COPD. They indicated that relationships do exist but they are limited to certain 
measures of SES and aspects of HCA and QoL which suggesting that additional 
measures need to be used in order to capture further associations that may exist. The 
cross-sectional design of the study limited interpretation of results as to causality. 
Longitudinal studies with participant follow-up over the course of time could help 
identify changes in illness perceptions and self-efficacy at different stages of the 
disease. This is important since COPD is a slowly progressing condition with symptoms 
deteriorating after a long time of subtle existence. The cost of this kind of study would 
need to be considered as well as the possibility of a higher attrition rate. The fact that 
the time of onset of COPD is difficult to identify because of its slow progression and 
subtle emergence of symptoms over time would probably be a factor to be taken into 
account when designing such as study. 
Socio-economic status (in terms of income level) was associated with QoL to an extent. 
Illness perceptions and self-efficacy mediated the relationship between income level 
and QoL suggesting that psychological variables may play a role in these associations. 
Higher SES in terms of income level was associated with more positive illness 
perceptions such as weaker identity and consequence beliefs as well as stronger self-
efficacy which were associated with better QoL. This was independent of health care 
access which was not lower in more deprived populations. It could be suggested that 
illness perceptions in particular and to a lesser degree self-efficacy and social capital 
could be included in the design and development of interventions targeting 
improvement of QoL in COPD. However, the difficulty in modifying illness perceptions, 
the small amount of variance explained by illness perceptions and the magnitude of 
their effect size would probably not lead to significant differences in outcomes. This is 
supported by evidence from interventions which attempted to modify illness 
perceptions. While a change in patients’ treatment beliefs and their understanding of 
their condition was observed, this change did not lead to a change in behaviour, for 
example, increase in treatment adherence (Karamanidou et al., 2008). Although the 
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present research has provided strong evidence for certain associations, it has also 
indicated that there are further variables to be considered in order to illuminate the 
nature of these relationships. Further research is warranted to identify additional 
psychosocial and biological variables (e.g. hostility, anger, stress response and 
physical effect) as well as physician-related factors (e.g. attitudes and perceptions) in 
order to increase our understanding of the associations between SES and HCA and 
QoL in COPD. In addition, future research might also attempt to increase 
representativeness of participants in terms of illness perceptions, self-efficacy and 
social capital through increasing response rates, for instance through administration of 






















Appendix A: SYSTEMATIC REVIEW SUPPLEMENTARY TABLES 
 
Appendix A1 – Supplementary Table 4.1: Search terms for Medline   
 
Table 4.1 Search terms for Medline 
_________________________________________________________________ 
socioeconomic status.mp. or exp Social Class/ 
social networks.mp. or Social Support/ 
exp Psychosocial Deprivation/ 
chronic obstructive pulmonary disease.mp. or exp Pulmonary Disease, Chronic 
Obstructive/ 
COPD.mp. or Pulmonary Disease, Chronic Obstructive/ 
Emphysema/ or Pulmonary Emphysema/ 
chronic bronchitis.mp. or exp Bronchitis, Chronic/ 
socioeconomic status.mp.  
social class.mp.  
social networks.mp.  
social support.mp.  
psychosocial deprivation.mp.  
social capital.mp.  
exp Socioeconomic Factors/ or exp Health Services Accessibility/ or exp Social 
Support/ or exp Health Status/ or social capital.mp. or exp Social Environment/ 
exp Primary Health Care/ or healthcare access.mp. 
health services utilisation.mp. 
healthcare access.mp.  
health outcome*.mp.  
exp "Outcome and Process Assessment (Agabiti, et al.)"/ or exp "Outcome 
Assessment (Agabiti, et al.)"/ or exp "Quality of Life"/ or health outcome*.mp. or exp 
Treatment Outcome/ or exp Health Status/ 
disease outcome.mp. 
disease outcome.mp.  
quality of life.mp.  
quality of life.mp. or exp "Quality of Life"/ 
health status.mp. or exp Health Status/ 
health status.mp.  
1 or 3 or 8 or 9 or 12 or 14 
2 or 10 or 11 or 13 
4 or 5 or 6 or 7 
15 or 16 or 17 or 19 
18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 






Appendix A2 – Supplementary Table 4.2: Quality assessment scale  
 
















N/A : Not 
applicable 
to study 
 1. Spirometry-based 
diagnosis 
    
 2. COPD severity 
assessed/classified 
    
 3. COPD severity 
controlled for 
    
 4. Sample size 
(sufficient power?) 
    
 5. Description of  
population selection 
    
 6. Inclusion criteria 
applied 
    
   7. Adequate 
description of methods 
(i.e. clear        
explanation of participant 
recruitment, inclusion 
criteria, methods of 
assessment, etc.) 
    
   8. Clear definition & 
classification of SES (i.e. 
low-   medium-high) 
    
9. Clearly defined & 
reliably measured 
HRQOL (i.e.   validated 
instruments) 
    
   10. Clearly defined & 
reliably measured HA 
    
   11. Examination & 
report of statistical 
analyses between SES & 
HRQOL &/or HA and 
quality of analyses. 
    
   13. Registration of loss 
to follow-up (if 
applicable) 
 




















































































Saadat et al. 
(2007) 
+ + - + +/- - + + + N/A + N/A 7.5 
2. Eisner et 
al. (2011) 
+ + + + + + + + N/A + + +/- 10.5 
3. Enright et 
al. (1994) 
+ _ + +/- + +/- + +/- +/- N/A + N/A 7 
4. Hesselink 
et al. (2006) 
+ + - + + + + + + N/A + + 10 
5. Hill (2005) 
 
+ + + + + + + + + N/A + N/A 10 
6. 
Johannesse
n     et al. 
(2010) 
+ - - +/- + +/- + + - N/A + + 7 
 
7. Kanervisto       
et al.  (2006) 
+ + - +/- + +/- + + + N/A + N/A 8 
 
8. Lin et al. 
(2005) 
















































































9. Moy et al. 
(2009) 
+ - - + + + + +/- + N/A + N/A 7.5 
10. Ng et al. 
(2007) 
+ + + + +/- + + - + N/A + + 10 
11. Prescott      
et al. (2009) 
+ - - +/- + +/- + + N/A +/- + + 7.5 
 
12. Prigatano        
et al. (1984) 
- - - + +/- + + - + N/A + N/A 5.5 
 
13. Shohaimi        
et al.  
- - - +/- +/- + + + - N/A + N/A 5 
 
14. Van 
Manen   et al. 
(2002) 
+ + - + + + + +/- + N/A + N/A 8.5 
 
15. Welle et al. 
(A. M. a. M. J. 
C. P. r. p. i. t. 
U. a. n. r. s. C. 
r.-. Yohannes, 
et al.)  
+ - - +/- + +/- + + - N/A + N/A 6 
16. Wijnhoven    
et al. (2001) 
+ - - + + + + + + N/A + N/A 8 
 
17. Goldstein       
et al. (2005) 































































































18. Montes de 
Oca et al. 
(2008) 
+ + - + + + + - N/A + + N/A 8.5 
 
19. Simoni et 
al. (2008) 
+ - - +/- + +/- + + N/A + + N/A 7 
 
20. Chandra et 
al. (2009) 




et al. (2010) 





+ : Fullfilled +/- : Partially fulfilled : Not fulfilled or no information provided N/A : Not applicable to the study 
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Appendix B: GP PRACTICE STUDY INFORMATION PACKAGE  
 
Appendix B1: GP practice invitation letter 
 
GP Practice Letterhead  
Practice Manager 
Practice Address                        
Date 




Re: ATHENA project: Access To HEalthcare iN Airways disease 
 
I am writing to ask for your help with a new research project whose aim is to find ways 
of improving healthcare access and quality of life for patients with COPD (Chronic 
Obstructive Pulmonary Disease) patients. The research is being undertaken with 
practices in Lambeth and Southwark Primary Care Trusts. I attach a sheet which 
summarises the study and what it would entail for the practice. 
  
Patients with COPD will be identified from the existing lists of COPD patients made by 
your practice for the Study of Intractable Breathlessness in COPD in which you have 
been participating. Letters of invitation prepared by us will be printed by the practice for 
signature by a practice GP and sent to eligible patients. Participating patients should: 
(a) have a diagnosis of COPD, and (b) the ability to understand and respond to 
questionnaires and interview questions in English.  
 
Eligible patients will be contacted after having expressed interest in the study and 
asked to agree to be interviewed in their homes. The interview will last between 60 and 
90 minutes. It will involve completing questionnaires about the way the illness affects 
patients’ psychological and physical health and their access to services. 
 
Enclosed with a description of the project are the patient invitation letter we would like 
to use and a patient information sheet (PIS) for patients telling them about the study. I 
will contact you by telephone within the next two weeks to see if the practice will be 
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ATHENA project: Access To HEalthcare iN Airways disease 
 
Lead Investigator: Sofia Georgopoulou sofia.georgopoulou@kcl.ac.uk 02078488734 
 





















Appendix B2: GP practice (patient) study information sheet 
 
 




We are writing to ask for your help with research that we are doing in people with 
COPD. This sheet gives a brief summary of the research and what will be entailed for 
the practice should you decide to take part. The study will provide us with information 
about the role of socio-economic deprivation and how it may impact on COPD patients’ 
quality of life and their access to health services. This will help us to better understand 
the factors influencing patients’ healthcare utilisation and well-being. Our aim is to find 
ways of improving healthcare access and the outcome of the disease for people with 
COPD.  
 
We need your help to identify patients who are suitable to take part in this research. 
This will be done by using the existing lists of COPD patients made by your practice for 
the Study of Intractable Breathlessness in COPD in which you have been participating. 
 
Guy’s, King’s 




Department of  
Primary Care &  




Head of Department 
Professor Brendan Delaney 
 
 
7th Floor, Capital House 
42 Weston Street 
London SE1 3QD 
Tel 020 7848 6649  
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We are looking for COPD patients who fit the following two eligibility criteria: a) a 
diagnosis of COPD (including emphysema or chronic bronchitis or both); and b) ability 
to understand and respond to questionnaires and interview questions in English.  
 
We would like the practice to send to eligible patients a letter of invitation to participate 
in the study. Patients who are interested will be asked to contact Sofia Georgopoulou 
directly or to send a reply paid letter to the practice which she will then pick up. Non-
respondents will be followed up with a reminder letter. Sofia will then arrange to 
interview consenting patients at their home. The interview will last between 60 and 90 
minutes and will be held at patients’ homes for their convenience. Patients will be 
asked at interview to allow access to their medical records. The information required 
from patients’ medical records will include: (a) other conditions patients may be 
suffering from, (b) their current treatment, (c) spirometry test results, (d) date of COPD 
diagnosis, (e) referrals given by their GP or consultant, and f) frequency and type of 
contacts with health services in the previous five years.  
 
The interview will involve completing questionnaires about the way the illness affects 
their psychological and physical health and their use of health services. Patients’ will 
have their lung function, and their height and weight assessed as well. Information 
gathered at interview including spirometry results will be summarised and provided to 
the practice. Patients will be free to withdraw from the study at any time without giving 
a reason. They will also be told this will not affect the care they receive from their GP 
practice. Patients’ details and other information provided will be destroyed at the end of 
the study. 
 
The key people working on the study are: 
 
Miss Sofia Georgopoulou, PhD Student and Chief Investigator 
Dr. Patrick White, Senior Lecturer and Supervisor of the project 
 


































Appendix C1: Participant invitation letter  
 




ATHENA project: Access To HEalthcare iN Airways disease 
I am writing to ask you if you would take part in a new research study which we are 
doing with the Department of Primary Care and Public Health Sciences at King’s 
College London. Our aim is to explore the things that make your chest trouble difficult 
and that interfere with the healthcare you receive. We want to find ways of improving 
your condition and our services. This study will provide you with the opportunity to tell 
the researchers how you are affected by your chest trouble. We are calling your chest 
trouble your airways disease. There is an information sheet with this letter for you to 
read.  
If you think you would be interested in taking part, or just finding out more, please 
return the enclosed slip and the contact details sheet to us in the envelope provided. 
Alternatively, you can phone Sofia Georgopoulou, the study researcher, directly on 020 
7848 8734. If we do not hear from you, we will send you a reminder letter in three 
weeks. If you do not wish to take part, please tick the appropriate box on the enclosed 
slip, return it to us and we will not contact you again about this research. If you are 
interested in taking part, Sofia will make a convenient time to visit you at home, or 
somewhere else if you prefer. Calling or writing for further information does not mean 
you have to take part. If you don’t want to take part, your care will not be affected in 
any way.  
We do hope you will be able to help us in supporting this study. 
Yours sincerely 
Dr (name of principal)  
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Appendix C2: Participant study information sheet 
 
Patient Information Sheet 
 
ATHENA project: Access To HEalthcare iN Airways disease 
 
This study aims to learn about the impact of your chest trouble on your daily life and 
how effective the health services are for you. It will give us the opportunity to learn 
about your experience with your chest trouble, airways disease. You are being invited 
to take part in this research study and it is important for you to understand why the 
study is being done and what it will involve.  Please take time to read the following 
information carefully. Discuss it with others if you wish.  Ask us if there is anything that 
is not clear or if you would like more information. Take time to decide whether or not 
you wish to take part. 
Purpose of the study: The purpose of the study is to learn about the impact of your 
chest trouble on your daily life and how effective the health services are for you. Our 
aim is to find ways of improving your well being and your access to services. Sofia 
 
Guy’s, King’s 




Department of  
Primary Care &  




Head of Department 
Professor Brendan Delaney 
 
 
7th Floor, Capital House 
42 Weston Street 
London SE1 3QD 
Tel 020 7848 6649  






Georgopoulou will be doing this study as part of her PhD degree in Primary Care 
Research. 
Why have I been invited? We are asking many patients with airways disease if they 
will agree to help with this research so that we can understand more fully how they are 
affected and how their health services and general health could be improved.  
Do I have to take part? It is up to you to decide whether or not to take part. If you do 
agree to take part you will have this information sheet to keep and you will be asked to 
sign a consent form. You can withdraw at any time and without giving a reason.  This 
will not affect the care you receive in any way.  
What will happen to me if I take part? We will arrange an interview at your home. 
Sofia Georgopoulou, the researcher, will explain the research and will answer any 
further questions you may have. She will ask you to sign a consent form agreeing to 
participate in the study. She will also ask you to allow us access to your medical 
records so we can learn about the treatment you have received so far. Sofia will ask 
you to complete some questionnaires and she will measure your height and weight and 
test your breathing. The questionnaires will ask how your chest trouble affects your 
daily activities and physical health. They will also ask about the social and financial 
resources available to you. The interview will take about an hour and a half and will be 
held at your home. If that is not convenient for you, we will arrange the interview in your 
GP’s surgery.  
What do I have to do? All you have to do is read this sheet and agree to take part by 
returning the enclosed slip and the contact details sheet to your GP practice. With your 
permission, the researcher, Sofia Georgopoulou, will then contact you and make an 
appointment for the interview. Alternatively, if you do not want to provide your details, 
you can contact Sofia directly and schedule an appointment. 
What are the disadvantages or risks of taking part? We think there are no 
disadvantages or risks to you, apart from the time you would be giving up. Sometimes 
people get upset talking about their illness, but we find most people enjoy the 
opportunity to explain how they have been affected.   
What are the possible benefits? If you agree we will pass a summary of the 
information that we get from the interview to your GP. For some people who take part 
this information may prove useful to their GP in making changes to their health services 
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provided. The information we get from this research will help us to learn how to 
improve the care of people with airways disease and make them more comfortable in 
their daily lives.  
What if there is a problem? Any complaint about the way you have been dealt with 
during the study or any possible harm you might suffer will be addressed.  In the 
unlikely event that something does go wrong, or that you are harmed during the 
research and the harm is due to someone’s negligence, then you may have grounds 
for legal action for compensation. Such legal action would be against King’s College 
London. In such an event you may have to pay your own legal costs. The normal 
National Health Service complaints mechanisms will still be available to you.   
Will my taking part in this study be kept confidential? All information which is 
collected about you during the course of the research will be kept strictly confidential 
and we take special steps to ensure that this is done. 
What will happen to the results of the research study? The results will be published 
in a research journal and will then be available to doctors and nurses who are looking 
after patients with airway disease.  
Who is organizing and funding the research? The research is organised and funded 
by the Department of Primary Care and Public Health Sciences at King’s College 
London School of Medicine.  
Who has reviewed this study? This study has been reviewed by the East London 
Research Ethics Proportionate Review Sub-Committee 3. 
 
Contact for further information 
For further information about this study and about the results you may contact: Miss 
Sofia Georgopoulou, Department of Primary Care and Public Health Sciences, King’s 
College London School of Medicine, 9th Floor, Capital House, 42 Weston Street, 
London SE1 3QD; Tel: 020 7848 8734; Fax: 0207848 6620; email: 
sofia.georgopoulou@kcl.ac.uk  




Appendix C3: Participant reply slip 
 
 
Patient Reply Slip 
 
 
ATHENA project: Access To HEalthcare iN Airways disease 
 
Patient Name: …………………Date of Birth: …………………Signature:……………… 
 
Please tick as appropriate: 
 
Yes, I would like to know more about this study. Please pass my contact details to the 
researcher so they can contact me with further information.  
 












Appendix C4: Participant contact details form 
 
ATHENA project: Access To HEalthcare iN Airways disease 
 
 
Chest clinic evaluation: Patient contact details 
 
Title (please circle): Miss Mrs. Mr. Other: ________________ 
Name:                          __________________________________________ 
Age:              __________________________________________ 
Postal address:           __________________________________________ 
              __________________________________________ 
              __________________________________________ 
Phone number:           __________________________________________ 
  
The details on this form will be used by the researcher to contact you in order to 
arrange an interview. They will be held in a secure database in the Department of 
Primary Care & Public Health Sciences at King’s College London. They will only be 
accessed by research staff and will not be passed on to any third party. Your contact 








Department of  
Primary Care &  




Head of Department 
Professor Brendan Delaney 
 
 
7th Floor, Capital House 
42 Weston Street 
London SE1 3QD 
Tel 020 7848 6649  









Appendix C5: Participant reminder letter  
 





ATHENA project: Access To HEalthcare iN Airways disease 
 
We are writing to remind you of the research study which we are doing with the 
Department of Primary Care and Public Health Sciences at King’s College London, and 
with which you may wish to help. This study, as mentioned in our initial letter, will 
provide you with the opportunity to tell the researchers how your airways disease 
affects you. Our aim is to find ways of improving your condition and our health services.  
Up to this date, we have not received the reply slip from you expressing interest in our 
research. We would appreciate it if you could let us know whether you would like to 
learn more about the study by returning the reply forms.  
If your reply slip has already been sent, please disregard this letter. If you don’t want to 
return the slip but do want to participate in the research, please call Sofia 
Georgopoulou, the study researcher, directly on 020 7848 8734. Please, remember 
that calling or writing for further information does not mean you have to take part. If you 
don’t want to take part, your care will not be affected in any way.  
We do hope you will be able to help us in supporting this project. Thank you for taking 
the time to read this letter. 
Yours sincerely  
Dr (name of principal)  
On behalf of (name of practice) 
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Appendix D1: Participant consent form  
 
Patient Identification Number for this research study: ______________________ 
 
CONSENT FORM 
Title of Project: 
  
ATHENA project: Access To HEalthcare iN Airways disease 
Name of Researcher: Sofia Georgopoulou  
Department of Primary Care and Public Health Sciences 
King’s College London 
9th Floor, Capital House 
42 Weston Street 
London SE1 3QD 




Please write your initials in each box if you agree to each statement:  
1. I confirm that I have read and understand the patient information sheet 
(Version 3, dated 06 08 10) for the above study and have had the opportunity to ask 
questions.     
2. I understand that my participation is voluntary and that I am free to withdraw at 








Department of  
Primary Care &  




Head of Department 
Professor Brendan Delaney 
 
 
7th Floor, Capital House 
42 Weston Street 
London SE1 3QD 
Tel 020 7848 6649  








3. I understand that sections of my medical notes from the GP practice may be 
looked at by responsible individuals from the Department of Primary Care and Public 
Health Sciences, King’s College London or from regulatory authorities where it is 
relevant to my taking part in research.  I give permission for these individuals to have 
access to my records. 
4. I agree to take part in the above study.  
5.    I understand that my involvement is strictly confidential and no information about 
me will be used in any way that reveals my identity other than to the researcher(s).
  
 
_______________________        ________________      _________________ 
Name of Patient                            Date                               Signature 
_______________________       _________________      _________________ 
Name of Person taking consent   Date                                Signature 
_______________________       _________________      __________________ 
Researcher                                   Date                                Signature 
 
Please tick the appropriate box(es): 
Yes, I would like to be considered for participation in a follow-up study if one    should 
take place in the future. 
No, I would not like to be considered for participation in a follow-up study if one should 
take place in the future. 
I would like to get feedback on the results of the study. 
 







Appendix D2 – Health Care Access (HCA): Variant of the Client Service Receipt 
Inventory CSRI including demographics and SES information questions 
 
 
     ATHENA project: Access To HEalthcare iN Airways disease 




SECTION A: MEDICATIONS 
 
Now can I just check what medication you’re using? (Inhalers, tablets, oxygen and the nippy 
machine)  How often do you take this? 
Colour of 
medicine 
Drugs (strength) Frequency Inhaler-
type 
Comment 




1. Salbutamol (Airomir, 
Asmanal, Autohaler, Click 
Haler, Easy-Breathe, Easy 
Haler Salbutamol, Pulvinal 
Salbutamol, Salamol, Ventolin, 
Salbulin novolizer) 
2. Terbutaline (Bricanyl) 
  
 




Both           
 3 







3. Salmeterol (Serevent) 
3a. Formoterol (Atimos, 
Foradil, Oxis) 








4. Ipratropium (Atrovent, 
Respontin) 
5. Tiotropium (Spiriva, 
Handyhaler, Respimat) 




Both           
 3 














3.2 Inhaled corticosteroids 
(strength) 




Cyclocaps, Easy Haler 
Beclometasone, Beclazone 
Easibreathe, Clenil Modulate, 
Qvar, Qvar Easibreathe) 
 
7. Budesonide (Budesonide 
Cyclocaps, Easy Haler 
Budesonide, Novolizer, 
Pulmicort) 
8. Ciclesonide (Alvesco) 
9. Fluticasone (Flixotide, 
Flixotide accuhaler, Flixotide 
evohaler, Flixotide disk haler) 










Both           
 3 











Compound inhalers (strength) 
11. Salmeterol & Fluticasone 
(Seretide, Seretide evohaler, 
Seretide accuhaler) 
 
12. Formoterol and 
Budesonide (Symbicort, 
Symbicort turbohaler) 
13. Formoterol and 
beclometasone (Fostair) 
 
   
 Tablets    
  
Oral corticosteroids (strength 
e.g. 5mg x 1) 
16. Prednisolone (Delta cortril) 
17. Betamethasone (Betnelan, 
Benesol) 
18. Cortisone  
19. Deflazacort (Calcort) 
20. Dexamethasone (Dexsol) 
21. Methylprednisolone 
(Medrone) 
   
 
 
Long  1 
Short  2 
  
Theophyllins 
22. Theophylline (Nuelin, Slo-
Phyllin, Uniphyllin) 
23. Aminophylline (Phyllo 
continus) 




24. Carbocisteine (Mucodine) 
25. Erdosteine (Erdotin) 
26. Mecysteine (Visclair) 
27. Dornase alfa (Pulmozyme) 
28. Sodium chloride nebuliser 
solution (Muco Clear) 
   
 Oral antibiotics 
29. Name of drug 
R if patient has supply in 
reserve 
   
Other 30. Other medications (Please 
specify) 
   





32. Inhaler technique 
Correct 1    Incorrect  2        N/A 3 
33. If incorrect: 
a) Did not shake     1 
b) Did not inhale correctly    2 
c) Pressed inhaler twice consecutively  3 
d) Did not hold breath in after inhaling  4 
 
 
SECTION B: SMOKING 
 
34. Have you ever smoked cigarettes, cigars or a pipe? 
 
No    0  Yes  1 
35. If yes 







36. How old were you when you started to smoke regularly?  
 
 
37. If cigarettes 
 
Do you smoke cigarettes at all nowadays? 
No    0  Yes  1  N/A  2 
 
38. About how many cigarettes a day do you usually smoke? 
If cigars  
39. Do you smoke cigars nowadays? 
No    0  Yes  1   N/A  2 
40. About how many cigars do you usually smoke in a week? 
If pipe 
41. Do you smoke a pipe at all nowadays? 
No    0  Yes  1  N/A  2 
 
If they did smoke, but do not nowadays 
42. About how many cigarettes did you smoke in a day OR cigars 
did you smoke in a week when you smoked them regularly?  
 
43. How long ago did you give up smoking cigarettes/cigars/a 
pipe regularly? 
Less than 6 months ago 1 
6 months but less than a 
year ago 
2 
1 year but less than 2 years 
ago 
3 
2 years but less than 5 
years ago 
4 
5 years but less than 10 
years ago 
5 









SECTION C: SMOKING CESSATION 
 
44. Has your GP or any other clinician (doctor/nurse/pharmacist) 
advised you to quit smoking? 
No    0  Yes  1  N/A  2 
45. Have you made a serious attempt to stop smoking before? 
No    0  Yes  1  N/A  2 
46. Have you ever been given a referral for smoking cessation? 
                   No    0  Yes  1  N/A  2 
 
 
SECTION D:   HOSPITAL OUTPATIENT APPOINTMENTS 
 
47. Do you attend the hospital for your COPD? 
No    0  Yes  1 
If yes  
48. Who do you see? 
Chest Specialist    1   Nurse Specialist    2 Other    3  N/A  4 
If not 
 
49. Who do you see? 
GP  1      Nurse    2          Private doctor   3    Other    4             N/A 5 
50. Do you have regular spirometry assessment? 
Yes    1           No  2                       N/A  3 
51. When was the last time you had it? 
1 month ago  1          3 months ago  2       6 months ago  3     More than 1 year  4 
More than 2 years  5 More than 3 years  6 More than 5 years 7  
Don’t know/remember  8 
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52. How often do you have spirometry? 
Every six months   1  Once a year   2   Every two years   3 When necessary   4      
53. When was the last time you attended the hospital?  
In the last week  1 
In the last month   2 
Three months ago  3 
In the last six months  4 
In the last year  5 
In the last two years  6 
N/A  7 
Awaiting first hospital 
consultation  
 8 
        More than two years                                                 9 
 
54. How frequently do you attend the hospital?  
Once a month      1 
Once every three months      2 
Less than every three 
months 
     3 
N/A      4 
Don’t Know      5 
Every 6 months                                                         6 
 
SECTION E: PULMONARY REHABILITATION 
 
55. Have you ever heard of pulmonary rehabilitation? 
No    0  Yes  1 
56. Who informed you about pulmonary rehabilitation? 
GP  1               Nurse  2    Other  3             N/A  4 
 
57. Have you ever been referred for pulmonary rehabilitation for your 
COPD? 
No    0  Yes  1 
58. Have you attended pulmonary rehabilitation for your COPD? 






59. If yes, when was the last time you attended pulmonary 
rehabilitation?  
In the last week  1 
In the last month   2 
Three months ago  3 
In the last six months  4 
In the last year  5 
More than a year ago  6 
N/A  7 
 
60. Have you completed pulmonary rehabilitation for your COPD? 
No    0  Yes  1                              N/A  3 
 
61. What are the benefits of attending pulmonary rehabilitation?  
Obtaining information on COPD Yes         1 No     0 
Meeting other people with your   
condition 
Yes         1 No     0 
Learning about your COPD Yes         1 No     0 
Feeling confident Yes         1 No     0 
Becoming fitter Yes         1 No     0 
Feeling better Yes         1 No     0 
Other Yes         1 No     0 
N/A                3  
 
62. Were there any problems with attending pulmonary 
rehabilitation?   
No    0 Yes  1  N/A  2 
If yes 
63. What were these problems? 
................................................................................................................................................. 
If attended >1 year ago or not at all 
64. Would you be interested in attending pulmonary rehabilitation 
(again)? 




SECTION F: ACUTE EXACERBATIONS & HOSPITAL 
ADMISSIONS 
Thinking now about the last time you experienced an exacerbation when 
you were very unwell with your COPD (an exacerbation is when your 
chest is worse with breathlessness and cough) 
 
65. Have you ever had an acute exacerbation where you have 
experienced extreme breathlessness (worsening of airways disease 
that lasted longer than 1-2 days)? 
 
No    0                Yes  1 
 
If yes 
When was the last time you felt very unwell with your breathing?         (months) 
  
66. About how many times has this happened in the last two years?     
  
 
67. Do the exacerbations vary in intensity?    
  No  0 Yes   1 Occasionally  2 N/A  3 
 
68. Do you get any warning signs?  
 
  No 
 
 0 Yes   1 Occasionally  2 N/A  3 
 




 1 At 
work  
 2 In the 
street 
 3            
Other  4 
 







70. What did you do when your last exacerbation happened?  
  
 
a) Waited and saw what happened  1 
b) Rested  2 
c) Took more inhalers  3 
d) Took oral steroids (prednisolone)  4 
e) Took oxygen  5 
f) Took antibiotics  6 
g) Contacted your GP  7 
h) Called the ambulance  8 
i) Other  9 
j) N/A 







71. Can I confirm whether you were admitted to hospital for 
your acute exacerbation? 
                     No    0  Yes  1  N/A  2 
 
 




73. How many times have you been in the past 3 months?   
…………... 
 
74.  How many nights have you spent in a general ward?   
………….…..        
 
75. How many nights have you spent in an Intensive Care Unit 
(ICU/ITU)?     …………….   
401 
 
                                                             
76. What treatment did you have in hospital when you were 
admitted?  
a) Oxygen  1 
b) Inhaler  2 
c) Non-invasive ventilation (Nippy)  3     
(This is where a mask is put tightly on your face and a 
machine helps you to breathe with air under pressure) 
d) Ventilator  4 
(This is where you are given an anaesthetic and a machine 
does the breathing for you) 
e) Morphine  5 
f) Nebuliser  6 
g) Other   7 





77.  Did you receive the treatment and help you required? 
No    0 Yes  1  N/A  2 
 
78. Did it relieve your breathing problems?   
No   0  Yes  1  Partially     2  N/A  3 
 
SECTION G: This group of questions asks about your airways 
disease in the past 3 months. Please put a tick in the box 
which best applies to you. 
 
79. In the past 3 months, how many times have you consulted with a 
doctor or nurse in the surgery because of airways disease? (apart from 
repeat prescriptions) 
never                            0 
once                                                        1 
twice                                                       2  




80. In the past 3 months, how many times has a doctor visited you at 
home because of airways disease? 
 
never                                                      0 
once 1 
twice 2 
three or more 3 
 
81. In the past 3 months, how many times have you been to the 
hospital outpatients department because of airways disease?  
 
never                     0 
once 1 
twice 2 
three or more 3 
 
82. In the past 3 months, how many times have you been admitted to 
hospital because of airways disease? 
 
never                                         0 
once 1 
twice 2 









SECTION H: COST OF AIRWAYS DISEASE 
 
83. In the past 3 months, have you paid for any airways disease 
medicines (including inhalers and tablets)? 
 
Please tick all that apply 
No, I did not have any medicines           1 
No, I get free prescriptions                                               2 
No, I used someone else’s medicine                                3 
Yes, I have a pre-payment certificate                                4 
Yes, I pay for prescriptions each time I get them            5          
I have paid £…….. for prescriptions in  the past 3 month 
Yes, I bought medicine without a prescription                6  
I have paid £…….. for medicine  (e.g. cough medicine, homeopathic and herbal                         
medicine) without a prescription in the past 3 months 
84. Please describe the last journey you made to the hospital or to 
your GP surgery because of your airways disease 
 
The last time you went to the hospital 
a) How did you get there?     Walk    1     Drive  2    Other  3      N/A  4    
b) If you had to pay anything to get there, how much did it cost you? 
                                        £ …………… 
 
The last time you went to your GP surgery 
c)  How did you get there?       Walk    1       Drive  2    Other  3      N/A  4    
 
d) If you had to pay anything to get there, how much did it cost you?  




85. Did you have to make special arrangements at home the last time 
you went to the hospital or the GP surgery because of your airways disease? 
(e.g. to take care of children or relatives who are elderly, disable or ill)  
 
           No    0                    Yes  1                              
         Please describe ……………………………………………………………………… 
                        
86. Did you or anyone else have to pay for these arrangements when 
you last went to the hospital or GP surgery? (e.g. paying for a baby-sitter)  
            No    0                       Yes  1                              N/A  2 
        How much altogether?                        £ …………………. 
                                                
87. Did anyone go with you or come and visit you when you last went 
to the hospital or GP surgery? 
 
No    0                       Yes  1                              N/A  2 
88. If yes, did they have to take time off work? 
 
                Yes                                1     How many hours altogether?  ………. hours       
                                                     
                 No                                0 
                 
                 Not working                 3 
           
                 N/A                          4 
 
89. Have they lost any pay because of this time off work? 
 
                Yes                               1                          
                                                    
                No                                 0 
 
                Don’t know                   3 
            





SECTION I: SOCIODEMOGRAPHIC 
It will help us to understand your answers better if we have a little 
background information from everyone: 
 
Gender   
Female     1  Male     2  
 
b) May I ask your age?    
 
Are you   
Married or living with a partner  
1
 






Or single (not now married and 
not  






90. Including yourself, how many people live in your household 
who are aged 18 or over?    
 
91. To which of the following ethnic groups would you say you 
belong?  
White English  1 
Black – Caribbean  2 
Black – African  3 
Black – other black groups  4 
Indian  5 
Pakistani  6 
Bangladeshi  7 
Chinese  8 
Other  9 




92. Which of the following best describes your main activity?
  
Retired from paid work  1 
Unable to work (due to illness)  2 
Unemployed  3 
In paid work (full / part time)  4 
Looking after the family, home or 
dependants 
 5 
Student  6 
Other …………………………..  7 
 
  
93. Have you ever been in paid employment or self-employed   
No   0  Yes  1 
94. Please give the title of your present or most recent job  
…………………………………………………………………………………………………………………… 
95. In that job are/were you   
A manager  1 
A foreman or supervisor  2 
An employee (other than 
manager or foreman) 
 3 




96. Is this, or has this been your main job, if not what was your 
previous job?  
……………………………………………………………………………………………………………………… 
97.  Did your education continue after the minimum school 
leaving age (16 years)? 
 
No    0  Yes  1 
98. Do you have a degree or equivalent qualification? 
  














1  2  3   4 
 
100. Are you currently receiving any financial benefits because of 
your condition? 
  1) Attendance allowance  No  0  Yes    1   
  2) Income support   No  0  Yes    1   
3) Housing benefit   No  0  Yes    1   
4) Statutory sick pay   No  0  Yes    1 
5) Incapacity benefit    No  0  Yes    1  
6) Council tax benefit   No  0  Yes    1 
7) Employment allowance  No  0  Yes    1 
8) Support allowance   No  0  Yes    1 
9) Disability living allowance  No  0  Yes    1 
10) State pension   No  0  Yes    1 
11) Occupational pension   No  0  Yes    1 
12) Pension Credit   No  0  Yes    1 





101. Do you have any financial problems at the moment 
(everyday life)?   







Appendix D3 – Quality of Life (QoL): Chronic Respiratory Questionnaire – 


















































Appendix D4 – Quality of Life (QoL): Hospital Depression and anxiety Scale 
(HADS) 
 
Hospital Anxiety and Depression Scale (HADS) 
Patient ID:.............. 
We are aware that emotions play an important part in most illnesses. Knowing how 
you feel will enable us to understand better how to help people with your condition. 
This questionnaire is designed to help us know how you feel. Read each item below 
and underline the reply which comes closest to how you have been feeling in the past 
week.  
Don’t take too long over your replies, your immediate reaction to each item will 
probably be more accurate than a long thought-out response. 
 
I feel tense or ‘wound up’ 
Most of the time 
A lot of the time 
From time to time, occasionally 
Not at all 
 
 
I feel as if I am slowed down 
Nearly all the time 
Very often 
Sometimes 
Not at all 
I still enjoy the things I used to enjoy 
Definitely as much 
Not quite so much 
Only a little 
Hardly at all 
I get a sort of frightened feeling like 
‘butterflies’ in the stomach 








I get a sort of frightened feeling as if 
something awful is about to happen 
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn’t worry me 
Not at all 
 
I have lost interest in my appearance 
Definitely 
I don’t take as much care as I should 
I may not take quite as much care 
I take just as much care as ever 
I can laugh and see the funny side of 
things 
As much as I always could 
Not quite so much now 
Definitely not so much now 
Not at all 
I feel restless as if I have to be on the 
move 
Very much indeed 
Quite a lot 
Not very much 
Not at all 
 
Worrying thoughts go through my mind 
A great deal of the time 
A lot of the time 





I look forward with enjoyment to 
things 
As much as I ever did 
Rather less than I used to 
Definitely less than I used to 








Most of the time 
I get sudden feelings of panic 
Very often indeed 
Quite often 
Not very often 
Not at all 
 




Not at all 



















Appendix D5 – Quality of Life / Disease Severity: Medical Research Council 
Dyspnoea Scale (MRC Dyspnoea Scale) 
 
MRC dyspnoea scale 
 
Medical Research Council dyspnoea scale for grading the 




Please tick the box with the option that applies to you: 
 
 
1. Not troubled by breathlessness except on strenuous exercise   
 
2. Short of breath when hurrying or walking up a slight hill 
 
 
3. Walks slower than contemporaries on the level because  




4. Stops for breath after about 100 m or after a few minutes  
on the level 
 
 
5. Too breathless to leave the house, or breathless when  





Appendix D6 – Illness Perceptions: Illness Perceptions Questionnaire – Revised 
(IPQ-R) – adapted for COPD 
 
YOUR VIEWS ABOUT YOUR AIRWAYS DISEASE 
Patient ID:...................... 
Listed below are a number of symptoms that you may or may not have experienced since your 
airways disease. Please indicate by circling Yes or No, whether you have experienced any of these 
symptoms since your airways disease, and whether you believe that these symptoms are related to 




I have experienced this symptom 
since my airways disease 
This symptom is related to my airways 
disease 


























































































































































We are interested in your own personal views of how you now see your current airways disease. 
Please indicate how much you agree or disagree with the following statements about your airways 
disease by ticking the appropriate box. 
 
 









IP1 My airways disease will last a 
short time 
     
IP2 My airways disease is likely to 
be permanent rather than 
temporary 
     
IP3 My airways disease will last for 
a long time 
     
IP4 This airways disease will pass 
quickly 
     
IP5 I expect to have this airways 
disease for the rest of my life 
     
IP6 My airways disease is a serious 
condition 
     
IP7 My airways disease has major 
consequences on  my life 
     
IP8 My airways disease does not 
have much effect on my life 
     
IP9 My airways disease strongly 
affects the way others see me 
     
IP10 My airways disease has serious 
financial consequences 
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IP11 My airways disease causes 
difficulties for those who are 
close to me 
     
IP12 There is a lot which I can do to 
control my symptoms 
     
IP13 What I do can determine 
whether my airways disease 
gets better or worse 
     
IP14 The course of my airways 
disease depends on me 
     
IP15 Nothing I do will affect my 
airways disease 
     
IP16 I have the power to influence 
my airways disease 
     
IP17 My actions will have no effect 
on the outcome of my airways 
disease 
     
IP18 My airways disease will 
improve in time 
     
IP19 There is very little that can be 
done to improve my airways 
disease 
     
IP20 My treatment will be effective 
in curing my airways disease 
     
IP21 The  negative effects of my 
airways disease can be 
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IP22 My treatment can control my 
airways disease 
     
IP23 There is nothing which can help 
my condition 
     
IP24 The symptoms of my condition 
are puzzling to me 
     
IP25 My airways disease is a mystery 
to me 
     
IP26 I don’t understand my airways 
disease 
     
IP27 My airways disease doesn’t 
make any sense to me 
     
IP28 I have a clear picture or 
understanding of my condition 
     
IP29 The symptoms of my airways 
disease change a great deal 
from day to day 
     
IP30 My symptoms come and go in 
cycles 
     
IP31 My airways disease is very 
unpredictable 
     
IP32 I go through cycles in which my 
airways disease gets better and 
worse 
     
IP33 I get depressed when I think 











CAUSES OF MY AIRWAYS DISEASE 
We are interested in what you consider may have been the cause of your airways disease. As people 
are very different, there is no correct answer for this question. We are most interested in your own 
views about the factors that caused your airways disease rather than what others including doctors or 
family may have suggested to you. Below is a list of possible causes for your airways disease. Please 
indicate how much you agree or disagree that they were causes for you by ticking the appropriate box. 
 
 










IP34 When I think about my airways 
disease I get upset 
     
IP35 My airways disease makes me 
feel angry 
     
IP36 My airways disease does not 
worry me 
     
IP37 Having this airways disease 
makes me feel anxious 
     
IP38 My airways disease makes me 
feel afraid 
     
 POSSIBLE CAUSES STRONGLY 
DISAGREE 




C1 Stress or worry      
C2 Hereditary – it runs in my 
family 
     
C3 A germ or virus      
C4 Diet or eating habits      
C5 Chance or bad luck      





Please list in rank-order the three most important factors that you now believe caused YOUR airways 














 POSSIBLE CAUSES STRONGLY 
DISAGREE 




C7 Pollution in the environment      
C8 My own behaviour      
C9 My mental attitude e.g. 
thinking about life negatively 
     
C10 Family problems or worries      
C11 Overwork      
C12 My emotional state e.g. 
feeling down, lonely, anxious, 
empty 
     
C13 Ageing      
C14 Alcohol      
C15 Smoking      
C16 Accident or injury      
C17 My personality      
C18 Altered immunity      
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Appendix D7 – General Self-Efficacy (GSE): General Self-Efficacy Scale 
 
General Self-Efficacy Scale (GSE) 
Patient Code:.............. 
Please tick one of the boxes according to how the statement applies to you 
 Not at all 
true 




1 2 3 4 
 I can always manage to solve 
difficult problems if I try hard 
enough. 
    
If someone opposes me, I can 
find the means and ways to get 
what I want. 
    
It is easy for me to stick to my 
aims and accomplish my goals. 
    
I am confident that I could deal 
efficiently with unexpected 
events. 
    
Thanks to my resourcefulness, I 
know how to handle 
unforeseen situations. 
    
I can solve most problems if I 
invest the necessary effort. 
    
I can remain calm when facing 
difficulties because I can rely on 
my coping abilities. 
    
When I am confronted with a 
problem, I can usually find 
several solutions. 
    
If I am in trouble, I can usually 
think of a solution. 
    
I can usually handle whatever 
comes my way. 




Appendix D8 – Social Capital: Social Capital Questionnaire including 




Patient ID:.............                          
 
Social Capital Questionnaire 
 
 
In the following questions please circle the most appropriate response 1, 2, 3 or 4 
 
 
1. Do you feel valued by society? 
No, not much     Yes, very much 
            1  2  3  4 
2. If you were to die tomorrow, would you be satisfied with what your life 
has meant? 
No, not much     Yes, very much  
1     2  3  4 
3. Have you ever picked up other people’s rubbish in a public place? 
No, never     Yes, frequently 
1  2  3  4 
4. Some say that by helping others you help yourself in the long run. Do 
you agree? 
No, not much     Yes, very much  
1  2  3  4 
5. Do you help out a local group as a volunteer? 
No, not at all    Yes, often (at least once a 
week) 
1  2  3  4 
6. Do you feel safe walking down your street after dark? 
No, not much     Yes, very much  
1  2  3  4 
7. Do you agree that most people can be trusted? 
No, not much     Yes, very much 
1  2  3  4 
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8. If someone’s car breaks down outside your house, do you invite them 
into your home to use the phone? 
No, not at all     Yes, definitely  
1  2  3  4 
9. Can you get help from friends when you need it? 
No, not at all     Yes, definitely 
1  2  3  4 
10. Does your area have a reputation for being a safe place? 
No, not at all      Yes  
1  2  3  4 
11. If you were caring for a child and needed to go out for a while, would 
you ask a neighbour for help? 
No, not at all     Yes, definitely 
1  2  3  4 
12. Have you visited a neighbour in the past week? 
No, not at all     Yes, frequently 
1  2  3  4 
13. Have you attended a local community event in the past 6 months (e.g. 
church fete, school concert, craft exhibition)? 
No, not at all     Yes, several (at least 3) 
1  2  3  4 
14. Are you an active member of a local organisation or club (e.g. sport, 
craft, social club)? 
No, not at all     Yes, very active  
1  2  3  4 
15. Does your local community feel like home? 
No, not at all     Yes, definitely 
1  2  3  4 
16. In the past week, how many phone conversations have you had with 
friends? 
        None      Many (at least 6)  
1  2  3  4 
17. How many people did you talk to yesterday? 
None at all      Many (at least 10) 
1  2  3  4 
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18. Over the weekend do you have lunch/dinner with other people outside 
your household? 
No, not much     Yes, nearly always  
1  2  3  4 
19. Do you go outside your local community to visit your family? 
No, not much     Yes, nearly always 
1  2  3  4 
20. When you go shopping in your local area are you likely to run into 
friends and acquaintances? 
No, not much     Yes, nearly always  
1  2  3  4 
21. If you need information to make a life decision, do you know where to 
find that information? 
No, not at all     Yes, definitely 
1  2  3  4 
22. In the past 6 months, have you done a favour for a sick neighbour? 
No, not at all          Yes, frequently (at least 5 times)
  
1  2  3  4 
23. Are you on a management committee or organising committee for any 
local group or organisation? 
No, not at all     Yes, several (at least 3) 
1  2  3  4 
24. In the past 3 years, have you ever joined a local community action to 
deal with an emergency? 
No, not at all            Yes, frequently (at least 5 
times)  
1  2  3  4 
25. In the past 3 years have you ever taken part in a local community 
project or working bee? 
No, not at all     Yes, very much 





26. Have you ever been part of a project to organise a new service in your 
area (e.g. youth club, scout hall, child care, recreation for disabled)? 
No, not at all     Yes, several times (at least 
3)  
1  2  3  4 
27. If you disagree with what everyone else agreed on, would you feel free 
to speak out? 
No, not at all     Yes, definitely 
1  2  3  4 
28. If you have a dispute with your neighbours (e.g. over fences or dogs) are 
you willing to seek mediation? 
No, not at all                Yes, definitely  
1  2  3  4 
29. Do you think that multiculturalism makes life in your area better? 
No, not at all     Yes, definitely 
1  2  3  4 
30. Do you enjoy living among people of different life styles? 
No, not at all     Yes, definitely  
1  2  3  4 
31. If a stranger, someone different, moves into your street, would they be 
accepted by the neighbours? 
No, not easily     Yes, definitely 
1  2  3  4 
 
The following five questions are for those in paid employment. If you are 
not in paid employment, please go to Question 37. 
 
32. Do you feel part of the local geographic community where you work? 
No, not at all     Yes, definitely  
1  2  3  4 
33. Are your workmates also your friends? 
No, not at all     Yes, definitely 
1  2  3  4 
34. Do you feel part of a team at work? 
                        No, not at all    Yes, definitely  
1  2  3  4 
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35. At work do you take the initiative to do what needs to be done even if 
no one asks you to? 
No, not at all     Yes, definitely 
1  2  3  4 
36. In the past week at work, have you helped a workmate even though it 
was not in your job description? 
No, not at all    Yes, several times (at least 5)  




In the following questions please tick the most appropriate response (or 
write in the correct answer in the questions with dots ..................). 
 
37. What is your gender?   [   ]  1. Female[   ]  2. Male 
 
38. Are you employed?  [   ]  Yes  If yes, how many hours per week ....... 
              Occupation: ........................ 
     [   ]  No 
39. What is your age in years?   ........ years 
 
40. What is the Postcode of your address? .................... postcode 
 
 
41. Are you living in:  [   ]  1. Private house, flat, unit 
     [   ]  2. Public housing 
     [   ]  3. Other 
 
42. Are you renting your accommodation? [   ]  1. Yes 
       [   ]  2. No 
 
 




44. Who do you live with? [   ]  1. alone 
     [   ]  2. just partner 
     [   ]  3. just children 
     [   ]  4. partner and children 
     [   ]  5. extended or blended family 
     [   ]  6. friends 
     [   ]  7. other 
 
45. Do you have children under 18 years of age? 
   [   ]  Yes  
 
                                                 If yes, How many under school age ....... 
            How many school age to 18 ........ 
 
   [   ]  No 
 
46. What language do you prefer to speak at home? 
     [   ] English 
     [   ] Other 
 
47. Which ethnic group do you belong to? 
[   ]    1. White British   [   ]   7.  Indian 
[   ]    2. White other   [   ]   8.  Pakistani 
[   ]    3. Black Caribbean          [   ]   9.  Asian other    
[   ]    4. Black African     [   ]  10. Chinese                 
[   ]    5. Black other   [   ]  11. None of these 
[   ]    6. Bangladeshi       
 
                    
48. What is the main source of income for your household? 
   [   ]  1. Wages or salary 
   [   ]  2. Pension or benefit 
   [   ]  3. Other 
49. What is your current weekly total household income before taxes and             
deductions? Please tick one 
   [   ]  1. £0 - £244  (£12688 per year) 
   [   ]  2. £244 - £339 (£12688 – £17628 per year) 
   [   ]  3. £340 - £451 (£17680 – £23452 per year) 
   [   ]  4. £452 - £625 (£23504 – £32500 per year)  




50. What are your qualifications? 
   [   ]  1. Primary School completed 
   [   ]  2. Secondary school completed or equivalent 
   [   ]  3. Certificate or Diploma 
   [   ]  4. Degree 





























ATHENA project: Access To HEalthcare iN Airways disease 
 
 
Thank you for taking the time to take part in this study! 
This research is investigating your experience of your 
chest condition and how social and financial issues 
may influence your healthcare services and 
your quality of life. 
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Appendix F1: Unadjusted analyses examining associations between SES and Quality of Life (QoL) 
 
Table F1a Associations between SES (IMD score) and QoL – unadjusted for disease severity (Pearson’s correlations) 
 
Dyspnoea Fatigue Emotional Function Mastery Anxiety Depression 
IMD scores  r= -0.01 (p=0.90) r= -0.04 (p=0.65) r= -0.10 (p=0.17) r= -0.04 (p=0.61) r= 0.08 (p=0.32) r= 0.09 (p=0.25) 
 



















































































































































































































































































F and p values 
F(1, 174)= 0.49; 
p= 0.48 
F(1, 174)= 0.11; 
p= 0.74 
F(1, 174)= 0.31; 
p= 0.58 
F(1, 174)= 0.004; p= 
0.95 
F(1, 174)= 0.11; 
p= 0.75 
F(1, 174)= 0.62; 
p= 0.43 
 

































































































Appendix F2: Unadjusted analyses examining associations between co-morbidities and Quality of Life (QoL) 
 































































































Appendix F3: Unadjusted analyses examining associations between SES and psychosocial variables (illness perceptions) 
 































































































































































































































































































































































































































3.60  (2.18) 
 
3.85  (0.54) 
 
2.87  (0.69) 
 
3.36  (0.75) 
 
3.13  (0.46) 
 
3.61  (0.70) 
 
2.91  (0.80) 
 





3.95  (2.49) 
 
3.81  (0.80) 
 
2.88  (0.73) 
 
3.58  (0.65) 
 
3.37  (0.49) 
 
3.74  (0.63) 
 
2.83  (0.79) 
 
2.50  (0.72) 
 
F and p 
values 
F(1, 174)= 
0.94; p= 0.33 
F(1, 174)= 0.17; 
p= 0.68 
F(1, 174)= 
0.009; p= 0.93 
F(1, 174)= 4.39; 
p= 0.04 
F(1, 174)= 
11.27; p= 0.001 
F(1, 174)= 1.52; 
p= 0.22 
F(1, 174)= 
0.36; p= 0.55 















































































































































Appendix F4: Unadjusted analyses examining associations between SES and psychosocial variables (self-efficacy) 
 






IMD Score  
 































F and p values 
 



























F and p values 
 
F(2, 173)=2.89; p=0.06 
 
 



















3.38  (0.55) 
 
F and p values 
 





























F and p values 
 











Appendix F5: Unadjusted analyses examining associations between SES and psychosocial variables (social capital) 
 




















































































































































































































































































































































































































1.31  (0.58) 
 
2.86  (0.61) 
 
2.44  (0.76) 
 
2.60  (0.81) 
 
2.66  (0.66) 
 
2.84  (0.68) 
 
2.75  (0.91) 
 





1.56  (0.75) 
 
3.07  (0.57) 
 
2.43  (0.66) 
 
2.72  (0.74) 
 
2.67  (0.72) 
 
3.02  (0.77) 
 
2.86  (0.83) 
 
3.22  (0.96) 
 
F and p 
values 
F(1, 174)= 6.35; 
p= 0.01 
F(1, 174)= 5.55; 
p= 0.02 
F(1, 174)= 0.004; 
p= 0.95 
F(1, 174)= 1.10; 
p= 0.30 
F(1, 174)= 
0.009; p= 0.93 
F(1, 174)= 2.92; 
p= 0.09 
F(1, 174)= 0.66; 
p= 0.42 























































































































































Appendix F6: Unadjusted analyses examining associations between psychosocial variables (illness perceptions) and health 
care access (HCA) 
 




(adjusted means & S.D.) 
 
Consultant Referrals 
(adjusted means & S.D.) 
 
Regular Spirometry 
(adjusted means & S.D.) 
 
PR awareness 
(adjusted means & S.D.) 
 
Identity  No: 3.68 (2.42)/Yes: 3.90 (2.37) No: 3.54 (2.27)/Yes: 4.85 (2.27) No: 3.80 (2.42)/Yes: 3.70 (2.24) No:  3.30 (2.36)/Yes: 4.19 (2.18) 
  F(1,140)= 0.31; p=0.58 F(1,174)= 7.61; p=0.006 F(1,174)= 0.08; p=0.78 F(1,174)= 6.87; p=0.008 
Timeline No: 3.94 (0.71)/Yes: 3.77 (0.61) No: 3.83 (0.65)/Yes: 3.86 (0.72) No: 3.77 (0.82)/Yes: 3.88 (0.51) No: 3.63 (0.73)/Yes: 4.03 (0.51) 
  F(1,140)= 2.26; p=0.14 F(1,174)= 0.05; p=0.83 F(1,174)= 1.22; p=0.27 F(1,174)=18.20; p<0.001 
Consequences   No: 2.87 (0.79)/Yes: 2.91 (0.64) No: 2.78 (0.67)/Yes: 3.38 (0.64) No: 2.83 (0.71)/Yes: 2.90 (0.70) No: 2.64 (0.65)/Yes: 3.11 (0.67) 
  F(1,140)= 0.10; p=0.75 F(1,174)= 18.03; p<0.001 F(1,174)= 0.47; p=0.50 F(1,174)= 22.11; p<0.001 
Pers. Control   No: 3.53 (0.73)/Yes: 3.49 (0.69) No: 3.43 (0.73)/Yes: 3.55 (0.66) No: 3.53 (0.68)/Yes: 3.39 (0.75) No: 3.44 (0.71)/Yes: 3.46 (0.73) 
  F(1,140)= 0.08; p=0.78 F(1,174)= 0.60; p=0.44 F(1,174)= 1.63; p=0.20 F(1,174)= 0.03; p=0.76 
Treatm. Control   No: 3.25 (0.50)/Yes: 3.26 (0.49) No: 3.21 (0.48)/Yes: 3.34 (0.52) No: 3.20 (0.53)/Yes: 3.25 (0.45) No: 3.32 (0.47)/Yes: 3.15 (0.49) 
  F(1,140)= 0.000; p=0.99 F(1,174)= 1.64; 0.20 F(1,174)= 0.52; p=0.47 F(1,174)= 5.56; p=0.02 
Illness Coher.   No: 3.67 (0.72)/Yes: 3.72 (0.63) No: 3.65 (0.66)/Yes: 3.74 (0.77) No: 3.66 (0.65)/Yes: 3.67 (0.70) No: 3.59 (0.67)/Yes: 3.73 (0.67) 
  F(1,140)= 0.17; p=0.68 F(1,174)= 0.43; p=0.51 F(1,174)= 0.01; p=0.91 F(1,174)= 1.87; p=0.24 
Timeline Cycl.   No: 2.73 (0.83)/Yes: 2.95 (0.75) No: 2.85 (0.79)/Yes: 2.99 (0.79) No: 2.89 (0.79)/Yes: 2.87 (0.80) No: 2.82 (0.82)/Yes: 2.93 (0.76) 
  F(1,140)= 2.54; p=0.11 F(1,174)= 0.68; 0.41 F(1,174)= 0.01; p=0.91 F(1,174)= 0.82; p=0.22 
Emotional Reps. No: 2.40 (0.73)/Yes: 2.68 (0.70) No: 2.53 (0.73)/Yes: 2.80 (0.64) No: 2.46 (0.70)/Yes: 2.65 (0.74) No: 2.46 (0.71)/Yes: 2.67 (0.72) 


















Identity  No:  3.44 (2.33)/Yes: 4.22 (2.21) No: 3.62 (2.43)/Yes: 4.28 (2.21) No: 4.60 (2.64)/Yes: 4.17 (2.06) No: 3.73 (2.43)/Yes: 3.78 (2.00) 
  F(1,174)= 4.87; p=0.02 F(1,68)= 0.93; p=0.34 F(1,55)= 0.42; p=0.52 F(1,174)= 0.02; p=0.89 
Timeline   No:  3.70 (0.70)/Yes: 4.04 (0.52) No:  3.90 (0.16)/Yes: 4.07 (0.56) No: 4.02 (0.43)/Yes: 4.09 (0.61) No: 3.87 (0.67)/Yes: 3.75 (0.62) 
  F(1,174)= 11.87; p=0.001 F(1,68)= 1.20; p=0.28 F(1,55)= 0.15; p=0.70 F(1,174)= 1.10; p=0.29 
Consequences   No:  2.68 (0.70)/Yes: 3.17 (0.60) No:  3.04 (0.69)/Yes: 3.18 (0.59) No: 3.46 (0.47)/Yes: 3.08 (0.60) No: 2.82 (0.71)/Yes: 3.00 (0.67) 
  F(1,174)= 22.30; p<0.001 F(1,68)= 0.56; p=0.46 F(1,55)= 4.78; p=0.03 F(1,174)= 2.43; p=0.14 
Pers. Control   No:  3.46 (0.72)/Yes: 3.44 (0.72) No:  3.41 (0.84)/Yes: 3.44 (0.70) No: 3.31 (0.79)/Yes: 3.48 (0.67) No: 3.45 (0.72)/Yes: 3.46 (0.72) 
  F(1,174)= 0.03; p=0.98 F(1,68)= 0.01; p=0.91 F(1,55)= 0.64; p=0.43 F(1,174)= 0.02; p=0.85 
Treatm. Control   No:  3.31 (0.49)/Yes: 3.11 (0.46) No:  3.08 (0.44)/Yes: 3.11 (0.47) No: 3.04 (0.36)/Yes: 3.13 (0.51) No: 3.23 (0.49)/Yes: 3.24 (0.47) 
  F(1,174)= 6.88; p=0.01 F(1,68)= 0.05; p=0.83 F(1,55)= 0.43; p=0.52 F(1,174)= 0.008; p=0.92 
Illness Coher.   No:  3.60 (0.69)/Yes: 3.76 (0.64) No:  3.66 (0.60)/Yes: 3.79 (0.65) No: 3.43 (0.87)/Yes: 3.91 (0.50) No: 3.67 (0.68)/Yes: 3.65 (0.67) 
  F(1,174)= 2.50; p=0.19 F(1,68)= 0.40; p=0.53 F(1,55)= 6.87; p=0.001 F(1,174)= 0.02; p=0.85 
 
Timeline Cycl.   No:  2.87 (0.80)/Yes: 2.88 (0.78) No:  2.73 (0.76)/Yes: 2.90 (0.79) No: 2.82 (0.78)/Yes: 2.93 (0.80) No: 2.74 (0.78)/Yes: 3.21 (0.72) 
  F(1,174)= 0.005; p=0.59 F(1,68)= 0.48; p=0.49 F(1,55)= 0.22; p=0.64 F(1,174)= 12.94; p<0.001 
Emotional Reps.   
 No:  2.50 (0.76)/Yes: 2.67 (0.66) No:  2.51 (0.61)/Yes: 2.69 (0.67) No: 2.89 (0.67)/Yes: 2.62 (0.67) No: 2.51 (0.74)/Yes: 2.71 (0.66) 












(adjusted means & S.D.) 
 
Appropriately Treated 
(adjusted means & S.D.) 
 
Under-treated 
(adjusted means & S.D.) 
 
Identity  No: 3.51 (2.15)/Yes: 4.18 (2.53) No: 3.59 (2.30)/Yes: 3.91 (2.32) No: 3.95 (2.41)/Yes: 3.19 (1.94) 
  F(1,174)= 3.41; p=0.07 F(1,174)= 0.80; p=0.37 F(1,174)= 3.73; p=0.055 
Timeline   No: 3.78 (0.73)/Yes: 3.93 (0.50) No: 3.76 (0.71)/Yes: 3.91 (0.60) No: 3.88 (0.63)/Yes: 3.71 (0.72) 
  F(1,174)= 2.01; p=0.16 F(1,174)= 2.18; p=0.14 F(1,174)= 2.40; p=0.12 
Consequences   No: 2.83 (0.72)/Yes: 2.95 (0.67) No: 2.75 (0.70)/Yes: 3.00 (0.68) No: 2.93 (0.68)/Yes: 2.71 (0.74) 
  F(1,174)= 1.12; p=0.29 F(1,174)= 5.70; p=0.02 F(1,174)= 3.55; p=0.06 
Personal Control  No: 3.40 (0.76)/Yes: 3.55 (0.63) No: 3.47 (0.74)/Yes: 3.43 (0.71) No: 3.47 (0.71)/Yes: 3.39 (0.74) 





















(adjusted means & S.D.) 
 
Appropriately Treated 
(adjusted means & S.D.) 
 
Under-treated 
(adjusted means & S.D.) 
 
 
Treatment  Control   No: 3.20 (0.54)/Yes: 3.29 (0.36) No: 3.23 (0.54)/Yes: 3.23 (0.43) No: 3.27 (0.46)/Yes: 3.11 (0.55) 
  F(1,174)= 1.29; p=0.26 F(1,174)= 0.000; p=0.998 F(1,174)= 0.45; p=0.51 
Illness Coherence    No: 3.66 (0.68)/Yes: 3.66 (0.68) No: 3.62 (0.70)/Yes: 3.71 (0.65) No: 3.71 (0.68)/Yes: 3.54 (0.66) 
  F(1,174)= 0.004; p=0.95 F(1,174)= 0.92; p=0.34 F(1,174)= 2.26; p=0.13 
Timeline Cyclical   No: 2.81 (0.75)/Yes: 2.99 (0.85) No: 2.87 (0.78)/Yes: 2.89 (0.81) No: 2.92 (0.80)/Yes: 2.76 (0.76) 
  F(1,174)= 2.25; p=0.14 F(1,174)= 0.03; p=0.87 F(1,174)= 1.34; p=0.25 
Emotional 
Representations   No: 2.49 (0.71)/Yes: 2.71 (0.73) No: 2.54 (0.74)/Yes: 2.60 (0.71) No: 2.62 (0.74)/Yes: 2.42 (0.68) 










Appendix F7: Unadjusted analyses examining associations between psychosocial variables (self-efficacy) and health care 
access (HCA) 
 


















(adjusted means & S.D.) 
 
 
Self-efficacy No: 3.34 (0.50)/Yes: 3.26 (0.62) No: 3.28 (0.60)/Yes: 3.33 (0.54) No: 3.32 (0.55)/Yes: 3.27 (0.62) No: 3.27 (0.62)/Yes: 3.30 (0.56) 
 




(adjusted means and SD) 
 
PR attendance 
(adjusted means and SD) 
 
PR completion 




(adjusted means and SD) 
 
Self-efficacy No: 3.28 (0.63)/Yes: 3.29 (0.52) No: 3.29 (0.61)/Yes: 3.27 (0.54) No: 3.19 (0.56)/Yes: 3.33 (0.52) No: 3.33 (0.59)/Yes: 3.22 (0.57) 
 
F(1,174)= 0.006; p=0.94 F(1,174)= 0.05; p=0.82 F(1, 61)= 0.91; p=0.34 F(1,171)= 1.24; p=0.27 
 





(adjusted means & S.D.) 
 
Appropriately Treated 
(adjusted means & S.D.) 
 
Under-treated 
(adjusted means & S.D.) 
 
Self-efficacy   No: 3.30 (0.61)/Yes: 3.27 (0.57) No: 3.25 (0.63)/Yes: 3.32 (0.55) No: 3.31 (0.55)/Yes: 3.23 (0.70) 




Appendix F8: Unadjusted analyses examining associations between psychosocial variables (social capital) and health care access (HCA) 





(adjusted means & S.D.) 
 
Consultant Referrals 
(adjusted means & S.D.) 
 
Regular Spirometry 
(adjusted means & S.D.) 
 
PR awareness 
(adjusted means & S.D.) 
 
Particip Local Com.  No: 1.43 (0.72)/Yes: 1.37 (0.59) No: 1.43 (0.67)/Yes: 1.32 (0.64) No: 1.47 (0.71)/Yes: 1.36 (0.63) No: 1.40 (0.66)/Yes: 1.42 (0.66) 
  F(1,140)= 0.24; p=0.63 F(1,174)= 0.63; p=0.43 F(1,174)= 1.14; p=0.29 F(1,174)= 0.05; p=0.77 
Social Agency   No: 3.04 (0.64)/Yes: 2.94 (0.56) No: 2.94 (0.61)/Yes: 2.99 (0.59) No: 2.97 (0.56)/Yes: 2.93 (0.64) No: 2.89 (0.61)/Yes: 3.00 (0.60) 
  F(1,140)= 1.05; p=0.31 F(1,174)= 0.15; p=0.70 F(1,174)= 0.21; p=0.65 F(1,174)= 1.38; p=0.22 
Trust & Safety   No: 2.46 (0.67)/Yes: 2.38 (0.74) No: 2.44 (0.71)/Yes: 2.42 (0.76) No: 2.45 (0.71)/Yes: 2.43 (0.72) No: 2.48 (0.75)/Yes: 2.38 (0.69) 
  F(1,140)= 0.54; p=0.46 F(1,174)= 0.009; p=0.92 F(1,174)= 0.03; p=0.86 F(1,174)= 0.85; p=0.45 
Neighbourhood Conn.  No: 2.74 (0.76)/Yes: 2.61 (0.81) No: 2.65 (0.80)/Yes: 2.63 (0.69) No: 2.64 (0.80)/Yes: 2.66 (0.77) No: 2.68 (0.81)/Yes: 2.62 (0.75) 
  F(1,140)= 0.93; p=0.34 F(1,174)= 0.02; p=0.88 F(1,174)= 0.02; p=0.88 F(1,174)= 0.33; p=0.59 
Friends & Family No: 2.67 (0.66)/Yes: 2.65 (0.69) No: 2.66 (0.68)/Yes: 2.64 (0.69) No: 2.70 (0.70)/Yes: 2.63 (0.67) No: 2.62 (0.68)/Yes: 2.70 (0.68) 
  F(1,140)= 0.02; p=0.88 F(1,174)= 0.03; p=0.88 F(1,174)= 0.38; p=0.54 F(1,174)= 0.60; p=0.49 
Tolerance of Diversity  No: 2.92 (0.70)/Yes: 2.98 (0.76) No: 2.91 (0.72)/Yes: 2.95 (0.77) No: 2.94 (0.69)/Yes: 2.89 (0.75) No: 2.86 (0.76)/Yes: 2.97 (0.68) 
  F(1,140)= 0.30; p=0.58 F(1,174)= 0.09; p=0.77 F(1,174)= 0.16; p=0.70 F(1,174)= 1.09; p=0.36 
Value of Life  No: 2.97 (0.73)/Yes: 2.59 (0.95) No: 2.82 (0.90)/Yes: 2.67 (0.72) No: 2.85 (0.84)/Yes: 2.75 (0.90) No: 2.88 (0.88)/Yes: 2.71 (0.87) 
  F(1,140)= 6.77; p=0.01 F(1,174)= 0.66; p=0.42 F(1,174)= 0.63; p=0.43 F(1,174)= 1.56; p=0.19 
Work Connections  No: 3.28 (1.12)/Yes: 2.91 (1.08) No: 2.94 (1.06)/Yes: 4.00 (---) No: 3.29 (0.79)/Yes: 2.77 (1.22) No: 3.03 (1.15)/Yes: 2.94 (0.93) 





PR referral PR attendance PR completion 
 
Hospital Admission 
Particip Local Com. No:  1.43 (0.69)/Yes: 1.38 (0.62) No:  1.19 (0.48)/Yes: 1.41 (0.64) No: 1.20 (0.56)/Yes: 1.49 (0.66) No: 1.27 (0.55)/Yes: 1.49 (0.66) 
 
F(1,174)= 0.30 F(1,68)= 1.42; p=0.24 F(1,55)= 2.28; p=0.21 F(1,174)= 1.77; p=0.19 
Social Agency No:  2.93 (0.61)/Yes: 2.98 (0.60) No:  2.90 (0.85)/Yes: 2.97 (0.56) No: 2.84 (0.56)/Yes: 3.01 (0.56) No: 2.89 (0.69)/Yes: 3.01 (0.56) 
 
F(1,174)= 0.26 F(1,68)= 0.14; p=0.71 F(1,55)= 2.28; p=0.14 F(1,174)= 0.55; p=0.47 
Trust & Safety No:  2.46 (0.77)/Yes: 2.39 (0.63) No:  2.23 (0.58)/Yes: 2.41 (0.67) No: 2.36 (0.62)/Yes: 2.42 (0.69) No: 2.34 (0.62)/Yes: 2.42 (0.69) 
 
F(1,174)= 0.35 F(1,68)= 0.78; p=0.38 F(1,55)= 0.98; p=0.33 F(1,174)= 1.42; p=0.26 
Neighbourhood Conn. No:  2.64 (0.80)/Yes: 2.66 (0.75) No:  2.37 (0.54)/Yes: 2.72 (0.78) No: 2.44 (0.61)/Yes: 2.82 (0.81) No: 2.47 (0.64)/Yes: 2.82 (0.81) 
 
F(1,174)= 0.04; p=0.81 F(1,68)= 2.37; p=0.13 F(1,55)= 0.10; p=0.75 F(1,174)= 2.74; p=0.10 
Friends & Family No:  2.62 (0.69)/Yes: 2.72 (0.67) No:  2.67 (0.73)/Yes: 2.72 (0.67) No: 2.69 (0.82)/Yes: 2.73 (0.61) No: 2.65 (0.74)/Yes: 2.73 (0.61) 
 
F(1,174)= 0.99; p=0.38 F(1,68)= 0.06; p=0.80 F(1,55)= 2.72; p=0.11 F(1,174)= 1.29; p=0.27 
Tolerance of Diversity No:  2.87 (0.74)/Yes: 2.99 (0.69) No:  2.85 (0.88)/Yes: 3.01 (0.64) No: 2.96 (0.45)/Yes: 3.02 (0.70) No: 2.92 (0.65)/Yes: 3.02 (0.70) 
 
F(1,174)= 1.15; p=0.36 F(1,68)= 0.57; p=0.45 F(1,55)= 0.04; p=0.84 F(1,174)= 0.005; p=0.91 
Value of Life No:  2.83 (0.88)/Yes: 2.74 (0.87) No:  2.92 (0.91)/Yes: 2.68 (0.87) No: 2.63 (0.72)/Yes: 2.69 (0.92) No: 2.73 (0.79)/Yes: 2.69 (0.92) 
 
F(1,174)= 0.42; p=0.45 F(1,68)= 0.85; p=0.36 F(1,55)= 0.12; p=0.73 F(1,174)= 1.48; p=0.23 
Work Connections No:  2.98 (1.14)/Yes: 3.08 (0.83) No:  3.00 (1.00)/Yes: 3.33 (---) N/A No: 3.08 (0.83)/Yes: --- (---) 
 










(adjusted means & S.D.) 
 
Appropriately Treated 
(adjusted means & S.D.) 
 
Under-treated 
(adjusted means & S.D.) 
 
Particip Local Com. No: 1.38 (0.60)/Yes: 1.47 (0.77) No: 1.47 (0.70)/Yes: 1.35 (0.61) No: 1.41 (0.68)/Yes: 1.42 (0.60) 
 
F(1,174)= 0.71; p=0.40 F(1,174)= 1.57; p=0.21 F(1,174)= 0.02; p=0.89 
Social Agency No: 2.93 (0.59)/Yes: 2.97 (0.64) No: 2.92 (0.61)/Yes: 2.98 (0.61) No: 2.98 (0.60)/Yes: 2.87 (0.61) 
 
F(1,174)= 0.14; p=0.71 F(1,174)= 0.49; p=0.49 F(1,174)= 1.10; p=0.30 
Trust & Safety No: 2.38 (0.71)/Yes: 2.53 (0.72) No: 2.48 (0.72)/Yes: 2.39 (0.72) No: 2.44 (0.70)/Yes: 2.42 (0.77) 
 
F(1,174)= 1.57; p=0.21 F(1,174)= 0.67; p=0.41 F(1,174)= 0.02; p=0.89 
Neighbourhood Conn. No: 2.63 (0.79)/Yes: 2.69 (0.78) No: 2.65 (0.78)/Yes: 2.65 (0.79) No: 2.69 (0.77)/Yes: 2.54 (0.81) 
 
F(1,174)= 0.30; p=0.59 F(1,174)= 0.000; p=0.99 F(1,174)= 1.37; p=0.24 
Friends & Family No: 2.58 (0.67)/Yes: 2.82 (0.68) No: 2.62 (0.66)/Yes: 2.70 (0.71) No: 2.72 (0.68)/Yes: 2.50 (0.66) 
 
F(1,174)= 5.15; p=0.02 F(1,174)= 0.59; p=0.44 F(1,174)= 3.47; p=0.06 
Tolerance of Diversity No: 2.86 (0.74)/Yes: 3.02 (0.68) No: 2.92 (0.76)/Yes: 2.90 (0.69) No: 2.95 (0.69)/Yes: 2.81 (0.81) 
 
F(1,174)= 1.97; p=0.16 F(1,174)= 0.04; p=0.85 F(1,174)= 1.34; p=0.25 
Value of Life No: 2.75 (0.92)/Yes: 2.87 (0.79) No: 2.85 (0.85)/Yes: 2.74 (0.90) No: 2.84 (0.84)/Yes: 2.66 (0.96) 
 
F(1,174)= 0.77; p=0.38 F(1,174)= 0.70; p=0.40 F(1,174)= 1.48; p=0.23 
Work Connections No: 2.94 (1.14)/Yes: 3.10 (0.98) No: 2.97 (1.11)/Yes: 3.06 (1.02) No: 3.20 (0.94)/Yes: 2.00 (1.20) 
 







Appendix F9: Unadjusted analyses examining associations between psychosocial variables (illness perceptions) and quality of life 
(QoL) 

















r= -0.36             
(p< 0.001) 
r= -0.38                      
(p< 0.001) 










































































































































































Appendix F11: Unadjusted analyses examining associations between psychosocial variables (social capital) and quality of life (QoL) 
 
 















Participation Local Com. 
 
r= 0.07 (p= 0.37) 
 
r= 0.05 (p= 0.52) 
 
r= -0.01 (p= 0.85) 
 
r= 0.05 (p= 0.48) 
 
r= 0.13 (p= 0.10) 
 




r= -0.03 (p= 0.76) 
 
r= 0.21 (p= 0.004) 
 
r= 0.19 (p= 0.01) 
 
r= 0.20 (p= 0.006) 
 
r= -0.09 (p= 0.25) 
 
r= -0.35 (p< 0.001) 
 
Trust and Safety 
 
r= 0.10 (p= 0.16) 
 
r= 0.23 (p= 0.002) 
 
r= 0.33 (p< 0.001) 
 
r= 0.31 (p< 0.001) 
 
r= -0.29 (p< 0.001) 
 




r= -0.07 (p= 0.38) 
 
r= 0.05 (p= 0.48) 
 
r= 0.17 (p= 0.02) 
 
r= 0.16 (p= 0.03) 
 
r= -0.09 (p= 0.26) 
 
r= -0.30 (p< 0.001) 
 
Family & Friends Con. 
 
r= -0.06 (p= 0.40) 
 
r= 0.16 (p= 0.04) 
 
r= 0.09 (p= 0.23) 
 
r= 0.13 (p= 0.09) 
 
r= -0.03 (p= 0.70) 
 
r= -0.26 (p= 0.001) 
 
Tolerance of Diversity 
 
r= -0.09 (p= 0.26) 
 
r= 0.06 (p= 0.45) 
 
r= 0.12 (p= 0.11) 
 
r= 0.06 (p= 0.42) 
 
r= -0.10 (p= 0.19) 
 
r= -0.11 (p= 0.13) 
 
Value of Life 
 
r= 0.02 (p= 0.80) 
 
r= 0.25 (p= 0.001) 
 
r= 0.32 (p< 0.001) 
 
r= 0.23 (p= 0.003) 
 
r= -0.23 (p= 0.002) 
 




r= -0.17 (p= 0.50) 
 
r= 0.03 (p= 0.90) 
 
r= 0.04 (p= 0.88) 
 
r= -0.23 (p= 0.35) 
 
r= -0.25 (p= 0.32) 
 






Appendix F12: Unadjusted mediation analyses examining illness perceptions, 
self-efficacy and social capital as mediators in the relationship between SES and 
HCA 
 
Table F12a Direct, total and specific indirect effects of IMD score and illness perceptions on 
HCA (smoking cessation referral) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
                   0.05                 2.90     0.004      0.0171                   0.0882 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.001       -0.0182          0.0185 
Specific indirect effects 
Identity        0.0003       -0.0049          0.0077 
Timeline       0.002       -0.0100                  0.0135 
Consequences      -0.002       -0.0137                  0.0060 
Personal Control     -0.0001       -0.0052                  0.0051 
Treatment Control      0.0008       -0.0065                  0.0068 
Illness Coherence      0.0004       -0.0050                  0.0075 
Timeline Cyclical      0.0005       -0.0041                  0.0062 




Figure F12a Multiple mediation analysis examining the relationship between IMD score and 
HCA (smoking cessation referrals) mediated by illness perceptions in COPD 
______________________________________________________________________________ 
 
            0.01         0.03 
                                               -0.002                                                               -0.65 
                                           0.004      -0.54 
  -0.005    0.01 
                                            -0.002  -0.39 
                                             0.0008                                                    0.50 
                                      0.003                                                    0.17 
                           -0.003                                                                         1.02* 
                                                     
             0.05* 

















Table F12b Direct, total and specific indirect effects of IMD quintiles and illness perceptions on 
HCA (smoking cessation referral) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
 
   -0.53     -2.32     0.02       -0.9698                 -0.0811 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.07        -0.1576          0.3493 
Specific indirect effects 
Identity       -0.005       -0.1264          0.0468 
Timeline       0.03        -0.0729                  0.2525 
Consequences       0.02        -0.0461                  0.1920 
Personal Control      0.003       -0.0910                  0.1121 
Treatment Control     -0.02        -0.1848                  0.0373 
Illness Coherence      0.008       -0.0676                  0.1095 
Timeline Cyclical     -0.0003       -0.0746                  0.0634 





Figure F12b Multiple mediation analysis examining the relationship between IMD quintiles and 
HCA (smoking cessation referrals) mediated by illness perceptions in COPD 
 
 
               -0.21    0.03 
                                                -0.04                                                               -0.70* 
                                          -0.04   -0.48 
   0.13    0.02 
                                           0.06     -0.38 
                                                0.02                                                    0.52 
                                      -0.001                                                  0.20 
                              0.04                                                                        0.98* 
                                                     
           -0.40* 

















Table F12c Direct, total and specific indirect effects of income level and illness perceptions on 
HCA (smoking cessation referral) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
    -0.76     -2.87    0.004      -1.2831                 -0.2407 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        -0.006       -0.2963          0.3257 
Specific indirect effects 
Identity        -0.01        -0.2046          0.1235 
Timeline        0.008       -0.1070                  0.1800 
Consequences        0.13        -0.0680                  0.4128 
Personal Control       0.007       -0.1631                  0.1677 
Treatment Control      -0.03        -0.2494                  0.1321 
Illness Coherence       0.07        -0.0037                  0.2151 
Timeline Cyclical      -0.03        -0.1916                  0.0639 




Figure F12c Multiple mediation analysis examining the relationship between income level and 
HCA (smoking cessation referrals) mediated by illness perceptions in COPD 
 
 
                -0.62*   0.02 
                                                  -0.01                                                               -0.61 
                                          -0.23*   -0.58 
   0.21*     0.03 
                                              0.16*    -0.21 
                                               0.13*                                                     0.57 
                                       -0.17*                                                     0.17 
                           -0.16*                                                                          0.92* 
                                                     
           -0.76* 


















Table F12d Direct, total and specific indirect effects of educational level and illness perceptions 
on HCA (regular spirometry) in COPD  
 
               95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
   0.25     3.14   0.002       0.0920                  0.4041 
____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        -0.02        -0.0859          0.0454 
Specific indirect effects 
Identity         0.01        -0.0110          0.0492 
Timeline        0.003        -0.0206                  0.0313 
Consequences       -0.0003       -0.0187                  0.0202 
Personal Control       0.03        -0.0033                  0.0709 
Treatment Control      -0.07        -0.1361                 -0.0210 
Illness Coherence       0.0006       -0.0160                  0.0227 
Timeline Cyclical      -0.002       -0.0243                  0.0129 




Figure F12d Multiple mediation analysis examining the relationship between educational level 
and HCA (regular spirometry) mediated by illness perceptions in COPD 
 
 
                 0.34   0.03 
                                                 -0.04                                                              -0.09 
                                             0.01   -0.03 
   0.23*     0.11 
                                             0.24**    -0.29* 
                                                0.13                                                    0.005 
                                     -0.07                                                     0.03 
                            -0.11                                                                            -0.10 
                                                     
            0.25* 

















Table F12e Direct, total and specific indirect effects of IMD scores and self-efficacy on HCA 
(smoking cessation referrals) in COPD 
  
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
 
                    0.05                 2.77      0.006     0.0134                   0.0781 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 





Figure F12e Multiple mediation analysis examining the relationship between IMD scores and 


































Table F12f Direct, total and specific indirect effects of IMD quintiles and self-efficacy on HCA 
(smoking cessation referrals) in COPD  
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
 
    -0.40                -1.96     0.05      -0.8030                  -0.0008 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 





Figure F12f Multiple mediation analysis examining the relationship between IMD quintiles and 





 -0.001 -0.28 
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Table F12g Direct, total and specific indirect effects of income level and self-efficacy on HCA 
(smoking cessation referrals) in COPD  
 
                  95% bias-corrected and 
                       accelerated CI 
         
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
 
                                           -0.68     -2.84     0.005    -1.1438                  -0.2095 
_____________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 




Figure F12g Multiple mediation analysis examining the relationship between income level and 




  0.11 -0.15 
 





















Table F12h Direct, total and specific indirect effects of educational level and self-efficacy on 
HCA (regular spirometry) in COPD  
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
                                                         0.22      2.93     0.004      0.0730                 0.3747 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 






Figure F12h Multiple mediation analysis examining the relationship between educational level 




  0.15 0.02 
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Table F12i Direct, total and specific indirect effects of IMD scores and social capital on HCA 
(smoking cessation referral) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower           Upper 
_____________________________________________________________________________ 
                                                      0.06               3.06     0.002      0.0209                   0.0958 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        -0.009       -0.0294          0.0096 
Specific indirect effects 
Participation in local community     0.0002       -0.0018          0.0058 
Social Agency/Proactivity     0.0007       -0.0096                  0.0113 
Feelings of trust & safety    -0.003       -0.0184                  0.0091 
Neighbourhood connections     0.0005       -0.0049                  0.0098 
Family & friends connections    -0.005       -0.0218                   0.0047 
Tolerance of diversity     -0.003       -0.0144                  0.0015 
Value of life       0.001       -0.0089                  0.0131 
 
 
Figure F12i Multiple mediation analysis examining the relationship between IMD score and 




               -0.001  -0.15 
                                                 -0.01*                                                         -0.06 
                                            -0.02**  0.17 
       
                                             -0.009  -0.05 
                                              -0.02*                                                    0.34 
                                      -0.007   0.38 
                          -0.002          -0.70* 
                                                     
             0.06* 












Family & Friend 
Connections 
Tolerance of Diversity 






Table F12j Direct, total and specific indirect effects of IMD quintiles and social capital on HCA 
(smoking cessation referral) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
                 
                  -0.51                 -2.23     0.03      -0.9620                  -0.0612 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.09          -0.1339          0.3345 
Specific indirect effects 
Participation in local community     0.0001       -0.0562         0.0517 
Social Agency/Proactivity    -0.01        -0.1647                  0.1050 
Feelings of trust & safety     0.009       -0.1383                  0.1611 
Neighbourhood connections    -0.006       -0.1179                  0.0347 
Family & friends connections     0.06        -0.0737                  0.2766 
Tolerance of diversity      0.06            -0.0151                  0.2411 
Value of life      -0.03        -0.1880                  0.0662 
 
 
Figure F12j Multiple mediation analysis examining the relationship between IMD quintiles and 




             -0.0004   -0.14 
                                                 0.14*                                                            -0.10 
                                               0.22* 0.04 
       
                                                0.06   -0.09 
                                              0.21*                                                     0.31 
                                      0.14*               0.42 
                             0.05          -0.62* 
                                                     
            -0.51* 
* significant at 0.05;  **significant at 0.001; ^ marginally not significant 
IMD 
Quintiles 
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Table F12k Direct, total and specific indirect effects of income level and social capital on HCA 
(smoking cessation referral) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
 
                                                          -0.67                 -2.59      0.01      -1.1793                -0.1622 
_____________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.06          -0.3491          0.2446 
Specific indirect effects 
Participation in local community     0.000       -0.0980          0.0824 
Social Agency/Proactivity    -0.02        -0.2257                  0.1711 
Feelings of trust & safety    -0.006       -0.1557                  0.1158 
Neighbourhood connections    -0.01        -0.1782                  0.0330 
Family & friends connections     0.08        -0.0879                  0.3089 
Tolerance of diversity      0.04            -0.0188                  0.1829 
Value of life      -0.14        -0.4143                 -0.0017 
 
 
Figure F12k Multiple mediation analysis examining the relationship between income level and 
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                                                   0.20*                                                        -0.09 
                                              0.18* -0.03 
       
                                              0.09  -0.15 
                                              0.24**                                                    0.33 
                                    0.12               0.37 
                            0.31*               -0.46^ 
                                                     
            -0.67* 
* significant at 0.05;  **significant at 0.001; ^ marginally not significant 
Income 
Level 
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Table F12l Direct, total and specific indirect effects of educational level and social capital on 
HCA (regular spirometry) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         z      p      Lower          Upper 
_____________________________________________________________________________ 
 
   -0.86     -2.63    0.009      -1.5089                 -0.2199 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.003         -0.2652          0.2852 
Specific indirect effects 
Participation in local community    -0.05        -0.2769          0.0702 
Social Agency/Proactivity     0.03        -0.1132                  0.2597 
Feelings of trust & safety     0.0003       -0.0629                  0.0690 
Neighbourhood connections     0.03        -0.0295                  0.2169 
Family & friends connections    -0.002       -0.1161                   0.0594 
Tolerance of diversity      0.009           -0.0846                  0.1562 




Figure F12l Multiple mediation analysis examining the relationship between educational level 




                0.25* -0.19 
                                                0.22*                                                      0.13 
                                             -0.007 -0.05 
       
                                               0.13   0.22 
                                              0.010                                                 -0.21 
                                    0.19             0.05 
                             0.11          -0.16 
                                                     
            -0.86* 
* significant at 0.05;  **significant at 0.001; ^ marginally not significant 
Educational 
Level 
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Appendix F13: Unadjusted mediation analyses examining illness perceptions, as 
mediators in the relationship between SES and QoL  
Table F13a Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (dyspnoea) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
                                                            0.09,                 0.86    0.39       -0.1173                  0.3002 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.32         0.1470          0.5039 
Specific indirect effects 
Identity        0.10         0.0245          0.2304 
Timeline       0.001       -0.0151                  0.0388 
Consequences       0.22         0.0885                  0.3968 
Personal Control      0.01        -0.0465                  0.0711 
Treatment Control      0.01        -0.0344                  0.0849 
Illness Coherence      0.01        -0.0064                  0.0626 
Timeline Cyclical     -0.02        -0.0763                  0.0107 
Emotional Representations    -0.01        -0.0862                  0.0269 
 
 
Figure F13a Multiple mediation analysis examining the relationship between income level and 




                -0.59*  -0.17* 
                                                  0.02                                                              0.06 
                                            -0.22*   -0.96** 
   0.20*     0.05 
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                                             0.09                                                          0.13 
                                     -0.17*   0.11 
                         -0.15*                                                                            0.07 
                                                     
            0.09 















Table F13b Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (fatigue) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
 
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
                                                         0.16                   1.21     0.23       -0.1031                  0.4282 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.31         0.1580          0.4845 
Specific indirect effects 
Identity        0.02        -0.0418          0.0988 
Timeline       0.004       -0.0207                  0.0588 
Consequences       0.18         0.0665                  0.3591 
Personal Control      0.06         0.0074                  0.1557 
Treatment Control     -0.02        -0.1103                  0.0322 
Illness Coherence      0.02        -0.0057                  0.0823 
Timeline Cyclical      0.03        -0.0063                  0.1163 
Emotional Representations     0.02        -0.0234                  0.1005 
 
 
Figure F13b Multiple mediation analysis examining the relationship between income level and 




            -0.59*         -0.03 
                                                 0.02                                                                        0.18 
                                         -0.22*     -0.81** 
  0.20*     0.30* 
                                             0.13*             -0.17 
                                             0.09                                                                0.21 
                                      -0.17*              -0.19 
                        -0.15*                                                                             -0.12 
                                                     
            0.16 















Table F13c Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (emotional function) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
                                                         0.19                  1.62     0.11      -0.0415                  0.4272 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.22         0.0857          0.3946 
Specific indirect effects 
Identity        0.06         0.0026          0.1563 
Timeline       0.006       -0.0278                  0.0766 
Consequences       0.06        -0.0125                  0.1809 
Personal Control     -0.009       -0.0751                  0.0480 
Treatment Control      0.03        -0.0213                  0.1145 
Illness Coherence      0.01        -0.0094                  0.0647 
Timeline Cyclical     -0.02        -0.0816                  0.0226 
Emotional Representations     0.09             0.0142                  0.2126 
 
 
Figure F13c Multiple mediation analysis examining the relationship between income level and 




                -0.59*   -0.10* 
                                                0.02                                                                0.26 
                                             -0.22*   -0.25 
   0.20*     -0.04 
                                            0.13*           0.21 
                                             0.09                                                          0.10 
                                    -0.17*            0.09 
                         -0.15*                                                                           -0.60** 
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Table F13d Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (mastery) in COPD 
 
                  95% bias-corrected and 
             accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
                                                        0.24                  1.97     0.05      -0.0003                  0.4878 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.31         0.1455          0.5143 
Specific indirect effects 
Identity        0.08         0.0162          0.1947 
Timeline       0.005       -0.0231                  0.0704 
Consequences       0.09         0.0112                  0.2204 
Personal Control      0.06         0.0088                  0.1647 
Treatment Control     -0.01        -0.0874                  0.0431 
Illness Coherence      0.02        -0.0046                  0.0767 
Timeline Cyclical     -0.02        -0.1013                  0.0144 





Figure F13d Multiple mediation analysis examining the relationship between income level and 




           -0.59*         -0.14* 
                                              0.02                                                                    0.21 
                                         -0.22*                                                                 -0.39* 
   0.20*    0.31* 
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                                             0.09                                                          0.18 
                                     -0.17*                                                      0.14 
                        -0.15*                                                                             -0.63** 
                                                     
            0.24 















Table F13e Direct, total and specific indirect effects of income level and illness perceptions on 
QoL (anxiety) in COPD  
 
                  95% bias-corrected and 
                      accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
    -0.33     -0.81     0.42      -1.1456                   0.4797 
____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.62        -1.1749        -0.0875 
Specific indirect effects 
Identity       -0.03        -0.2738         0.1670 
Timeline      -0.005       -0.1787                  0.0664 
Consequences      -0.14        -0.5049                  0.0820 
Personal Control     -0.03         -0.2937                  0.1357 
Treatment Control      0.09        -0.0684                  0.3632 
Illness Coherence     -0.10        -0.3495                  0.0111 
Timeline Cyclical     -0.003       -0.1829                  0.1539 
Emotional Representations    -0.39        -0.8741                 -0.0453 
 
 
Figure F13e Multiple mediation analysis examining the relationship between income level and 
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                                                  0.02                                                              -0.24 
                                             -0.22*  0.65 
   0.20*   -0.17 
                                            0.13*        0.71 
                                             0.09                                                        -1.11* 
                                      -0.17*       0.02 
                          -0.15*              2.52**                                                                       
                                                     
             -0.33 
















Table F13f Direct, total and indirect effects of income level and illness perceptions on QoL 
(depression) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
 
                                                       -0.64                 -1.70     0.09      -1.3765                  0.1040 
____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.75        -1.2755         -0.3186 
Specific indirect effects 
Identity       -0.18        -0.5299          0.0053 
Timeline      -0.006       -0.1718                  0.0488 
Consequences      -0.19        -0.5219                  0.0229 
Personal Control     -0.04        -0.2690                  0.1475 
Treatment Control     -0.23        -0.6530                 -0.0107 
Illness Coherence     -0.03        -0.2230                  0.0476 
Timeline Cyclical      0.04        -0.0791                  0.2525 




Figure F13f Multiple mediation analysis examining the relationship between income level and 
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Appendix F14: Unadjusted mediation analyses examining self-efficacy as a 
mediator in the relationship between SES and QoL 
 
 
Table F14a Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(dyspnoea) in COPD  
 
               95% bias-corrected and 
                        accelerated CI 
          
Direct effect  Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
                   0.39                  2.93     0.004     0.1280                  0.6551 
_____________________________________________________________________________ 
 
Indirect effects  Point estimate                   Lower          Upper 
 
Specific indirect effect 





Figure F14a Multiple mediation analysis examining the relationship between income level and 
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Figure F14b Multiple mediation analysis examining the relationship between income level and 
QoL (fatigue) mediated by self-efficacy in COPD 
 
                  95% bias-corrected and 
            accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
 
    0.41                  2.85     0.005      0.1268                  0.6950 
_____________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 








Table F14b Direct, total and specific indirect effects of income level and self-efficacy on QoL 




  0.13* 0.52* 
 





















Table F14c Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(emotional function) in COPD  
 
              95% bias-corrected and 
                     accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
 
    0.34                  2.72    0.007      0.0921                   0.5808 
____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 






Figure F14c Multiple mediation analysis examining the relationship between income level and 
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Table F14d Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(mastery) in COPD  
 
                  95% bias-corrected and 
                     accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
 
    0.44                  3.29     0.001      0.1761                  0.7049 
_____________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 





Figure F14d Multiple mediation analysis examining the relationship between income level and 
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Table F14e Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(anxiety) in COPD  
 
                  95% bias-corrected and 
                      accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
 
   -0.70                 -1.55     0.12       -1.5956                   0.1917 
_____________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 





Figure F14e Multiple mediation analysis examining the relationship between income level and 
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Table F14f Direct, total and specific indirect effects of income level and self-efficacy on QoL 
(depression) in COPD  
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
____________________________________________________________________________ 
 
    1.07                 -2.94    0.004      -1.7871                 -0.3515 
______________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Specific indirect effect 







Figure F14f Multiple mediation analysis examining the relationship between income level and 
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Appendix F15: Unadjusted mediation analyses examining social capital as a 
mediator in the relationship between SES and QoL 
Table F15a Direct, total and specific indirect effects of income level and social capital on QoL 
(dyspnoea) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    0.44      3.11     0.002     0.1589                   0.7112 
______________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.02        -0.1532          0.1076 
Specific indirect effects 
Participation in local community     0.03         -0.0045          0.1061 
Social Agency/Proactivity    -0.02        -0.1186                  0.0605 
Feelings of trust & safety     0.05        -0.0012                  0.1460 
Neighbourhood connections    -0.01        -0.0849                  0.0111 
Family & friends connections    -0.04         -0.1410                  0.0204 
Tolerance of diversity     -0.03        -0.1034                  0.0024 
Value of life       0.007         -0.0540                  0.0794 
 
 
Figure F15a Multiple mediation analysis examining the relationship between income level and 
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                                                 0.19*                                                          -0.08 
                                           0.18* 0.25 
       
                                            0.08  -0.15 
                                               0.22*                                                  -0.20 
                                      0.13   -0.24 
                           0.23*          0.03 
                                                     
            0.44* 
* significant at 0.05;  **significant at 0.001; ^ marginally not significant 
Income 
Level 
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Table F15b Direct, total and specific indirect effects of income level and social capital on QoL 
(fatigue) in COPD 
 
                  95% bias-corrected and 
                    accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    0.30                 2.00      0.05       0.0043                  0.5972 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.18         0.0275          0.3517 
Specific indirect effects 
Participation in local community    -0.005        -0.0888          0.0465 
Social Agency/Proactivity     0.06        -0.0156                  0.1777 
Feelings of trust & safety     0.06         0.0046                  0.1768 
Neighbourhood connections    -0.02        -0.0990                  0.0092 
Family & friends connections     0.02         -0.0567                  0.1174 
Tolerance of diversity     -0.02        -0.0856                  0.0113 




Figure F15b Multiple mediation analysis examining the relationship between income level and 
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                                        0.13                                                         -0.14 
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Table F15c Direct, total and specific indirect effects of income level and social capital on QoL 
(emotional function) in COPD 
 
                  95% bias-corrected and 
                      accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
   0.30     2.31       0.02      0.0430                   0.5471 
____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.12        -0.0209          0.2947 
Specific indirect effects 
Participation in local community    -0.03         -0.1293          0.0047 
Social Agency/Proactivity     0.03        -0.0269                  0.1227 
Feelings of trust & safety     0.08         0.0173                  0.1869 
Neighbourhood connections     0.008       -0.0127                  0.0705 
Family & friends connections    -0.03         -0.1233                  0.0368 
Tolerance of diversity     -0.003       -0.0507                  0.0298 
Value of life       0.07           0.0106                  0.1851 
 
 
Figure F15c Multiple mediation analysis examining the relationship between income level and 
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Table F15d Direct, total and specific indirect effects of income level and social capital on QoL 
(mastery) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
  
    0.43      2.90     0.004      0.1363                  0.7188 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.13        -0.0039          0.3138 
Specific indirect effects 
Participation in local community    -0.02         -0.0861          0.0176 
Social Agency/Proactivity     0.04        -0.0311                  0.1467 
Feelings of trust & safety     0.09         0.0199                  0.2178 
Neighbourhood connections     0.006       -0.0151                  0.0724 
Family & friends connections    -0.01         -0.0965                  0.0656 
Tolerance of diversity     -0.02        -0.0917                  0.0114 




Figure F15d Multiple mediation analysis examining the relationship between income level and 
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Table F15e Direct, total and specific indirect effects of income level and social capital on QoL 
(anxiety) in COPD  
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect    Point estimate   t           p      Lower          Upper 
_____________________________________________________________________________ 
 
                                                 -0.72                 -1.60     0.11           -1.6023                  0.1661 
_____________________________________________________________________________ 
 
Indirect effects    Point estimate                                 Lower          Upper 
 
Total       -0.23        -0.7823         0.2660 
Specific indirect effects 
Participation in local community     0.20         -0.0017         0.5697 
Social Agency/Proactivity    -0.03        -0.2963                  0.1901 
Feelings of trust & safety    -0.28        -0.6579                 -0.0640 
Neighbourhood connections    -0.01        -0.2093                  0.0665 
Family & friends connections     0.08         -0.1474                  0.3854 
Tolerance of diversity     -0.009       -0.1898                  0.1009 
Value of life      -0.18          -0.5182                 -0.0118 
 
 
Figure F15e Multiple mediation analysis examining the relationship between income level and 
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Table F15f Direct, total and specific indirect effects of income level and social capital on QoL 
(depression) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    -0.81                -2.14      0.03      -1.5577                 -0.0612 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.57        -1.1181         -0.1402 
Specific indirect effects 
Participation in local community     0.06         -0.0178          0.3069 
Social Agency/Proactivity    -0.23        -0.5110                 -0.0510 
Feelings of trust & safety    -0.15        -0.4330                 -0.0181 
Neighbourhood connections    -0.05        -0.3005                  0.0227 
Family & friends connections    -0.06         -0.3264                  0.1716 
Tolerance of diversity      0.04        -0.0462                  0.2078 
Value of life      -0.19          -0.5020                 -0.0272 
 
 
Figure F15f Multiple mediation analysis examining the relationship between income level and 
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Appendix F16: Unadjusted mediation analyses examining illness perceptions, 
self-efficacy and social capital as mediators in the relationship between SES and 
QoL 
Table F16a Direct, total and specific indirect effects of income level and illness perceptions, 
self-efficacy and social capital on QoL (fatigue) in COPD 
 
                  95% bias-corrected and 
                      accelerated CI 
          
 
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
     0.14        1.05     0.30      -0.1238                  0.4054 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.34         0.1749          0.5281 
Specific indirect effects 
Consequences       0.19         0.0760                  0.3388 
Personal Control      0.04        -0.0046                  0.1175 
Self-efficacy       0.03        -0.0047                  0.1132 
Feelings of trust and safety     0.03        -0.0200          0.1055 
Value of life       0.04        -0.0044          0.1403 
 
 
Figure F16a Multiple mediation analysis examining the relationship between income level and 
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Table F16b Direct, total and specific indirect effects of income level, illness perceptions and 
self-efficacy on QoL (emotional function) in COPD 
  _____________________________________________________________________ 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    0.21                  1.86      0.06      -0.0124                 0.4290 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.21         0.0764          0.3563 
Specific indirect effects 
Identity        0.06         0.0147                  0.2030 
Emotional representations     0.09         0.0045                  0.1634 





Figure F16b Multiple mediation analysis examining the relationship between income level and 
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Table F16c Direct, total and specific indirect effects of income level, illness perceptions and 
self-efficacy on QoL (mastery) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
    0.20      1.76    0.08       -0.0245          0.4323 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total        0.35         0.1672          0.5647 
Specific indirect effects 
Identity        0.08          0.0193         0.1884 
Consequences       0.07         0.0048                  0.1760 
Personal Control                             0.05                                        -0.0003                 0.1256 
Emotional representations              0.08         0.0112                  0.2039 




Figure F16c Multiple mediation analysis examining the relationship between income level and 
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Table F16d Direct, total and specific indirect effects of income level, illness perceptions, self-
efficacy and social capital on QoL (depression) in COPD 
 
                  95% bias-corrected and 
                       accelerated CI 
          
Direct effect   Point estimate         t      p      Lower          Upper 
_____________________________________________________________________________ 
 
      -0.62                 -1.72     0.09      -1.3299                  0.0912 
_____________________________________________________________________________ 
 
Indirect effects   Point estimate                   Lower          Upper 
 
Total       -0.76        -1.3166         -0.3222 
Specific indirect effects 
Treatment Control     -0.17         -0.4201         -0.0239 
Self-efficacy      -0.18        -0.5185                 -0.0201 
Social Agency/social proactivity    -0.14        -0.3670                 -0.0017 
Feelings of trust and safety    -0.12        -0.3900                 -0.0005 




Figure F16d Multiple mediation analysis examining the relationship between income level and 
QoL (depression) mediated by illness perceptions, self-efficacy and social capital in COPD 
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